CDC_Test_ID,TestCase_Name,DOB,gender,Med_History_Text,Med_History_Code,Med_History_Code_Sys,Series_Status,Date_Administered_1,Vaccine_Name_1,CVX_1,MVX_1,Evaluation_Status_1,Evaluation_Reason_1,Date_Administered_2,Vaccine_Name_2,CVX_2,MVX_2,Evaluation_Status_2,Evaluation_Reason_2,Date_Administered_3,Vaccine_Name_3,CVX_3,MVX_3,Evaluation_Status_3,Evaluation_Reason_3,Date_Administered_4,Vaccine_Name_4,CVX_4,MVX_4,Evaluation_Status_4,Evaluation_Reason_4,Date_Administered_5,Vaccine_Name_5,CVX_5,MVX_5,Evaluation_Status_5,Evaluation_Reason_5,Date_Administered_6,Vaccine_Name_6,CVX_6,MVX_6,Evaluation_Status_6,Evaluation_Reason_6,Date_Administered_7,Vaccine_Name_7,CVX_7,MVX_7,Evaluation_Status_7,Evaluation_Reason_7,Forecast_#,Earliest_Date,Recommended_Date,Past_Due_Date,Vaccine_Group,Assessment_Date,Evaluation_Test_Type,Date_Added,Date_Updated,Forecast_Test_Type,Reason_For_Change,Changed_In_Version,General_Description
2013-0001,Newborn Testing,05/10/2021,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/21/2021,07/10/2021,09/06/2021,DTAP,05/10/2021,No Doses Administered,01/01/2013,08/18/2020,Recommended based on age,,1.0,This test case describes the forecasting of the DTaP vaccine for a newborn at six weeks of age.
2013-0002,DTaP #2 at age 10 weeks-5 days,03/06/2021,F,,,,Not complete,04/14/2021,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/06/2021,09/02/2021,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/19/2020,Recommended based on age,,1.0,This test case describes when a child is administered a second dose of the DTaP vaccine at 10 weeks - 5 days that the dose is not valid.  A repeat dose should be forecast.
2013-0003,DTaP #2 at 10 wks-4 days,03/05/2021,F,,,,Not complete,04/16/2021,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/11/2021,09/05/2021,11/01/2021,DTAP,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/19/2020,Recommended based on age,,1.0,This test case describes when a child is administered a second dose of the DTaP vaccine at 10 weeks - 4 days that the dose is valid.  Another dose should be forecast.
2013-0004,DTaP # 2 at age 10 weeks,03/01/2021,F,,,,Not complete,04/12/2021,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,09/01/2021,10/28/2021,DTAP,05/10/2021,Age: At Minimum,01/01/2013,06/19/2020,Recommended based on age,,1.0,This test case describes when a child is administered a second dose of the DTaP vaccine at 10 weeks that the dose is valid.  Another dose should be forecast.
2013-0005,DTaP # 2 at age 4 months,01/10/2021,F,,,,Not complete,03/10/2021,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,07/10/2021,09/06/2021,DTAP,05/10/2021,Age: At Recommended,01/01/2013,06/22/2020,Recommended based on age,,1.0,"This test case describes when a child is administered a second dose of the DTaP vaccine at age 4 months, that the dose is valid. Another dose should be forecast."
2013-0007,# 2 (Tdap) to child age 7.  DTaP # 1 given before age 12 months.  Forecast # 3 (Td) in 4 weeks. ,05/10/2014,F,,,,Not complete,07/10/2014,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,BOOSTRIX,115,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/07/2021,06/07/2021,DTAP,05/10/2021,Age: At Minimum,01/01/2013,06/22/2020,Recommended based on minimum interval from previous dose (catch-up),Past Due Date was missing and child is in catch-up.  Past Due Date added to align with Recommended Date.,1.1,This test case describes when a child is administered a Tdap vaccine as a second dose (with a first dose of DTaP vaccine before 12 months of age) that the dose is valid. Another dose should be forecast.
2013-0008,# 2 (Tdap) to child age 7.  DTaP # 1 at ≥ 12 months.  Forecast dose 3 for 6 months. ,05/10/2014,F,,,,Not complete,05/10/2015,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,BOOSTRIX,115,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,11/10/2021,11/10/2021,11/10/2021,DTAP,05/10/2021,Age: At Minimum,01/01/2013,06/22/2020,Recommended based on minimum interval from previous dose (catch-up),Past Due Date was missing and child is in catch-up.  Past Due Date added to align with Recommended Date.,1.1,This test case describes when a child is administered a Tdap vaccine as a second dose (with a first dose of DTaP vaccine at greater than or equal to  12 months of age) that the dose is valid. Another dose should be forecast.
2013-0010,# 1 (Td) to # 2 (Tdap) interval 28-4 days in child age > 7 years.  Forecast # 3 in six months. ,01/13/2013,F,,,,Not complete,04/16/2021,"Td, adsorbed",09,MBL,Valid,,05/10/2021,BOOSTRIX,115,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,11/10/2021,11/10/2021,11/10/2021,DTAP,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/22/2020,Recommended based on minimum interval from previous dose (catch-up),Past Due Date was missing and child is in catch-up.  Past Due Date added to align with Recommended Date.,1.1,This test case describes when a child 8 years of age is administered a Tdap vaccine as a second dose (and at an interval of 28 -4 days from the first dose) that the dose is valid. Another dose should be forecast.
2013-0011,#3 at age 14 weeks-5 days,02/06/2021,F,,,,Not complete,03/20/2021,"DTaP, unspecified formulation",107,,Valid,,04/17/2021,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/06/2021,10/03/2021,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/22/2020,Recommended based on age,,1.0,This test case describes when a third dose of the DTaP vaccine is administered at age 14 weeks - 5 days that the dose is not valid.  A repeat dose should be forecast.
2013-0012,Age 6.  No vaccinations. Forecast DTaP.,05/10/2015,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/21/2015,07/10/2015,09/06/2015,DTAP,05/10/2021,No Doses Administered,01/01/2013,06/22/2020,Recommended based on age,,1.0,This test case describes when a child age 6 years has no history of the DTAP/Tdap/Td that the first dose should be forecast.
2013-0013,#3 at age 14 weeks-4 days,02/05/2021,F,,,,Not complete,03/19/2021,"DTaP, unspecified formulation",107,,Valid,,04/14/2021,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,05/05/2022,05/05/2022,10/02/2022,DTAP,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/22/2020,Recommended based on age,V3.3: Updated per the 2017 General Best Practice Guidelines which moved the Minimum and Recommended Age to 15 months,3.3,This test case describes when a child is administered a third dose of the DTAP/Tdap/Td at age 14 weeks - 4 days that the dose is valid.  Another dose should be forecast.
2013-0014,#3 at age 14 weeks,02/01/2021,F,,,,Not complete,03/15/2021,"DTaP, unspecified formulation",107,,Valid,,04/12/2021,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,05/01/2022,05/01/2022,09/28/2022,DTAP,05/10/2021,Age: At Minimum,01/01/2013,06/22/2020,Recommended based on age,Updated per the 2017 General Best Practice Guidelines which moved the Minimum and Recommended Age to 15 months,3.3,This test case describes when a child is administered a third dose of the DTAP/Tdap/Td at age 14 weeks that the dose is valid.  Another dose should be forecast.
2013-0015,#3 at age 6 months,11/10/2020,F,,,,Not complete,01/10/2021,"DTaP, unspecified formulation",107,,Valid,,02/10/2021,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,02/10/2022,02/10/2022,07/07/2022,DTAP,05/10/2021,Age: At Recommended,01/01/2013,06/22/2020,Recommended based on age,Updated per the 2017 General Best Practice Guidelines which moved the Minimum and Recommended Age to 15 months,3.3,This test case describes when a child is administered a third dose of the DTAP/Tdap/Td at age 6 months that the dose is valid.  Another dose should be forecast.
2013-0016,Doses # 2 and #3 at ≥ age 7 years; # 1 at age < 12 mo.  Forecast # 4 in 6 mo. ,04/10/2014,F,,,,Not complete,12/10/2014,"DTaP, unspecified formulation",107,,Valid,,04/10/2021,"Td, adsorbed",09,MBL,Valid,,05/10/2021,BOOSTRIX,115,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,11/10/2021,11/10/2021,11/10/2021,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,06/22/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered the first dose of DTaP at less than 12 months of age and the second and third dose at greater than 7 years of age that the doses are valid. Another dose should be forecast.
2013-0017,Doses # 2 and # 3 at ≥7 years old; dose # 1 at ≥ 12 months old.,07/21/2013,F,,,,Not complete,09/23/2014,"DTaP, unspecified formulation",107,,Valid,,07/29/2020,"Td, adsorbed",09,MBL,Valid,,05/10/2021,BOOSTRIX,115,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,07/21/2024,07/21/2024,08/17/2026,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,06/22/2020,Recommended based on interval,"V4.0: Updated Forecast per new Tdap Catch-up Job-Aid. Tdap is needed at 11 years.
V1.1: Past Due Date was missing. Added past due date per NIPInfo guidance.",4.0,This test case describes when a child is administered the first dose of DTaP at greater than 12 months of age and the second and third dose at greater than 7 years of age that the doses are valid. Another dose should be forecast.
2013-0019,"1 Tdap, 2 Td with appropriate intervals to child ≥ age 7",10/10/2013,F,,,,Not complete,10/11/2020,BOOSTRIX,115,SKB,Valid,,11/10/2020,"Td, adsorbed",09,MBL,Valid,,05/10/2021,"Td, adsorbed",09,MBL,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,10/10/2024,10/10/2024,11/06/2026,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,11/16/2020,Recommended based on interval,"V4.0: Updated Forecast per new Tdap Catch-up Job-Aid. Tdap is needed at 11 years.
V1.1: Past Due Date was missing. Added past due date per NIPInfo guidance.",4.0,"This test case describes when a child is administered the first dose, of the Diphtheria, Tetanus, and Pertussis vaccine, as Tdap and the second dose as Td at an age greater than 7 years that the doses are valid. Another dose should be forecast."
2013-0020,"1 Tdap, 2 Td to child ≥ 7 years old with 6 mo-5 day interval between doses 2 and 3.",10/10/2012,F,,,,Not complete,10/10/2020,BOOSTRIX,115,SKB,Valid,,11/10/2020,"Td, adsorbed",09,MBL,Valid,,05/05/2021,"Td, adsorbed",09,MBL,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,3,11/05/2021,11/05/2021,11/05/2021,DTAP,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/22/2020,Recommended based on minimum interval from invalid dose,Past Due Date was missing and child is in catch-up.  Past Due Date added to align with Recommended Date.,1.1,"This test case describes when a child is administered the third dose ( first dose was Tdap, second dose was Td) of the DTaP vaccine at an interval of 6 months - 5 days from the second dose that the dose is not valid.  A repeat dose should be forecast."
2013-0021,"1 Tdap, 2 Td to child ≥ 7 years old with 6 mo-4 day interval between doses 2 and 3. ",09/10/2013,F,,,,Not complete,09/10/2020,"Td, adsorbed",09,MBL,Valid,,11/10/2020,BOOSTRIX,115,SKB,Valid,,05/06/2021,"Td, adsorbed",09,MBL,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,09/10/2024,09/10/2024,10/07/2026,DTAP,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/22/2020,Recommended based on interval,"V4.2: Mild adjustments to relative date settings to avoid administration dates in the future. Test case expectations (e.g, evaluation status or forecast) have not changed.
V4.0: Updated Forecast per new Tdap Catch-up Job-Aid. Tdap is needed at 11 years.
V1.1: Past Due Date was missing. Added past due date per NIPInfo guidance.",4.2,"This test case describes when a child is administered the third dose ( first dose was Tdap, second dose was Td) of the DTaP vaccine at an interval of 6 months - 4 days from the second dose that the dose is valid.  Another dose should be forecast."
2013-0022,Age 7.  Two DTaP˂ 12 months old.  Needs Tdap.,05/10/2014,F,,,,Not complete,08/06/2014,"DTaP, unspecified formulation",107,,Valid,,11/12/2014,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,05/10/2021,05/10/2021,05/10/2021,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,06/22/2020,Recommended based on age,,1.0,This test case describes a child who is currently age seven years but was administered two doses of the DTaP vaccine at less than 12 months of age that the doses are valid and that another dose should be forecast (preferably Tdap).
2013-0023,Age 7.  No vaccinations.  Forecast Tdap.,05/10/2014,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/10/2021,05/10/2021,05/10/2021,DTAP,05/10/2021,No Doses Administered,01/01/2013,06/22/2020,Recommended based on age,Past Due Date was missing and child is in catch-up.  Past Due Date added to align with Recommended Date.,1.1,This test case describes a child  7 years of age with no history of the DTaP/Tdap/Td vaccine that a first dose should be forecast.
2013-0024,Age 7. Two DTaP˂ 12 mos old & 1 ≥ 12 mo.  Needs Tdap.,05/10/2014,F,,,,Not complete,08/10/2014,"DTaP, unspecified formulation",107,,Valid,,12/10/2014,"DTaP, unspecified formulation",107,,Valid,,05/12/2016,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,05/10/2021,05/10/2021,05/10/2021,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,06/22/2020,Recommended based on minimum interval from previous dose (catch-up),V1.1: Past Due Date was missing and child is in catch-up.  Past Due Date added to align with Recommended Date.,1.1,This test case describes a child who is currently seven years of age but was administered one dose of the DTaP vaccine at less than 12 months of age and another dose at greater than twelve months of age that the doses are valid.  Another dose should be forecast (preferably Tdap).
2013-0025,#4 at age 12 mo-5 days,05/15/2020,F,,,,Not complete,07/15/2020,"DTaP, unspecified formulation",107,,Valid,,09/15/2020,"DTaP, unspecified formulation",107,,Valid,,11/11/2020,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,4,11/10/2021,11/10/2021,01/11/2022,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/22/2020,Recommended based on minimum interval from inValid dose,,1.0,This test case describes when a child is administered a fourth dose of the DTaP/Tdap/Td vaccine at age 12 months - 5 days that the dose is not valid.  A repeat dose should be forecast.
2013-0026,#4 at age 12 mo-4 days,05/14/2020,F,,,,Not complete,07/14/2020,"DTaP, unspecified formulation",107,,Valid,,09/14/2020,"DTaP, unspecified formulation",107,,Valid,,11/11/2020,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,5,05/14/2024,05/14/2024,05/13/2027,DTAP,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/23/2020,Recommended based on age,,1.0,This test case describes when a child is administered a fourth dose of the DTaP/Tdap/Td vaccine at age 12 months - 4 days that the dose is valid.  Another dose should be forecast.
2013-0027,#4 at age 12 months old,05/10/2020,F,,,,Not complete,07/10/2020,"DTaP, unspecified formulation",107,,Valid,,09/10/2020,"DTaP, unspecified formulation",107,,Valid,,11/10/2020,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,5,05/10/2024,05/10/2024,05/09/2027,DTAP,05/10/2021,Age: At Recommended,01/01/2013,06/23/2020,Recommended based on age,,1.0,This test case describes when a child is administered a fourth dose of the DTaP/Tdap/Td vaccine at age 12 months that the dose is valid.  Another dose should be forecast.
2013-0028,#4 at age 4 is UTD until age 11.,05/10/2017,F,,,,Not complete,08/05/2017,"DTaP, unspecified formulation",107,,Valid,,10/05/2017,"DTaP, unspecified formulation",107,,Valid,,12/05/2017,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,5,05/10/2028,05/10/2028,06/06/2030,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,06/23/2020,Recommended based on age,"V3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versions
V1.4: Updated past due date to shift 1 day earlier to align with business rule calculation and other similar tests in the DTaP/Tdap/Td forecasting at 11 years.",3.4,This test case describes when a child is administered a fourth dose of the DTaP/Tdap/Td vaccine at age 4 years that the dose is valid.  Another dose should be forecast.
2013-0029,5 year old with no previous DTP product receives 4 vaccinations prior to age 7 years,03/05/2015,F,,,,Not complete,03/05/2020,"DTaP, unspecified formulation",107,,Valid,,05/05/2020,"DTaP, unspecified formulation",107,,Valid,,11/07/2020,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,5,03/05/2026,03/05/2026,04/01/2028,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,06/23/2020,Recommended based on age,"V3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versions
V1.4: Updated past due date to shift 1 day earlier to align with business rule calculation and other similar tests in the DTaP/Tdap/Td forecasting at 11 years.",3.4,This test case describes when a child age 5 years has no history of a DTP vaccine that a dose should be forecast.
2013-0030,#5 at age 4 years-5 days,05/15/2017,F,,,,Not complete,07/15/2017,"DTaP, unspecified formulation",107,,Valid,,08/15/2017,"DTaP, unspecified formulation",107,,Valid,,10/15/2017,"DTaP, unspecified formulation",107,,Valid,,05/16/2018,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Not Valid,Age: Too Young,,,,,,,,,,,,,5,11/10/2021,11/10/2021,05/14/2024,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/23/2020,Recommended based on minimum interval from invalid dose,,1.0,This test case describes when a child is administered a fifth dose of the DTaP vaccine at an interval of 4 years - 5 days that the dose is not valid.  A repeat dose should be forecast.
2013-0031,#5 at age 4 years-4 days,05/14/2017,F,,,,Not complete,07/14/2017,"DTaP, unspecified formulation",107,,Valid,,08/14/2017,"DTaP, unspecified formulation",107,,Valid,,10/14/2017,"DTaP, unspecified formulation",107,,Valid,,05/15/2018,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,6,05/14/2028,05/14/2028,06/10/2030,DTAP,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/23/2020,Recommended based on age,"V3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versions
V1.4: Updated past due date to shift 1 day earlier to align with business rule calculation and other similar tests in the DTaP/Tdap/Td forecasting at 11 years.",3.4,This test case describes when a child is administered a fifth dose of the DTaP vaccine at an interval of 4 years - 4 days that the dose is valid.  Another dose should be forecast.
2013-0032,# 5 at age 4 years,05/10/2017,F,,,,Not complete,07/10/2017,"DTaP, unspecified formulation",107,,Valid,,10/23/2017,"DTaP, unspecified formulation",107,,Valid,,01/12/2018,"DTaP, unspecified formulation",107,,Valid,,07/28/2019,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,6,05/10/2028,05/10/2028,06/06/2030,DTAP,05/10/2021,Age: At Minimum,01/01/2013,06/23/2020,Recommended based on age,"V3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versions
V1.4: Updated past due date to shift 1 day earlier to align with business rule calculation and other similar tests in the DTaP/Tdap/Td forecasting at 11 years.",3.4,This test case describes when a child is administered a fifth dose of the DTaP vaccine at an age 4 years that the dose is valid.  Another dose should be forecast.
2013-0033,DTaP #1 at age 6 weeks-5 days,04/03/2021,F,,,,Not complete,05/10/2021,"DTaP, unspecified formulation",107,,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/15/2021,06/03/2021,07/30/2021,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/23/2020,Recommended based on age,,1.0,This test case describes when a child is administered a first dose of the DTaP vaccine at 6 weeks - 5 days that the dose is not valid.  A repeat dose should be forecast.
2013-0034,# 6 DTaP before age 4.  Nothing more until Tdap at age 7 even if some are invalid. ,11/10/2017,F,,,,Not complete,01/10/2018,"DTaP, unspecified formulation",107,,Valid,,03/10/2018,"DTaP, unspecified formulation",107,,Valid,,05/10/2018,"DTaP, unspecified formulation",107,,Valid,,11/10/2019,"DTaP, unspecified formulation",107,,Valid,,02/10/2020,"DTaP, unspecified formulation",107,,Not Valid,Age: Too Young,05/10/2021,"DTaP, unspecified formulation",107,,Not Valid,Age: Too Young,,,,,,,5,11/10/2024,11/10/2024,11/10/2024,DTAP,05/10/2021,Extra Doses,01/01/2013,06/23/2020,Recommended based on age,Updated Forecast number from 6 to 5,3.2,This test case describes when a child who is administered a sixth dose of the DTaP vaccine before age 4 that the dose is not valid.  A repeat dose should be forecast.
2013-0035,Adolescent with Td but no Tdap.  ,09/02/2008,F,,,,Not complete,11/02/2008,"DTaP, unspecified formulation",107,,Valid,,01/02/2009,"DTaP, unspecified formulation",107,,Valid,,03/02/2009,"DTaP, unspecified formulation",107,,Valid,,12/05/2009,"DTaP, unspecified formulation",107,,Valid,,11/30/2013,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"Td, adsorbed",09,MBL,Valid,,,,,,,,7,05/10/2021,05/10/2021,09/29/2021,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,06/23/2020,Recommended based on minimum interval from previous dose (catch-up),"V3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versions
V2.2.: New logic concerning Tdap",3.4,This test case describes when an adolescent is administered Td as a sixth dose that another dose (preferably Tdap) should be forecast.
2013-0036,Invalid age for dose # 1 in first of series,11/10/2020,F,,,,Not complete,12/10/2020,"DTaP, unspecified formulation",107,,Not Valid,Age: Too Young,03/10/2021,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/07/2021,07/07/2021,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/26/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered a first dose of the DTaP vaccine at an invalid age but repeats the dose at three months later and the dose is valid. Another dose should be administered.
2013-0037,Invalid age for  dose # 2 in midst of others,11/10/2020,F,,,,Not complete,01/09/2021,"DTaP, unspecified formulation",107,,Valid,,01/31/2021,"DTaP, unspecified formulation",107,,Not Valid,Interval: too short,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/07/2021,07/07/2021,DTAP,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/26/2020,Recommended based on minimum interval from invalid dose,,1.0,This test case describes when a child is administered an invalid second dose of the DTaP vaccine but a repeat is given at an appropriate interval that the dose is valid.  Another dose should be forecast.
2013-0038,Invalid age for dose #3 in midst of others,05/09/2020,F,,,,Not complete,06/20/2020,"DTaP, unspecified formulation",107,,Valid,,07/15/2020,"DTaP, unspecified formulation",107,,Valid,,08/09/2020,"DTaP, unspecified formulation",107,,Not Valid,Age: Too Young,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,4,11/10/2021,11/10/2021,01/05/2022,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/26/2020,Recommended based on minimum interval from invalid dose,,1.0,This test case describes when a child is administered an invalid third dose of the DTaP vaccine but a repeat is administered at an appropriate age and interval that the dose is valid.  Another dose should be forecast.
2013-0039,Invalid age for dose # 4 in midst of others ,05/10/2017,F,,,,Not complete,07/10/2017,"DTaP, unspecified formulation",107,,Valid,,09/10/2017,"DTaP, unspecified formulation",107,,Valid,,11/03/2017,"DTaP, unspecified formulation",107,,Valid,,05/05/2018,"DTaP, unspecified formulation",107,,Not Valid,Age: Too Young,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,5,05/10/2028,05/10/2028,06/06/2030,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/26/2020,Recommended based on age,"V3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versions
V1.4: Updated past due date to shift 1 day earlier to align with business rule calculation and other similar tests in the DTaP/Tdap/Td forecasting at 11 years.",3.4,This test case describes when a child is administered an invalid fourth dose of the DTaP vaccine but a repeat is administered at an appropriate age and interval that the dose is valid.  Another dose should be forecast.
2013-0040,Invalid age dose 5 in midst of others,05/10/2010,F,,,,Not complete,07/11/2010,"DTaP, unspecified formulation",107,,Valid,,09/13/2010,"DTaP, unspecified formulation",107,,Valid,,11/24/2010,"DTaP, unspecified formulation",107,,Valid,,08/10/2011,"DTaP, unspecified formulation",107,,Valid,,06/05/2013,"DTaP, unspecified formulation",107,,Not Valid,Age: Too Young,05/10/2021,BOOSTRIX,115,SKB,Valid,,,,,,,,6,05/10/2026,05/10/2031,06/06/2031,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/26/2020,Recommended based on interval,Past Due Date was missing. Added past due date per NIPInfo guidance.,1.1,This test case describes when a child is administered an invalid fifth dose of the DTaP vaccine but a repeat is administered at an appropriate age and interval that the dose is valid.  Another dose should be forecast.
2013-0041,Dose 1 to dose 2 interval 28-5 days,02/15/2021,F,,,,Not complete,04/15/2021,"DTaP, unspecified formulation",107,,Valid,,05/08/2021,"DTaP, unspecified formulation",107,,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/05/2021,06/15/2021,08/11/2021,DTAP,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/26/2020,Recommended based on age,,1.0,"This test case describes when a child is administered a second dose of the DTaP vaccine at an interval of 28-5 days after the first dose, that the dose is not valid. A repeat dose should be forecast."
2013-0042,Dose 1 to dose 2 interval 28-4 days,02/16/2021,F,,,,Not complete,04/16/2021,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/16/2021,10/13/2021,DTAP,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/26/2020,Recommended based on age,,1.0,"This test case describes when a child is administered a second dose of the DTaP vaccine at an interval of 28-4 days after the first dose, that the dose is valid. Another dose should be forecast."
2013-0043,Dose 1 to dose 2 interval 28 days,01/18/2021,F,,,,Not complete,04/11/2021,"DTaP, unspecified formulation",107,,Valid,,05/09/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/06/2021,07/18/2021,09/14/2021,DTAP,05/10/2021,Interval: At Minimum,01/01/2013,06/26/2020,Recommended based on age,,1.0,"This test case describes when a child is administered a second dose of the DTaP vaccine at an interval of 28 days after the first dose, that the dose is valid. Another dose should be forecast."
2013-0044,DTaP #1 at age 6 weeks-4 days,04/02/2021,F,,,,Not complete,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/11/2021,08/02/2021,09/29/2021,DTAP,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/29/2020,Recommended based on age,,1.0,This test case describes when a patient is administered a first dose of the DTaP vaccine at 6 weeks- 4 days that the dose is valid.  Another dose should be forecast.
2013-0045,Dose 2 to dose 3 interval 28-5 days,12/17/2020,F,,,,Not complete,02/17/2021,"DTaP, unspecified formulation",107,,Valid,,04/17/2021,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/17/2021,08/13/2021,DTAP,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/29/2020,Recommended based on age,,1.0,This test case describes when a child is administered dose three of the DTaP vaccine at an interval of 28 -5 days after the second dose that the dose is not valid.  A repeat dose should be forecast.
2013-0046,Dose 2 to dose 3 interval 28-4 days,01/28/2021,F,,,,Not complete,03/09/2021,"DTaP, unspecified formulation",107,,Valid,,04/16/2021,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,04/28/2022,04/28/2022,09/24/2022,DTAP,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/29/2020,Recommended based on age,Updated per the 2017 General Best Practice Guidelines which moved the Minimum and Recommended Age to 15 months,3.3,This test case describes when a child is administered dose three of the DTaP vaccine at an interval of 28 - 4 days after the second dose that the dose is valid.  Another dose should be forecast.
2013-0047,Dose 2 to dose 3 interval 28 days,02/03/2021,F,,,,Not complete,03/15/2021,"DTaP, unspecified formulation",107,,Valid,,04/13/2021,"DTaP, unspecified formulation",107,,Valid,,05/11/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,05/03/2022,05/03/2022,09/30/2022,DTAP,05/10/2021,Interval: At Minimum,01/01/2013,06/29/2020,Recommended based on age,Updated per the 2017 General Best Practice Guidelines which moved the Minimum and Recommended Age to 15 months,3.3,This test case describes when a child is administered dose three of the DTaP vaccine at an interval of 28 days after the second dose that the dose is valid.  Another dose should be forecast.
2013-0049,Dose 3 to dose 4 interval 6 months-4 days,05/08/2020,F,,,,Not complete,07/09/2020,"DTaP, unspecified formulation",107,,Valid,,09/09/2020,"DTaP, unspecified formulation",107,,Valid,,11/14/2020,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,5,05/08/2024,05/08/2024,05/07/2027,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,06/29/2020,Recommended based on age,,1.0,This test case describes when a child is administered dose four of the DTaP vaccine at an interval of 6 months - 4 days months after the third dose that the dose is valid.  Another dose should be forecast.
2013-0050,Dose 3 to dose 4 interval 6 months,05/04/2020,F,,,,Not complete,07/05/2020,"DTaP, unspecified formulation",107,,Valid,,09/05/2020,"DTaP, unspecified formulation",107,,Valid,,11/10/2020,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,5,05/04/2024,05/04/2024,05/03/2027,DTAP,05/10/2021,Interval: At Minimum,01/01/2013,06/29/2020,Recommended based on age,,1.0,This test case describes when a child is administered dose four of the DTaP vaccine at an interval of 6 months after the third dose that the dose is valid.  Another dose should be forecast.
2013-0052,Dose 3 to dose 4 interval 4 months,05/10/2020,F,,,,Not complete,07/10/2020,"DTaP, unspecified formulation",107,,Valid,,09/10/2020,"DTaP, unspecified formulation",107,,Valid,,01/10/2021,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,5,05/10/2024,05/10/2024,05/09/2027,DTAP,05/10/2021,Interval: At Minimum,01/01/2013,06/29/2020,Recommended based on age,,1.0,This test case describes when a child is administered dose four of the DTaP vaccine at an interval of 4 months after the third dose that the dose is valid.  Another dose should be forecast.
2013-0053,Invalid dose 1 to dose 2 interval in midst of other vaccines ,05/06/2020,F,,,,Not complete,07/06/2020,"DTaP, unspecified formulation",107,,Valid,,07/26/2020,"DTaP, unspecified formulation",107,,Not Valid,Interval: too short,11/06/2020,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,4,11/10/2021,11/10/2021,01/02/2022,DTAP,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/29/2020,Recommended based on minimum interval from invalid dose,,1.0,This test case describes when a child is administered an invalid second dose of the DTaP vaccine at an interval less than 4 weeks - 4 days but was administered a valid repeat and third dose that the doses are valid.  Another dose should be forecast.
2013-0054,Invalid dose 2 to dose 3 interval in midst of other vaccines.,03/08/2020,F,,,,Not complete,05/08/2020,"DTaP, unspecified formulation",107,,Valid,,07/05/2020,"DTaP, unspecified formulation",107,,Valid,,07/27/2020,"DTaP, unspecified formulation",107,,Not Valid,Interval: too short,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,4,11/10/2021,11/10/2021,11/10/2021,DTAP,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,09/10/2020,Recommended based on minimum interval from invalid dose,,1.0,"This test case describes when a child is administered an invalid third dose of the DTaP vaccine at an interval of less than 4 weeks - 4 days but was administered a repeat dose at an interval of 4 weeks after the invalid dose, that the dose is valid. Another dose should be forecast."
2013-0055,DTaP #1 at age 6 weeks,03/29/2021,F,,,,Not complete,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/29/2021,09/25/2021,DTAP,05/10/2021,Age: At Minimum,01/01/2013,06/29/2020,Recommended based on age,,1.0,This test case describes when a child is administered a first dose of the DTaP vaccine at 6 weeks of age that the dose is valid.  Another dose should be forecast.
2013-0056,Invalid dose 3 to dose 4 interval in midst of other vaccinations,05/10/2020,F,,,,Not complete,10/10/2020,"DTaP, unspecified formulation",107,,Valid,,12/10/2020,"DTaP, unspecified formulation",107,,Valid,,02/01/2021,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,4,11/10/2021,11/10/2021,01/06/2022,DTAP,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,07/01/2020,Recommended based on minimum interval from inValid dose,,1.0,This test case describes when a child is administered an invalid fourth dose of the DTaP vaccine at an interval of less than 4 months - 4 days that a repeat dose should be forecast.
2013-0057,Invalid dose 4 to dose 5 interval in midst of others,05/09/2010,F,,,,Not complete,07/09/2010,"DTaP, unspecified formulation",107,,Valid,,09/09/2010,"DTaP, unspecified formulation",107,,Valid,,11/09/2010,"DTaP, unspecified formulation",107,,Valid,,01/28/2014,"DTaP, unspecified formulation",107,,Valid,,05/10/2014,"DTaP, unspecified formulation",107,,Not Valid,Interval: too short,05/10/2021,BOOSTRIX,115,SKB,Valid,,,,,,,,6,05/10/2026,05/10/2031,06/06/2031,DTAP,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,07/01/2020,Recommended based on interval,V1.4: Updated past due date to align with EIPB guidance clarification on  past due date and other test cases.,1.4,This test case describes when a child is administered an invalid fifth dose of the DTaP vaccine at an interval of less than 6 months - 4 days but was administered another valid dose at age 11 years.  A decennial dose should be forecast.
2013-0058,Tdap as dose #1,04/10/2020,F,,,,Not complete,06/10/2020,BOOSTRIX,115,SKB,Not Valid,Inadvertent Vaccine,08/12/2020,"DTaP, unspecified formulation",107,,Valid,,10/14/2020,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,4,11/10/2021,11/10/2021,12/07/2021,DTAP,05/10/2021,Vaccine: Invalid Usage,01/01/2013,06/30/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child has been administered an invalid Tdap vaccine dose as the first dose but has received a valid repeat and valid second and third DTaP doses.  Another dose should be forecast.
2013-0059,Tdap as dose #2,05/10/2020,F,,,,Not complete,07/10/2020,"DTaP, unspecified formulation",107,,Valid,,09/12/2020,BOOSTRIX,115,SKB,Not Valid,Inadvertent Vaccine,11/14/2020,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,4,11/10/2021,11/10/2021,01/06/2022,DTAP,05/10/2021,Vaccine: Invalid Usage,01/01/2013,06/30/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child has been administered an invalid Tdap vaccine dose as the second dose but has received a valid repeat and valid third DTaP doses.  Another dose should be forecast.
2013-0060,Tdap as dose 3 to child under age 4=invalid as DTaP 3,08/10/2020,F,,,,Not complete,11/10/2020,"DTaP, unspecified formulation",107,,Valid,,01/10/2021,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,BOOSTRIX,115,SKB,Not Valid,Inadvertent Vaccine,,,,,,,,,,,,,,,,,,,,,,,,,3,05/10/2021,05/10/2021,05/10/2021,DTAP,05/10/2021,Vaccine: Invalid Usage,01/01/2013,07/01/2020,Recommended based on minimum interval from invalid dose,,1.0,This test case describes when a child is administered an invalid third dose of the DTaP vaccine as Tdap that a repeat dose (DTaP) should be forecast.
2013-0061,Tdap as dose 4 to age 15 months=valid as DTaP,02/06/2020,F,,,,Not complete,05/06/2020,"DTaP, unspecified formulation",107,,Valid,,07/06/2020,"DTaP, unspecified formulation",107,,Valid,,11/06/2020,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,BOOSTRIX,115,SKB,Valid,,,,,,,,,,,,,,,,,,,,5,02/06/2024,02/06/2024,02/05/2027,DTAP,05/10/2021,Vaccine: Off Label,01/01/2013,07/01/2020,Recommended based on age,,1.0,This test case describes when a child is administered Tdap as a fourth dose at age 15 months that the dose is valid.  Another dose should be forecast.
2013-0062,Tdap as dose 5 to age 4 years-5 days=invalid as dose 5 of DTaP,05/15/2017,F,,,,Not complete,08/04/2017,"DTaP, unspecified formulation",107,,Valid,,10/04/2017,"DTaP, unspecified formulation",107,,Valid,,02/04/2018,"DTaP, unspecified formulation",107,,Valid,,09/09/2018,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,BOOSTRIX,115,SKB,Not Valid,Age: Too Young,,,,,,,,,,,,,5,11/10/2021,11/10/2021,05/14/2024,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,07/01/2020,Recommended based on minimum interval from invalid dose,,1.0,This test case describes when a child is administered Tdap as a fifth at age 4 years - 5 days that the dose is not valid.  A repeat dose should be forecast.
2013-0063,Tdap as dose 5 to age 4-4 days. Counts as valid DTaP.  Child will need another Tdap in adolescence.,05/14/2017,F,,,,Not complete,08/03/2017,"DTaP, unspecified formulation",107,,Valid,,10/03/2017,"DTaP, unspecified formulation",107,,Valid,,02/03/2018,"DTaP, unspecified formulation",107,,Valid,,09/08/2018,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,BOOSTRIX,115,SKB,Valid,,,,,,,,,,,,,,6,05/14/2028,05/14/2028,06/10/2030,DTAP,05/10/2021,Age: At Absolute Minimum,01/01/2013,07/01/2020,Recommended based on age,"V3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versions
V1.4: Updated past due date to shift 1 day earlier to align with business rule calculation and other similar tests in the DTaP/Tdap/Td forecasting at 11 years.",3.4,This test case describes when a child is administered Tdap as a fifth at age 4 years - 4 days that the dose is valid.  Another dose should be forecast at age 11 years.
2013-0064,Tdap as dose 5 to age 4 years old=valid as DTaP 5.  ,05/10/2017,F,,,,Not complete,07/30/2017,"DTaP, unspecified formulation",107,,Valid,,09/30/2017,"DTaP, unspecified formulation",107,,Valid,,01/30/2018,"DTaP, unspecified formulation",107,,Valid,,09/04/2018,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,BOOSTRIX,115,SKB,Valid,,,,,,,,,,,,,,6,05/10/2028,05/10/2028,06/06/2030,DTAP,05/10/2021,Vaccine: Off Label,01/01/2013,07/01/2020,Recommended based on age,"V3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versions
V1.1: Past Due Date was missing.  Added past due date of 13 years - 1 day to be consistent with supporting data a logic specficiation business rule calculations.",3.4,This test case describes when a child is administered Tdap as a fifth at age 4 years that the dose is valid.  Another dose should be forecast at age 11 years.
2013-0065,Tdap as dose 1 at age 7 years old,05/10/2014,F,,,,Not complete,05/10/2021,BOOSTRIX,115,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,07/01/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered Tdap at age 7 years as the first dose that the dose is valid.  Another dose should be forecast.
2013-0066,DTaP # 1 at age 2 months,03/10/2021,F,,,,Not complete,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/10/2021,09/06/2021,DTAP,05/10/2021,Age: At Recommended,01/01/2013,07/01/2020,Recommended based on age,,1.0,This test case describes when a child is administered a first of the DTaP vaccine at 2 months of age that the dose is valid.  Another dose should be forecast.
2013-0067,Tdap as dose 2 at age ≥7 years,03/12/2014,F,,,,Not complete,04/12/2021,"Td, adsorbed",09,MBL,Valid,,05/10/2021,BOOSTRIX,115,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,11/10/2021,11/10/2021,11/10/2021,DTAP,05/10/2021,Interval: At Minimum,01/01/2013,07/02/2020,Recommended based on minimum interval from previous dose (catch-up),Past Due Date was missing and child is in catch-up.  Past Due Date added to align with Recommended Date.,1.1,This test case describes when a child is administered Tdap at age 7 years as the second dose that the dose is valid.  Another dose should be forecast.
2013-0068,Tdap as dose 3 to ≥ 7 years old,10/02/2013,F,,,,Not complete,10/12/2020,"DTaP, unspecified formulation",107,,Valid,,11/09/2020,"DTaP, unspecified formulation",107,,Valid,,05/09/2021,BOOSTRIX,115,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,10/02/2024,10/02/2024,10/29/2026,DTAP,05/10/2021,Interval: At Minimum,01/01/2013,07/01/2020,Recommended based on interval,"V4.0: Updated Forecast per new Tdap Catch-up Job-Aid. Tdap is needed at 11 years.
V1.1: Past Due Date was missing. Added past due date per NIPInfo guidance.",4.0,This test case describes when a child is administered Tdap at age 7 years as the third dose that the dose is valid.  Another dose should be forecast.
2013-0069,Tdap at age 7 years-5 days. Current age 7 years,05/10/2014,F,,,,Not complete,05/05/2021,BOOSTRIX,115,SKB,Not Valid,Inadvertent Vaccine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/10/2021,05/10/2021,05/10/2021,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,07/02/2020,Recommended based on age,Past Due Date was missing and child is in catch-up.  Past Due Date added to align with Recommended Date.,1.1,This test case describes when a child is administered Tdap at age 7 years - 5 days as a first dose that the dose is not valid.  A repeat dose should be forecast.
2013-0070,Tdap at age 11 to child up-to-date with DTaP,03/04/2010,F,,,,Not complete,05/06/2010,"DTaP, unspecified formulation",107,,Valid,,07/08/2010,"DTaP, unspecified formulation",107,,Valid,,09/10/2010,"DTaP, unspecified formulation",107,,Valid,,04/05/2011,"DTaP, unspecified formulation",107,,Valid,,05/10/2014,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,BOOSTRIX,115,SKB,Valid,,,,,,,,7,05/10/2026,05/10/2031,06/06/2031,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,07/06/2020,Recommended based on interval,Past Due Date was missing. Added past due date per NIPInfo guidance.,1.1,This test case describes when a child is up-to-date on DTaP vaccinations and is administered a Tdap dose at age 11 years  that the dose is valid.  The decennial dose should be forecast.
2013-0074,4 doses of Tetramune to child,05/05/1995,F,,,,Not complete,07/05/1995,DTP-Hib,22,,Valid,,09/05/1995,DTP-Hib,22,,Valid,,11/05/1995,DTP-Hib,22,,Valid,,10/05/1996,DTP-Hib,22,,Valid,,,,,,,,,,,,,,,,,,,,5,05/05/2002,05/05/2002,05/05/2002,DTAP,05/05/2002,All Valid: Forecast Test,01/01/2013,07/06/2020,Recommended based on age,Updated due to new conditional skip logic which caused the next forecast dose to be administered at age 7 rather than age 8 due to need Pertussis dose. V1.4: Updated past due date to shift 1 day earlier to align with business rule calculation and other similar tests in the DTaP/Tdap/Td forecasting at 11 years.,2.2,This test case describes when a child is administered 4 valid doses of DTaP (Tetramune) that another dose should be forecast.
2013-0075,4 doses of Tetramune with a DTaP booster.  Forecast Tdap.,12/12/1999,F,,,,Not complete,02/15/2000,DTP-Hib,22,,Valid,,04/15/2000,DTP-Hib,22,,Valid,,06/15/2000,DTP-Hib,22,,Valid,,02/15/2001,DTP-Hib,22,,Valid,,12/01/2004,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,6,12/12/2010,12/12/2010,01/08/2013,DTAP,12/01/2004,All Valid: Forecast Test,01/01/2013,07/06/2020,Recommended based on age,V1.4: Updated past due date to shift 1 day earlier to align with business rule calculation and other similar tests in the DTaP/Tdap/Td forecasting at 11 years.,1.4,This test case describes when a child is administered 5 valid doses of DTaP that another dose should be forecast.
2013-0076,4 Tetramune and Tdap at age 11=UTD for 10 years,03/03/1996,F,,,,Not complete,05/05/1996,DTP-Hib,22,,Valid,,08/08/1996,DTP-Hib,22,,Valid,,01/04/1997,DTP-Hib,22,,Valid,,04/04/1998,DTP-Hib,22,,Valid,,03/18/2007,BOOSTRIX,115,SKB,Valid,,,,,,,,,,,,,,6,03/18/2012,03/18/2017,04/14/2017,DTAP,03/18/2007,All Valid: Forecast Test,01/01/2013,07/06/2020,Recommended based on interval,Past Due Date was missing. Added past due date per NIPInfo guidance.,1.1,This test case describes when a child was administered 4 previous valid doses of DTaP (Tetramune) at appropriate ages and intervals and a Tdap dose at 11 years of age that another dose (decennial) should be forecast.
2013-0077,DTaP #1 at age 6.5 years. ,11/10/2014,F,,,,Not complete,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,07/06/2020,Recommended based on minimum interval from previous dose (catch-up),V3.5: Test case Recommended and Past Due Dates were incorrectly mapped when moving to new test case management tool. These were corrected in this version.,3.5,This test case describes when a child is administered the first dose of DTaP at age 6.5 years that the dose is valid.  Another dose should be forecast.
2013-0078,TriHibit as primary dose.  DTaP=valid.,05/01/2011,F,,,,Not complete,07/01/2011,TRIHIBIT,50,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,07/29/2011,09/01/2011,10/28/2011,DTAP,07/01/2011,Vaccine: Off Label,01/01/2013,07/06/2020,Recommended based on age,,1.0,This test case describes when a child is administered the first dose of DTaP (TriHibit) that the dose is valid.  Another dose should be forecast.
2013-0079,TriHibit as valid dose 4 of DTaP,02/02/2008,F,,,,Not complete,04/04/2008,"DTaP, unspecified formulation",107,,Valid,,06/06/2008,"DTaP, unspecified formulation",107,,Valid,,08/08/2008,"DTaP, unspecified formulation",107,,Valid,,05/19/2009,TRIHIBIT,50,PMC,Valid,,,,,,,,,,,,,,,,,,,,5,02/02/2012,02/02/2012,02/01/2015,DTAP,05/19/2009,Vaccine: Off Label,01/01/2013,07/06/2020,Recommended based on age,,1.0,This test case describes when a child is administered the fourth dose of DTaP (TriHibit) that the dose is valid.  Another dose should be forecast.
2013-0080,TriHibit as valid dose 5 of DTaP,10/08/2006,F,,,,Not complete,11/29/2006,PEDIARIX,110,SKB,Valid,,01/29/2007,PEDIARIX,110,SKB,Valid,,03/29/2007,PEDIARIX,110,SKB,Valid,,02/02/2008,PEDIARIX,110,SKB,Valid,,10/09/2010,TRIHIBIT,50,PMC,Valid,,,,,,,,,,,,,,6,10/08/2017,10/08/2017,11/04/2019,DTAP,10/09/2010,All Valid: Forecast Test,01/01/2013,07/06/2020,Recommended based on age,V1.4: Updated past due date to align with ACIP and other test cases to be 1 day before the 13th birthday.,1.4,This test case describes when a child is administered the fifth dose of DTaP (TriHibit) that the dose is valid.  Another dose should be forecast.
2013-0081,Pentavalente (Mexico) DTaP/IPV/HIB counts as valid. ,03/01/2020,F,,,,Not complete,07/01/2020,DTAP/IPV/HIB - non-US,170,,Valid,,09/01/2020,DTAP/IPV/HIB - non-US,170,,Valid,,11/01/2020,DTAP/IPV/HIB - non-US,170,,Valid,,05/10/2021,DTAP/IPV/HIB - non-US,170,,Valid,,,,,,,,,,,,,,,,,,,,5,03/01/2024,03/01/2024,02/28/2027,DTAP,05/10/2021,Vaccine: Off Label,01/01/2013,07/06/2020,Recommended based on age,,1.0,This test case describes when a child is administered  4 doses of Pentavalente (Mexico) at appropriate intervals and age that the doses are valid.  Another DTaP (U.S) dose should be forecast.
2013-0082,Kinrix at age 2 months as Dose 1 of DTaP.  Off label but valid. ,03/10/2021,F,,,,Not complete,05/10/2021,KINRIX,130,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/10/2021,09/06/2021,DTAP,05/10/2021,Vaccine: Off Label,01/01/2013,07/13/2020,Recommended based on age,,1.0,"This test case describes when a child is administered a dose of Kinrix as the first dose of the DTaP vaccine series, at two months of age, that the dose is valid.  Another dose should be forecast."
2013-0083,Kinrix at age 4 months as dose 2 of DTaP.  Off label but valid. ,01/10/2021,F,,,,Not complete,03/16/2021,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,KINRIX,130,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,07/10/2021,09/06/2021,DTAP,05/10/2021,Vaccine: Off Label,01/01/2013,07/13/2020,Recommended based on age,,1.0,"This test case describes when a child is administered a dose of Kinrix as a second dose of DTaP in the vaccine series, at four months of age, that the dose is valid.  Another dose should be forecast."
2013-0084,Kinrix at age 6 months as dose 3 of DTaP.  Off label but valid. ,11/10/2020,F,,,,Not complete,01/12/2021,"DTaP, unspecified formulation",107,,Valid,,03/14/2021,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,KINRIX,130,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,02/10/2022,02/10/2022,07/07/2022,DTAP,05/10/2021,Vaccine: Off Label,01/01/2013,07/13/2020,Recommended based on age,Updated per the 2017 General Best Practice Guidelines which moved the Minimum and Recommended Age to 15 months,3.3,"This test case describes when a child is administered a dose of Kinrix as a third dose of DTaP in the vaccine series, at six months of age, that the dose is valid.  Another dose should be forecast."
2013-0085,Kinrix at age 12 months as dose 4 of DTaP=valid,05/10/2020,F,,,,Not complete,07/12/2020,"DTaP, unspecified formulation",107,,Valid,,09/14/2020,"DTaP, unspecified formulation",107,,Valid,,11/02/2020,"DTaP, unspecified formulation",107,,Valid,,05/10/2021,KINRIX,130,SKB,Valid,,,,,,,,,,,,,,,,,,,,5,05/10/2024,05/10/2024,05/09/2027,DTAP,05/10/2021,Age: At Minimum,01/01/2013,07/13/2020,Recommended based on age,,1.0,"This test case describes when a child is administered a dose of Kinrix as a fourth dose of DTaP in the vaccine series, at twelve months of age, that the dose is valid.  Another dose should be forecast."
2013-0086,Kinrix at age 4 to child with appropriate DTaP=UTD until adolescence,05/10/2017,F,,,,Not complete,07/12/2017,PEDIARIX,110,SKB,Valid,,09/10/2017,PEDIARIX,110,SKB,Valid,,11/12/2017,PEDIARIX,110,SKB,Valid,,05/10/2018,PEDIARIX,110,SKB,Valid,,05/10/2021,KINRIX,130,SKB,Valid,,,,,,,,,,,,,,6,05/10/2028,05/10/2028,06/06/2030,DTAP,05/10/2021,Age: At Minimum,01/01/2013,07/13/2020,Recommended based on age,"V3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versions
V1.4: Updated past due date to align with ACIP and other test cases to be 1 day before the 13th birthday.",3.4,"This test case describes when a child is administered a dose of Kinrix at age four years,that the dose is valid.  Another dose should be forecast."
2013-0087,Kinrix at age 4 years-5 days,05/15/2017,F,,,,Not complete,07/08/2017,PEDIARIX,110,SKB,Valid,,09/01/2017,PEDIARIX,110,SKB,Valid,,01/11/2018,PEDIARIX,110,SKB,Valid,,09/27/2018,PEDIARIX,110,SKB,Valid,,05/10/2021,KINRIX,130,SKB,Not Valid,Age: Too Young,,,,,,,,,,,,,5,11/10/2021,11/10/2021,05/14/2024,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,07/13/2020,Recommended based on minimum interval from invalid dose,,1.0,"This test case describes when a child is administered a dose of Kinrix at age 4 years - 5 days,that the dose is not valid.  A repeat dose should be forecast."
2013-0088,DTaP # 1 at age 7 years (off label but counts as valid). ,05/10/2014,F,,,,Not complete,05/10/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,DTAP,05/10/2021,Vaccine: Off Label,01/01/2013,08/17/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,"This test case describes when a child is administered a first dose of DTaP vaccine at age seven years,that the dose is valid.  Another dose should be forecast."
2013-0089,Kinrix at age 4 years -4 days,05/14/2017,F,,,,Not complete,07/03/2017,PEDIARIX,110,SKB,Valid,,08/31/2017,PEDIARIX,110,SKB,Valid,,10/31/2017,PEDIARIX,110,SKB,Valid,,07/23/2018,PEDIARIX,110,SKB,Valid,,05/10/2021,KINRIX,130,SKB,Valid,,,,,,,,,,,,,,6,05/14/2028,05/14/2028,06/10/2030,DTAP,05/10/2021,Age: At Absolute Minimum,01/01/2013,07/13/2020,Recommended based on age,"V3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versions
V1.1: Past Due Date was missing.  Added past due date of 13 years - 1 day to be consistent with supporting data a logic specficiation business rule calculations.",3.4,"This test case describes when a child is administered a dose of Kinrix at age 4 years - 4 days,that the dose is valid.  Another dose should be forecast."
2013-0090,Newborn forecasting,05/10/2021,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/21/2021,07/10/2021,09/06/2021,DTAP,05/10/2021,No Doses Administered,01/01/2013,08/18/2020,Recommended based on age,,1.0,This test case describes the forecasting of the DTaP vaccine for a newborn at 6 weeks of age.
2013-0091,# 2 Pediarix at 6 yrs 11.5 mo,05/25/2014,F,,,,Not complete,05/10/2017,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,11/10/2021,11/10/2021,11/10/2021,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,08/17/2020,Recommended based on minimum interval from previous dose (catch-up),V4.0: Forecast updated to reflect new Tdap catch-up Job Aid. Forecast should be in 6 months from previous dose.,4.0,"This test case describes when a child is administered, Pediarix as the second dose of the DTaP vaccine, at age 6 years 11.5 months that the dose is valid.  Another dose should be forecast."
2013-0092,# 2 Pediarix at 7 yrs; # 1 at less than 12 mo. ,05/10/2014,F,,,,Not complete,08/10/2014,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/07/2021,06/07/2021,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,08/21/2020,Recommended based on minimum interval from previous dose (catch-up),Past Due Date was missing and child is in catch-up.  Past Due Date added to align with Recommended Date.,1.1,"This test case describes when a child is administered Pediarix as the second dose of the DTaP vaccine at age 7 years and a first dose at less than 12 months of age, that the dose is valid.  Another dose should be forecast."
2013-0093,# 2 Pediarix at 7 yrs; # 1 ≥ 12 mo. Need 6 mo interval from 2 to 3.,05/10/2014,F,,,,Not complete,06/10/2015,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,11/10/2021,11/10/2021,11/10/2021,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,07/24/2020,Recommended based on minimum interval from previous dose (catch-up),Past Due Date was missing and child is in catch-up.  Past Due Date added to align with Recommended Date.,1.1,This test case describes when a child is administered Pediarix as the second dose of the DTaP vaccine at age 7 years and a first dose at greater than 12 months that the dose is valid.  Another dose should be forecast.
2013-0094,# 1 and 2 Pediarix at ≥7 yrs  with 28 day interval.  Off label but does not need repeating. ,04/12/2014,F,,,,Not complete,04/12/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,11/10/2021,11/10/2021,11/10/2021,DTAP,05/10/2021,Interval: At Minimum,01/01/2013,08/17/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,"This test case describes when a child is administered, Pediarix as the first and second dose of the DTaP vaccine series with a 28 day interval that the doses are valid.  Another dose should be forecast."
2013-0095,# 3 Pediarix at 14 wks-5 days,02/06/2021,F,,,,Not complete,03/16/2021,PEDIARIX,110,SKB,Valid,,04/13/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/06/2021,10/03/2021,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,08/17/2020,Recommended based on age,,1.0,"This test case describes when a child is administered, Pediarix as the third dose of DTaP vaccine, at age 14 weeks - 5 days that the dose is not valid.  A repeat dose should be forecast."
2013-0096,# 3 Pediarix at 14 wks-4 days.,02/05/2021,F,,,,Not complete,03/17/2021,PEDIARIX,110,SKB,Valid,,04/14/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,05/05/2022,05/05/2022,10/02/2022,DTAP,05/10/2021,Age: At Absolute Minimum,01/01/2013,08/17/2020,Recommended based on age,Updated per the 2017 General Best Practice Guidelines which moved the Minimum and Recommended Age to 15 months,3.3,"This test case describes when a child is administered, Pediarix as the third dose of DTaP vaccine, at age 14 weeks - 4 days that the dose is valid.  Another dose should be forecast."
2013-0097,#3 Pediarix at age 24 weeks- 5 days,11/28/2020,F,,,,Not complete,01/09/2021,PEDIARIX,110,SKB,Valid,,03/11/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,02/28/2022,02/28/2022,07/25/2022,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,08/17/2020,Recommended based on age,Updated per the 2017 General Best Practice Guidelines which moved the Minimum and Recommended Age to 15 months,3.3,"This test case describes when a child is administered Pediarix, as the third dose of DTaP vaccine, at age 24 weeks - 5 days that the dose is valid.  Another dose should be forecast."
2013-0099,# 3 Pediarix at 6 yrs 11.5 mo,05/22/2014,F,,,,Not complete,03/22/2017,PEDIARIX,110,SKB,Valid,,06/23/2018,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,05/22/2021,05/22/2021,05/22/2021,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,06/16/2020,Recommended based on minimum interval from previous dose (catch-up),V4.3: test case updated to reflect changes to current catch-up guidance for children 7 through 9 years of age. (Feb. 2020),4.3,"This test case describes that when a child has received three doses of the DTaP vaccine and the first dose was administered at 12 months or older, and the third dose was administered prior to age 7, that another dose should be forecast at age 7."
2013-0100,# 4 Pediarix at 1 yr -5 days.,05/15/2020,F,,,,Not complete,07/15/2020,PEDIARIX,110,SKB,Valid,,09/15/2020,PEDIARIX,110,SKB,Valid,,11/21/2020,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,4,11/10/2021,11/10/2021,01/11/2022,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,08/17/2020,Recommended based on minimum interval from inValid dose,,1.0,"This test case describes when a child is administered Pediarix, as the fourth dose of DTaP vaccine, at age 1 yr - 5 days that the dose is not valid.  A repeat dose should be forecast."
2013-0101,# 1 Pediarix at 6 wks-5 days,04/03/2021,F,,,,Not complete,05/10/2021,PEDIARIX,110,SKB,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/15/2021,06/03/2021,07/30/2021,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,08/17/2020,Recommended based on age,,1.0,"This test case describes when a patient is administered Pediarix, as a first dose of the DTaP vaccine, at age 6 weeks- 5 days that the dose is not valid.  A repeat dose should be forecast."
2013-0102,# 4 Pediarix at 1 yr -4 days,05/14/2020,F,,,,Not complete,07/14/2020,PEDIARIX,110,SKB,Valid,,10/14/2020,PEDIARIX,110,SKB,Valid,,12/28/2020,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,5,05/14/2024,05/14/2024,05/13/2027,DTAP,05/10/2021,Age: At Absolute Minimum,01/01/2013,08/17/2020,Recommended based on age,,1.0,"This test case describes when a child is administered Pediarix, as the fourth dose of DTaP vaccine, at age 1 yr - 4 days that the dose is valid.  Another dose should be forecast."
2013-0103,# 4 Pediarix at 3 yrs 11.5 mo. ,05/26/2017,F,,,,Not complete,07/26/2017,PEDIARIX,110,SKB,Valid,,10/26/2017,PEDIARIX,110,SKB,Valid,,01/26/2018,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,5,11/10/2021,11/10/2021,05/25/2024,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,08/17/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,"This test case describes when a child is administered Pediarix, as the fourth dose of the DTaP/Tdap/Td vaccine, at 3 years and 11.5 months that the dose is valid.  Another dose should be forecast."
2013-0104,# 4 Pediarix at 4 yrs=complete until age 11,05/10/2017,F,,,,Not complete,09/13/2017,PEDIARIX,110,SKB,Valid,,03/07/2018,PEDIARIX,110,SKB,Valid,,07/14/2019,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,5,05/10/2028,05/10/2028,06/06/2030,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,08/17/2020,Recommended based on age,"V3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versions
V1.1: Past Due Date was missing.  Added past due date of 13 years - 1 day to be consistent with supporting data a logic specficiation business rule calculations.",3.4,"This test case describes when a child is administered Pediarix, as the fourth dose of the DTaP/Tdap/Td vaccine, at 4 years that the dose is valid.  Another dose should be forecast."
2013-0105,# 5 Pediarix at 4 yrs -5 days.,05/15/2017,F,,,,Not complete,07/15/2017,PEDIARIX,110,SKB,Valid,,08/15/2017,PEDIARIX,110,SKB,Valid,,12/16/2017,PEDIARIX,110,SKB,Valid,,08/24/2018,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Not Valid,Age: Too Young,,,,,,,,,,,,,5,11/10/2021,11/10/2021,05/14/2024,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,08/17/2020,Recommended based on minimum interval from invalid dose,,1.0,"This test case describes when a child is administered Pediarix, as the fifth dose of the DTaP/Tdap/Td vaccine, at 4 years - 5 days that the dose is not valid.  A repeat dose should be forecast."
2013-0106,# 5 Pediarix at 4 yrs -4 days,05/14/2017,F,,,,Not complete,07/14/2017,PEDIARIX,110,SKB,Valid,,08/14/2017,PEDIARIX,110,SKB,Valid,,12/15/2017,PEDIARIX,110,SKB,Valid,,08/23/2018,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,6,05/14/2028,05/14/2028,06/10/2030,DTAP,05/10/2021,Age: At Absolute Minimum,01/01/2013,08/17/2020,Recommended based on age,"V3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versions. 
V1.1: Past Due Date was missing.  Added past due date of 13 years - 1 day to be consistent with supporting data a logic specficiation business rule calculations.",3.4,"This test case describes when a child is administered Pediarix, as the fifth dose of the DTaP/Tdap/Td vaccine, at 4 years - 4 days that the dose is valid.  Another dose should be forecast."
2013-0107,# 5 Pediarix at 6 yrs 11.5 mo,05/26/2014,F,,,,Not complete,07/26/2014,PEDIARIX,110,SKB,Valid,,09/26/2014,PEDIARIX,110,SKB,Valid,,11/26/2014,PEDIARIX,110,SKB,Valid,,06/26/2015,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,6,05/26/2025,05/26/2025,06/22/2027,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,08/17/2020,Recommended based on age,"V3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versions
V1.1: Past Due Date was missing.  Added past due date of 13 years - 1 day to be consistent with supporting data a logic specficiation business rule calculations.",3.4,"This test case describes when a child is administered Pediarix, as the fifth dose of the DTaP/Tdap/Td vaccine, at 6 years and 11.5 months of age that the dose is valid.  Another dose should be forecast."
2013-0108,# 5 Pediarix at 7 yrs.  Off label but valid. ,05/10/2014,F,,,,Not complete,08/10/2014,PEDIARIX,110,SKB,Valid,,11/10/2014,PEDIARIX,110,SKB,Valid,,02/10/2015,PEDIARIX,110,SKB,Valid,,11/25/2015,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,6,05/10/2025,05/10/2025,06/06/2027,DTAP,05/10/2021,Vaccine: Off Label,01/01/2013,08/17/2020,Recommended based on age,"V4.0: Updated forecast to recommend Tdap at 11-12 year dose per new Tdap Catch-up Job Aid
V1.4: Updated to reflect 10 year recurring dose since the DTaP at age 7 can count as the adolescent (11 - 12 year) Tdap dose per conversation with EIPB and guidance in MMWRs",4.0,"This test case describes when a child is administered Pediarix, as the fifth dose of the DTaP/Tdap/Td vaccine, at 7 years of age that the dose is valid.  Another dose should be forecast."
2013-0109,Invalid age dose 1 as first of others. ,02/10/2021,F,,,,Not complete,03/19/2021,PEDIARIX,110,SKB,Not Valid,Age: Too Young,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/10/2021,08/06/2021,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,08/17/2020,Recommended based on age,,1.0,"This test case describes when a child is administered Pediarix, at less than 6 weeks - 4 days but another dose is administered at age 3 months that, that the dose is valid.  Another dose should be forecast."
2013-0110,Invalid age dose 2 in midst of others,11/10/2020,F,,,,Not complete,12/18/2020,PEDIARIX,110,SKB,Valid,,01/13/2021,PEDIARIX,110,SKB,Not Valid,Age: Too Young,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/07/2021,07/07/2021,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,08/17/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,"This test case describes when a child is administered a second dose of Pediarix, at less than 10 weeks - 4 days, but is administered a repeat dose at 6 months later, that the dose is valid.  Another dose should be forecast."
2013-0111,invalid age dose 3 in midst of others,05/10/2020,F,,,,Not complete,06/23/2020,PEDIARIX,110,SKB,Valid,,07/19/2020,PEDIARIX,110,SKB,Valid,,08/10/2020,PEDIARIX,110,SKB,Not Valid,Interval: too short,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,4,11/10/2021,11/10/2021,01/06/2022,DTAP,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,08/17/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,"This test case describes when a child is administered a third dose of Pediarix, at less than 14 weeks - 4 days, but is administered a repeat dose that the dose is valid.  Another dose should be forecast."
2013-0112,# 1 Pediarix at 6 wks-4 days,04/02/2021,F,,,,Not complete,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/11/2021,08/02/2021,09/29/2021,DTAP,05/10/2021,Age: At Absolute Minimum,01/01/2013,08/17/2020,Recommended based on age,,1.0,"This test case describes when a child is administered Pediarix, as a first dose of the DTaP/Tdap/Td vaccine, at 6 weeks - 4 days that the dose is valid. Another dose should be forecast."
2013-0113,"dose 1 to 2 Pediarix, interval 28-5 days",02/13/2021,F,,,,Not complete,04/17/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/13/2021,08/09/2021,DTAP,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,08/17/2020,Recommended based on minimum interval from invalid dose,,1.0,"This test case describes when a child is administered a second dose of the DTaP vaccine (Pediarix) at an interval of 28-5 days after the first dose, that the dose is not valid. A repeat dose should be forecast."
2013-0114,"dose 1 to 2 Pediarix, interval 28-4 days",02/16/2021,F,,,,Not complete,04/16/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/16/2021,10/13/2021,DTAP,05/10/2021,Interval: At Absolute Minimum,01/01/2013,08/17/2020,Recommended based on age,,1.0,"This test case describes when a child is administered a second dose of the DTaP vaccine (Pediarix) at an interval of 28-4 days after the first dose, that the dose is valid. Another dose should be forecast."
2013-0115,"dose 2 to 3 Pediarix, interval 28-5 days",12/17/2020,F,,,,Not complete,02/17/2021,PEDIARIX,110,SKB,Valid,,04/17/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/17/2021,08/13/2021,DTAP,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,08/17/2020,Recommended based on age,,1.0,This test case describes when a child is administered dose three of the DTaP vaccine (Pediarix) at an interval of 28 -5 days after the second dose that the dose is not valid.  A repeat dose should be forecast.
2013-0116,"dose 2 to 3 Pediarix, interval 28-4 days.",12/16/2020,F,,,,Not complete,02/16/2021,PEDIARIX,110,SKB,Valid,,04/16/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,03/16/2022,03/16/2022,08/12/2022,DTAP,05/10/2021,Interval: At Absolute Minimum,01/01/2013,08/17/2020,Recommended based on age,Updated per the 2017 General Best Practice Guidelines which moved the Minimum and Recommended Age to 15 months,3.3,This test case describes when a child is administered dose three of the DTaP vaccine (Pediarix) at an interval of 28 -4 days after the second dose that the dose is valid.  Another dose should be forecast.
2013-0117,"dose 3 to 4 Pediarix, interval 6m-5 days",03/10/2020,F,,,,Not complete,05/10/2020,PEDIARIX,110,SKB,Valid,,07/10/2020,PEDIARIX,110,SKB,Valid,,11/10/2020,PEDIARIX,110,SKB,Valid,,05/05/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,5,03/10/2024,03/10/2024,03/09/2027,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,08/18/2020,Recommended based on age,,1.0,This test case describes when a child is administered dose four of the DTaP vaccine (Pediarix) at an interval of 6 months - 5 days months after the third dose that the dose is not valid.  A repeat dose should be forecast.
2013-0118,"dose 3 to 4 Pediarix, interval 6m-4 days",03/10/2020,F,,,,Not complete,05/10/2020,PEDIARIX,110,SKB,Valid,,07/10/2020,PEDIARIX,110,SKB,Valid,,11/10/2020,PEDIARIX,110,SKB,Valid,,05/06/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,5,03/10/2024,03/10/2024,03/09/2027,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,09/02/2020,Recommended based on age,,1.0,This test case describes when a child is administered dose four of the DTaP vaccine (Pediarix) at an interval of 6 months - 4 days after the third dose that the dose is valid.  Another dose should be forecast.
2013-0120,"dose 3 to 4 Pediarix, interval 4 mo",03/10/2020,F,,,,Not complete,05/10/2020,PEDIARIX,110,SKB,Valid,,07/10/2020,PEDIARIX,110,SKB,Valid,,01/10/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,5,03/10/2024,03/10/2024,03/09/2027,DTAP,05/10/2021,Interval: At Absolute Minimum,01/01/2013,08/18/2020,Recommended based on age,,1.0,This test case describes when a child is administered dose four of the DTaP vaccine (Pediarix) at an interval of 4 months after the third dose that the dose is valid.  Another dose should be forecast.
2013-0121,invalid dose 1-2 interval in midst of others,01/10/2021,F,,,,Not complete,03/10/2021,PEDIARIX,110,SKB,Valid,,03/29/2021,PEDIARIX,110,SKB,Not Valid,Interval: too short,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,07/10/2021,09/06/2021,DTAP,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,09/10/2020,Recommended based on age,,1.0,"This test case describes when a child is administered an invalid second dose of the DTaP vaccine (Pediarix) at an interval less than 4 weeks - 4 days but was administered a repeat vaccine dose at 4 weeks after the invalid dose, that the dose is valid..    Another dose should be forecast."
2013-0122,invalid dose 2-3 interval in midst of others,05/10/2020,F,,,,Not complete,07/10/2020,PEDIARIX,110,SKB,Valid,,09/10/2020,PEDIARIX,110,SKB,Valid,,10/03/2020,PEDIARIX,110,SKB,Not Valid,Interval: too short,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,4,11/10/2021,11/10/2021,01/06/2022,DTAP,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,09/10/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered an invalid third dose of the DTaP vaccine (Pediarix) at an interval of less than 4 weeks - 4 days but was administered a repeat dose at an interval of 4 weeks after the invalid dose that the dose is valid.  Another dose should be forecast.
2013-0123,# 1 Pediarix at 6 wks,03/29/2021,F,,,,Not complete,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/29/2021,09/25/2021,DTAP,05/10/2021,Age: At Minimum,01/01/2013,08/18/2020,Recommended based on age,,1.0,This test case describes when a child is administered Pediarix as a first dose of the DTaP vaccine at 6 weeks of age that the dose is valid.  Another dose should be forecast.
2013-0124,invalid dose 3-4 interval in midst of others,05/08/2017,F,,,,Not complete,07/08/2017,PEDIARIX,110,SKB,Valid,,09/08/2017,PEDIARIX,110,SKB,Valid,,04/02/2018,PEDIARIX,110,SKB,Valid,,07/28/2018,PEDIARIX,110,SKB,Not Valid,Interval: too short,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,5,05/08/2028,05/08/2028,06/04/2030,DTAP,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,08/18/2020,Recommended based on age,"V3.5: Dose 4 - intended to be invalid - was modified to be 4 months - 5 days from the previous dose. 
V3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versions
V3.3: Updated per 2017 General Best Practice Guidelines which allows for an allowable interval of 4 months - 4 days.",3.5,"This test case describes when the fourth dose of DTaP vaccine (Pediarix) is administered at less than 4 months - 4 days from dose #3, that the dose is not valid."
2013-0127,# 1 Pediarix at 6 yrs 11.5 mo,05/25/2014,F,,,,Not complete,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,08/18/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered Pediarix as the first dose of DTaP vaccine at age 6 years and 11.5 months that the dose is valid.  Another dose should be forecast.
2013-0128,# 1 Pediarix at 7 years,05/10/2014,F,,,,Not complete,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,08/18/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered Pediarix as the first dose of DTaP vaccine at age 7 years that the dose is valid.  Another dose should be forecast.
2013-0129,# 2 Pediarix at 10 wks-5 days.,03/06/2021,F,,,,Not complete,04/13/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/06/2021,09/02/2021,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,08/18/2020,Recommended based on age,,1.0,This test case describes when a child is administered Pediarix as a second dose of the DTaP vaccine at 10 weeks - 5 days that the dose is not valid.  A repeat dose should be forecast.
2013-0130,# 2 Pediarix at 10 wks-4 days,03/05/2021,F,,,,Not complete,04/16/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/11/2021,09/05/2021,11/01/2021,DTAP,05/10/2021,Age: At Absolute Minimum,01/01/2013,08/18/2020,Recommended based on age,,1.0,This test case describes when a child is administered Pediarix as a second dose of the DTaP vaccine at 10 weeks - 4 days that the dose is valid.  Another dose should be forecast.
2013-0131,# 2 Pediarix at 10 wks,03/01/2021,F,,,,Not complete,04/12/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,09/01/2021,10/28/2021,DTAP,05/10/2021,Age: At Minimum,01/01/2013,08/18/2020,Recommended based on age,,1.0,This test case describes when a child is administered Pediarix as a second dose of the DTaP vaccine at 10 weeks that the dose is valid.  Another dose should be forecast.
2013-0132,Newborn,05/10/2021,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/21/2021,07/10/2021,09/06/2021,DTAP,05/10/2021,No Doses Administered,01/01/2013,08/18/2020,Recommended based on age,,1.0,This test case describes the forecasting of the DTaP vaccine for a newborn at 6 weeks of age.
2013-0133,# 2 Pentacel at 6 yrs 11.5 mo. Off label but counts. Current Age 7 years,05/10/2014,F,,,,Not complete,01/31/2017,PENTACEL,120,PMC,Valid,,04/24/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,10/24/2021,10/24/2021,10/24/2021,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,08/21/2020,Recommended based on minimum interval from previous dose (catch-up),"V4.0: Updated forecast to align with new Tdap Catch-up Job Aid. Forecast in 6 months.
Past Due Date was missing and child is in catch-up.  Past Due Date added to align with Recommended Date.
Interval Priority Flag with Override allows for a vaccine to be given sooner than a previous date set by multiple vaccines.",4.0,"This test case describes when a child is administered, Pentacel, as the second dose of the DTaP vaccine, at age 6 years 11.5 months that the dose is valid.  Another dose should be forecast."
2013-0134,# 2 Pentacel at 7 yrs; # 1 at age < 12 mo,05/06/2014,F,,,,Not complete,10/15/2014,INFANRIX,20,SKB,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/07/2021,06/07/2021,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,08/21/2020,Recommended based on minimum interval from previous dose (catch-up),Past Due Date was missing and child is in catch-up.  Past Due Date added to align with Recommended Date.,1.1,"This test case describes when a child is administered Pentacel, as the second dose of the DTaP vaccine, at age 7 years and a first dose (Infanrix) at less than 12 months of age, that the dose is valid.  Another dose should be forecast."
2013-0135,# 2 Pentacel at 7 yrs; # 1 at age ≥ 12 mo.,05/06/2014,F,,,,Not complete,07/09/2015,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,11/10/2021,11/10/2021,11/10/2021,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,08/21/2020,Recommended based on minimum interval from previous dose (catch-up),Past Due Date was missing and child is in catch-up.  Past Due Date added to align with Recommended Date.,1.1,"This test case describes when a child is administered Pentacel, as the second dose of the DTaP vaccine, at age 7 years and a first dose at greater than 12 months of age, that the dose is valid.  Another dose should be forecast."
2013-0136,# 3 Pentacel at 14 wks-5 days,02/06/2021,F,,,,Not complete,03/16/2021,PENTACEL,120,PMC,Valid,,04/13/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/06/2021,10/03/2021,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,08/21/2020,Recommended based on age,,1.0,This test case describes when a third dose of the DTaP vaccine (Pentacel) is administered at age 14 weeks - 5 days that the dose is not valid.  A repeat dose should be forecast.
2013-0137,# 3 Pentacel at 14 wks-4 days,02/05/2021,F,,,,Not complete,03/15/2021,PENTACEL,120,PMC,Valid,,04/12/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,05/05/2022,05/05/2022,10/02/2022,DTAP,05/10/2021,Age: At Absolute Minimum,01/01/2013,08/21/2020,Recommended based on age,Updated per 2017 General Best Practice Guidelines which allows for an allowable interval of 4 months - 4days.,3.3,This test case describes when a third dose of the DTaP vaccine (Pentacel) is administered at age 14 weeks - 4 days that the dose is valid.  Another dose should be forecast.
2013-0138,# 3 Pentacel at 6 yrs 11.5 mo,05/25/2014,F,,,,Not complete,07/20/2014,DTaP-Hib-IPV,120,,Valid,,10/25/2017,DTaP-Hib-IPV,120,,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,11/10/2021,11/10/2021,11/10/2021,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,08/21/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes that when a child is administered a third dose of the DTaP vaccine (Pentacel) at 6 years and 11.5 months that the dose is valid.  Another dose should be forecast.
2013-0139,# 4 Pentacel at 1 yr -5 days.  ,05/15/2020,F,,,,Not complete,07/15/2020,PENTACEL,120,PMC,Valid,,09/15/2020,PENTACEL,120,PMC,Valid,,11/15/2020,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,4,11/10/2021,11/10/2021,01/11/2022,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,08/21/2020,Recommended based on minimum interval from invalid dose,,1.0,"This test case describes when a child is administered Pentacel, as the fourth dose of DTaP vaccine, at age 1 yr - 5 days that the dose is not valid.  A repeat dose should be forecast."
2013-0140,# 4 Pentacel at 1 yr -4 days,05/14/2020,F,,,,Not complete,07/14/2020,PENTACEL,120,PMC,Valid,,09/14/2020,PENTACEL,120,PMC,Valid,,11/14/2020,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,5,05/14/2024,05/14/2024,05/13/2027,DTAP,05/10/2021,Age: At Absolute Minimum,01/01/2013,08/21/2020,Recommended based on age,,1.0,"This test case describes when a child is administered Pentacel, as the fourth dose of the DTaP vaccine, at age 1 yr - 4 days that the dose is valid.  Another dose should be forecast."
2013-0141,# 4 Pentacel at age 12 mo,05/10/2020,F,,,,Not complete,07/10/2020,PENTACEL,120,PMC,Valid,,09/10/2020,PENTACEL,120,PMC,Valid,,11/10/2020,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,5,05/10/2024,05/10/2024,05/09/2027,DTAP,05/10/2021,Age: At Minimum,01/01/2013,08/21/2020,Recommended based on age,,1.0,This test case describes when a child is administered a fourth dose of the DTaP/Tdap/Td vaccine (Pentacel) at age 12 months that the dose is valid.  Another dose should be forecast.
2013-0142,# 4 Pentacel at 4 yrs,05/10/2017,F,,,,Not complete,09/19/2017,PENTACEL,120,PMC,Valid,,05/02/2018,PENTACEL,120,PMC,Valid,,11/06/2020,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,5,05/10/2028,05/10/2028,06/06/2030,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,08/24/2020,Recommended based on age,"V3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versions
V1.4: Updated past due date to shift 1 day earlier to align with business rule calculation and other similar tests in the DTaP/Tdap/Td forecasting at 11 years.",3.4,"This test case describes when a child is administered Pentacel, as the fourth dose of the DTaP/Tdap/Td vaccine, at 4 years that the dose is valid.  Another dose should be forecast."
2013-0143,# 5 Pentacel at ≥ 4 yrs,04/18/2017,F,,,,Not complete,03/18/2018,PENTACEL,120,PMC,Valid,,06/18/2018,PENTACEL,120,PMC,Valid,,09/18/2018,PENTACEL,120,PMC,Valid,,02/19/2019,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,6,04/18/2028,04/18/2028,05/15/2030,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,08/24/2020,Recommended based on age,"V3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versions
V1.4: Updated past due date to align with ACIP and other test cases to be 1 day before the 13th birthday.",3.4,"This test case describes when a child is administered Pentacel, as a fifth dose of the DTaP/Tdap/Td vaccine, at 4 years that the dose is valid.  Another dose should be forecast."
2013-0144,# 4 Pentacel at 5 yrs=off label but counts. ,05/10/2016,F,,,,Not complete,09/10/2016,PENTACEL,120,PMC,Valid,,03/09/2017,PENTACEL,120,PMC,Valid,,05/11/2017,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,5,05/10/2027,05/10/2027,06/06/2029,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,08/24/2020,Recommended based on age,"V3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versions
V1.4: Updated past due date to shift 1 day earlier to align with business rule calculation and other similar tests in the DTaP/Tdap/Td forecasting at 11 years.",3.4,"This test case describes when a child is administered Pentacel, as a fourth of the DTaP/Tdap/Td vaccine, at 5 years of age that the dose is valid.  Another dose should be forecast."
2013-0145,invalid age dose 2 in midst of others,05/08/2020,F,,,,Not complete,06/15/2020,PENTACEL,120,PMC,Valid,,07/12/2020,PENTACEL,120,PMC,Not Valid,Age: Too Young,09/28/2020,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,4,11/10/2021,11/10/2021,01/04/2022,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,08/24/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,"This test case describes when a child is administered a second dose of Pentacel, at less than 10 weeks - 4 days, but is administered a repeat dose at, an interval at least 4 weeks from the previous dose, that the dose is valid."
2013-0146,invalid age dose 3 in midst of others,04/04/2020,F,,,,Not complete,05/12/2020,PENTACEL,120,PMC,Valid,,06/09/2020,PENTACEL,120,PMC,Valid,,07/06/2020,PENTACEL,120,PMC,Not Valid,Age: Too Young,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,4,11/10/2021,11/10/2021,12/01/2021,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,08/24/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,"This test case describes when a child is administered an invalid third dose of the DTaP vaccine, Pentacel, but a repeat is administered at an appropriate age and interval that the dose is valid.  Another dose should be forecast."
2013-0147,"dose 1 to 2 Pentacel, interval 28-5 days",02/21/2021,F,,,,Not complete,04/17/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/21/2021,08/17/2021,DTAP,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,08/24/2020,Recommended based on age,,1.0,"This test case describes when a child is administered a second dose of the DTaP vaccine (Pentacel) at an interval of 28-5 days after the first dose, that the dose is not valid. A repeat dose should be forecast."
2013-0148,"dose 1 to 2 Pentacel, interval 28-4 days",02/12/2021,F,,,,Not complete,04/16/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/12/2021,10/09/2021,DTAP,05/10/2021,Interval: At Absolute Minimum,01/01/2013,08/27/2020,Recommended based on age,,1.0,"This test case describes when a child is administered a second dose of the DTaP vaccine (Pentacel) at an interval of 28-4 days after the first dose, that the dose is valid. Another dose should be forecast."
2013-0149,"dose 2 to 3 Pentacel, interval 28-5 days",12/17/2020,F,,,,Not complete,02/17/2021,PENTACEL,120,PMC,Valid,,04/17/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/17/2021,08/13/2021,DTAP,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,08/27/2020,Recommended based on age,,1.0,This test case describes when a child is administered dose three of the DTaP vaccine (Pentacel) at an interval of 28 -5 days after the second dose that the dose is not valid.  A repeat dose should be forecast.
2013-0150,"dose 2 to 3 Pentacel, interval 28-4 days",12/16/2020,F,,,,Not complete,02/16/2021,PENTACEL,120,PMC,Valid,,04/16/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,03/16/2022,03/16/2022,08/12/2022,DTAP,05/10/2021,Interval: At Absolute Minimum,01/01/2013,08/27/2020,Recommended based on age,Updated per 2017 General Best Practice Guidelines which allows for an allowable interval of 4 months - 4days.,3.3,This test case describes when a child is administered dose three of the DTaP vaccine (Pentacel) at an interval of 28 -4 days after the second dose that the dose is valid.  Another dose should be forecast.
2013-0152,# 1 Pentacel at 6 wks-4 days,04/02/2021,F,,,,Not complete,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/11/2021,08/02/2021,09/29/2021,DTAP,05/10/2021,Age: At Absolute Minimum,01/01/2013,09/02/2020,Recommended based on age,,1.0,This test case describes when a child is administered Pentacel as a first dose of the DTaP vaccine at 6 weeks - 4 days of age that the dose is valid.  Another dose should be forecast.
2013-0153,"dose 3 to 4 Pentacel, interval 6m-4 days",03/14/2020,F,,,,Not complete,05/14/2020,PENTACEL,120,PMC,Valid,,09/14/2020,PENTACEL,120,PMC,Valid,,11/14/2020,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,5,03/14/2024,03/14/2024,03/13/2027,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,09/02/2020,Recommended based on age,,1.0,This test case describes when a child is administered dose four of the DTaP vaccine (Pentacel) at an interval of 6 months - 4 days after the third dose that the dose is valid.  Another dose should be forecast.
2013-0155,"dose 3 to 4 Pentacel, interval 4 mo.",04/10/2020,F,,,,Not complete,06/10/2020,PENTACEL,120,PMC,Valid,,10/10/2020,PENTACEL,120,PMC,Valid,,01/10/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,5,04/10/2024,04/10/2024,04/09/2027,DTAP,05/10/2021,Interval: At Absolute Minimum,01/01/2013,09/02/2020,Recommended based on age,,1.0,This test case describes when a child is administered dose four of the DTaP vaccine (Pentacel) at an interval of 4 months after the third dose that the dose is valid.  Another dose should be forecast.
2013-0156,invalid dose 1-2 interval in midst of others,11/19/2020,F,,,,Not complete,01/19/2021,PENTACEL,120,PMC,Valid,,02/11/2021,PENTACEL,120,PMC,Not Valid,Interval: too short,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/07/2021,07/16/2021,DTAP,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,09/10/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered an invalid second dose of the DTaP vaccine (Pentacel) at an interval less than 4 weeks - 4 days but was administered a valid dose at an interval of 4 weeks after the invalid dose.   Another dose should be forecast.
2013-0157,invalid dose 2-3 interval in midst of others,05/07/2020,F,,,,Not complete,07/07/2020,PENTACEL,120,PMC,Valid,,09/07/2020,PENTACEL,120,PMC,Valid,,09/28/2020,PENTACEL,120,PMC,Not Valid,Interval: too short,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,4,11/10/2021,11/10/2021,01/03/2022,DTAP,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,09/10/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered an invalid third dose of the DTaP vaccine (Pentacel) at an interval of less than 4 weeks - 4 days but was administered a repeat dose at an interval of 4 weeks after the invalid dose that the dose is valid.  Another dose should be forecast.
2013-0161,# 1 Pentacel at 6 wks,03/29/2021,F,,,,Not complete,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/29/2021,09/25/2021,DTAP,05/10/2021,Age: At Minimum,01/01/2013,09/10/2020,Recommended based on age,,1.0,This test case describes when a child is administered Pentacel as a first dose of the DTaP vaccine at 6 weeks of age that the dose is valid.  Another dose should be forecast.
2013-0162,# 1 Pentacel at 6 yrs 11.5 mo,05/22/2014,F,,,,Not complete,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,09/10/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered Pentacel as the first dose of DTaP vaccine at age 6 years and 11.5 months that the dose is valid.  Another dose should be forecast.
2013-0163,# 1 Pentacel at 7 yrs.  Off label use but counts as dose 1. ,05/10/2014,F,,,,Not complete,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,09/10/2020,Recommended based on age,,1.0,"This test case describes when a child is administered a first dose of DTaP vaccine (Pentacel) at age seven years,that the dose is valid.  Another dose should be forecast."
2013-0164,# 2 Pentacel at 10 wks-5 days,03/06/2021,F,,,,Not complete,04/13/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/06/2021,09/02/2021,DTAP,05/10/2021,Age: Below Absolute Minimum,01/01/2013,09/10/2020,Recommended based on age,,1.0,This test case describes when a child is administered Pentacel as a second dose of the DTaP vaccine at 10 weeks - 5 days that the dose is not valid.  A repeat dose should be forecast.
2013-0165,# 2 Pentacel at 10 wks-4 days,03/05/2021,F,,,,Not complete,04/12/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/11/2021,09/05/2021,11/01/2021,DTAP,05/10/2021,Age: At Absolute Minimum,01/01/2013,09/10/2020,Recommended based on age,,1.0,This test case describes when a child is administered Pentacel as a second dose of the DTaP vaccine at 10 weeks - 4 days that the dose is valid.  Another dose should be forecast.
2013-0166,# 2 Pentacel at 6 yrs .  Off label but counts. ,05/10/2015,F,,,,Not complete,05/10/2016,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/07/2021,06/07/2021,DTAP,05/10/2021,All Valid: Forecast Test,01/01/2013,09/10/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,"This test case describes when a child is administered a second dose of DTaP (Pentacel) vaccine at age six years of age,that the dose is valid.  Another dose should be forecast."
2016-0001,"Dose #1 received at 4 months, dose #2 received at 8 months, dose #3 received at 2 years, and dose #4 received at 3 years. Current Age is 7 yrs.",05/10/2014,F,,,,Not complete,09/10/2014,"DTaP, unspecified formulation",107,,Valid,,01/10/2015,"DTaP, unspecified formulation",107,,Valid,,05/10/2016,"DTaP, unspecified formulation",107,,Valid,,05/10/2017,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,5,05/10/2021,05/10/2021,05/10/2021,DTAP,05/10/2021,All Valid: Forecast Test,03/15/2016,09/14/2020,Recommended based on age,New logic concerning Tdap,2.2,"This test case describes when a patient has been administered dose #1 at 4 months dose #2 at 8 months, and dose #3 at two years of age and dose #4 at three years of age and patient is now 7 years of age that another dose should be forecast."
2016-0002,"Dose #1 received at 2 years, dose #2 received at 3 years, and dose #3 received at 4 years. Current age 7 yrs",05/10/2014,F,,,,Not complete,07/10/2016,"DTaP, unspecified formulation",107,,Valid,,07/24/2017,"DTaP, unspecified formulation",107,,Valid,,10/10/2018,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,05/10/2021,05/10/2021,05/10/2021,DTAP,05/10/2021,All Valid: Forecast Test,03/15/2016,09/14/2020,Recommended based on age,New logic concerning Tdap,2.2,"This test case describes when a patient has been administered dose #1 at 2 years of age #2 at 3 years of age, and dose #3 at 4 years of age and patient is now 7 years of age that another dose should be forecast."
2016-0003,3 Dose received at < 12 months.  Current age is 7 years. ,05/10/2014,F,,,,Not complete,07/10/2014,"DTaP, unspecified formulation",107,,Valid,,09/10/2014,"DTaP, unspecified formulation",107,,Valid,,01/10/2015,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,05/10/2021,05/10/2021,05/10/2021,DTAP,05/10/2021,All Valid: Forecast Test,03/15/2016,09/14/2020,Recommended based on age,New logic concerning Tdap,2.2,"This test case describes when a patient has been administered three doses (at ages 2, 4, and 8 months) of the DTaP vaccine at less than 12 months of age and patient is now 7 years of age that another dose should be forecast."
2016-0004,Dose #1 given at < 12 months. Current age is 7. ,05/10/2014,F,,,,Not complete,10/10/2014,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,05/10/2021,05/10/2021,05/10/2021,DTAP,05/10/2021,All Valid: Forecast Test,03/15/2016,09/14/2020,Recommended based on age,New logic concerning Tdap,2.2,This test case describes when a patient has been administered a dose of the DTaP vaccine at less than 12 months of age and patient is now 7 years of age that another dose should be forecast.
2016-0005,"Dose #1 given at 3 months, dose #2 given at 1 year, dose #3 given at 2 years, and dose # 4 given at 3 years. Current age is 7 yrs ",05/10/2014,F,,,,Not complete,08/10/2014,"DTaP, unspecified formulation",107,,Valid,,05/10/2015,"DTaP, unspecified formulation",107,,Valid,,05/10/2016,"DTaP, unspecified formulation",107,,Valid,,05/10/2017,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,5,05/10/2021,05/10/2021,05/10/2021,DTAP,05/10/2021,All Valid: Forecast Test,03/15/2016,09/14/2020,Recommended based on age,New logic concerning Tdap,2.2,"This test case describes when a patient has been administered dose #1 at 3 months, dose #2 at 1 year of age, dose #3 at 2 years, #3 at 2 years of age, and dose #4 at three years of age and patient is now 7 years of age that another dose should be forecast."
2016-0006,"Dose #1 given at 5 months, dose #2 given at 1 year, dose #3 given at 2 years. Current age is 7 yrs ",05/10/2014,F,,,,Not complete,10/10/2014,"DTaP, unspecified formulation",107,,Valid,,04/30/2015,"DTaP, unspecified formulation",107,,Valid,,05/10/2016,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,05/10/2021,05/10/2021,05/10/2021,DTAP,05/10/2021,All Valid: Forecast Test,03/15/2016,09/14/2020,Recommended based on age,New logic concerning Tdap,2.2,"This test case describes when a patient has been administered dose #1 at 5 months, dose #2 at 1 year of age, dose #3 at 2 years, and patient is now 7 years of age that another dose should be forecast."
2016-0007,"Dose #1 at 9 months, dose #2 at 2 years, and dose #3 at 5 years. Current Age is 7 yrs",05/10/2014,F,,,,Not complete,02/10/2015,"DTaP, unspecified formulation",107,,Valid,,05/10/2016,"DTaP, unspecified formulation",107,,Valid,,05/10/2019,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,05/10/2021,05/10/2021,05/10/2021,DTAP,05/10/2021,All Valid: Forecast Test,03/15/2016,09/15/2020,Recommended based on age,New logic concerning Tdap,2.2,"This test case describes when a patient has been administered dose #1 at 9 months, dose #2 at 2 year of age, dose #3 at 5 years, and patient is now 7 years of age that another dose should be forecast."
2016-0008,Dose 1 given at < 12 mo Dose 2 given at 2 yrs Current age 7 yrs,05/10/2014,F,,,,Not complete,07/10/2014,"DTaP, unspecified formulation",107,,Valid,,05/10/2016,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,05/10/2021,05/10/2021,05/10/2021,DTAP,05/10/2021,All Valid: Forecast Test,03/15/2016,09/17/2020,Recommended based on age,New logic concerning Tdap,2.2,This test case describes a child who is currently age seven years but was administered a first dose of the DTaP vaccine at less than 12 months of age and a second dose at age 2 years that the doses are valid and that another dose should be forecast.
2016-0009,"3 doses at < 12 mos, 1 dose at 1.5 yrs. Current Age is 7 yrs.",05/10/2014,F,,,,Not complete,07/10/2014,"DTaP, unspecified formulation",107,,Valid,,11/10/2014,"DTaP, unspecified formulation",107,,Valid,,01/10/2015,"DTaP, unspecified formulation",107,,Valid,,10/10/2015,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,5,05/10/2021,05/10/2021,05/10/2021,DTAP,05/10/2021,All Valid: Forecast Test,03/15/2016,09/17/2020,Recommended based on age,New logic concerning Tdap,2.2,This test case describes a child who is currently age seven years but was administered three dose of the DTaP vaccine at less than 12 months of age and one dose at 1.5 years that the doses are valid and that another dose should be forecast.
2016-0010,Dose 1 and 2 given at < 12 months of age. Dose # 3 given at 2 years and dose #4 given at 3 years. Current age is 7 years. ,05/10/2014,F,,,,Not complete,08/10/2014,"DTaP, unspecified formulation",107,,Valid,,02/10/2015,"DTaP, unspecified formulation",107,,Valid,,05/22/2016,"DTaP, unspecified formulation",107,,Valid,,06/24/2017,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,5,05/10/2021,05/10/2021,05/10/2021,DTAP,05/10/2021,All Valid: Forecast Test,03/15/2016,09/21/2020,Recommended based on age,New logic concerning Tdap,2.2,"This test case describes a child who is currently age seven years but was administered a first and second dose of the DTaP vaccine at less than 12 months of age, a third dose was administered at age 2 years, and a fourth dose was administered at 3 years that the doses are valid and that another dose should be forecast."
2017-0003,DTaP - Dose 3 to dose 4 interval 4 months-4 days,04/10/2020,F,,,,Not complete,06/10/2020,"DTaP, unspecified formulation",107,,Valid,,08/10/2020,"DTaP, unspecified formulation",107,,Valid,,01/10/2021,"DTaP, unspecified formulation",107,,Valid,,05/06/2021,"DTaP, unspecified formulation",107,,Valid,,,,,,,,,,,,,,,,,,,,5,04/10/2024,04/10/2024,04/09/2027,DTAP,05/10/2021,All Valid: Forecast Test,06/12/2017,06/17/2020,Recommended based on interval,Updated to allow the grace period for dose #4 of DTaP.,3.3,This test case describes when  dose #4 of DTaP is administered at least 4 months -4 days from Dose #3 that the dose is considered to be valid.
2017-0005,DTaP - Dose 3 to dose 4 interval 4 months-5 days,04/10/2020,F,,,,Not complete,06/10/2020,"DTaP, unspecified formulation",107,,Valid,,08/10/2020,"DTaP, unspecified formulation",107,,Valid,,01/10/2021,"DTaP, unspecified formulation",107,,Valid,,05/05/2021,"DTaP, unspecified formulation",107,,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,4,11/05/2021,11/05/2021,12/07/2021,DTAP,05/10/2021,Interval: Below Absolute Minimum,06/12/2017,06/18/2020,Recommended based on interval,,3.3,This test case describes when  dose #4 of DTaP is administered at least 4 months -5 days from Dose #3 that the dose is not valid.
2020-0002,Decennial dose as Tdap.,05/10/1999,F,,,,Not complete,07/10/1999,"DTaP, unspecified formulation",107,,Valid,,09/10/1999,"DTaP, unspecified formulation",107,,Valid,,11/10/1999,"DTaP, unspecified formulation",107,,Valid,,08/10/2000,"DTaP, unspecified formulation",107,,Valid,,05/10/2003,"DTaP, unspecified formulation",107,,Valid,,05/10/2011,Tdap,115,,Valid,,05/10/2021,Tdap,115,,Valid,,7,05/10/2026,05/10/2031,06/06/2031,DTAP,05/10/2021,All Valid: Forecast Test,02/09/2020,02/11/2020,Recommended based on interval,,4.3,"This test case describes when a patient receives Tdap as the decennial dose, that the dose is considered to be valid and another dose should be forecast."
2020-0003,Adult with no previous dose of the Tdap vaccine,05/10/1990,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/10/1997,05/10/1997,05/10/1997,DTAP,05/10/2021,No doses administered,02/09/2020,06/18/2020,Recommended based on age,,4.3,"This test case describes when a patient has no previous doses of the tetanus, diphtheria, or pertussis vaccines, that the first dose should be forecast."
2020-0004,Adult patient with dose #1 of DTaP/Tdap/Td,05/10/1990,F,,,,Not complete,05/10/2021,Tdap,115,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,DTAP,05/10/2021,All Valid: Forecast Test,02/09/2020,06/18/2020,Recommended based on minimum interval from previous dose (catch-up),,4.3,This test case describes when a patient has received the first dose of the DTaP/Tdap/Td vaccine that another dose should be forecast.
2020-0005,Adult patient with dose #2 of DTaP/Tdap/Td at 4 weeks,04/12/1990,F,,,,Not complete,04/12/2021,Tdap,115,,Valid,,05/10/2021,Td(adult) unspecified formulation,139,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,11/10/2021,11/10/2021,11/10/2021,DTAP,05/10/2021,All Valid: Forecast Test,02/09/2020,06/18/2020,Recommended based on interval,,4.3,This test case describes when a patient has received the second dose of  DTaP/Tdap/Td vaccine at 4 weeks that another dose should be forecast.
2020-0006,Adult patient with dose #2 of DTaP/Tdap/Td at 4 weeks - 4 days,04/16/1990,F,,,,Not complete,04/16/2021,Tdap,115,,Valid,,05/10/2021,Td(adult) unspecified formulation,139,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,11/10/2021,11/10/2021,11/10/2021,DTAP,05/10/2021,Interval: At Absolute minimum,02/09/2020,06/18/2020,Recommended based on interval,,4.3,This test case describes when a patient has received the second dose of DTap/Tdap/Td vaccine at 4 weeks - 4 days that the dose should be considered valid and that another dose should be forecast.
2020-0007,Adult patient with dose #2 of DTaP/Tdap/Td at 4 weeks - 5 days,04/17/1990,F,,,,Not complete,04/17/2021,Tdap,115,,Valid,,05/10/2021,Td(adult) unspecified formulation,139,,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,DTAP,05/10/2021,Interval: Below Absolute Minimum,02/09/2020,06/18/2020,Recommended based on interval,,4.3,This test case describes when a patient has received the second dose of DTaP/Tdap/Td vaccine at 4 weeks - 5 days that the dose should not be considered to be valid.  Another dose should be forecast.
2020-0008,Adult patient with dose #3 of Td at 6 mos,10/10/1989,F,,,,Not complete,10/10/2020,Tdap,115,,Valid,,11/07/2020,Td(adult) unspecified formulation,139,,Valid,,05/07/2021,Td(adult) unspecified formulation,139,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,05/07/2026,05/07/2031,06/03/2031,DTAP,05/10/2021,All Valid: Forecast Test,02/09/2020,06/18/2020,Recommended based on interval,,4.3,This test case describes when a patient has received the third dose of DTaP/Tdap/Td vaccine at 6 months that the dose is considered to be valid.  Forecast another dose.
2020-0009,Adult patient with dose #3 of Td at 6 mos - 4 days,10/10/1989,F,,,,Not complete,10/10/2020,Tdap,115,,Valid,,11/07/2020,Td(adult) unspecified formulation,139,,Valid,,05/03/2021,Td(adult) unspecified formulation,139,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,05/03/2026,05/03/2031,05/30/2031,DTAP,05/10/2021,All Valid: Forecast Test,02/09/2020,06/18/2020,Recommended based on interval,,4.3,This test case describes when a patient has received the third dose of DTaP/Tdap/Td vaccine at 6 months - 4 days that the dose is considered to be valid.  Forecast another dose.
2020-0010,Adult patient with dose #3 of Td at 6 mos - 5 days,10/10/1989,F,,,,Not complete,10/10/2020,Tdap,115,,Valid,,11/07/2020,Td(adult) unspecified formulation,139,,Valid,,05/02/2021,Td(adult) unspecified formulation,139,,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,3,11/02/2021,11/02/2021,11/02/2021,DTAP,05/10/2021,All Valid: Forecast Test,02/09/2020,06/18/2020,Recommended based on interval,,4.3,This test case describes when a patient has received the third dose of DTaP/Tdap/Td vaccine at 6 months - 5 days that the dose is not valid.  Forecast a repeat dose.
2013-0167,Newborn,08/01/2020,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,02/01/2021,02/01/2021,,FLU,08/01/2020,No Doses Administered,01/01/2013,08/11/2020,Recommended based on age,"V4.4: Rolled test cases forward from 2019-2020 season to 2019-2020 season.
V4.1:  Rolled test cases forward from 2018-19 season to 2019-2020 season.
V3.5: Rolled test cases forward from 2017-18 season to 2018-19 season.",4.4,This test case describes when assessing a newborn for the first dose of the Influenza vaccine that it should be administered at the recommended age of 6 months.
2013-0168,# 1 to # 2 interval 28 days,05/01/2019,F,,,,Not complete,12/01/2019,"influenza, unspecified formulation",88,,Valid,,12/29/2019,"influenza, unspecified formulation",88,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,07/01/2020,07/01/2020,,FLU,12/29/2019,Interval: At Minimum,01/01/2013,08/11/2020,Recommended based on seasonal start date,"V4.4: Rolled test cases forward from 2019-2020 season to 2020-2021 season.
V4.1: Rolled test cases forward from 2018-19 season to 2019-20 season.
V3.5: Rolled test cases forward from 2017-18 season to 2018-19 season.",4.4,This test case describes when a newborn receives the first dose of the Influenza vaccine at 6 months and a second dose at 28 days later that the next dose of influenza is recommended at the next seasonal flu begin date.
2013-0169,Child under 9 needs two in first season,09/01/2013,F,,,,Not complete,09/01/2020,"Afluria, quadrivalent",158,SEQ,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,09/29/2020,09/29/2020,,FLU,09/01/2020,All Valid: Forecast Test,01/01/2013,08/11/2020,Recommended based on interval,"V4.4: Rolled test cases forward from 2019-2020 season to 2020-2021 season. Updated Administered vaccine to quadrivalent as trivalent will eventually phase out.
V4.1: Rolled test cases forward from 2018-19 season to 2019-2020 season.
V3.5: Rolled test cases forward from 2017-18 season to 2018-19 season.",4.4,"This test case describes when a child under the age of 9 receives dose 1 of the influenza vaccine in his first season, that a second dose is recommended at 4 weeks later."
2013-0170,Child under 9 received only one in first season,04/04/2014,F,,,,Not complete,10/15/2020,"influenza, unspecified formulation",88,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,11/12/2020,11/12/2020,,FLU,10/15/2020,All Valid: Forecast Test,01/01/2013,08/11/2020,Recommended based on interval,"V4.4: Rolled test cases forward from 2019-2020 season to 2020-2021 season.
V4.1: Rolled test cases forward from 2018-2019 season to 2019-2020 season.
V3.5: Rolled test cases forward from 2017-18 season to 2018-19 season.",4.4,"This test case describes when a child under the age of 9 receives only one influenza dose in his first season, that a second dose is recommended at 4 weeks later."
2013-0171,Child under 9 received two in first season,05/10/2014,F,,,,Complete,08/01/2020,"influenza, unspecified formulation",88,,Valid,,09/04/2020,"influenza, unspecified formulation",88,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,FLU,11/27/2020,All Valid: Forecast Test,01/01/2013,08/11/2020,Recommended based on seasonal start date,"V4.4: Rolled test cases forward from 2019-2020 season to 2020-2021 season.
V4.1: Rolled test cases forward from 2018-19 season to 2019-20 season.
V3.5: Rolled test cases forward from 2016-17 season to 2017-18 season.",4.4,"This test case describes when a child under 9 years of age receives two doses of the Influenza vaccine in his first season, that no additional doses are needed during that season."
2013-0172,Invalid dose 1st season,05/01/2020,F,,,,Not complete,10/01/2020,"Afluria, quadrivalent",158,SEQ,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,11/01/2020,11/01/2020,,FLU,10/15/2020,Age: Below Absolute Minimum,01/01/2013,08/11/2020,Recommended based on age,"V4.4: Rolled test cases forward from 2019-2020 season to 2020-2021 season. Updated CVX and MVX  codes to use quadrivalent.
V4.1: Rolled test cases forward from 2018-19 season to 2019-20 season.
V3.5: Rolled test cases forward from 2017-18 season to 2018-19 season.",4.4,"This test case describes when a child receives his first dose of the influenza vaccine before the age of 6 months, that the dose is not valid and should be repeated at the recommended age."
2013-0178,# 1 at 6 mo-4 days,04/01/2020,F,,,,Not complete,09/27/2020,"influenza, unspecified formulation",88,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,10/25/2020,10/25/2020,,FLU,09/27/2020,Age: At Absolute Minimum,01/01/2013,08/11/2020,Recommended based on interval,"V4.4: Rolled test cases forward from 2019-2020 season to 2020-2021 season.
V4.1: Rolled test cases forward from 2018-19 season to 2019-20 season.
V3.5: Rolled test cases forward from 2017-18 season to 2018-19 season.",4.4,"This test case describes when a child receives his first dose of the influenza vaccine at 6 months - 4 days, that the dose is considered to be valid, and the next dose should be forecasted."
2013-0179,# 1 at 6 mo,04/01/2020,F,,,,Not complete,10/01/2020,"influenza, unspecified formulation",88,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,10/29/2020,10/29/2020,,FLU,10/01/2020,Age: At Minimum,01/01/2013,08/11/2020,Recommended based on interval,"V4.4: Rolled test cases forward from 2019-2020 season to 2020-2021 season.
V4.1: Rolled test cases forward from 2018-19 season to 2019-20 season.
V3.5: Rolled test cases forward from 2017-18 season to 2018-19 season.",4.4,"This test case describes when a child receives his first dose of the Influenza vaccine at 6 months of age, that the dose is considered to be valid, and the second dose should be forecasted."
2013-0183,# 1 to # 2 interval 23 days,02/01/2020,F,,,,Not complete,09/01/2020,"influenza, unspecified formulation",88,,Valid,,09/24/2020,"influenza, unspecified formulation",88,,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,10/22/2020,10/22/2020,,FLU,09/24/2020,Interval: Below Absolute Minimum,01/01/2013,08/11/2020,Recommended based on minimum interval from invalid dose,"V4.4: Rolled test cases forward from 2019-2020 season to 2020-2021 season.
V4.1: Rolled test cases forward from 2018-19 season to 2019-20 season.
V3.5: Rolled test cases forward from 2017-18 season to 2018-19 season.",4.4,"This test case describes when a child receives the second dose of the Influenza vaccine at less than 4 weeks - 4 days from the previous dose, that the dose is not valid and a repeat dose should be recommended at 4 weeks later."
2013-0184,# 1 to # 2 interval 24 days,01/09/2020,F,,,,Complete,09/01/2020,"influenza, unspecified formulation",88,,Valid,,09/25/2020,"influenza, unspecified formulation",88,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,FLU,09/25/2020,Interval: At Absolute Minimum,01/01/2013,08/11/2020,Recommended based on seasonal start date,"V4.4: Rolled test cases forward from 2019-2020 season to 2020-2021 season.
V4.1: Rolled test cases forward from 2018-19 season to 2019-20 season.
V3.5: Rolled test cases forward from 2017-18 season to 2018-19 season.",4.4,"This test case describes when a child receives the second dose of the influenza vaccine 24 days after the first dose, that the dose is considered to be valid. "
2016-0012,Child under 9 received one in previous season and one in current season,06/01/2019,M,,,,Not complete,12/01/2019,"influenza, unspecified formulation",88,,Valid,,09/01/2020,"influenza, unspecified formulation",88,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,09/29/2020,09/29/2020,,FLU,09/01/2020,Interval: At Minimum,09/27/2016,08/11/2020,Recommended based on interval,"V4.4: Rolled test cases forward from 2019-2020 season to 2020-2021 season.
V4.1: Rolled test cases forward from 2018-19 season to 2019-20 season.
V3.5: Rolled test cases forward from 2017-18 season to 2018-19 season.",4.4,This test case describes when a child under 9 years of age received one dose of the Influenza vaccine in a previous season and one in the current season that an additional dose is recommended in the current season. Forecast second dose at 4 weeks later.
2018-0024,Patient 9 years or older with no current seasonal dose,08/10/2010,M,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,07/01/2020,07/01/2020,,FLU,11/27/2020,No Doses Administered,11/26/2018,08/11/2020,Recommended based on age,"V4.4: Rolled test cases forward from 2019-2020 season to 2020-2021 season.
V4.2: Updated forecast dose number from #2 to #1
V4.1: Rolled test case forward from 2018-19 season to 2019-20 season.",4.4,This test case describes when a patient is 9 years or older and does not have a current seasonal dose that a dose should be forecast.
2018-0025,Patient 9 years or older with one current seasonal dose,08/10/2011,M,,,,Complete,09/10/2020,"influenza, unspecified formulation",88,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,FLU,09/10/2020,All Valid: Forecast Test,11/26/2018,08/11/2020,Recommended based on seasonal start date,"V4.4: Rolled test cases forward from 2019-2020 season to 2020-2021 season.
V4.1: Rolled test cases forward from 2018-19 season to 2019-20 season.",4.4,This test case describes when a patient is 9 years or older and has been administered a dose of the flu vacccine in the current season that no additional doses should be forecast for the season.
2018-0026,Child under 9 years with dose in current season and two doses in previous different seasons,03/06/2017,M,,,,Complete,09/15/2017,"influenza, unspecified formulation",88,,Valid,,10/13/2017,"influenza, unspecified formulation",88,,Valid,,09/04/2020,"influenza, unspecified formulation",88,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,FLU,09/04/2020,All Valid: Forecast Test,11/26/2018,08/11/2020,Recommended based on seasonal start date,"V4.4: Rolled test cases forward from 2019-2020 season to 2020-2021 season.
V4.1: Rolled test cases forward from 2018-19 season to 2019-20 season.",4.4,"This test case describes when a child under 9 years of age receives a flu vaccine in the current season and two vaccine doses in previous different season, that the series is complete for the season."
2019-0004,Child received first dose at 9 years.  Series complete,08/10/2011,M,,,,Complete,08/18/2020,"influenza, unspecified formulation",88,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,FLU,08/18/2020,All Valid: Forecast Test,11/26/2018,08/11/2020,Recommended based on seasonal start date,V4.4: Rolled test cases forward from 2019-2020 season to 2020-2021 season.,4.4,This test case describes when a child age 9 years is administered a first dose of the Flu vaccine that no additional doses are needed.  Series is complete for season.
2019-0005,"Child entered season at 8 years of age, received dose before 9. Forecast another dose",09/01/2011,M,,,,Not complete,08/31/2020,"influenza, unspecified formulation",88,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,09/28/2020,09/28/2020,,FLU,09/01/2020,All Valid: Forecast Test,11/26/2018,08/11/2020,Recommended based on interval.,V4.4: Rolled test cases forward from 2019-2020 season to 2020-2021 season.,4.4,"This test case describes when a child enters the flu season at age 8 years, received their first dose, but is now 9 years old. Per 2019-20 ACIP flu recommendations, the patient needs a second dose."
2019-0015,Adult with no previous dose of the Influenza vaccine,09/01/1983,M,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,07/01/2020,07/01/2020,,FLU,09/01/2020,No Doses Administered ,11/26/2018,08/11/2020,Recommended based on seasonal date,V4.4: Rolled test cases forward from 2019-2020 season to 2020-2021 season.,4.4,"This test case describes when an adult patient has not received any doses of the influenza vaccine, that a dose should be forecast."
2019-0016,Adult with a dose of the influenza vaccine,09/01/1983,M,,,,Complete,09/01/2020,"Fluzone, Quadrivalent",158,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,FLU,09/01/2020,All Valid: Forecast Test,11/26/2018,08/11/2020,Not Recommended: series complete,V4.4: Rolled test cases forward from 2019-2020 season to 2020-2021 season.,4.4,"This test case describes when an adult patient has received a dose of the  influenza vaccine, that no additional doses are needed. Series is complete for the season."
2013-0185,Infant forecasting,05/10/2021,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/10/2022,05/10/2022,06/06/2023,HepA,05/10/2021,No Doses Administered,01/01/2013,11/15/2017,Recommended based on age,,1.0,This test case describes when assessing a newborn for the first dose of the 2-dose Hep A vaccine that it is not recommended until at least 12 months of age.
2013-0186,Dose 1 to dose 2 interval 6 months.  Series complete. ,09/10/2019,F,,,,Complete,11/10/2020,"Hep A, unspecified formulation",85,,Valid,,05/10/2021,"Hep A, unspecified formulation",85,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepA,05/10/2021,Interval: At Minimum,01/01/2013,11/15/2017,Not recommended: series complete,,1.0,"This test case describes when the second dose of the 2 dose Hep A vaccine is administered at least 6 months after the first dose, that no additional doses are recommended and that the series is considered complete."
2013-0188,Adult dose mistakenly given to a child.  Counts as valid. ,05/10/2020,F,,,,Not complete,05/10/2021,HAVRIX-ADULT,52,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,11/10/2021,11/10/2021,06/06/2022,HepA,05/10/2021,Vaccine: Off Label,01/01/2013,11/15/2017,Recommended based on age,"Past Due Date was previously calculated based on an interval, but should have been calculated based on age of 24 months + 4 weeks - 1 day",1.1,"This test case describes when an adult dose of the Hep A vaccine is erroneously administered to a child, that the dose is considered valid.  The second (age appropriate ) dose should be forecasted."
2013-0189,Dose # 1 at age 12 months-5 days,05/15/2020,F,,,,Not complete,05/10/2021,"Hep A, unspecified formulation",85,,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/15/2021,05/15/2021,06/11/2022,HepA,05/10/2021,Age: Below Absolute Minimum,01/01/2013,11/15/2017,Recommended based on age,,1.0,"This test case describes when  a dose of the Hep A  2 dose vaccine is administered to a child at 12 months - 5 days, that the dose is not considered to be valid."
2013-0190,Dose # 1 at age 12 months-4 days,05/14/2020,F,,,,Not complete,05/10/2021,"Hep A, unspecified formulation",85,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,11/14/2021,11/14/2021,06/10/2022,HepA,05/10/2021,Age: At Absolute Minimum,01/01/2013,05/29/2020,Recommended based on age,"V1.1: Past Due Date was previously calculated based on an interval, but should have been calculated based on age of 24 months + 4 weeks - 1 day",1.1,"This test case describes when a first dose of the Hep A 2 dose vaccine is administered to a child at 12 months - 4 days, that the dose is considered to be valid.  The second dose should be forecasted."
2013-0191,Dose # 1 at age 12 months.,05/10/2020,F,,,,Not complete,05/10/2021,"Hep A, unspecified formulation",85,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,11/10/2021,11/10/2021,06/06/2022,HepA,05/10/2021,Age: At Minimum,01/01/2013,11/15/2017,Recommended based on age,"Past Due Date was previously calculated based on an interval, but should have been calculated based on age of 24 months + 4 weeks - 1 day",1.1,"This test case describes when a first dose of the Hep A 2 dose vaccine is administered to a child at 12 months of age, that the dose is considered to be valid.  Forecast second dose."
2013-0192,Dose 1 to dose 2 interval 6 mo-5 days=invalid,11/15/2019,F,,,,Not complete,11/15/2020,"Hep A, unspecified formulation",85,,Valid,,05/10/2021,"Hep A, unspecified formulation",85,,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,11/10/2021,11/10/2021,12/12/2021,HepA,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,11/15/2017,Recommended based on minimum interval from invalid dose,"V1.1: Past Due Date was previously calculated based on an interval, but should have been calculated based on age of 24 months + 4 weeks - 1 day",1.1,"This test case describes when the second dose of the 2 dose Hep A vaccine is administered at 6 months - 5 days after the first dose, that the dose is not considered to be valid.  A repeat dose should be forecasted."
2013-0193,Dose 1 to Dose 2 interval 6 mo-4 days.  Series complete.,11/14/2016,F,,,,Complete,11/14/2020,"Hep A, unspecified formulation",85,,Valid,,05/10/2021,"Hep A, unspecified formulation",85,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepA,05/10/2021,Interval: At Absolute Minimum,01/01/2013,05/29/2020,Not recommended: series complete,V3.5: Lowered Age from 8 years to 4 years to better associate with new Age Groupings. No Effective change to test case other than Age of patient and vaccinations.,3.5,"This test case describes when the second dose of the HepA 2 dose vaccine is administered at 6 months - 4 days, that the dose is considered valid and the series is considered complete."
2013-0194,Dose # 2 at 18 months=series complete. ,11/10/2019,F,,,,Complete,11/10/2020,"Hep A, unspecified formulation",85,,Valid,,05/10/2021,"Hep A, unspecified formulation",85,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepA,05/10/2021,Age: At Minimum,01/01/2013,11/15/2017,Not recommended: series complete,,1.0,"This test case describes when the second dose of a HepA 2 dose vaccine is administered to child at 18 months of age and at an interval of 6 months from the previous dose, that the dose is considered valid and the series is considered complete."
2013-0196,Dose 1 to dose 2 interval 6 mo-5 days,09/10/2019,F,,,,Not complete,11/10/2020,"Hep A, unspecified formulation",85,,Valid,,05/05/2021,"Hep A, unspecified formulation",85,,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,11/05/2021,11/05/2021,11/05/2021,HepA,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,08/24/2018,Recommended based on minimum interval from invalid dose,Child is lapse enough that the Past Due Date should have been aligned with the earliest and recommended.,1.1,"This test case describes when a second dose of the Hep A 2 dose vaccine is administered to a child at 6 months -5 days, that the dose is not considered valid.  A repeat dose should be forecasted."
2013-0197,Dose 1 to dose 2 interval 6 months-4 days.  Series complete. ,09/10/2019,F,,,,Complete,11/10/2020,"Hep A, unspecified formulation",85,,Valid,,05/06/2021,"Hep A, unspecified formulation",85,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepA,05/10/2021,Interval: At Absolute Minimum,01/01/2013,05/29/2020,Not recommended: series complete,,1.0,"This test case describes when a second dose of the Hep A 2 dose vaccine is administered to a child at 18 months age and with an interval of at least 6 months -4 days after the previous dose, that the dose is considered valid and no additional doses are recommended.  The series is complete. "
2019-0010,No doses of Hep A vaccine at age 18 years,05/10/2003,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/10/2004,05/10/2004,06/06/2005,HepA,05/10/2021,No Doses Administered,09/19/2019,05/29/2020,Recommended based on age,Added a past due date.,4.3,This test case describes when a patient is 18 years of age and has no previous doses of the Hep A vaccine that the first dose should be forecast.
2019-0011,Dose #1 of Hep A at age 18 years,05/10/2003,F,,,,Not complete,05/10/2021,"Hep A, adult",52,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,11/10/2021,11/10/2021,11/10/2021,HepA,05/10/2021,Age: At Minimum,09/19/2019,05/29/2020,Recommended based on age,,4.3,This test case describes when dose #1 of the Hep A vaccine is administered to an adolescent that a second dose should be forecast.
2019-0012,Dose 2 of Hep A at 6 months,11/10/2002,F,,,,Complete,11/10/2020,HAVRIX-ADULT,52,SKB,Valid,,05/10/2021,HAVRIX-ADULT,52,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepA,05/10/2021,Interval: At Minimum,09/19/2019,02/11/2020,Not recommended: series complete,,4.3,"This test case describes when an adolescent receives a second dose of the Hep A vaccine at an interval of 6 month, that no additional doses are needed.  The series is complete."
2019-0013,Dose 2 of Hep A at 6 months -4 days,11/10/2002,F,,,,Complete,11/10/2020,HAVRIX-ADULT,52,SKB,Valid,,05/06/2021,HAVRIX-ADULT,52,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepA,05/10/2021,Interval: At Absolute Minimum,09/19/2019,05/29/2020,Not recommended: series complete,,4.3,"This test case describes when an adolescent receives a second dose of the Hep A vaccine at an interval of 6 month- 4 days, that no additional dose  are needed.  The series is complete."
2019-0014,Dose 2 of Hep A at 6 months -5 days,11/10/2002,F,,,,Not complete,11/10/2020,HAVRIX-ADULT,52,SKB,Valid,,05/05/2021,HAVRIX-ADULT,52,SKB,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,11/05/2021,11/05/2021,11/05/2021,HepA,05/10/2021,Interval: Below Absolute Minimum,09/19/2019,02/11/2020,Recommended based on minimum interval from previous dose (catch-up),,4.3,"This test case describes when an adolescent receives a second dose of the Hep A vaccine at an interval of 6 month- 5 days, that  another dose should be forecast."
2020-0001,Dose#3 administered at least 6 months after 1st valid dose,11/10/2019,F,,,,Complete,11/10/2020,"Hep A, unspecified formulation",85,,Valid,,04/10/2021,"Hep A, unspecified formulation",85,,Not Valid,Interval: too short,05/10/2021,"Hep A, unspecified formulation",85,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HepA,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,02/06/2020,Recommended based on minimum interval from invalid dose,,4.3,"This test case describes when a third dose is administered at least 6 months after the first dose, that the dose is considered to be valid.  The series is complete. The invalid dose (2nd dose administered) is not considered in the spacing."
2013-0198,Newborn Testing.  No vaccinations to date. ,05/10/2021,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/10/2021,05/10/2021,06/06/2021,HepB,05/10/2021,No Doses Administered,01/01/2013,02/09/2018,Recommended based on age,,1.0,This test case describes the forecasting of the Hep B vaccine for a newborn.
2013-0199,Dose 1 to dose 2 interval 28-5 days,03/17/2021,F,,,,Not complete,04/17/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,05/10/2021,RECOMBIVAX-PEDS,08,MSD,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,07/14/2021,HepB,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/18/2020,Recommended based on minimum interval from invalid dose,,1.0,This test case describes when dose #2 of the Hep B vaccine is administered at an interval 28-5 days after dose #1 that the dose is not valid.  A repeat dose should be forecast.
2013-0200,Dose 1 to dose 2 interval 28-4 days,04/16/2021,F,,,,Not complete,04/16/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,05/10/2021,"Hep B, adolescent or pediatric",08,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,10/01/2021,10/16/2021,12/13/2022,HepB,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/18/2020,Recommended based on age,,1.0,This test case desribes when dose #2 of the Hep B vaccine is administered at an interval of 28-4 days after dose #1 that the dose is considered to be valid.
2013-0201,Dose 1 to dose 2 interval 28 days,04/12/2021,F,,,,Not complete,04/12/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,05/10/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,09/27/2021,10/12/2021,12/09/2022,HepB,05/10/2021,Interval: At Minimum,01/01/2013,02/09/2018,Recommended based on age,,1.0,This test case desribes when dose #2 of the Hep B vaccine is administered at an interval of 28 days after dose #1 that the dose is considered to be valid.
2013-0202,Dose 2 to dose 3 interval 8 wks-5 days. 4th dose needed.,09/20/2020,F,,,,Not complete,12/20/2020,RECOMBIVAX-PEDS,08,MSD,Valid,,03/20/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,05/10/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,05/15/2021,05/15/2021,05/17/2022,HepB,05/10/2021,All Valid: Forecast Test,01/01/2013,06/18/2020,Recommended based on interval ,"V4.2: Updated Forecast Test Type to ""Recommended based on interval""
V4.1: Changed forecast to reflect new 4-dose guidance from CEB.
v3.1: Changed dose 3 from not valid to valid due to Hep B 4 dose series",4.2,"This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 8 weeks - 5 days after dose #2, that the dose is considered valid, but a 4th dose is needed to complete the series."
2013-0203,Dose 2 to dose 3 interval 8 wks-4 days.  Series complete,09/29/2020,F,,,,Complete,10/17/2020,"Hep B, adolescent or pediatric",08,,Valid,,03/17/2021,"Hep B, adolescent or pediatric",08,,Valid,,05/08/2021,"Hep B, adolescent or pediatric",08,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/18/2020,Not recommended: series complete,,1.0,"This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 8 weeks - 4 days after dose #2, that the dose is considered to be valid. The series is complete."
2013-0204,Dose 2 to dose 3 interval is 8 weeks.  Series complete.,09/10/2020,F,,,,Complete,11/10/2020,"Hep B, adolescent or pediatric",08,,Valid,,03/10/2021,"Hep B, adolescent or pediatric",08,,Valid,,05/05/2021,"Hep B, adolescent or pediatric",08,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,Interval: At Minimum,01/01/2013,08/24/2018,Not recommended: series complete,,1.0,"This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 8 weeks after dose #2, that the dose is considered to be valid. The series is complete."
2013-0205,Dose 1 to dose 3 interval 16 weeks-5 days. 4th dose needed,10/23/2020,F,,,,Not complete,01/23/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,03/01/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,05/10/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,05/15/2021,05/15/2021,06/19/2022,HepB,05/10/2021,All Valid: Forecast Test,01/01/2013,06/18/2020,Recommended based on interval ,"V4.2: Updated Forecast Test Type to ""Recommended based on interval"".
V4.1: Changed forecast to reflect new 4 dose guidance from CEB.
V3.1: Changed dose 3 from valid to not valid due to Hep B 4 dose series",4.2,"This test case describes when dose #3 of the Hep B vaccine is administered at an interval less than 16 weeks - 4 days from dose #1 that the dose is considered to be valid, but a 4th dose is needed to complete the series."
2013-0206,Dose 1 to dose 3 interval 16 weeks-4 days. Series complete. ,10/25/2020,F,,,,Complete,01/22/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,03/17/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,05/10/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/18/2020,Not recommended: series complete,,1.0,This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 16 weeks - 4 days from dose #1 that the dose is considered to be valid.  The series is complete.
2013-0207,Dose 1 to dose 3 interval 16 weeks.  Series complete. ,10/18/2020,F,,,,Complete,01/18/2021,"Hep B, adolescent or pediatric",08,,Valid,,03/05/2021,"Hep B, adolescent or pediatric",08,,Valid,,05/10/2021,"Hep B, adolescent or pediatric",08,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,Interval: At Minimum,01/01/2013,02/09/2018,Not recommended: series complete,,1.0,This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 16 weeks from dose #1 that the dose is considered to be valid.  The series is complete.
2013-0208,Recombivax Hep B ages 11-15.  Dose 2 recommended in 4-6 months. ,10/20/2008,F,,,,Not complete,05/10/2021,RECOMBIVAX-ADULT,43,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,09/10/2021,09/10/2021,01/06/2022,HepB,05/10/2021,All Valid: Forecast Test,01/01/2013,06/18/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,"This test case describes when dose #1 of the Hep B Recombivax vaccine is administered at age 12 years, that dose #2 should be administered at 4 months - 6 months later."
2013-0209,Dose # 1 at age 0 days. ,05/10/2021,F,,,,Not complete,05/10/2021,"Hep B, unspecified formulation",45,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/10/2021,09/06/2021,HepB,05/10/2021,Age: At Minimum,01/01/2013,02/09/2018,Recommended based on age,,1.0,This test case describes when dose #1 of the Hep B vaccine is administered at 0 days that the dose is considered to be valid. 
2013-0210,Doses 1 and 2 of Recombvx at ages 11-15 years with ≥ 4 mo interval = series complete. ,07/04/2008,F,,,,Complete,01/10/2021,RECOMBIVAX-ADULT,43,MSD,Valid,,05/10/2021,RECOMBIVAX-ADULT,43,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,Interval: At Minimum,01/01/2013,06/18/2020,Not recommended: series complete,,1.0,"This test case describes when dose #2 of the Hep B Recombivax vaccine is administered at an interval of 6 months from dose #1  to a child age 12 years, that dose is considered to be valid.  The series is complete."
2013-0211,Dose 1 to dose 2 Recombivax interval  4 months-5 days.  Two dose adolescent schedule no longer applies.  ,01/15/2010,F,,,,Not complete,01/15/2021,RECOMBIVAX-ADULT,43,MSD,Valid,,05/10/2021,RECOMBIVAX-ADULT,43,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,07/05/2021,07/05/2021,07/05/2021,HepB,05/10/2021,All Valid: Forecast Test,01/01/2013,06/18/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,"This test case describes when dose #2 of the Hep B Recombivax vaccine is administered at an interval of 4 months - 5 days after dose #1 to a child age 11 years of age, that dose is not valid."
2013-0212,Dose 2 to dose 3 interval 8 wks-5 days in adolescent with two Recombivax not meeting rules for two dose adoles. 4th dose needed,08/10/2007,F,,,,Not complete,12/10/2020,RECOMBIVAX-ADULT,43,MSD,Valid,,03/10/2021,RECOMBIVAX-ADULT,43,MSD,Valid,,04/30/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,05/05/2021,05/05/2021,05/05/2021,HepB,05/10/2021,All Valid: Forecast Test,01/01/2013,06/18/2020,Recommended based on interval ,"V4.2: Updated Forecast Test Type to ""Recommended base on interval""
V4.1: Changed forecast to reflect new 4-dose guidance from CEB.
V3.1: Changed dose 3 from not valid to valid due to recent clarifications.  Also changed test case name to reflect a 4th dose is required.",4.2,"This test case describes when dose #3 of the Hep B Recomibivax vaccine is administered at an interval of 8 weeks - 5 days from dose #2 to an adolescent child, that the dose is valid, but a fourth dose is required."
2013-0213,Hep at birth.  Comvax at 6 wks and 6 mo. Hep series complete. ,02/04/2004,F,,,,Complete,02/04/2004,RECOMBIVAX-PEDS,08,MSD,Valid,,03/13/2004,COMVAX,51,MSD,Valid,,08/04/2004,COMVAX,51,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepB,08/04/2004,All Valid: Forecast Test,01/01/2013,02/26/2018,Not recommended: series complete,,1.0,"This test case describes when dose #1 of the Hep B vaccine is administered at birth, dose #2 is administered at an interval of 6 weeks after previous dose , and dose #3 is administered at 6 months after dose #2, that the series is complete. "
2013-0216,Hep B at birth. Comvax at 4 weeks and 6 months.  Series complete for Hep B.  ,02/02/2006,F,,,,Complete,02/02/2006,"Hep B, unspecified formulation",45,,Valid,,03/02/2006,COMVAX,51,MSD,Valid,,08/02/2006,COMVAX,51,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepB,08/02/2006,Interval: At Minimum,01/01/2013,02/26/2018,Not recommended: series complete,,1.0,"This test case describes when dose #1 of the Hep B vaccine is administered at birth, dose #2 is administered at an interval of 4 weeks after previous dose , and dose #3 is administered at 6 months after dose #2, that the series is complete. "
2013-0219,Hep B at birth. Comvax at 5 mo and 8 wks-4 days later.  Series complete for Hep B. ,05/05/2006,F,,,,Complete,05/05/2006,RECOMBIVAX-PEDS,08,MSD,Valid,,10/05/2006,COMVAX,51,MSD,Valid,,11/26/2006,COMVAX,51,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepB,11/26/2006,Interval: At Absolute Minimum,01/01/2013,06/18/2020,Not recommended: series complete,,1.0,"This test case describes when dose #1 of the Hep B vaccine is administered at birth, dose #2 is administered at an interval of 5 months after previous dose , and dose #3 is administered at 8 weeks - 4 days after dose #2, that the series is complete. "
2013-0220,Dose # 1 at age 1 day,05/09/2021,F,,,,Not complete,05/10/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/09/2021,09/05/2021,HepB,05/10/2021,All Valid: Forecast Test,01/01/2013,08/21/2019,Recommended based on age,V4.1: Updated Forecast Recommended Age to 1 month instead of 4 weeks after birth.,4.1,This test case describes when a newborn is administered dose #1 for he Hep B vaccine at age 1 day that the dose is considered to be valid.
2013-0221,Hep at birth.  Comvax at 5 mo and 8 wks later.  Series complete for Hep B. ,06/06/2006,F,,,,Complete,06/06/2006,RECOMBIVAX-PEDS,08,MSD,Valid,,11/06/2006,COMVAX,51,MSD,Valid,,01/01/2007,COMVAX,51,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepB,01/01/2007,Interval: At Minimum,01/01/2013,02/26/2018,Not recommended: series complete,,1.0,"This test case describes when dose #1 of the Hep B vaccine is administered at birth, dose #2 is administered at an interval of 5 months after previous dose , and dose #3 is administered at 8 weeks after dose #2, that the series is complete. "
2013-0222,Dose 1 to dose 3 interval of Comvax 16 wks-5 days. 4th dose needed,05/15/2002,F,,,,Not complete,08/01/2002,COMVAX,51,MSD,Valid,,09/20/2002,COMVAX,51,MSD,Valid,,11/16/2002,COMVAX,51,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,11/21/2002,11/21/2002,01/11/2004,HepB,11/16/2002,All Valid: Forecast Test,01/01/2013,06/18/2020,Recommended based on interval,"V4.2: Updated Forecast Test Type to ""Recommended based on interval""
V4.1: Changed forecast to reflect new 4 dose guidance from CEB.
v3.1: Changed dose 3 from not valid to valid due to recent clarifications.",4.2,"This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 16 weeks - 5 days from dose #1 that the dose is valid, but a 4th dose is needed to complete the series."
2013-0223,Dose 1 to dose 3 interval of Comvax 16 wks-4 days=valid Hep B # 3.  Hep B series complete. ,07/07/2006,F,,,,Complete,10/18/2006,COMVAX,51,MSD,Valid,,12/09/2006,COMVAX,51,MSD,Valid,,02/03/2007,COMVAX,51,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepB,02/03/2007,Interval: At Absolute Minimum,01/01/2013,06/18/2020,Not recommended: series complete,,1.0,This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 16 weeks - 4 days from dose #1 that the dose is considered to be valid.  The series is complete.
2013-0224,Dose 1 to dose 3 interval of Comvax is 16 weeks.   Series complete for Hep B. ,08/08/2006,F,,,,Complete,10/31/2006,COMVAX,51,MSD,Valid,,12/22/2006,COMVAX,51,MSD,Valid,,02/20/2007,COMVAX,51,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepB,02/20/2007,Interval: At Minimum,01/01/2013,02/26/2018,Not recommended: series complete,,1.0,This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 16 weeks from dose #1 that the dose is considered to be valid.  The series is complete.
2013-0225,Comvax given at birth.,10/10/2006,F,,,,Not complete,10/10/2006,COMVAX,51,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,11/07/2006,11/10/2006,02/06/2007,HepB,10/10/2006,Age: At Minimum,01/01/2013,02/26/2018,Recommended based on age,,1.0,This test case describes when dose #1 of the Hep B vaccine (Comvax) is administered at birth that the dose is considered to be valid. 
2013-0227,Dose # 2 at 28-5 days,04/17/2021,F,,,,Not complete,04/17/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,05/10/2021,RECOMBIVAX-PEDS,08,MSD,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,08/13/2021,HepB,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/18/2020,Recommended based on minimum interval from invalid dose,,1.0,This test case describes when dose #2 of the Hep B vaccine is administered at an interval of 28 - 5 days that the dose is not valid. 
2013-0228,Dose # 2 at 28-4 days,04/16/2021,F,,,,Not complete,04/16/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,05/10/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,10/01/2021,10/16/2021,12/13/2022,HepB,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/18/2020,Recommended based on age,,1.0,This test case describes when dose #2 of the Hep B vaccine is administered at an interval of 28 - 4 days that the dose is considered to be valid.
2013-0229,Dose # 2 at 28 days,04/12/2021,F,,,,Not complete,04/12/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,05/10/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,09/27/2021,10/12/2021,12/09/2022,HepB,05/10/2021,Interval: At Minimum,01/01/2013,02/09/2018,Recommended based on age,,1.0,This test case describes when dose #2 of the Hep B vaccine is administered at an interval of 28 days that the dose is considered to be valid.
2013-0230,Dose # 3 at age 24 weeks-5 days. 4th dose needed.,11/28/2020,F,,,,Not complete,11/28/2020,ENGERIX B-PEDS,08,SKB,Valid,,12/26/2020,ENGERIX B-PEDS,08,SKB,Valid,,05/10/2021,ENGERIX B-PEDS,08,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,05/15/2021,05/28/2021,07/25/2022,HepB,05/10/2021,All Valid: Forecast Test,01/01/2013,11/14/2019,Recommended based on interval,"V4.2: Updated Forecast Test Type to ""Recommended based on interval"".
V4.1: Changed forecast to reflect new 4-dose guidance from CEB.
V3.1: Changed dose 3 to valid due to recent clarifications.",4.2,"This test case describes when dose #3 of the Hep B vaccine is administered at 24 weeks - 5 days of age, that the dose is valid, but a 4th dose is needed to completed the series."
2013-0231,Dose # 3 at age 24 weeks-4 days.  Series complete. ,11/27/2020,F,,,,Complete,11/27/2020,RECOMBIVAX-PEDS,08,MSD,Valid,,12/27/2020,RECOMBIVAX-PEDS,08,MSD,Valid,,05/10/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/18/2020,Not recommended: series complete,,1.0,"This test case describes when dose #3 of the Hep B vaccine is administered at 24 weeks - 4 days of age, that the series is complete. "
2013-0232,Dose # 3 at 24 weeks.  Series complete.,11/23/2020,F,,,,Complete,11/23/2020,RECOMBIVAX-PEDS,08,MSD,Valid,,01/23/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,05/10/2021,"Hep B, unspecified formulation",45,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,Age: At Minimum,01/01/2013,02/09/2018,Not recommended: series complete,,1.0,"This test case describes when dose #3 of the Hep B vaccine is administered at 24 weeks of age, that the series is complete. "
2013-0233,Newborn forecasting,05/10/2021,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/10/2021,05/10/2021,06/06/2021,HepB,05/10/2021,No Doses Administered,01/01/2013,02/09/2018,Recommended based on age,,1.0,This test case describes the forecasting of the Hep B vaccine for a newborn.
2013-0234,# 2 Pediarix at 6 yrs 11.5 mo,05/26/2014,F,,,,Not complete,05/11/2017,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,07/05/2021,07/05/2021,07/05/2021,HepB,05/10/2021,All Valid: Forecast Test,01/01/2013,06/18/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,"This test case describes when dose #2 of the Hep B vaccine is administered at 6 years and 11 months after dose #1, that the dose is considered to b valid."
2013-0235,# 2 Pediarix at 7 yrs; # 1 at less than 12 mo. ,05/10/2014,F,,,,Not complete,08/10/2014,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,07/05/2021,07/05/2021,07/05/2021,HepB,05/10/2021,All Valid: Forecast Test,01/01/2013,06/18/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,"This test case describes when dose #2 of the Hep B vaccine is administered at 7 years after dose #1 (child less than 12 months), that the dose is considered to b valid."
2013-0236,# 2 Pediarix at 7 yrs; # 1 ≥ 12 mo.,05/10/2014,F,,,,Not complete,06/10/2015,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,07/05/2021,07/05/2021,07/05/2021,HepB,05/10/2021,All Valid: Forecast Test,01/01/2013,06/18/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,"This test case describes when dose #2 of the Hep B vaccine is administered at 7 years after dose #1 (child is 12 months of age), that the dose is considered to b valid."
2013-0237,# 1 and 2 Pediarix at ≥7 yrs  with 28 day interval.,04/12/2014,F,,,,Not complete,04/12/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,08/02/2021,08/02/2021,08/02/2021,HepB,05/10/2021,Interval: At Minimum,01/01/2013,06/18/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when dose #2 of the Hep B Vaccine (Pediarix) is administered at an interval of 28 days after dose #1 that the dose is considered to be valid. 
2013-0238,# 3 Pediarix at 14 wks-5 days,02/06/2021,F,,,,Not complete,03/16/2021,PEDIARIX,110,SKB,Valid,,04/13/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,07/24/2021,08/06/2021,10/03/2022,HepB,05/10/2021,All Valid: Forecast Test,01/01/2013,02/09/2018,Recommended based on age,,1.0,This test case describes when dose #3 of the HepB vaccine (Pediarix) is administered at 14 weeks - 5 days from dose #2 that the dose is not valid. 
2013-0239,# 3 Pediarix at 14 wks-4 days,02/05/2021,F,,,,Not complete,03/17/2021,PEDIARIX,110,SKB,Valid,,04/14/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,07/23/2021,08/05/2021,10/02/2022,HepB,05/10/2021,All Valid: Forecast Test,01/01/2013,02/09/2018,Recommended based on age,,1.0,This test case describes when dose #3 of the HepB vaccine (Pediarix) is administered at 14 weeks - 4 days from dose #2 that the dose is not valid.
2013-0241,# 3 Pediarix at 24 weeks-4 days. Valid for dose 3,11/27/2020,F,,,,Complete,01/08/2021,"Hep B, adolescent or pediatric",08,,Valid,,03/10/2021,"Hep B, adolescent or pediatric",08,,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/18/2020,Not recommended: series complete,,1.0,"This test case describes when dose #3 of the HepB vaccine (Pediarix) is administered at 24 weeks - 4 days from dose #2, that the dose is considered to be valid."
2013-0243,# 4 Pediarix at 1 yr -5 days,05/15/2020,F,,,,Complete,07/15/2020,PEDIARIX,110,SKB,Valid,,09/15/2020,PEDIARIX,110,SKB,Valid,,11/21/2020,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Extraneous,Series Already Complete,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,Extra Doses,01/01/2013,05/07/2021,Not recommended: series complete,,1.0,"This test case describes when an extra dose (#4) of the HepB vaccine (Pediarix) is administered at age 1 yr - 5 days, that the dose is considered to be extraneous. The series is complete."
2013-0244,# 1 Pediarix at 6 wks-5 days,04/03/2021,F,,,,Not complete,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,07/30/2021,HepB,05/10/2021,All Valid: Forecast Test,01/01/2013,06/18/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,"This test case describes when dose #1 is administered to a patient at 6 weeks - 5 days, that the dose is considered to be valid."
2013-0245,# 4 Pediarix at 1 yr -4 days,05/14/2020,F,,,,Complete,07/14/2020,PEDIARIX,110,SKB,Valid,,10/14/2020,PEDIARIX,110,SKB,Valid,,12/28/2020,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Extraneous,Series Already Complete,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,Extra Doses,01/01/2013,05/07/2021,Not recommended: series complete,,1.0,"This test case describes when an extra dose (#4) of the HepB vaccine (Pediarix) is administered at age 1 yr - 4 days, that the dose is considered to be extraneous. The series is complete."
2013-0246,# 4 Pediarix at 3 yrs 11.5 mo. ,05/26/2017,F,,,,Complete,07/26/2017,PEDIARIX,110,SKB,Valid,,10/26/2017,PEDIARIX,110,SKB,Valid,,01/26/2018,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Extraneous,Series Already Complete,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,Extra Doses,01/01/2013,05/07/2021,Not recommended: series complete,,1.0,"This test case describes when an extra dose (#4) of the HepB vaccine (Pediarix) is administered at 3 yr - 11.5 monts from dose #3, that the dose is considered to be extraneous. The series is complete."
2013-0247,# 4 Pediarix at 4 yrs,05/10/2017,F,,,,Complete,09/13/2017,PEDIARIX,110,SKB,Valid,,03/07/2018,PEDIARIX,110,SKB,Valid,,07/14/2019,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Extraneous,Series Already Complete,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,Extra Doses,01/01/2013,05/07/2021,Not recommended: series complete,,1.0,"This test case describes when extra doses (#4) of the HepB vaccine (Pediarix) is administered at age 4 years,  that the dose is considered to be extraneous. The series is complete."
2013-0248,# 5 Pediarix at 4 yrs -5 days,05/15/2017,F,,,,Complete,07/15/2017,PEDIARIX,110,SKB,Valid,,08/15/2017,PEDIARIX,110,SKB,Valid,,12/16/2017,PEDIARIX,110,SKB,Valid,,08/24/2018,PEDIARIX,110,SKB,Extraneous,Series Already Complete,05/10/2021,PEDIARIX,110,SKB,Extraneous,Series Already Complete,,,,,,,,,,,,,-,,,,HepB,05/10/2021,Extra Doses,01/01/2013,05/07/2021,Not recommended: series complete,,1.0,"This test case describes when extra doses (#4 and #5) of the HepB vaccine (Pediarix) is administered at age 4 years - 5 days, that the dose is considered to be extraneous. The series is complete."
2013-0249,# 5 Pediarix at 4 yrs -4 days,05/14/2017,F,,,,Complete,07/14/2017,PEDIARIX,110,SKB,Valid,,08/14/2017,PEDIARIX,110,SKB,Valid,,12/15/2017,PEDIARIX,110,SKB,Valid,,08/23/2018,PEDIARIX,110,SKB,Extraneous,Series Already Complete,05/10/2021,PEDIARIX,110,SKB,Extraneous,Series Already Complete,,,,,,,,,,,,,-,,,,HepB,05/10/2021,Extra Doses,01/01/2013,05/07/2021,Not recommended: series complete,,1.0,"This test case describes when extra doses (#4 and #5) of the HepB vaccine (Pediarix) is administered at age 4 years - 4 days, that the dose is considered to be extraneous. The series is complete."
2013-0250,# 5 Pediarix at 6 yrs 11.5 mo,05/26/2014,F,,,,Complete,07/26/2014,PEDIARIX,110,SKB,Valid,,09/26/2014,PEDIARIX,110,SKB,Valid,,11/26/2014,PEDIARIX,110,SKB,Valid,,06/26/2015,PEDIARIX,110,SKB,Extraneous,Series Already Complete,05/10/2021,PEDIARIX,110,SKB,Extraneous,Series Already Complete,,,,,,,,,,,,,-,,,,HepB,05/10/2021,Extra Doses,01/01/2013,05/07/2021,Not recommended: series complete,,1.0,"This test case describes when dose # 5 of the HepB vaccine (Pediarix) is administered at age 6 years and 11 months, that the dose is considered to be extraneous. The series is complete."
2013-0251,# 5 Pediarix at 7 yrs,05/10/2014,F,,,,Complete,08/10/2014,PEDIARIX,110,SKB,Valid,,11/10/2014,PEDIARIX,110,SKB,Valid,,02/10/2015,PEDIARIX,110,SKB,Valid,,11/25/2015,PEDIARIX,110,SKB,Extraneous,Series Already Complete,05/10/2021,PEDIARIX,110,SKB,Extraneous,Series Already Complete,,,,,,,,,,,,,-,,,,HepB,05/10/2021,Extra Doses,01/01/2013,05/07/2021,Not recommended: series complete,,1.0,"This test case describes when dose # 5 of the HepB vaccine (Pediarix) is administered at age 7 years, that the dose is considered to be extraneous. The series is complete."
2013-0255,# 1 Pediarix at 6 wks-4 days,04/02/2021,F,,,,Not complete,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,07/29/2021,HepB,05/10/2021,All Valid: Forecast Test,01/01/2013,06/18/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when dose #1 of the HepB vaccine is administered at 6 weeks - 4 days that the dose is considered to be valid.
2013-0256,"dose 1 to 2 Pediarix, interval 28-5 days",02/17/2021,F,,,,Not complete,04/17/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/13/2021,HepB,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/18/2020,Recommended based on minimum interval from invalid dose,,1.0,This test case describes when dose #2 of the HepB vaccine is administered at an interval of 28 - 5 days that the dose is not valid.
2013-0257,"dose 1 to 2 Pediarix, interval 28-4 days",02/16/2021,F,,,,Not complete,04/16/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,08/06/2021,08/16/2021,10/13/2022,HepB,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/18/2020,Recommended based on age,,1.0,This test case describes when dose #2 of the HepB vaccine is administered at an interval of 28 - 4 days that the dose is considered to be valid.
2013-0258,"dose 2 to 3 Pediarix, interval 8 weeks-5 days. 4th dose needed.",11/23/2020,F,,,,Not complete,01/16/2021,PEDIARIX,110,SKB,Valid,,03/20/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,05/15/2021,05/23/2021,07/20/2022,HepB,05/10/2021,All Valid: Forecast Test,01/01/2013,11/14/2019,Recommended based on interval,"V4.2: Updated Forecast Test Type to ""Recommended based on interval""
V4.1: Changed forecast to reflect new 4-dose guidance from CEB.
V3.1: Changed dose 3 from not valid to valid due to recent clarifications.",4.2,"This test case describes when dose #3 of the HepB vaccine is administered at an interval of 8 weeks - 5 days that the dose is valid, but a 4th dose is needed to complete the series."
2013-0259,"dose 2 to 3 Pediarix, interval 8 weeks-4 days ",11/23/2020,F,,,,Complete,01/17/2021,PEDIARIX,110,SKB,Valid,,03/19/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/18/2020,Not recommended: series complete,,1.0,This test case describes when dose #3 of the HepB vaccine (Pediarix) is administered at an interval of 8 weeks - 4 days that the dose is considered to be valid. The series is complete.
2013-0260,"dose 3 to 4 Pediarix, interval 6m-5 days",03/10/2020,F,,,,Complete,05/10/2020,PEDIARIX,110,SKB,Valid,,07/10/2020,PEDIARIX,110,SKB,Valid,,11/10/2020,PEDIARIX,110,SKB,Valid,,05/05/2021,PEDIARIX,110,SKB,Extraneous,Series Already Complete,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,Extra Doses,01/01/2013,05/07/2021,Not recommended: series complete,,1.0,"This test case describes when an extra dose ( dose #4) of the HepB vaccine is administered at an interval of 6 months - 5 days, that the dose is considered to be extraneous. The series is complete."
2013-0261,"dose 3 to 4 Pediarix, interval 6m-4 days",03/10/2020,F,,,,Complete,05/10/2020,PEDIARIX,110,SKB,Valid,,07/10/2020,PEDIARIX,110,SKB,Valid,,11/10/2020,PEDIARIX,110,SKB,Valid,,05/06/2021,PEDIARIX,110,SKB,Extraneous,Series Already Complete,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,Extra Doses,01/01/2013,05/07/2021,Not recommended: series complete,.,1.0,"This test case describes when an extra dose ( dose #4) of the HepB vaccine is administered at an interval of 6 months - 5 days, that the dose is considered to be extraneous. The series is complete."
2013-0262,"dose 3 to 4 Pediarix, interval 4 mo-1 day",03/10/2020,F,,,,Complete,05/10/2020,PEDIARIX,110,SKB,Valid,,07/10/2020,PEDIARIX,110,SKB,Valid,,01/10/2021,PEDIARIX,110,SKB,Valid,,05/09/2021,PEDIARIX,110,SKB,Extraneous,Series Already Complete,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,Extra Doses,01/01/2013,05/07/2021,Not recommended: series complete,,1.0,"This test case describes when an extra dose ( dose #4) of the HepB vaccine is administered at an interval of 4 months - 1 day, that the dose is considered to be extraneous. The series is complete."
2013-0263,"dose 3 to 4 Pediarix, interval 4 mo",03/10/2020,F,,,,Complete,05/10/2020,PEDIARIX,110,SKB,Valid,,07/10/2020,PEDIARIX,110,SKB,Valid,,01/10/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Extraneous,Series Already Complete,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,Extra Doses,01/01/2013,05/07/2021,Not recommended: series complete,,1.0,"This test case describes when an extra dose ( dose #4) of the HepB vaccine is administered at an interval of 4 months, that the dose is considered to be extraneous. The series is complete."
2013-0264,invalid dose 1-2 interval in midst of others,01/10/2021,F,,,,Not complete,03/10/2021,PEDIARIX,110,SKB,Valid,,03/29/2021,PEDIARIX,110,SKB,Not Valid,Interval: too short,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,3,07/05/2021,07/10/2021,09/06/2022,HepB,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,02/13/2018,Recommended based on age,,1.0,"This test case describes when dose #2 of the HepB vaccine is administered at an interval less than 4 weeks - 4 days in the midst of other valid doses (first and third), that the dose is not valid. "
2013-0266,# 1 Pediarix at 6 wks,03/29/2021,F,,,,Not complete,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,07/26/2021,HepB,05/10/2021,All Valid: Forecast Test,01/01/2013,06/18/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,"This test case describes when dose # 1 of the HepB vaccine is administered at 6 weeks, that the dose is considered to be valid. "
2013-0267,# 1 Pediarix at 6 yrs 11.5 mo,05/25/2014,F,,,,Not complete,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,HepB,05/10/2021,All Valid: Forecast Test,01/01/2013,06/18/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when dose # 1 of the HepB vaccine is administered at 6 years and 11.5 months that the dose is considered to be valid.
2013-0268,# 1 Pediarix at 7 yrs,05/10/2014,F,,,,Not complete,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,HepB,05/10/2021,All Valid: Forecast Test,01/01/2013,06/18/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when dose #1 of the HepB vaccine (Pediarix) is administered at 7 years that the dose is considered to be valid.
2013-0269,# 2 Pediarix at 10 wks-5 days,03/06/2021,F,,,,Not complete,04/13/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,08/21/2021,09/06/2021,11/02/2022,HepB,05/10/2021,All Valid: Forecast Test,01/01/2013,06/18/2020,Recommended based on age,,1.0,"This test case describes when dose #2 of the HepB vaccine is administered at an interval of 10 weeks - 5 days, that the dose is considered to be valid. "
2013-0270,# 2 Pediarix at 10 wks-4 days,03/05/2021,F,,,,Not complete,04/05/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,08/20/2021,09/05/2021,11/01/2022,HepB,05/10/2021,All Valid: Forecast Test,01/01/2013,02/13/2018,Recommended based on age,,1.0,"This test case describes when dose #2 of the HepB vaccine is administered at an interval of 10 weeks - 4 days, that the dose is considered to be valid. "
2013-0271,# 2 Pediarix at 10 wks,03/01/2021,F,,,,Not complete,04/01/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,08/16/2021,09/01/2021,10/28/2022,HepB,05/10/2021,All Valid: Forecast Test,01/01/2013,02/13/2018,Recommended based on age,,1.0,"This test case describes when dose #2 of the HepB vaccine is administered at an interval of 10 weeks, that the dose is considered to be valid. "
2016-0022,Hep B- Dose #4 administered < 8 weeks after dose #3.,09/19/2020,F,,,,Complete,12/19/2020,RECOMBIVAX-PEDS,08,MSD,Valid,,02/21/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,04/09/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,05/06/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,All Valid: Forecast Test,12/02/2016,06/18/2020,Recommended based on interval,v3.3: Updated the evaluation type to All Valid: Forecast Test,3.3,This test cases describes when a patient is administered dose #4 at less than 8 weeks after dose #3  and at least 16 weeks after dose #1 that the dose is considered to be valid. The series is complete.
2017-0002,Hep B- Dose #4 administered at 24 weeks of age and at least 16 weeks from dose #1.,08/25/2020,F,,,,Complete,11/25/2020,PEDIARIX,110,SKB,Valid,,01/25/2021,PEDIARIX,110,SKB,Valid,,03/15/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,All Valid: Forecast Test,01/30/2016,06/18/2020,Not recommended: series complete,Updated dose #3 to valid since the interval is now at 0 days in the third dose of the HepB 4 dose series and the fourth dose was administered at least 16 weeks from dose #1..,3.3,"This test case describes when dose #4 of the HepB vaccine is administered  at least 24 weeks of age and at least 16 weeks from dose  #1,  that the dose is considered to be valid. Patient series is complete."
2018-0015,Hep B: Patient is 18 years and has received the first dose of the Hep B (Heplisav) vaccine,05/10/2003,F,,,,Not complete,05/10/2021,"Hep B, adjuvanted",189,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,07/04/2021,HepB,05/10/2021,Age: At Minimum,03/28/2018,06/18/2020,Recommended based on interval,,3.4,This test case describes when a patient is administered the first dose of the Hep B (Heplisav) vaccine that the second dose should be forecast.
2018-0016,Hep B: Patient is 18 years and has received the second dose of the Hep B (Heplisav) vaccine at 4 weeks.,04/12/2003,F,,,,Complete,04/12/2021,"Hep B, adjuvanted",189,,Valid,,05/10/2021,"Hep B, adjuvanted",189,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,All Valid: Forecast Test,03/28/2018,06/18/2020,Not recommended: series complete,,3.4,"This test case describes that when a patient is administered the second dose of the Hep B (Heplisav) vaccine at 4 weeks that the dose is considered to be valid, and the series is Complete."
2018-0017,Hep B: Patient is 18 years and has received the second dose of the Hep B (Heplisav) vaccine at 4 weeks - 5 days,04/17/2003,F,,,,Not complete,04/17/2021,"Hep B, adjuvanted",189,,Valid,,05/10/2021,"Hep B, adjuvanted",189,,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,07/04/2021,HepB,05/10/2021,Interval: Below Absolute Minimum,03/28/2018,06/18/2020,Recommended based on minimum interval from invalid dose,V3.5: Updated the earliest and recommended forecast to reflect 4 weeks after the second dose.,3.5,This test case describes when a patient is administered the second dose of the Hep B (Heplisav) vaccine at 4 weeks - 5 days that the vaccine dose is not valid. A repeat dose is recommended.
2018-0018,Hep B: Patient is 18 years and has received the second dose of the Hep B  (Heplisav) vaccine at 4 weeks - 4 days.,04/16/2003,F,,,,Complete,04/16/2021,"Hep B, adjuvanted",189,,Valid,,05/10/2021,"Hep B, adjuvanted",189,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,All Valid: Forecast Test,03/28/2018,06/18/2020,Not recommended: series complete,,3.4,This test case describes when a patient is administered the second dose of the Hep B (Heplisav) vaccine at 4 weeks - 4 days that the dose is considered to be valid.  The series is complete.
2018-0019,Hep B: Patient is 18 years - 4 days with first dose of Heplisav,05/14/2003,F,,,,Not complete,05/10/2021,"Hep B, adjuvanted",189,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,07/04/2021,HepB,05/10/2021,Interval: At Absolute Minimum,04/11/2018,06/18/2020,Recommended based on interval,,3.4,"This test case describes when a patient is administered the first dose of the Hep B (Heplisav) vaccine at 18 years - 4 days, that the dose is considered to be valid."
2018-0020,Hep B: Patient is 18 years and has received a previous dose of Hep B vaccine and one dose of Heplisav B vaccine,05/10/2003,F,,,,Not complete,05/10/2018,RECOMBIVAX-PEDS,08,MSD,Valid,,05/10/2021,HEPLISAV-B,189,DVX,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,07/05/2021,07/05/2021,07/05/2021,HepB,05/10/2021,All Valid: Forecast Test,04/11/2018,06/18/2020,Recommended based on interval,,3.4,"This test case describes when a patient is administered a previous dose of Hep B Vaccine, (at age 15)  and one dose of the Hep B (Heplisav) vaccine that the doses are considered to be valid.  Another dose of the vaccine should be forecasted."
2018-0021,Hep B: Patient is 18 years and has received a previous dose of Hep B vaccine and two doses of Hep B (Heplisav) vaccine,03/15/2003,F,,,,Complete,03/15/2018,"Hep B, adolescent or pediatric",08,,Valid,,03/15/2021,HEPLISAV-B,189,DVX,Valid,,05/10/2021,HEPLISAV-B,189,DVX,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HepB,05/10/2021,All Valid: Forecast Test,04/11/2018,06/18/2020,Not recommended: series complete,"V4.2: Mild adjustments to relative date settings to avoid administration dates in the future. Test case expectations (e.g, evaluation status or forecast) have not changed.
v4.1: Updated dose #1 to reflect a valid dose based on Ask the Expert guidance
v3.5: Updated dose #1 to reflect an invalid dose reason of Vaccine Dose Administered was administered at too young of an age.",4.2,"This test case describes when a patient is administered a previous dose of Hep B vaccine (at age 15) and two doses of the Hep B (Heplisav) vaccine at 8 weeks a part, that the doses are considered valid.  The series is complete."
2018-0022,Hep B: Patient is 18 years - 5 days with first dose of Hep B (Hepislav) vaccine,05/15/2003,F,,,,Not complete,05/10/2021,HEPLISAV-B,189,DVX,Not Valid,Inadvertent Vaccine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/10/2021,05/10/2021,05/10/2021,HepB,05/10/2021,Interval: Below Absolute Minimum,04/12/2018,06/18/2020,Recommended based on age,"v4.1: Updated forecast dates to reflect a 0 day interval for administration of any age appropriate HepB vaccine. 
v4.0: Updated dose #1 to reflect an invalid dose reason of 'Vaccine product was not a preferable or allowable vaccine for this series'.
v3.5: Updated dose #1 to reflect an invalid dose reason of Vaccine Dose Administered was administered at too young of an age.",4.1,This test cases describes when a patient is administered a dose of the Hep B (Heplisav) vaccine at 18 years - 5 days that the dose is not valid.
2018-0023,"Hep B: Patient is 18 years and has received a dose of Hep B (Heplisav) vaccine, and one dose of Hep B (alum) ",04/12/2003,M,,,,Not complete,04/12/2021,HEPLISAV-B,189,DVX,Valid,,05/10/2021,RECOMBIVAX-PEDS,08,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,08/02/2021,08/02/2021,08/02/2021,HepB,05/10/2021,All Valid: Forecast Test,04/12/2018,06/18/2020,Recommended based on interval,,3.4,"This test case describes when a patient is administered Hep B (Heplisav) as a first dose, and Hep B (alum) as a second dose, that a third dose should be forecasted."
2013-0273,"Child<2 months, no shots, #1 forecasted at 2 months of age",05/10/2021,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/21/2021,07/10/2021,09/06/2021,HIB,05/10/2021,No Doses Administered,01/01/2013,05/29/2020,Recommended based on age,,1.0,"This test case describes when a child < 2 months of age with no history of the Hib vaccine, that the first dose should be forecast."
2013-0274,# 1 at 6 wks-5 days,04/03/2021,F,,,,Not complete,05/10/2021,ACTHIB,48,PMC,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/15/2021,06/03/2021,07/30/2021,HIB,05/10/2021,Age: Below Absolute Minimum,01/01/2013,05/29/2020,Recommended based on age,,1.0,This test case describes when a child is administered the first dose of the Hib vaccine at 6 weeks - 5 days that the dose is not valid.  Another dose should be forecast.
2013-0275,# 1 at 6 wks-4 days,04/02/2021,F,,,,Not complete,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/11/2021,08/02/2021,09/29/2021,HIB,05/10/2021,Age: At Absolute Minimum,01/01/2013,05/29/2020,Recommended based on age,,1.0,This test case describes when a child is administered the first dose of the Hib vaccine at 6 weeks - 4 days that the dose is valid.  Another dose should be forecast.
2013-0276,# 1 at 6 wks -3 days,04/01/2021,F,,,,Not complete,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/10/2021,08/01/2021,09/28/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/29/2020,Recommended based on age,,1.0,This test case describes when a child is administered the first dose of the Hib vaccine at 6 weeks - 3 days that the dose is valid.  Another dose should be forecast.
2013-0277,# 1 at 3 months,02/10/2021,F,,,,Not complete,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/10/2021,08/06/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/29/2020,Recommended based on age,,1.0,This test case describes when a child is administered the first dose of the Hib vaccine at 3 months of age that the dose is valid.  Another dose should be forecast.
2013-0278,#1 at 3 months and 3 days-catchup- #2 recommended at +28 days,02/07/2021,F,,,,Not complete,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,08/03/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/29/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered the first dose of the Hib vaccine at 3 months and 3 days of age that the dose is valid.  Another dose should be forecast.
2013-0279,#1 at 6 months - catchup- #2 recommended at +28 days,11/10/2020,F,,,,Not complete,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/19/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered the first of the Hib vaccine at 6 months and a second dose at 28 days later that the doses are valid.
2013-0280,#1 at 7 and <11 months - catchup- drop to 3 dose schedule,10/10/2020,F,,,,Not complete,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/19/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered the first dose of the Hib vaccine at 7 months that the dose is valid. Another dose should be forecast.
2013-0281,"#1 at 12 months, drop to 2-dose schedule",05/10/2020,F,,,,Not complete,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,07/05/2021,07/05/2021,07/05/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/19/2020,Recommended based on minimum interval from previous dose (catch-up),Past Due Date was incorrect.  Should be in alignment with the earliest and recommended.  Child is in catch-up schedule.,1.1,This test case describes when a child is administered the first dose of the Hib vaccine at 12 months of age that the dose is valid.  Another dose should be forecast.
2013-0282,#1 at 15m -drop to 1 dose schedule,02/10/2020,F,,,,Complete,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/19/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered the first dose of the Hib vaccine at 15 months of age that the dose is valid.  No additional doses should be forecast. The series is complete.
2013-0283,#1 at 3 years -drop to 1 dose schedule,05/10/2018,F,,,,Complete,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/19/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered a dose of the Hib at 3 years of age that the dose is valid.  No additional doses should be forecast.  The series is complete.
2013-0284,#1 at  5 years,05/10/2016,F,,,,Aged out,05/10/2021,ACTHIB,48,PMC,Extraneous,Age: Too Old,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Age: Too Old,01/01/2013,05/19/2020,Not recommended: too old,"v1.6: Updated Series Status from ""Not Complete"" to ""Aged Out"" to align with updated CDSi Logic Specification Series Statuses.

v1.2:Within the scope of the CDSi effort, Hib on or after 5 years is not recommended.  The last administered dose was changed to Extraneous to reflect this.",1.6,This test case describes when a child is administered the first dose of the Hib vaccine at 5 years that the dose is considered to be extraneous.  No further doses should be forecast.
2013-0285,#1 at 6 years,05/10/2015,F,,,,Aged out,05/10/2021,ACTHIB,48,PMC,Extraneous,Age: Too Old,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Age: Too Old,01/01/2013,05/19/2020,Not recommended: too old,"v3.5: Lowered Age to be 6 year old to better align with new Age Groupings. No real effective change in test case other than age of patient and vaccination. Expectations remained the same.
v1.6: Updated Series Status from ""Not Complete"" to ""Aged Out"" to align with updated CDSi Logic Specification Series Statuses.
v1.2: Within the scope of the CDSi effort, Hib on or after 5 years is not recommended.  The last administered dose was changed to Extraneous to reflect this.",3.5,This test case describes when a child is administered the first dose of the Hib vaccine at age 6 years that the dose is considered to be extraneous.  No further doses should be forecast.
2013-0286,# 2 at 10 wks-5 days,03/06/2021,F,,,,Not complete,04/13/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/06/2021,09/02/2021,HIB,05/10/2021,Age: Below Absolute Minimum,01/01/2013,05/19/2020,Recommended based on age,,1.0,This test case describes when a child is administered the second dose of the Hib vaccine at 10 wks - 5 days that the dose is not valid.  A repeat dose should be forecast.
2013-0287,# 2 at 10 wks-4 days,03/05/2021,F,,,,Not complete,04/12/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/11/2021,09/05/2021,11/01/2021,HIB,05/10/2021,Age: At Absolute Minimum,01/01/2013,05/19/2020,Recommended based on age,,1.0,This test case describes when a child is administered the second dose of the Hib vaccine at 10 wks - 4 days that the dose is valid.   Another dose should be forecast.
2013-0288,# 2 at 10 wks -3 days,03/04/2021,F,,,,Not complete,04/11/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/10/2021,09/04/2021,10/31/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/19/2020,Recommended based on age,,1.0,This test case describes when a child is administered the second dose of the Hib vaccine at 10 wks - 3 days that the dose is valid.  Another dose should be forecast.
2013-0289,# 2 at 4 months,01/10/2021,F,,,,Not complete,03/10/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,07/10/2021,09/06/2021,HIB,05/10/2021,Age: At Recommended,01/01/2013,05/19/2020,Recommended based on age,,1.0,This test case describes when a child is administered the second dose of the Hib vaccine at 4 months that the dose is valid. Another dose should be forecast.
2013-0290,#2 at 5 months,12/10/2020,F,,,,Not complete,02/10/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/10/2021,08/06/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/22/2020,Recommended based on age,,1.0,This test case describes when a child is administered the second dose of the Hib vaccine 5 months after the first dose that the dose is valid.  Another dose should be forecast.
2013-0291,#2 at 5 months and 3 days-catchup-#3 at +28 days,12/07/2020,F,,,,Not complete,02/07/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/07/2021,08/03/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/19/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when child is administered the second dose of the Hib vaccine at 5 months and 3 days and the third dose at 28 days later that the doses are valid.
2013-0292,#2 at 12 m - 5 days,05/15/2020,F,,,,Not complete,07/15/2020,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,07/05/2021,07/05/2021,10/12/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,08/21/2019,Recommended based on minimum interval from previous dose (catch-up),"V4.1: updated forecast dose number from 4 to 3.
V4.0: updated forecast to recommend a dose in 8 weeks - previously 4 weeks - since the patient will be over 12 months old at the time of the next dose and the spacing should be 8 weeks.",4.1,This test case describes when a second dose of Hib is administered to a child at age 12 m- 5 days that the dose is valid. Forecast another dose.
2013-0293,#2 at 12 m - 4 days ,05/14/2020,F,,,,Not complete,07/14/2020,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,07/05/2021,07/05/2021,10/11/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/19/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when child is administered the second dose of the Hib vaccine at 12 months - 4 days that the dose is valid.  Another dose should be forecast.
2013-0294,#2 at 15 months,02/10/2020,F,,,,Complete,04/10/2020,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/19/2020,Not recommended: series complete,,1.0,This test case describes when child is administered the second dose of the Hib vaccine at 15 months of age that the dose is valid. No further doses should be forecast.  The series is complete.
2013-0295,#2 at 5 years,05/10/2016,F,,,,Aged out,07/10/2016,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Extraneous,Age: Too Old,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Age: Too Old,01/01/2013,05/19/2020,Not recommended: too old,"v1.6: Updated Series Status from ""Not Complete"" to ""Aged Out"" to align with updated CDSi Logic Specification Series Statuses.

v1.2: Within the scope of the CDSi effort, Hib on or after 5 years is not recommended.  The last administered dose was changed to Extraneous to reflect this.",1.6,This test case describes when a child is administered the second dose of the Hib vaccine at 5 years of age that the dose is Extraneous.  No further does should be forecast.  The series is complete.
2013-0296,"dose 1 to 2, interval 4 weeks -5 days",02/17/2021,F,,,,Not complete,04/17/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/17/2021,08/13/2021,HIB,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,05/22/2020,Recommended based on age,,1.0,This test case describes when a child is administered the second dose of the Hib vaccine at an interval of 4 weeks - 5 days that the dose is Extraneous.  No further does should be forecast.  The series is complete.
2013-0297,"dose 1 to 2, interval 4 weeks -4 days",02/16/2021,F,,,,Not complete,04/16/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/16/2021,10/13/2021,HIB,05/10/2021,Interval: At Absolute Minimum,01/01/2013,05/27/2020,Recommended based on age,,1.0,This test case describes when a child is administered the second dose of the Hib vaccine at an interval of 4 weeks - 4 days that the dose is valid.  Another dose should be forecast.
2013-0298,"dose 1 to 2, interval 25 days",02/15/2021,F,,,,Not complete,04/15/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/15/2021,10/12/2021,HIB,05/10/2021,Interval: At Minimum,01/01/2013,05/27/2020,Recommended based on age,,1.0,This test case describes when a child is administered the second dose of the Hib vaccine at an interval of 25 days that the dose is valid.  Another dose should be forecast.
2013-0299,#3 at 14 weeks-5 days,02/06/2021,F,,,,Not complete,03/16/2021,ACTHIB,48,PMC,Valid,,04/13/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/06/2021,10/03/2021,HIB,05/10/2021,Age: Below Absolute Minimum,01/01/2013,05/22/2020,Recommended based on age,Changed Doses 2 and 3 to be ACTHIB rather than PRP-OMP vaccines to avoid possible confusion with PRP-OMP product specific schedule,1.1,This test case describes when a child is administered the third dose of the Hib vaccine at an interval of 14 weeks - 5 days after the second dose that the dose is not valid.   A repeat dose should be forecast.
2013-0300,#3  at 6 months,11/10/2020,F,,,,Not complete,01/10/2021,ACTHIB,48,PMC,Valid,,03/10/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,11/10/2021,11/10/2021,04/06/2022,HIB,05/10/2021,Age: At Recommended,01/01/2013,05/22/2020,Recommended based on age,,1.0,This test case describes when a child is administered the third dose of the Hib vaccine at an interval of 6 months after the second dose that the dose is valid.  Another dose should be forecast.
2013-0301,"Dose 2 to 3, interval 4 weeks-5 days",12/17/2020,F,,,,Not complete,02/17/2021,ACTHIB,48,PMC,Valid,,04/17/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/17/2021,08/13/2021,HIB,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,05/22/2020,Recommended based on age,,1.0,This test case describes when a child is administered the third dose of the Hib vaccine at an interval of 4 weeks - 5 days after the second dose  that the dose is not valid.  A repeat dose should be forecast.
2013-0302,"Dose 2 to 3, interval 4 weeks -4 days",12/16/2020,F,,,,Not complete,02/16/2021,ACTHIB,48,PMC,Valid,,04/16/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,12/16/2021,12/16/2021,05/13/2022,HIB,05/10/2021,Interval: At Absolute Minimum,01/01/2013,05/27/2020,Recommended based on age,,1.0,This test case describes when a child is administered the third dose of the Hib vaccine at an interval of 4 weeks - 4 days after the second dose  that the dose is valid.  Another dose should be forecast.
2013-0303,"Dose 2 to 3, interval 4 weeks",12/12/2020,F,,,,Not complete,02/12/2021,ACTHIB,48,PMC,Valid,,04/12/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,12/12/2021,12/12/2021,05/09/2022,HIB,05/10/2021,Interval: At Minimum,01/01/2013,05/22/2020,Recommended based on age,,1.0,This test case describes when a child is administered the third dose of the Hib vaccine at an interval of 4 weeks after the second dose that the dose is valid.  Another dose should be forecast.
2013-0304,"#4 at 12 months - 5 days of age, interval between #3-4 >8 weeks",05/15/2020,F,,,,Not complete,07/15/2020,ACTHIB,48,PMC,Valid,,09/15/2020,ACTHIB,48,PMC,Valid,,11/15/2020,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,4,07/05/2021,07/05/2021,10/12/2021,HIB,05/10/2021,Age: Below Absolute Minimum,01/01/2013,05/22/2020,Recommended based on minimum interval from inValid dose,,1.0,This test case describes when a child is administered the fourth dose of the Hib vaccine at age 12 months -5 days and at an interval of 4 - 8 weeks after the third dose that the dose is not valid.  A repeat dose should be forecast.
2013-0305,"#4 at 12 months - 4 days of age, interval between #3-4 >8 weeks",05/14/2020,F,,,,Complete,07/14/2020,ACTHIB,48,PMC,Valid,,09/14/2020,ACTHIB,48,PMC,Valid,,11/14/2020,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Age: At Absolute Minimum,01/01/2013,05/27/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered the fourth dose of the Hib vaccine at age 12 months -4 days and at an interval of 4 - 8 weeks after the third dose that the dose is valid. The series is complete.
2013-0306,"#4 at 12 months - 3 days of age, interval between #3-4 >8 weeks",05/13/2020,F,,,,Complete,07/13/2020,ACTHIB,48,PMC,Valid,,09/13/2020,ACTHIB,48,PMC,Valid,,11/13/2020,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/27/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered the fourth dose of the Hib vaccine at age 12 months -3 days and at an interval of 4 - 8 weeks after the third dose that the dose is valid. The series is complete.
2013-0307,"#4 at 15 months of age, interval between #3-4 > 8 weeks",02/10/2020,F,,,,Complete,04/10/2020,ACTHIB,48,PMC,Valid,,06/10/2020,ACTHIB,48,PMC,Valid,,08/10/2020,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/22/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered the fourth dose of the Hib vaccine at age 15 months and at an interval of 4 - 8 weeks after the third dose that the dose is valid. The series is complete.
2013-0308,"#4 at 12 months of age, interval between #3-4 8 weeks -5 days",05/10/2020,F,,,,Not complete,07/10/2020,ACTHIB,48,PMC,Valid,,09/10/2020,ACTHIB,48,PMC,Valid,,03/20/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,4,07/05/2021,07/05/2021,10/07/2021,HIB,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,05/22/2020,Recommended based on minimum interval from inValid dose,,1.0,This test case describes when a child is administered the fourth dose of the Hib vaccine at age 12 months and at an interval of 4 - 8 weeks - 5 days  after the third dose that the dose is not valid. A repeat dose should be forecast.
2013-0309,"#4 at 12 months of age, interval between #3-4 8 weeks -4 days",05/10/2020,F,,,,Complete,07/10/2020,ACTHIB,48,PMC,Valid,,09/10/2020,ACTHIB,48,PMC,Valid,,03/19/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Interval: At Absolute Minimum,01/01/2013,05/27/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered the fourth dose of the Hib vaccine at age 12 months and at an interval of 4 - 8 weeks - 4 days  after the third dose that the dose is valid.  The series is complete.
2013-0310,# 4 at 15 months of age,02/10/2020,F,,,,Complete,04/10/2020,ACTHIB,48,PMC,Valid,,06/10/2020,ACTHIB,48,PMC,Valid,,09/10/2020,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Age: At Recommended,01/01/2013,05/22/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered the fourth dose of the Hib vaccine at age 15 months that the dose is valid.  The series is complete.
2013-0313,#4 at 5 years,05/10/2016,F,,,,Aged out,07/10/2016,ACTHIB,48,PMC,Valid,,09/10/2016,ACTHIB,48,PMC,Valid,,12/10/2016,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Extraneous,Age: Too Old,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Age: Too Old,01/01/2013,05/26/2020,Not recommended: too old,"v1.6: Updated Series Status from ""Not Complete"" to ""Aged Out"" to align with updated CDSi Logic Specification Series Statuses.

v1.2: Within the scope of the CDSi effort, Hib on or after 5 years is not recommended.  The last administered dose was changed to Extraneous to reflect this.",1.6,This test case describes when a child is administered the fourth dose of the Hib vaccine at 5 years of age that the dose is considered to be Extraneous.  No further doses should be forecast.  Series is complete.
2013-0314,#4 at 7 years,05/10/2015,F,,,,Aged out,07/10/2015,ACTHIB,48,PMC,Valid,,09/10/2015,ACTHIB,48,PMC,Valid,,01/10/2016,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Extraneous,Age: Too Old,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Age: Too Old,01/01/2013,05/26/2020,Not recommended: too old,"V3.5: Lowered age of last vaccination from 7 years to 6 years to better align with new Age Groupings. No impact on test case expectations.
v1.6: Updated Series Status from ""Not Complete"" to ""Aged Out"" to align with updated CDSi Logic Specification Series Statuses.
v1.2: Within the scope of the CDSi effort, Hib on or after 5 years is not recommended.  The last administered dose was changed to Extraneous to reflect this.",3.5,This test case describes when a child is administered the fourth dose of the Hib vaccine at 7 years of age that the dose is considered to be Extraneous.  No further doses should be forecast.  Series is complete.
2013-0315,"Child<2 months, no shots, #1 forecasted at 2 months of age",05/10/2021,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/21/2021,07/10/2021,09/06/2021,HIB,05/10/2021,No Doses Administered,01/01/2013,05/26/2020,Recommended based on age,,1.0,This test case describes when a child is less than two months of age and has not received any doses of the Hib vaccine that the first dose should be forecast at 2 months of age.
2013-0317,"# 2 at 10 wks-4 days, PRP-OMP series",03/05/2021,F,,,,Not complete,04/12/2021,PEDVAXHIB,49,MSD,Valid,,05/10/2021,PEDVAXHIB,49,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,03/05/2022,03/05/2022,08/01/2022,HIB,05/10/2021,Interval: At Absolute Minimum,01/01/2013,05/26/2020,Recommended based on age,,1.0,This test case describes when a child is administered a second dose of the HIb vaccine at 10 weeks - 4 days that the dose is valid.  Another dose should be forecast.
2013-0318,"# 2 at 10 wks-3 days, PRP-OMP series",03/04/2021,F,,,,Not complete,04/11/2021,PEDVAXHIB,49,MSD,Valid,,05/10/2021,PEDVAXHIB,49,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,03/04/2022,03/04/2022,07/31/2022,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/26/2020,Recommended based on age,,1.0,This test case describes when a child is administered a second dose of the HIb vaccine at 10 weeks - 3 days that the dose is valid.  Another dose should be forecast.
2013-0319,# 2 at 12 months,05/10/2020,F,,,,Not complete,07/10/2020,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,07/05/2021,07/05/2021,10/07/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/26/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered the second dose of the Hib vaccine at 12 months that the dose is valid.  Another dose should be forecast.
2013-0320,"#3 at 5m (#1, #2 at 2 and 4m)",12/10/2020,F,,,,Not complete,02/10/2021,ACTHIB,48,PMC,Valid,,04/10/2021,PEDVAXHIB,49,MSD,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,12/10/2021,12/10/2021,05/07/2022,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/26/2020,Recommended based on age,,1.0,This test case describes when a child is administered a third dose of the Hib vaccine at 5 months that the dose is valid.  Another dose should be forecast.
2013-0321,"#3 at 10 months and 9 days (#1,2 at 2 and 3 m)",07/01/2020,F,,,,Not complete,09/01/2020,ACTHIB,48,PMC,Valid,,10/01/2020,ACTHIB,48,PMC,Valid,,05/10/2021,PEDVAXHIB,49,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,07/05/2021,07/05/2021,11/28/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/29/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered a third dose of the Hib vaccine at 10 months that the dose is valid.  Another dose should be forecast.
2013-0322,#3 at 11 months,06/10/2020,F,,,,Not complete,08/10/2020,ACTHIB,48,PMC,Valid,,10/10/2020,PEDVAXHIB,49,MSD,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,07/05/2021,07/05/2021,11/06/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/29/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered a third dose of the Hib vaccine at 11 months that the dose is valid.  Another dose should be forecast.
2013-0323,#3 at 12 months -5 days,05/15/2020,F,,,,Not complete,07/15/2020,ACTHIB,48,PMC,Valid,,09/15/2020,ACTHIB,48,PMC,Valid,,05/10/2021,PEDVAXHIB,49,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,07/05/2021,07/05/2021,10/12/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/29/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered a third dose of the Hib vaccine at 12 months - 5 days that the dose is valid.  Another dose should be forecast.
2013-0324,#3 at 12 months - 3 days,05/13/2020,F,,,,Complete,07/13/2020,ACTHIB,48,PMC,Valid,,09/13/2020,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/29/2020,Not recommended: series complete,"V3.5: Patient's age was incorrect.  Age should have been 12 Months, not 12 years. No effective change to test case.
V1.1: This patient should have been marked complete for Hib.  No Further Doses Needed.",3.5,This test case describes when a child is administered a third dose of the Hib vaccine at 12 months - 3 days that the dose is valid and the patient is complete
2013-0325,#3 at 15 months,02/10/2020,F,,,,Complete,04/10/2020,ACTHIB,48,PMC,Valid,,06/10/2020,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/26/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered a third dose of the Hib vaccine at 15 months that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0326,#3 at 59 months,05/11/2016,F,,,,Complete,07/11/2016,ACTHIB,48,PMC,Valid,,09/11/2016,PEDVAXHIB,49,MSD,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/26/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered a third dose of the Hib vaccine at 59 months that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0327,#1 at 7 months-5 days,10/15/2020,F,,,,Not complete,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/29/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered the first dose of the Hib vaccine at 7 months-5 days that the dose is valid.  Another dose should be forecast.
2013-0328,#1 at 7 months- 3 days,10/13/2020,F,,,,Not complete,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/26/2020,Recommended based on minimum interval from previous dose (catch-up),Past Due Date was incorrect.  Should be in alignment with the earliest and recommended.  Child is in catch-up schedule.,1.1,This test case describes when a child is administered the first dose of the Hib vaccine at 7 months-3 days that the dose is valid.  Another dose should be forecast.
2013-0329,"Dose 2 to 3, interval 8 weeks -3 days, #3 after 12 months of age",05/04/2020,F,,,,Complete,07/04/2020,ACTHIB,48,PMC,Valid,,03/18/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/26/2020,Not recommended: series complete,This patient should have been marked complete for Hib.  No Further Doses Needed.,1.1,This test case describes when a child is administered the second and third  dose of the Hib vaccine at 8 weeks - 3 days and after 12 months of age that the doses are valid.  No further doses of the Hib vaccine should be forecast.  The series is complete.
2013-0330,# 1 at 7 months -4 days,10/14/2020,F,,,,Not complete,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/26/2020,Recommended based on minimum interval from previous dose (catch-up),Past Due Date was incorrect.  Should be in alignment with the earliest and recommended.  Child is in catch-up schedule.,1.1,This test case describes when a child is administered the first dose of the Hib vaccine at 7 months- 4 days that the dose is valid.  Another dose should be forecast.
2013-0331,# 1 at 12 months minus 5 days,05/15/2020,F,,,,Not complete,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/26/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered the first dose of the Hib vaccine at 12 months- 5 days that the dose is valid.  Another dose should be forecast.
2013-0332,# 1 at 12 months -4 days,05/14/2020,F,,,,Not complete,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,07/05/2021,07/05/2021,07/05/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/26/2020,Recommended based on minimum interval from previous dose (catch-up),Past Due Date was incorrect.  Should be in alignment with the earliest and recommended.  Child is in catch-up schedule.,1.1,This test case describes when a child is administered the first dose of the Hib vaccine at 12 months- 4 days that the dose is valid.  Another dose should be forecast.
2013-0333,# 1 at 12 months -3 days,05/13/2020,F,,,,Not complete,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,07/05/2021,07/05/2021,07/05/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/26/2020,Recommended based on minimum interval from previous dose (catch-up),Past Due Date was incorrect.  Should be in alignment with the earliest and recommended.  Child is in catch-up schedule.,1.1,This test case describes when a child is administered the first dose of the Hib vaccine at 12 months- 3 days that the dose is valid.  Another dose should be forecast.
2013-0334,#2 at 7 m and 23 days (#1 at 7 m),09/17/2020,F,,,,Not complete,04/17/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,HIB,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,05/26/2020,Recommended based on minimum interval from invalid dose,,1.0,This test case describes when a child is administered the second dose of the Hib vaccine at 7 months and 23 days that the dose is not valid.  A repeat dose should be forecast.
2013-0335,#2 at 7 m and 24 days (#1 at 7 m),09/16/2020,F,,,,Not complete,04/16/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,09/16/2021,09/16/2021,02/12/2022,HIB,05/10/2021,Interval: At Absolute Minimum,01/01/2013,05/29/2020,Recommended based on age,,1.0,This test case describes when a child is administered the second dose of the Hib vaccine at 7 months and 24 days that the dose is valid. Another dose should be forecast.
2013-0336,#2 at 11 m (#1 at 7 m),06/10/2020,F,,,,Not complete,01/10/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,07/05/2021,07/05/2021,11/06/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/26/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered the second dose of the Hib vaccine at 11 months that the dose is valid.  Another dose should be forecast.
2013-0337,#2 at 12 m  (#1 at 7 m),05/10/2020,F,,,,Not complete,12/10/2020,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,07/05/2021,07/05/2021,10/07/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/26/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered the second dose of the Hib vaccine at 12 months that the dose is valid.  Another dose should be forecast.
2013-0338,"#3 at 365 d -5 days (#1 at 7m, #2 at 8m)",05/15/2020,F,,,,Not complete,12/15/2020,ACTHIB,48,PMC,Valid,,01/15/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,3,07/05/2021,07/05/2021,10/12/2021,HIB,05/10/2021,Age: Below Absolute Minimum,01/01/2013,05/26/2020,Recommended based on minimum interval from invalid dose,Dose 3 was too young by 1 day according to the cath-up schedule.  Evaluation of dose 3 was changed from valid to not valid with a reason of Age: Too Young which aligns with original test case evaluation test type and forecast test type,1.2,This test case describes when a child is administered the third dose of the Hib vaccine at 365 days - 5 days that the dose is not valid.  Another dose should be forecast.
2013-0339,"#3 at 365 d -4 days (#1 at 7m, #2 at 8m)",05/14/2020,F,,,,Complete,12/14/2020,ACTHIB,48,PMC,Valid,,01/14/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Age: At Absolute Minimum,01/01/2013,05/26/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered the third dose of the Hib vaccine at 365 days - 4 days that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0340,"#3 at 365 days - 3 days (#1 at 7m, #2 at 8m)",05/13/2020,F,,,,Complete,12/13/2020,ACTHIB,48,PMC,Valid,,01/13/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/26/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered the third dose of the Hib vaccine at 365 days - 3 days that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0341,"#3 at 59 months (#1 at 7m, #2 at 8m)",06/10/2016,F,,,,Complete,01/10/2017,ACTHIB,48,PMC,Valid,,02/10/2017,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/26/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered the third dose of the Hib vaccine at 59 months that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0342,"#3 at 5 years (#1 at 7m, #2 at 8m)",05/10/2016,F,,,,Aged out,12/10/2016,ACTHIB,48,PMC,Valid,,01/10/2017,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Extraneous,Age: Too Old,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Age: Too Old,01/01/2013,05/27/2020,Not recommended: too old,"v1.6: Updated Series Status from ""Not Complete"" to ""Aged Out"" to align with updated CDSi Logic Specification Series Statuses.

v1.2: Within the scope of the CDSi effort, Hib on or after 5 years is not recommended.  The last administered dose was changed to Extraneous to reflect this.",1.6,This test case describes when a child is administered the third dose of the Hib vaccine at 5 years that the dose is extraneous.  No further doses should be forecast.  The series is complete
2013-0343,"Dose 2 to 3, interval 8 weeks-5 days, #3 after 12 months of age",04/03/2020,F,,,,Not complete,06/03/2020,ACTHIB,48,PMC,Valid,,03/17/2021,PEDVAXHIB,49,MSD,Valid,,05/07/2021,PEDVAXHIB,49,MSD,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,3,07/02/2021,07/02/2021,08/30/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/29/2020,Recommended based on minimum interval from previous dose (catch-up),Dose 3 should be invalid due to an interval violation,1.1,This test case describes when a child greater than 12 months of age is administered a third dose of the Hib vaccine at an interval of 8 weeks - 5 days from the second dose that the dose is not valid.  Another dose should be forecast.
2013-0344,"Dose 2 to 3, interval 8 weeks -4 days, #3 after 12 months of age",04/03/2020,F,,,,Complete,06/03/2020,ACTHIB,48,PMC,Valid,,03/17/2021,PEDVAXHIB,49,MSD,Valid,,05/08/2021,PEDVAXHIB,49,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/27/2020,Not recommended: series complete,,1.0,This test case describes when a child greater than 12 months of age is administered a third dose of the Hib vaccine at an interval of 8 weeks - 4 days from the second dose that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0346,#1 at 15 months -5 days,02/15/2020,F,,,,Not complete,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,07/05/2021,07/05/2021,07/05/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/27/2020,Recommended based on minimum interval from previous dose (catch-up),Past Due Date was incorrect.  Should be in alignment with the earliest and recommended.  Child is in catch-up schedule.,1.1,This test case describes when a child is administered the first dose of the Hib vaccine at 15 months - 5 days that the dose is valid.  Another dose should be forecast.
2013-0347,#1 at 15 months -4 days,02/14/2020,F,,,,Complete,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/29/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered the first dose of the Hib vaccine at 15 months - 4 days that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0348,Dose 1 to 2 at 8 weeks -5 days (#1 at 1 year),03/20/2020,F,,,,Not complete,03/20/2021,ACTHIB,48,PMC,Valid,,05/10/2021,PEDVAXHIB,49,MSD,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,07/05/2021,07/05/2021,07/05/2021,HIB,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,05/27/2020,Recommended based on minimum interval from invalid dose,Condensed the past due date to align with the earliest and recommended date since this child is in catch-up,1.2,This test case describes when a child greater than 12 months of age is administered a second dose of the Hib vaccine at an interval of 8 weeks - 5 days from the first dose that the dose is not valid.  Another dose should be forecast.
2013-0349,Dose 1 to 2 at 8 weeks -4 days (#1 at >=1 year),03/19/2020,F,,,,Complete,03/19/2021,HIBERIX,48,SKB,Valid,,05/10/2021,HIBERIX,48,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Interval: At Absolute Minimum,01/01/2013,05/27/2020,Not recommended: series complete,,1.0,This test case describes when a child greater than 12 months of age is administered a second dose of the Hib vaccine at an interval of 8 weeks - 4 days from the first dose that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0350,Dose 1 to 2 at 8 weeks - 3 days (#1 at >=1 year),03/18/2020,F,,,,Complete,03/18/2021,ACTHIB,48,PMC,Valid,,05/10/2021,Hib (PRP-OMP),49,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Interval: At Absolute Minimum,01/01/2013,05/27/2020,Not recommended: series complete,,1.0,This test case describes when a child greater than 12 months of age is administered a second dose of the Hib vaccine at an interval of 8 weeks - 3 days from the first dose that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0351,"# 3 (#1 at  one year, #2 at 15 months)",12/15/2019,F,,,,Complete,12/15/2020,ACTHIB,48,PMC,Valid,,03/15/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Extraneous,Series Already Complete,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Extra Doses,01/01/2013,05/27/2020,Not recommended: series complete,,1.0,"This test case describes when a child is administered a first dose of the Hib vaccine at one year of age, a second dose of the Hib vaccine at 15 months of age, and a third dose at greater than 15 months that the third dose is extraneous.  No further doses should be forecast.  The series is complete."
2013-0352,# 1 at 15 m - 3 days,02/13/2020,F,,,,Complete,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/27/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered a first dose of the Hib vaccine at 15 months - 3 days that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0353,# 1 at 5 years - 1 day,05/11/2016,F,,,,Complete,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/27/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered a first dose of the Hib vaccine at 5 years - 1 day that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0354,"#2 at 2 years, #1 at 15 m",05/10/2019,F,,,,Complete,08/10/2020,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Extraneous,Series Already Complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Extra Doses,01/01/2013,05/27/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered a first dose of the Hib vaccine at 15 months and a second dose at 2 years that the second dose is extraneous. No further doses should be forecast.  The series is complete.
2013-0355,#2 at 5 months,12/10/2020,F,,,,Not complete,02/10/2021,ACTHIB,48,PMC,Valid,,05/10/2021,ACTHIB,48,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/10/2021,08/06/2021,HIB,05/10/2021,All Valid: Forecast Test,01/01/2013,05/27/2020,Recommended based on age,,1.0,This test case describes when a child is administered a second dose of the Hib vaccine at 5 months that the dose is valid. Another dose should be forecast.
2013-0356,# 2 Pentacel at 6 yrs 11.5 mo.,05/26/2014,F,,,,Complete,02/16/2017,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Extraneous,Series Already Complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Age: Too Old,01/01/2013,05/29/2020,Not recommended: series complete,,1.0,"This test case describes when a child is administered a first dose of the Hib vaccine at  2 years of age and a second dose at 6 years, 11.5 months that the second dose is extraneous.  No further doses should be forecast.  The series is complete."
2013-0357,# 3 Pentacel at 14 wks-5 days,02/06/2021,F,,,,Not complete,03/16/2021,PENTACEL,120,PMC,Valid,,04/13/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/06/2021,10/03/2021,HIB,05/10/2021,Age: Below Absolute Minimum,01/01/2013,05/29/2020,Recommended based on age,Past Due Date was incorrectly calculated as it was missing the 4 week buffer for overdue.,1.1,This test case describes when a child is administered a third dose of the Hib vaccine at an interval of 14 weeks - 5 days from the previous dose that the dose is not valid.  Another dose should be forecast.
2013-0358,invalid age dose 1 as first of others,11/10/2020,F,,,,Not complete,12/15/2020,PENTACEL,120,PMC,Not Valid,Age: Too Young,03/10/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/07/2021,07/07/2021,HIB,05/10/2021,Age: Below Absolute Minimum,01/01/2013,05/29/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered the first dose of the Hib vaccine at less than 6 weeks - 4 days of age that the dose is not valid.
2013-0359,"dose 1 to 2 Pentacel, interval 28-4 days",02/12/2021,F,,,,Not complete,04/16/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/12/2021,10/09/2021,HIB,05/10/2021,Interval: At Absolute Minimum,01/01/2013,05/29/2020,Recommended based on age,Past Due Date was incorrectly calculated as it was missing the 4 week buffer for overdue.,1.1,This test case describes when a child is administered a second dose of the Hib vaccine at 28-4 days from the first dose that the dose is valid.  Another dose should be forecast.
2013-0360,"dose 2 to 3 Pentacel, interval 28-5 days",12/17/2020,F,,,,Not complete,02/17/2021,PENTACEL,120,PMC,Valid,,04/17/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/17/2021,08/13/2021,HIB,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,05/29/2020,Recommended based on age,Past Due Date was incorrectly calculated as it was missing the 4 week buffer for overdue.,1.1,This test case describes when a child is administered a third dose of the Hib vaccine at 28-5 days from the second dose that the dose is not valid.  A repeat dose should be forecast.
2013-0365,# 1 Pentacel at 6 wks,03/29/2021,F,,,,Not complete,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/29/2021,09/25/2021,HIB,05/10/2021,Age: At Minimum,01/01/2013,05/29/2020,Recommended based on age,,1.0,This test case describes when a child is administered the first dose of the Hib vaccine at 6 weeks that the dose is valid.  Another dose should be forecast.
2013-0366,# 1 Pentacel at 6 wks-4 days,04/02/2021,F,,,,Not complete,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/11/2021,08/02/2021,09/29/2021,HIB,05/10/2021,Age: At Absolute Minimum,01/01/2013,05/29/2020,Recommended based on age,,1.0,This test case describes when a child is administered the first dose of the Hib vaccine at 6 weeks - 4 days that the dose is valid.  Another dose should be forecast.
2013-0367,# 1 Pentacel at 6 wks-5 days.  ,04/03/2021,F,,,,Not complete,05/10/2021,PENTACEL,120,PMC,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/15/2021,06/03/2021,07/30/2021,HIB,05/10/2021,Age: Below Absolute Minimum,01/01/2013,05/29/2020,Recommended based on age,,1.0,This test case describes when a child is administered the first dose of the Hib vaccine at 6 weeks - 5 days that the dose is not valid.  A repeat dose should be forecast.
2013-0368,# 2 Pentacel at 10 wks-4 days,03/05/2021,F,,,,Not complete,04/12/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/11/2021,09/05/2021,11/01/2021,HIB,05/10/2021,Age: At Absolute Minimum,01/01/2013,05/29/2020,Recommended based on age,,1.0,This test case describes when a child is administered the second dose of the Hib vaccine at 10 weeks -4 days that the dose is  valid.  Another dose should be forecast.
2013-0369,# 2 Pentacel at 10 wks-5 days,03/06/2021,F,,,,Not complete,04/13/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/06/2021,09/02/2021,HIB,05/10/2021,Age: Below Absolute Minimum,01/01/2013,05/29/2020,Recommended based on age,,1.0,his test case describes when a child is administered the second dose of the Hib vaccine at 10 weeks - 5 days that the dose is  not valid.  A repeat dose should be forecast.
2013-0370,# 3 Pentacel at 14 wks-4 days,02/05/2021,F,,,,Not complete,03/15/2021,PENTACEL,120,PMC,Valid,,04/12/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,02/05/2022,02/05/2022,07/02/2022,HIB,05/10/2021,Age: At Absolute Minimum,01/01/2013,05/29/2020,Recommended based on age,Past Due Date was incorrect based on recommendations.,1.1,This test case describes when a child is administered the third dose of the Hib vaccine at 14 weeks - 4 days that the dose is   valid.  Another dose should be forecast.
2013-0371,# 4 Pentacel ≥ age 12 mo,05/10/2020,F,,,,Complete,07/10/2020,PENTACEL,120,PMC,Valid,,09/10/2020,PENTACEL,120,PMC,Valid,,11/10/2020,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Age: At Minimum,01/01/2013,05/29/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered the fourth dose of the Hib vaccine at 12 months of age that the dose is   valid.  No further doses should be forecast.  The series is complete.
2013-0372,# 4 Pentacel at 1 yr -4 days,05/14/2020,F,,,,Complete,07/14/2020,PENTACEL,120,PMC,Valid,,09/14/2020,PENTACEL,120,PMC,Valid,,11/14/2020,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Age: At Absolute Minimum,01/01/2013,05/29/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered the fourth dose of the Hib vaccine at 1 year - 4 days of age that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0373,# 4 Pentacel at 1 yr -5 days.  ,05/15/2020,F,,,,Not complete,07/15/2020,PENTACEL,120,PMC,Valid,,09/15/2020,PENTACEL,120,PMC,Valid,,10/27/2020,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,4,07/05/2021,07/05/2021,10/12/2021,HIB,05/10/2021,Age: Below Absolute Minimum,01/01/2013,05/29/2020,Recommended based on minimum interval from invalid dose,Past Due Date was incorrect based on recommendations.,1.1,This test case describes when a child is administered the fourth dose of the Hib vaccine at 1 year - 5 days of age that the dose is not valid.  A repeat dose should be forecast.
2013-0374,# 4 Pentacel at 4 yrs,05/06/2017,F,,,,Complete,09/15/2017,PENTACEL,120,PMC,Valid,,04/28/2018,PENTACEL,120,PMC,Valid,,12/12/2020,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Extraneous,Series Already Complete,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Extra Doses,01/01/2013,05/29/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered the fourth dose of the Hib vaccine at 4 years of age that the dose is extraneous. No further dose should be forecast.  The series is complete.
2013-0375,# 4 Pentacel at 5 yrs,05/10/2016,F,,,,Aged out,09/10/2016,PENTACEL,120,PMC,Valid,,03/09/2017,PENTACEL,120,PMC,Valid,,05/05/2017,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Extraneous,Age: Too Old,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Age: Too Old,01/01/2013,05/29/2020,Not recommended: too old,"v1.6: Updated Series Status from ""Not Complete"" to ""Aged Out"" to align with updated CDSi Logic Specification Series Statuses.

v1.1: Changed Dose 3 vaccination date from 2/7/08 to 2/3/08 to avoid completion of series on dose 3 to properly test off-label usage on dose 4 as test case name indicates.  Within the scope of the CDSi effort, Hib on or after 5 years is not recommended.  The last administered dose was changed to Extraneous to reflect this.",1.6,This test case describes when a child is administered the fourth dose of the Hib vaccine (Pentacel) at 5 years of age that the dose is extraneous. No further dose should be forecast.  The series is complete.
2013-0376,# 5 Pentacel at ≥ 4 yrs is off label but counts,04/18/2017,F,,,,Complete,03/18/2018,PENTACEL,120,PMC,Valid,,06/18/2018,PENTACEL,120,PMC,Valid,,09/18/2018,PENTACEL,120,PMC,Valid,,02/19/2019,PENTACEL,120,PMC,Extraneous,Series Already Complete,05/10/2021,PENTACEL,120,PMC,Extraneous,Series Already Complete,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Extra Doses,01/01/2013,05/29/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered a fifth dose of the Hib vaccine (Pentacel) at greater than or equal to 4 years of age that the dose is extraneous. No further dose should be forecast.  The series is complete.
2013-0378,"dose 1 to 2 Pentacel, interval 28-5 days",02/21/2021,F,,,,Not complete,04/17/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/21/2021,08/17/2021,HIB,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,05/29/2020,Recommended based on age,,1.0,This test case describes when a child is administered the second dose of the Hib vaccine (Pentacel) at 28-5 days after the previous dose that the dose is not valid.  A repeat dose should be forecast.
2013-0379,"dose 2 to 3 Pentacel, interval 28-4 days",12/16/2020,F,,,,Not complete,02/16/2021,PENTACEL,120,PMC,Valid,,04/16/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,12/16/2021,12/16/2021,05/13/2022,HIB,05/10/2021,Interval: At Absolute Minimum,01/01/2013,05/29/2020,Recommended based on age,Past Due Date was incorrect based on recommendations.,1.1,This test case describes when a child is administered the third dose of the Hib vaccine (Pentacel) at 28-4 days from the second dose that the dose is valid.  Another dose should be forecast.
2013-0380,invalid age dose 2 in midst of others,05/08/2020,F,,,,Complete,06/15/2020,PENTACEL,120,PMC,Valid,,07/12/2020,PENTACEL,120,PMC,Not Valid,Age: Too Young,09/28/2020,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Age: Below Absolute Minimum,01/01/2013,05/29/2020,Not recommended: series complete,This patient should have been marked complete for Hib.  No Further Doses Needed.,1.1,This test case describes when a child is administered the second dose of the Hib vaccine at less than 10 weeks - 4 days of age that the dose is not valid.
2013-0381,invalid age dose 3 in midst of others,04/04/2020,F,,,,Complete,05/12/2020,PENTACEL,120,PMC,Valid,,06/09/2020,PENTACEL,120,PMC,Valid,,07/06/2020,PENTACEL,120,PMC,Not Valid,Age: Too Young,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Age: Below Absolute Minimum,01/01/2013,05/29/2020,Not recommended: series complete,This patient should have been marked complete for Hib.  No Further Doses Needed.,1.1,This test case describes when a child is administered the third dose of the Hib vaccine at less than 14 weeks - 4 days of age that the dose is not valid.
2013-0382,invalid dose 1-2 interval in midst of others,11/19/2020,F,,,,Not complete,01/19/2021,PENTACEL,120,PMC,Valid,,02/11/2021,PENTACEL,120,PMC,Not Valid,Interval: too short,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/07/2021,07/16/2021,HIB,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,05/29/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered the second dose of the Hib vaccine at an interval less than 4 weeks - 4 days that the dose is not valid.
2013-0383,Newborn,05/10/2021,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/21/2021,07/10/2021,09/06/2021,HIB,05/10/2021,No Doses Administered,01/01/2013,05/29/2020,Recommended based on age,,1.0,This test case describes when a child is a newborn and has not received any doses of the Hib vaccine that the first dose should be forecast at 2 months of age.
2013-0384,Pentacel at 6 yrs,05/10/2015,F,,,,Aged out,10/19/2015,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Extraneous,Age: Too Old,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HIB,05/10/2021,Age: Too Old,01/01/2013,05/29/2020,Not recommended: too old,"V3.5: Changed age of patient and vaccination from 7 years to 6 years to better align with new Age Groupings. No effective change of test case expectations.
v1.6: Updated Series Status from ""Not Complete"" to ""Aged Out"" to align with updated CDSi Logic Specification Series Statuses.
v1.2: Within the scope of the CDSi effort, Hib on or after 5 years is not recommended.  The last administered dose was changed to Extraneous to reflect this.",3.5,This test case describes when a child is administered a second dose of the Hib vaccine at 6 years that the dose is extraneous.  No further doses should be forecast.  The series is complete.
2013-0392,"#1 @ 9 yrs - 4 days, female, gardasil ",05/14/2012,F,,,,Not complete,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,10/10/2021,11/10/2021,07/07/2022,HPV,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/08/2020,Recommended based on interval,Updated to reflect current ACIP Recommendations for the 2 dose HPV vaccine.,3.2,This test case describes when the first dose of the HPV vaccine is administered at 9 years - 4 days that the CDSi engine forecasts the second dose of the HPV 2 dose series.
2013-0394,"#1 @ 9 yrs - 0 days, female, gardasil",05/10/2012,F,,,,Not complete,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,10/10/2021,11/10/2021,07/07/2022,HPV,05/10/2021,Age: At Minimum,01/01/2013,02/13/2018,Recommended based on interval,Updated to reflect current ACIP Recommendations for the 2 dose HPV vaccine.,3.2,This test case describes whether or not the first dose is valid at age 9 years - 0 days and thus forecast the second dose of the HPV 2 dose series.
2013-0395,"#1 @ 11 yrs - 0 days, female, gardasil ",05/10/2010,F,,,,Not complete,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,10/10/2021,11/10/2021,07/07/2022,HPV,05/10/2021,Age: At Recommended,01/01/2013,02/13/2018,Recommended based on interval,Updated to reflect current ACIP Recommendations for the 2 dose HPV vaccine.,3.2,This test case describes whether or not the first dose is valid at age 11 years - 0 days and thus forecast the second dose.
2013-0396,"#1 @ 9 yrs - 4 days, male, gardasil ",05/14/2012,M,,,,Not complete,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,10/10/2021,11/10/2021,07/07/2022,HPV,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/08/2020,Recommended based on interval,Updated to reflect current ACIP Recommendations for the 2 dose HPV vaccine.,3.2,This test case describes whether or not the first dose is valid at age 9 years - 4 days and thus forecast the second dose of the HPV 2 dose series.
2013-0398,"#1 @ 9 yrs - 0 days, male, gardasil ",05/10/2012,M,,,,Not complete,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,10/10/2021,11/10/2021,07/07/2022,HPV,05/10/2021,Age: At Minimum,01/01/2013,02/13/2018,Recommended based on interval,Updated to reflect current ACIP Recommendations for the 2 dose HPV vaccine.,3.2,This test case describes when the first dose is administered at age 9 years - 0 days that the CDS engine should forecast a second dose of the HPV 2 dose series.
2013-0399,"#1 @ 11 yrs - 0 days, male, gardasil ",05/10/2010,M,,,,Not complete,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,10/10/2021,11/10/2021,07/07/2022,HPV,05/10/2021,Age: At Recommended,01/01/2013,02/13/2018,Recommended based on interval,Updated to reflect current ACIP Recommendations for the 2 dose HPV vaccine.,3.2,This test case describes when the first dose is administered at age 11 years - 0 days that the second dose of the HPV 2 dose series should be forecasted.
2013-0400,"#2 @ 9 yrs, 4 wks - 4 days, female, gardasil ",04/16/2012,F,,,,Not complete,04/12/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,09/12/2021,10/12/2021,06/08/2022,HPV,05/10/2021,Interval: At Minimum,01/01/2013,06/08/2020,Recommended based on interval,Updated to reflect current ACIP Recommendations for the 2 dose HPV vaccine.,3.2,This test case describes when the second dose is administered at an interval of 4 weeks - 4 days (less than 5 months) that a third dose of the HPV vaccine should be forecasted at 5 to 6 months from the first dose.
2013-0402,"#2 @ 9 yrs, 4 wks - 0 days, female gardasil ",04/12/2012,F,,,,Not complete,04/12/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,09/12/2021,10/12/2021,06/08/2022,HPV,05/10/2021,Interval: At Minimum,01/01/2013,06/15/2020,Recommended based on interval,Updated to reflect ACIP recommendations for the HPV 2 dose series.,3.2,"This test case describes when the second dose is administered 4 weeks (less than 5 months) after the first dose, that a third dose of the HPV vaccine should be forecasted."
2013-0403,"#2 @ 11 yrs + 2 mo, female, gardasil ",03/10/2010,F,,,,Not complete,03/10/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,08/10/2021,09/10/2021,05/07/2022,HPV,05/10/2021,Interval: At Minimum,01/01/2013,06/15/2020,Recommended based on interval,Updated to reflect current ACIP Recommendations for the 2 dose HPV vaccine.,3.2,"This test case describes when the second dose is administered 2 months (less than 5 months) after the first dose, that a third dose of the HPV vaccine should be forecasted."
2013-0404,"#2 @ 9 yrs, 4 wks - 4 days, male, gardasil ",04/16/2012,M,,,,Not complete,04/13/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,09/13/2021,10/13/2021,06/09/2022,HPV,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/08/2020,Recommended based on interval,Updated to reflect current ACIP Recommendations for the 2 dose HPV vaccine.,3.2,This test case describes when the second dose is administered at an interval of 4 weeks - 4 days  that a repeat dose of the HPV vaccine should be forecasted 5 to 6 months from the first dose.
2013-0405,"#2 @ 9 yrs, 4 wks - 5 days, male gardasil ",04/21/2012,M,,,,Not complete,04/17/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,09/17/2021,10/17/2021,06/13/2022,HPV,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/01/2018,Recommended based on interval,"V3.5: Updated test case Forecast number from 3 to 2.  There is only 1 valid dose, so this should be forecast dose number 2.
V3.3: Updated test case Forecast number from 2 to 3",3.5,This test case describes when the second dose is administered at an interval of 4 weeks - 5 day  that a repeat dose of the HPV vaccine should be forecasted at least 5 to 6 months from the first dose.
2013-0406,"#2 @ 9 yrs, 4 wks - 0 days, male gardasil",04/12/2012,M,,,,Not complete,04/12/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,09/12/2021,10/12/2021,06/08/2022,HPV,05/10/2021,Interval: At Minimum,01/01/2013,06/15/2020,Recommended based on interval,Updated to reflect current ACIP Recommendations for the 2 dose HPV vaccine.,3.2,This test case describes when the second dose is administered at an interval of 4 weeks that a repeat dose of the HPV vaccine should be forecasted at least 5 to 6 months from the first dose.
2013-0407,"#2 @ 11 yrs + 2 mo, male, gardasil",03/10/2010,M,,,,Not complete,03/10/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,08/10/2021,09/10/2021,05/07/2022,HPV,05/10/2021,Interval: At Minimum,01/01/2013,06/15/2020,Recommended based on interval,Updated to reflect ACIP recommendations for the HPV 2 dose series.,3.2,"This test case describes when the second dose is administered 2 months (less than 5 months) after the first dose, that a third dose of the HPV vaccine should be forecasted."
2013-0409,"#3 @ 9 yrs, 16 weeks - 1 days, female, gardasil",05/01/2002,F,,,,Complete,04/30/2011,GARDASIL,62,MSD,Valid,,05/28/2011,GARDASIL,62,MSD,Valid,,08/20/2011,GARDASIL,62,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,08/20/2011,Interval: At Absolute Minimum,01/01/2013,06/15/2020,Not recommended: series complete,v2.1 Removal of Age requirements to allow for a more aligned dosing schedule based on intervals rather than age.,2.1,"This test case describes when a child is administered a third dose of the HPV vaccine at 16 weeks - 1 day, after the first dose, that the dose is considered to be valid.  The series is complete. (Prior to 12/16/16, 16 weeks - 4 days was allowed to be used as an Absolute Minimum Interval from Target Dose #1)."
2013-0410,"#3 @ 9 yrs, 24 weeks, 0 days, female, gardasil",11/23/2011,F,,,,Complete,11/23/2020,HPV9,165,,Valid,,12/21/2020,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,05/10/2021,Age: At Minimum,01/01/2013,10/30/2019,Not recommended: series complete,Added a description.,4.2,"This test case describes when a third dose of the HPV vaccine is administered at 24 weeks from dose number 1, that the dose is valid.  The series is complete."
2013-0411,"#3 @ 11 yrs + 6 mo, female, gardasil ",11/10/2009,F,,,,Complete,11/10/2020,HPV9,165,,Valid,,01/10/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,05/10/2021,Age: At Recommended,01/01/2013,10/30/2019,Not recommended: series complete,Added Description.,4.2,"This test case describes when the third dose of the HPV vaccine is administered at 6 months from dose number 1, that the dose is valid.  The series is complete."
2013-0413,"#3 @ 9 yrs, 16 weeks - 1 days, male, gardasil",05/01/2002,M,,,,Complete,04/30/2011,GARDASIL,62,MSD,Valid,,05/28/2011,GARDASIL,62,MSD,Valid,,08/20/2011,GARDASIL,62,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,08/20/2011,Interval: At Absolute Minimum,01/01/2013,06/15/2020,Not recommended: series complete,v2.1 Removal of Age requirements to allow for a more aligned dosing schedule based on intervals rather than age.,2.1,"This test case describes when a child is administered a third dose of the HPV vaccine at 16 weeks - 1 day, after the first dose,  that the dose is considered to be valid.  The series is complete. (Prior to 12/16/16, 16 weeks - 4 days was allowed to be used as an Absolute Minimum Interval from Target Dose #1)."
2013-0414,"#3 @ 9 yrs, 24 weeks, 0 days, male, gardasil",11/23/2011,M,,,,Complete,11/23/2020,HPV9,165,,Valid,,12/21/2020,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,05/10/2021,Age: At Minimum,01/01/2013,06/15/2020,Not recommended: series complete,v1.1 Dose 1 must be Gardasil for it to be valid and match test case purpose.,1.1,This test case describes when a child is administered a third dose of the HPV vaccine at 24 weeks that the dose is considered to be valid.  The series is complete.
2013-0415,"#3 @ 11 yrs + 6 mo, male, gardasil",11/10/2009,M,,,,Complete,11/10/2020,HPV9,165,,Valid,,01/10/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,05/10/2021,Age: At Recommended,01/01/2013,06/15/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered a third dose of the HPV vaccine at 6 months after the first dose that the dose is considered to be valid.  The series is complete.
2013-0416,"Any dose 26 yrs, female, gardasil",05/09/1995,F,,,,Not complete,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,08/29/2021,HPV,05/10/2021,Age: At Recommended,01/01/2013,03/27/2018,Recommended based on interval,"V3.4: Earliest Recommended Date was changed from 8 weeks to 4 weeks on Dose 2 per HPV MMWR language. 
V3.0 Updated test came name and date of birth to reflect the age of 26 and to reflect that the second dose of the HPV vaccine should be forecasted.",3.4,This test case describes when a female receives the first dose of the HPV vaccine at age 26 years that a second dose should forecast at an interval of 4 - 8 weeks.
2013-0418,"#1 @ 9 yrs - 4 days, female, Cervarix ",05/01/2002,F,,,,Not complete,04/27/2011,CERVARIX,118,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,09/27/2011,10/27/2011,06/23/2012,HPV,04/27/2011,Age: At Absolute Minimum,01/01/2013,06/15/2020,Recommended based on interval,v3.2 - Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.,3.2,"This test case describes when a child is administered the first dose of the HPV vaccine at age 9 years -4 days, that another dose should be forecast."
2013-0421,"#1 @ 9 yrs - 0 days, female, Cervarix ",05/01/2002,F,,,,Not complete,05/01/2011,CERVARIX,118,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,10/01/2011,11/01/2011,06/28/2012,HPV,05/01/2011,Age: At Minimum,01/01/2013,06/15/2020,Recommended based on interval,Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.,3.2,"This test case describes when a child is administered the first dose of the HPV vaccine at age 9 years, that another dose should be forecast."
2013-0422,"#1 @ 11 yrs - 0 days, female, Cervarix ",05/01/2000,F,,,,Not complete,05/01/2011,CERVARIX,118,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,10/01/2011,11/01/2011,06/28/2012,HPV,05/01/2011,Age: At Recommended,01/01/2013,06/15/2020,Recommended based on interval,v3.2 - Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.,3.2,"This test case describes when a child is administered the first dose of the HPV vaccine at age 11 years -0 days, that another dose should be forecast."
2013-0423,"#1 @ 9 yrs - 4 days, male, Cervarix ",05/01/2002,M,,,,Not complete,04/28/2011,CERVARIX,118,SKB,Not Valid,Inadvertent Vaccine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/01/2011,05/01/2013,05/28/2015,HPV,04/28/2011,Inadvertent vaccine,01/01/2013,06/15/2020,Recommended based on age,Updated reason code on dose #1 to Inadvertent vaccine: Inadvertent administration,3.2,This test case describes when a male receives Cervarix that the dose should not count as a valid dose and a repeat dose should be given at the correct age or interval.
2013-0424,"#1 @ 9 yrs - 5 days, male, Cervarix ",05/01/2002,M,,,,Not complete,04/27/2011,CERVARIX,118,SKB,Not Valid,Inadvertent Vaccine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/01/2011,05/01/2013,05/28/2015,HPV,04/27/2011,Inadvertent vaccine,01/01/2013,02/13/2018,Recommended based on age,Updated reason code on dose #1 to Inadvertent vaccine. Inadvertent Administration.,3.2,This test case describes when a vaccine dose is given less than the vaccine grace period and that vaccine (Cervarix)  is administered to a male that the dose is not valid and that a subsequent dose of a preferred or allowed vaccine should be administered as soon as possible.
2013-0425,"#1 @ 9 yrs - 0 days, male, Cervarix",05/01/2002,M,,,,Not complete,05/01/2011,CERVARIX,118,SKB,Not Valid,Inadvertent Vaccine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/01/2011,05/01/2013,05/28/2015,HPV,05/01/2011,Inadvertent vaccine,01/01/2013,02/13/2018,Recommended based on age,Updated reason code on dose #1 to Inadvertent vaccine. Inadvertent Administration.,3.2,This test case describes when the Cervarix vaccine is administered to a male that the dose is not valid and that a subsequent dose of a preferred or allowed vaccine should be administered as soon as possible.
2013-0426,"#1 @ 11 yrs - 0 days, male, Cervarix ",05/01/2000,M,,,,Not complete,05/01/2011,CERVARIX,118,SKB,Not Valid,Inadvertent Vaccine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/01/2011,05/01/2011,05/28/2013,HPV,05/01/2011,Inadvertent vaccine,01/01/2013,02/13/2018,Recommended based on age,Updated the Earliest date to 05/01/2011,3.3,This test case describes when a male receives Cervarix that the dose should not count as a valid dose and a repeat dose should be given at the correct age or interval.
2013-0427,"#2 @ 9 yrs, 4 wks - 4 days, female, Cervarix ",05/01/2002,F,,,,Not complete,04/28/2011,CERVARIX,118,SKB,Valid,,05/25/2011,CERVARIX,118,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,09/28/2011,10/28/2011,06/24/2012,HPV,05/25/2011,Interval: At Absolute Minimum,01/01/2013,06/08/2020,Recommended based on interval,Updated to reflect ACIP recommendations for the HPV 2 dose series.,3.2,This test case describes when a second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose or third dose should be forecasted.
2013-0428,"#2 @ 9 yrs, 4 wks - 0 days, female Cervarix ",05/01/2002,F,,,,Not complete,05/01/2011,CERVARIX,118,SKB,Valid,,05/29/2011,CERVARIX,118,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,10/01/2011,11/01/2011,06/28/2012,HPV,05/29/2011,Interval: At Minimum,01/01/2013,06/15/2020,Recommended based on interval,Updated to reflect ACIP recommendations for the HPV 2 dose series.,3.2,This test case describes when a second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose or third dose should be forecasted.
2013-0429,"#2 @ 11 yrs + 2 mo, female, Cervarix ",05/01/2000,F,,,,Not complete,05/01/2011,CERVARIX,118,SKB,Valid,,07/01/2011,CERVARIX,118,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,10/01/2011,11/01/2011,06/28/2012,HPV,07/01/2011,Interval: At Minimum,01/01/2013,10/05/2020,Recommended based on interval,Updated to reflect ACIP recommendations for the HPV 2 dose series.,3.2,This test case describes when a patient is administered a second dose of the HPV vaccine at 11 years and 2 months of age (8 weeks after the previous dose) that the dose is valid.  Another dose should be forecast.
2013-0430,"#2 @ 9 yrs, 4 wks - 4 days, male, Cervarix ",05/01/2002,M,,,,Not complete,04/28/2011,CERVARIX,118,SKB,Not Valid,Inadvertent Vaccine,05/22/2011,CERVARIX,118,SKB,Not Valid,Inadvertent Vaccine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/22/2011,05/01/2013,05/28/2015,HPV,05/22/2011,Inadvertent vaccine,01/01/2013,02/13/2018,Recommended based on age,Updated the Earliest date to 05/22/2011,3.3,This test case describes when the first and second dose are given at an invalid age or interval and the vaccine administered was to a male that the vaccine dose should be repeated as soon as possible.
2013-0433,"#3 @ 9 yrs, 24 weeks, 0 days, female, Cervarix ",05/01/2002,F,,,,Complete,05/01/2011,CERVARIX,118,SKB,Valid,,05/29/2011,CERVARIX,118,SKB,Valid,,10/16/2011,CERVARIX,118,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,10/16/2011,Interval: At Minimum,01/01/2013,06/15/2020,Not recommended: series complete,,1.0,"This test case describes when a child is administered the third dose of the HPV vaccine at 24 weeks from dose one, that the dose is valid.  Series is complete."
2013-0434,"#3 @ 11 yrs + 6 mo, female, Cervarix ",05/01/2000,F,,,,Complete,05/01/2011,CERVARIX,118,SKB,Valid,,07/01/2011,CERVARIX,118,SKB,Valid,,11/01/2011,CERVARIX,118,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,11/01/2011,Age: At Recommended,01/01/2013,06/15/2020,Not recommended: series complete,,1.0,"This test case describes when a child is administered the third dose of the HPV vaccine at 6 months from dose one, that the dose is valid.  Series is complete."
2013-0437,"#3 @ 9 yrs, 24 weeks, 0 days, male, Cervarix ",05/01/2002,M,,,,Not complete,05/01/2011,CERVARIX,118,SKB,Not Valid,Inadvertent Vaccine,05/29/2011,CERVARIX,118,SKB,Not Valid,Inadvertent Vaccine,10/19/2011,CERVARIX,118,SKB,Not Valid,Inadvertent Vaccine,,,,,,,,,,,,,,,,,,,,,,,,,1,10/19/2011,05/01/2013,05/28/2015,HPV,10/19/2011,Inadvertent vaccine,01/01/2013,02/13/2018,Recommended based on age,Updated the Earliest date to reflect the last dose received.,3.3,"This test case describes when an invalid vaccine is administered in doses 1, 2, and 3 that a repeat dose should be administered as soon as possible."
2013-0438,"#3 @ 11 yrs + 6 mo, male, Cervarix ",05/01/2000,M,,,,Not complete,05/01/2011,CERVARIX,118,SKB,Not Valid,Inadvertent Vaccine,07/01/2011,CERVARIX,118,SKB,Not Valid,Inadvertent Vaccine,11/01/2011,CERVARIX,118,SKB,Not Valid,Inadvertent Vaccine,,,,,,,,,,,,,,,,,,,,,,,,,1,11/01/2011,11/01/2011,05/28/2013,HPV,11/01/2011,Inadvertent vaccine,01/01/2013,02/13/2018,Recommended based on age,Updated the Earliest Date to reflect the last dose received.,3.3,"This test case describes when an invalid vaccine is administered in doses 1, 2, and 3 that a repeat dose should be administered as soon as possible."
2013-0439,"Any dose 26 yrs, female, Cervarix",05/01/1986,F,,,,Not complete,05/02/2012,CERVARIX,118,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,05/30/2012,05/30/2012,08/21/2012,HPV,05/02/2012,Age: At Recommended,01/01/2013,06/15/2020,Recommended based on interval,"V3.5: Updated Recommended Date to reflect change in supporting data (v3.6) from 8 weeks to 4 weeks.
V3.0 Updated test came name and date of birth to reflect the age of 26 and to reflect that the second dose of the HPV vaccine should be forecast.",3.5,"This test case describes when a patient 26 years of age has received dose number one of the HPV vaccine, that another dose should be forecast."
2013-0440,#2 with interval of 4 weeks from #1,04/12/2010,F,,,,Not complete,04/12/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,09/12/2021,10/12/2021,06/08/2022,HPV,05/10/2021,Interval: At Minimum,01/01/2013,06/15/2020,Recommended based on interval,Updated to reflect ACIP recommendations for the HPV 2 dose series.,3.2,This test case describes when a second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose or third dose should be forecasted.
2013-0441,#2 with interval of 4 weeks - 4 days from #1,04/16/2010,F,,,,Not complete,04/16/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,09/16/2021,10/16/2021,06/12/2022,HPV,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/08/2020,Recommended based on interval,Updated to reflect ACIP recommendations for the HPV 2 dose series.,3.2,This test case describes when a second dose is administered at an interval of 4 weeks -4 days ( less than 5 months) that a repeat or third dose should be forecasted.
2013-0442,#2 with interval of 4 weeks - 5 days from #1,04/17/2010,F,,,,Not complete,04/17/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,09/17/2021,10/17/2021,06/13/2022,HPV,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on interval,v3.2: Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.,3.2,"This test case describes when an adolescent child is administered dose two of the HPV vaccine at 4 weeks - 5 days from dose number one, that the dose is not valid, and another dose should be forecast."
2013-0443,#2 with interval of 2 mo from #1,03/10/2010,F,,,,Not complete,03/10/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,08/10/2021,09/10/2021,05/07/2022,HPV,05/10/2021,Interval: At Recommended,01/01/2013,10/05/2020,Recommended based on interval,Updated to reflect ACIP recommendations for the HPV 2 dose series.,3.2,"This test case describes when a adolescent child has been administered a second dose of the HPV vaccine at 8 weeks after the first dose, that the dose is valid.  Another dose should be forecast."
2013-0444,#3 with interval of 12 weeks from #2,05/01/2002,F,,,,Complete,05/01/2011,"HPV, unspecified formulation",137,,Valid,,05/29/2011,"HPV, unspecified formulation",137,,Valid,,08/21/2011,"HPV, unspecified formulation",137,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,08/21/2011,Interval: At Minimum,01/01/2013,06/15/2020,Not recommended: series complete,,1.0,"This test case describes when a child is administered the third dose of the HPV vaccine at 12 weeks from dose number 2 and at least 16 weeks - 4 days from dose number one, that the dose is considered to be valid.  The series is complete. (Prior to 12/16/16, 16 weeks - 4 days was allowed to be used as an Absolute Minimum Interval from Target Dose #1, and 12 weeks -4 days was allowed to be used as an Absolute Minimum Interval from Target Dose #2)."
2013-0445,#3 with interval of 12 weeks - 4 days from #2,05/01/2000,F,,,,Complete,05/01/2011,"HPV, unspecified formulation",137,,Valid,,06/06/2011,"HPV, unspecified formulation",137,,Valid,,08/25/2011,"HPV, unspecified formulation",137,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,08/25/2011,Interval: At Absolute Minimum,01/01/2013,06/15/2020,Not recommended: series complete,,1.0,"This test case describes when a child is administered the third dose of the HPV vaccine at 12 weeks - 4 days from dose number 2 and at least 16 weeks - 4 days from dose number one, that the dose is considered to be valid.  The series is complete. (Prior to 12/16/16, 16 weeks - 4 days was allowed to be used as an Absolute Minimum Interval from Target Dose #1, and 12 weeks -4 days was allowed to be used as an Absolute Minimum Interval from Target Dose #2)."
2013-0446,#3 with interval of 12 weeks - 5 days from #2,01/15/2010,F,,,,Not complete,01/15/2021,HPV9,165,,Valid,,02/20/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,3,08/02/2021,08/02/2021,03/14/2022,HPV,05/10/2021,Interval: At Below Absolute Minimum,01/01/2013,02/13/2018,Recommended based on minimum interval from invalid dose,Updated the Forecasted Recommended Date to reflect current ACIP recommendation for interval from invalid dose.,3.2,This test case describes when a third dose is administered an at an interval of 12 weeks - 5 days that a repeat dose should be forecasted 12 weeks later.
2013-0447,#3 with interval of 4 mo from #2,11/10/2009,F,,,,Complete,11/10/2020,HPV9,165,,Valid,,01/10/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,05/10/2021,Interval: At Recommended,01/01/2013,06/15/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered the third dose of the HPV vaccine four months after the second dose that the dose is valid.  The series is complete.
2013-0448,#3 with interval of 24 weeks from #1 ,11/23/2010,F,,,,Complete,11/23/2020,HPV9,165,,Valid,,12/21/2020,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,05/10/2021,Interval: At Minimum,01/01/2013,06/15/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered the third dose of the HPV vaccine 24 weeks after dose number one that the dose is valid.  The series is complete.
2013-0450,#3 with interval of 16 weeks from #1 ,05/01/2000,F,,,,Complete,05/01/2010,"HPV, unspecified formulation",137,,Valid,,05/29/2010,"HPV, unspecified formulation",137,,Valid,,08/21/2010,"HPV, unspecified formulation",137,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,08/21/2010,Interval: At Minimum,01/01/2013,06/15/2020,Not recommended: series complete,,1.0,"This test case describes when a child is administered a third dose of the HPV vaccine at 16 weeks after the first dose that the dose is  valid.  The series is complete. (Prior to 12/16/16, 16 weeks - 4 days was allowed to be used as an Absolute Minimum Interval from Target Dose #1)."
2013-0451,"#1 @ 8 yrs - 5 days, #2 @ 9 yrs - 5 days",05/15/2012,F,,,,Not complete,05/10/2020,HPV9,165,,Not Valid,Age: Too Young,05/10/2021,HPV9,165,,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/15/2021,05/15/2023,06/11/2025,HPV,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on age,,1.0,This test case describes when a child is administered dose number one of the HPV vaccine at 8 years - 5 days and dose number two at 9 years - 5 days that the doses are not valid.  Another dose should be forecast.
2013-0452,"#1 @ 9 yrs - 5 days, #2 @ 9 yrs - 4 days",05/14/2012,F,,,,Not complete,05/09/2021,HPV9,165,,Not Valid,Age: Too Young,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,10/10/2021,11/10/2021,07/07/2022,HPV,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on interval,v3.2: Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.,3.2,This test case describes when a child is administered dose number one of the HPV vaccine at 9 years - 5 days and another dose  at 9 years - 4 days that the second dose is valid.  Another dose should be forecast.
2013-0453,"#1 @ 9 yrs, #2 @ 9 yrs + 2 weeks",04/26/2012,F,,,,Not complete,04/26/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,09/26/2021,10/26/2021,06/22/2022,HPV,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on interval,v3.2: Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.,3.2,This test case describes when a child is administered dose number two of the HPV vaccine at 2 weeks from dose number one that the the dose is not valid.  Another dose should be forecast.
2013-0454,"#1 @ 9 yrs, #2 @ 12 yrs, 2 mo, 3 days",03/07/2009,F,,,,Complete,03/07/2018,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,05/10/2021,All Valid: Forecast Test,01/01/2013,06/15/2020,Not recommended: series complete,v3.2: Updated to reflect ACIP recommendations for the HPV 2 dose series.,3.2,This test case describes when an adolescent child is administered dose number two of the HPV vaccine at greater than 5 months after dose number one that the dose is valid. Series is complete.
2013-0455,"#1 @ 9 yrs, #2 @ 11 yr, 6 mo",11/10/2009,F,,,,Complete,11/10/2018,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,05/10/2021,All Valid: Forecast Test,01/01/2013,06/15/2020,Not recommended: series complete,v3.2: Updated to reflect ACIP recommendations for the HPV 2 dose series.,3.2,This test case describes when an adolescent child is administered dose number two of the HPV vaccine at greater than 5 months after dose number one that the dose is valid. Series is complete.
2013-0456,"#1 @ 8 yrs - 5 days, #2 @ 9 yrs - 6 days, #3 @ 9 yrs - 5 days",05/15/2012,F,,,,Not complete,05/10/2020,HPV9,165,,Not Valid,Age: Too Young,05/09/2021,HPV9,165,,Not Valid,Age: Too Young,05/10/2021,HPV9,165,,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,1,05/15/2021,05/15/2023,06/11/2025,HPV,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on age,,1.0,This test case describes when a child is administered three doses of the HPV vaccine before 9 years - 4 days that the doses are not valid.  Another dose should be forecast.
2013-0457,"#1 @ 8 yrs - 5 days, #2 @ 9 yrs - 6 days, #3 @ 9 yrs - 0 days",05/10/2012,F,,,,Not complete,05/05/2020,HPV9,165,,Not Valid,Age: Too Young,05/04/2021,HPV9,165,,Not Valid,Age: Too Young,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,2,10/10/2021,11/10/2021,07/07/2022,HPV,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on interval,v3.2: Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.,3.2,"This test case describes when a child is administered dose number one of the HPV vaccine at seven years of age, dose number two at 9 years - 6 days and dose three at 9 years of age that another dose should be forecast."
2013-0458,"#1 @ 9 yrs - 5 days, #2 @ 9 yrs + 4 weeks, #3 @ 9 yrs, 8 weeks",03/15/2012,F,,,,Not complete,03/10/2021,HPV9,165,,Not Valid,Age: Too Young,04/12/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,3,09/12/2021,10/12/2021,06/08/2022,HPV,05/10/2021,Age: At Minimum,01/01/2013,06/15/2020,Recommended based on interval,Updated to reflect ACIP recommendations for the HPV 2 dose series.,3.2,This test case describes when a valid second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose  should be forecasted.
2013-0459,"#1 @ 9 yrs - 5 days, #2 @ 9 yrs + 4 weeks, #3 @ 9 yrs, 8 weeks, #4 @ 9 yrs, 24 weeks",05/01/2002,F,,,,Complete,04/26/2011,"HPV, unspecified formulation",137,,Not Valid,Age: Too Young,05/29/2011,"HPV, unspecified formulation",137,,Valid,,06/26/2011,"HPV, unspecified formulation",137,,Valid,,10/19/2011,"HPV, unspecified formulation",137,,Valid,,,,,,,,,,,,,,,,,,,,-,,,,HPV,10/19/2011,Age: Below Absolute Minimum,01/01/2013,06/15/2020,Not recommended: series complete,,1.0,This test case describes when a child is administered three valid dose that no further dose should be forecast.  Series is complete.
2013-0460,"Adolescent male, no HPV yet given.",06/14/2012,M,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/14/2021,06/14/2023,07/11/2025,HPV,05/10/2021,No Doses Administered,01/01/2013,06/15/2020,Recommended based on age,,1.0,This test case describes when a child is eight years of age and has no history of the HPV vaccine that the first dose should be forecast.
2013-0462,# 2 at age 9 years 4 weeks-4 days,04/16/2012,F,,,,Not complete,04/15/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,09/15/2021,10/15/2021,06/11/2022,HPV,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/08/2020,Recommended based on interval,Updated to reflect ACIP recommendations for the HPV 2 dose series.,3.2,This test case describes when a second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose  should be forecasted.
2013-0463,# 2 at age 9 years 4 weeks,04/12/2012,F,,,,Not complete,04/12/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,09/12/2021,10/12/2021,06/08/2022,HPV,05/10/2021,Interval: At Minimum,01/01/2013,06/15/2020,Recommended based on interval,Updated to reflect ACIP recommendations for the HPV 2 dose series.,3.2,This test case describes when a second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose  should be forecasted.
2013-0465,# 3 at age 9 years 16 weeks-1 days. ,12/01/2001,F,,,,Complete,11/30/2010,"HPV, unspecified formulation",137,,Valid,,12/28/2010,"HPV, unspecified formulation",137,,Valid,,03/22/2011,"HPV, unspecified formulation",137,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,03/22/2011,Interval: At Absolute Minimum,01/01/2013,06/15/2020,Not recommended: series complete,v2.1 Removal of Age requirements to allow for a more aligned dosing schedule based on intervals rather than age.,2.1,"This test case describes when an adolescent child is administered a third dose of the HPV vaccine at 16 weeks minus 1 day after the first dose that the dose is considered to be valid.  The series is complete. (Prior to 12/16/16, 16 weeks - 4 days was allowed to be used as an Absolute Minimum Interval from Target Dose #1)."
2013-0466,# 3 at age 9 years 16 weeks,12/01/2002,F,,,,Complete,12/01/2011,"HPV, unspecified formulation",137,,Valid,,12/29/2011,"HPV, unspecified formulation",137,,Valid,,03/22/2012,"HPV, unspecified formulation",137,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,03/22/2012,Age: At Absolute Minimum,01/01/2013,06/15/2020,Not recommended: series complete,,1.0,"This test case describes when an adolescent child is administered a third dose of the HPV vaccine at 16 weeks after the first dose that the dose is considered to be valid.  The series is complete. (Prior to 12/16/16, 16 weeks - 4 days was allowed to be used as an Absolute Minimum Interval from Target Dose #1)."
2013-0467,# 2 at age 26 yrs 11 months 15 days; forecast # 3; female,05/25/1994,F,,,,Aged out,05/25/2019,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HPV,05/10/2021,All Valid: Forecast Test,01/01/2013,11/14/2019,Not recommended: too old,"V4.2: Updated test case to remove forecast dose for the third dose of HPV because patient will have reached age 27 before administration of the dose based on newly published MMWR for Shared Clinical Decision Making starting at 27 years.
V4.0: Updated recommended and past due to reflect general best practice recommendations timing and spacing table 3-1 (Rec. Date in 4 months)",4.2,This test case describes when the first and second dose is given after age 15 years that the third dose of the vaccine should be given at the recommended minimum interval.
2013-0468,Dose 1 to dose 2 interval 28-5 days,04/17/2009,F,,,,Not complete,04/17/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,09/17/2021,10/17/2021,06/13/2022,HPV,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on minimum interval from previous dose (catch-up),v3.2 Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.,3.2,This test case describes when an adolescent child is administered a second dose of the HPV vaccine at 28 - 5 days after the first dose that the dose is not valid.   Another dose of the HPV vaccines should be forecast.
2013-0469,Dose 1 to dose 2 interval 28 days,04/12/2009,F,,,,Not complete,04/12/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,09/12/2021,10/12/2021,06/08/2022,HPV,05/10/2021,Interval: At Minimum,01/01/2013,06/08/2020,Recommended based on minimum interval from previous dose (catch-up),Updated to reflect ACIP recommendations for the HPV 2 dose series.,3.2,This test case describes when a second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose  should be forecasted.
2013-0470,"Adolescent female, no HPV yet  given.",12/03/2012,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,12/03/2021,12/03/2023,12/30/2025,HPV,05/10/2021,No Doses Administered,01/01/2013,06/15/2020,Recommended based on age,,1.0,This test case describes when a child has no history of the HPV vaccine that a dose should be forecast.
2013-0471,Dose 2 to dose 3 interval 12 weeks-5 days,12/20/2010,F,,,,Not complete,12/20/2020,HPV9,165,,Valid,,02/20/2021,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,3,08/02/2021,08/02/2021,02/16/2022,HPV,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,04/23/2018,Recommended based on interval,Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.,3.2,"This test case describes when a second and third dose is administered less than 5 months- 4 days from target dose #1, that a repeat dose of the vaccine should be give 12 weeks later. "
2013-0472,Dose 2 to dose 3 interval 12 weeks-4 days,09/16/2000,F,,,,Complete,09/20/2010,"HPV, unspecified formulation",137,,Valid,,11/20/2010,"HPV, unspecified formulation",137,,Valid,,02/08/2011,"HPV, unspecified formulation",137,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,02/08/2011,Interval: At Absolute Minimum,01/01/2013,06/15/2020,Not recommended: series complete,,1.0,"This test case describes when a child is administered a third dose of the HPV vaccine at 12 weeks minus 4 days after the second dose and at least 16 weeks - 4 days from dose number one, that the dose is considered to be valid.  The series is complete. (Prior to 12/16/16, 16 weeks - 4 days was allowed to be used as an Absolute Minimum Interval from Target Dose #1)."
2013-0473,Dose 2 to dose 3 interval 12 weeks,09/16/2000,F,,,,Complete,09/20/2010,"HPV, unspecified formulation",137,,Valid,,11/20/2010,"HPV, unspecified formulation",137,,Valid,,02/12/2011,"HPV, unspecified formulation",137,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,02/12/2011,Interval: At Minimum,01/01/2013,06/15/2020,Not recommended: series complete,,1.0,"This test case describes when a child is administered a third dose of the HPV vaccine at 12 weeks after the second dose and at least 16 weeks - 4 days from dose number one, that the dose is considered to be valid.  The series is complete. (Prior to 12/16/16, 16 weeks - 4 days was allowed to be used as an Absolute Minimum Interval from Target Dose #1)."
2013-0474,Dose 1 to dose 3 interval 16 weeks -5 days,03/21/1996,F,,,,Not complete,04/18/2008,"HPV, unspecified formulation",137,,Valid,,05/16/2008,"HPV, unspecified formulation",137,,Valid,,07/31/2008,"HPV, unspecified formulation",137,,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,3,10/23/2008,10/23/2008,06/14/2009,HPV,08/07/2008,Interval: Below Absolute Minimum,01/01/2013,08/21/2019,Recommended based on minimum interval from invalid dose,"V4.1: Updated to meet ACIP recommendation concerning the 4 day grace period for the third dose prior to December 16.2016. 
V3.2: Updated to reflect current ACIP recommendations for forecasting of the earliest and recommended date which is set by 12 weeks from invalid dose.",4.1,"This test case describes when the third dose of the HPV vaccine is administered at 16 weeks - 5 days from target dose #1, that a repeat dose of the vaccine should be give 12 weeks later."
2013-0475,Dose 1 to dose 3 interval 16 weeks=valid when administered prior to 12/16/2016,03/21/1996,F,,,,Complete,04/18/2008,"HPV, unspecified formulation",137,,Valid,,05/16/2008,"HPV, unspecified formulation",137,,Valid,,08/08/2008,"HPV, unspecified formulation",137,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,08/08/2008,Interval: At Minimum,01/01/2013,06/15/2020,Not recommended: series complete,,1.0,"This test case describes when a adolescent child is administered a third dose of the HPV vaccine at 12 weeks after the second dose and at least 16 weeks - 4 days from dose number one, that the dose is considered to be valid.  The series is complete. (Prior to 12/16/16, 16 weeks - 4 days was allowed to be used as an Absolute Minimum Interval from Target Dose #1)."
2013-0476,# 2 to # 3 interval 12 wks-4 days,05/26/2007,F,,,,Complete,11/26/2020,HPV9,165,,Valid,,02/18/2021,HPV9,165,,Valid,,05/09/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/15/2020,Not recommended: series complete,,1.0,"This test case describes when an adolescent child is administered a third dose of the HPV vaccine at 12 weeks - 4 days after the second dose and at least 5 months from dose number one, that the dose is considered to be valid.  The series is complete."
2013-0477,Invalid dose 1 of three doses given,07/26/2011,F,,,,Complete,07/06/2020,HPV9,165,,Not Valid,Age: Too Young,10/26/2020,HPV9,165,,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/15/2020,Not recommended: series complete,v3.2: Updated to reflect ACIP recommendations for the HPV 2 dose series.,3.2,"This test case describes when a child is administered a first dose of the HPV vaccine at less than 9 years - 4 days, but receives a second and third dose of the vaccine at valid intervals and age, that the doses are considered to be valid.  The series is complete."
2013-0478,Invalid dose 2 in midst of others,09/10/2009,F,,,,Complete,11/10/2020,HPV9,165,,Valid,,12/01/2020,HPV9,165,,Not Valid,Interval: too short,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/15/2020,Not recommended: series complete,v3.2: Updated to reflect ACIP recommendations for the HPV 2 dose series.,3.2,"This test case describes when a child is administered a second dose of the HPV vaccine too soon, but receives a third dose of the vaccine 12 weeks from the previous dose and at least 5 months from the first dose that the doses are considered to be valid.  The series is complete."
2013-0480,"Adult female age 27 years, No Doses",05/10/1994,F,,,,Aged out,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,05/10/2021,No Doses Administered,01/01/2013,06/15/2020,Not recommended: too old,"v1.6: Updated Series Status from ""Not Complete"" to ""Aged Out"" to align with updated CDSi Logic Specification Series Statuses.",1.6,This test case describes when an adult patient has no history of the HPV vaccine and is at age 27 that no doses should be forecast. The patient has aged out.
2013-0481,Male age 27. HPV not recommended.,05/10/1994,M,,,,Aged out,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,05/10/2021,No Doses Administered,01/01/2013,06/15/2020,Not recommended: too old,"v1.6: Updated Series Status from ""Not Complete"" to ""Aged Out"" to align with updated CDSi Logic Specification Series Statuses.

v1.1: Gender should be M rather than F based on test case name; Also changed birth date to make patient 27 years old based on MMWR language allowing Males to be vaccinated through 26 years.",1.6,This test case describes when an adult patient has no history of the HPV vaccine and is at age 27 that no doses should be forecast. The patient has aged out.
2013-0482,"Female, age 14.  HPV recommended",05/10/2007,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/10/2016,05/10/2018,06/06/2020,HPV,05/10/2021,No Doses Administered,01/01/2013,06/15/2020,Recommended based on age,,1.0,"This test case describes when an adolescent, age 14 years, has no history of the HPV vaccine that the first dose should be forecast."
2013-0483,HPV bivalent to male adolescent. Not valid. Forecast quadrivalent,06/18/2000,M,,,,Not complete,06/20/2011,CERVARIX,118,SKB,Not Valid,Inadvertent Vaccine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/20/2011,06/20/2011,07/15/2013,HPV,06/20/2011,Inadvertent vaccine,01/01/2013,02/13/2018,Recommended based on age,Updated to reflect an inadvertent vaccine: Inadvertent administration reason,3.2,This test case describes when an invalid vaccine is administered (Cervarix) that a repeat dose should be administered as soon as possible.
2013-0484,# 1 at age 9 years-5 days,05/15/2012,F,,,,Not complete,05/10/2021,HPV9,165,,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/15/2021,05/15/2023,06/11/2025,HPV,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on age,,1.0,This test case describes when a child is administered dose number one of the HPV vaccine at 9 years - 5 days that the dose is not valid.  Another dose should be forecast.
2013-0485,# 1 at age  9 years-4 days,05/14/2012,F,,,,Not complete,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,10/10/2021,11/10/2021,07/07/2022,HPV,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/15/2020,Recommended based on interval,v3.2: Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.,3.2,This test case describes when a child is administered the first dose of the HPV vaccine at 9 years - 4 days that the dose is valid.  Another dose should be forecast.
2013-0486,# 1 at age 9 years,05/10/2012,F,,,,Not complete,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,10/10/2021,11/10/2021,07/07/2022,HPV,05/10/2021,Age: At Minimum,01/01/2013,06/15/2020,Recommended based on interval,v3.2: Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.,3.2,This test case describes when a child is administered the first dose of the HPV vaccine at 9 years that the dose is valid.  Another dose should be forecast.
2016-0013,"Female age 26, No HPV doses",05/10/1995,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/10/2004,05/10/2006,06/06/2008,HPV,05/10/2021,No Doses Administered,10/13/2016,06/15/2020,Recommended based on age,,1.0,This test case describes when an adult age 26 years has no history of the HPV vaccine that the first dose should be forecast.
2016-0015,Adolescent child with first dose of HPV vaccine at 13 years and second dose after 15 years of age. ,04/10/2006,M,,,,Complete,04/24/2019,Gardasil 9,165,MSD,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,05/10/2021,All Valid: Forecast Test,12/02/2016,06/15/2020,Not recommended: series complete,,1.0,This test case describes when an adolescent child has received the first dose of the HPV vaccine at 13 years and a second dose 2 years later that the doses are valid.  The series is complete.
2016-0016,Adolescent child age 15 with no previous doses.,12/10/2005,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,12/10/2014,12/10/2016,01/06/2019,HPV,05/10/2021,No Doses Administered,12/02/2016,06/15/2020,Recommended based on age,,1.0,This test case describes when an adolescent child age 15 years has no previous history of the HPV vaccine that the first dose should be forecast.
2016-0017,Adolescent child age 15 with one dose of the HPV vaccine,12/10/2005,F,,,,Not complete,05/10/2021,Gardasil 9,165,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,08/29/2021,HPV,05/10/2021,All Valid: Forecast Test,12/02/2016,06/15/2020,Recommended based on interval,v3.4: Earliest Recommended Date was changed from 8 weeks to 4 weeks on Dose 2 per HPV MMWR language.,3.4,This test case describes when an adolescent child age 15 years has been administered the first dose of the HPV vaccine that another dose should be forecast.
2016-0018,Adolescent child age 15 with two previous doses of the HPV vaccine.,11/12/2005,F,,,,Not complete,04/12/2021,Gardasil 9,165,MSD,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,09/12/2021,10/12/2021,12/09/2021,HPV,05/10/2021,All Valid: Forecast Test,12/02/2016,06/15/2020,Recommended based on interval,,1.0,This test case describes when an adolescent age 15 years old has been administered a first and second dose of the HPV vaccine that another dose should be forecast.
2016-0019,Adolescent child age 15 with three doses of the HPV vaccine,06/10/2005,F,,,,Complete,11/10/2020,Gardasil 9,165,MSD,Valid,,12/08/2020,HPV9,165,,Valid,,05/08/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,05/10/2021,All Valid: Forecast Test,12/02/2016,06/15/2020,Not recommended: series complete,,1.0,This test case describes when an adolescent child age 15 years old has been administered all three doses of the HPV vaccine at valid intervals that the doses are valid.   The series is complete.
2016-0020,Adolescent child with a history of 2 doses of the HPV vaccine 1st dose given at 11 years and the 2nd dose give at 2 months later.,02/10/2009,M,,,,Not complete,03/10/2021,Gardasil 9,165,MSD,Valid,,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,08/10/2021,09/10/2021,05/07/2022,HPV,05/10/2021,All Valid: Forecast Test,12/02/2016,10/05/2020,Recommended based on interval,Updated to reflect ACIP recommendations for the HPV 2 dose series.,3.2,This test case describes when an adolescent child is administered a second dose of the HPV vaccine at an interval of 2 months after the first dose that the doses are valid.  Another dose should be forecast.
2016-0021,Adolescent child 15 years -1 days with no previous history of HPV vaccine,05/11/2006,M,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/11/2015,05/11/2017,06/07/2019,HPV,05/10/2021,No Doses Administered,12/02/2016,06/15/2020,Recommended based on interval,v1.0 Corrected forecast dates to match test case title,1.0,This test case describes when an adolescent child age 15 years - 1 day has no previous history of the HPV vaccine that the first dose should be forecast.
2016-0023,Adolescent child age 11 with 2nd dose of HPV at 5 months - 5 days,10/25/2009,F,,,,Not complete,12/13/2020,Gardasil 9,165,MSD,Valid,,05/08/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,07/31/2021,07/31/2021,02/09/2022,HPV,05/10/2021,Interval: Below Absolute Minimum,12/02/2016,06/15/2020,Recommended based on interval,Updated to reflect current ACIP recommendations for forecasting of the earliest and recommended date which is set by 12 weeks from invalid dose.,3.2,This test case describes when a second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose  should be forecasted.
2016-0024,Adolescent child age 11 with 2nd dose of HPV at 5 months - 4 days,10/24/2009,F,,,,Complete,12/12/2020,Gardasil 9,165,MSD,Valid,,05/08/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,05/10/2021,All Valid: Forecast Test,12/02/2016,06/15/2020,Not recommended: series complete,,1.0,This test case describes when an adolescent child age 11 years old is administered the second dose of the the HPV vaccine at 5 months - 4 days that the dose is valid.  The series is complete.
2017-0001,Child is age 9 with 3rd dose of HPV at 5 months from first dose,09/10/2011,F,,,,Complete,12/10/2020,Gardasil 9,165,MSD,Valid,,02/08/2021,Gardasil 9,165,MSD,Valid,,05/10/2021,Gardasil 9,165,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,HPV,05/10/2021,All Valid: Forecast Test,03/02/2017,02/20/2018,Recommended based on interval,,3.2,This test case describes when a third dose is administered an at an interval at least 5 months from the first dose and 12 weeks from the previous dose that no further doses are recommended.  Series is complete.
2019-0006,"Any dose 26 years, Male, gardasil",05/10/1995,M,,,,Not complete,05/10/2021,HPV9,165,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,08/29/2021,HPV,05/10/2021,All Valid: Forecast Test,07/01/2019,11/14/2019,Recommended based on interval,v4.2: Added past due date.,4.2,This test case describes when a male receives the first dose of the HPV vaccine at age 26 years that a second dose should be forecast.
2019-0007,"Male age 26, No HPV doses",05/10/1995,M,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/10/2004,05/10/2006,06/06/2008,HPV,05/10/2021,No Doses Administered,07/01/2019,08/26/2019,Recommended based on age,,4.1,"This test case describes when a male, age 26 years has no previous doses of the HPV vaccine that the first dose should be forecast."
2013-0487,"#1 @ 11 yrs, 0 days, MCV4",05/10/2010,F,,,,Not complete,05/10/2021,MENACTRA,114,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,05/10/2026,05/10/2026,06/06/2027,MCV,05/10/2021,Age: At Minimum,01/01/2013,11/15/2017,Recommended based on age,v1.6: An EIPB clarification has resulted in a change to when dose 2 of MCV should be forecasted and validated.  The second dose must come on or after 16 years (- 4 days) of age to be considered valid.,1.6,This test case describes when dose 1 of a Mening vaccine is given at 11 years that the dose is considered to be valid.
2013-0488,"#2 @ 16 yr - 4 days, MCV4",05/14/2005,F,,,,Complete,05/14/2016,MENACTRA,114,PMC,Valid,,05/10/2021,MENACTRA,114,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,MCV,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/01/2020,Not recommended: series complete,v1.6: Updated Test case to reflect new absolute minimum age on dose 2 based on EIPB clarification,1.6,"This test case describes when dose #2 of a Mening vaccine is given at 16 years - 4 days, that the dose is considered valid.  The series is complete. "
2013-0489,"#2 @ 10 16 yr - 5 days, MCV4",05/15/2005,F,,,,Not complete,05/15/2016,MENACTRA,114,PMC,Valid,,05/10/2021,MENACTRA,114,PMC,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,07/05/2021,07/05/2021,06/11/2022,MCV,05/10/2021,Age: Below Absolute Minimum,01/01/2013,11/15/2017,Recommended based on minimum interval from invalid dose,v1.6: Updated Test case to reflect new absolute minimum age on dose 2 based on EIPB clarification,1.6,"This test case describes when dose #2 of a Mening vaccine is given at 16 years - 5 days, that the dose is considered invalid.  "
2013-0491,"#2 @ 16 years, MCV4",05/10/2005,F,,,,Complete,05/10/2016,MENACTRA,114,PMC,Valid,,05/10/2021,MENACTRA,114,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,MCV,05/10/2021,Age: At Recommended,01/01/2013,11/15/2017,Not recommended: series complete,,1.0,"This test case describes when dose #1 and dose #2 of a Mening vaccine are administered at the recommended ages (11 and 16 years), that the doses are considered valid.  The series is complete."
2013-0495,#2 with interval of 5 years of #1,05/10/2003,F,,,,Complete,05/10/2016,MENACTRA,114,PMC,Valid,,05/10/2021,MENACTRA,114,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,MCV,05/10/2021,Interval: At Recommended,01/01/2013,06/01/2020,Not recommended: series complete,Test case was set to have the first dose at age 16 and second dose at 21 years.  Test case was adjusted to be at 13 years and 18 years to avoid the 16 year age skip dose which is tested in another test,1.2,"This test case describes when dose #2 of a Mening vaccine is administered 5 years after dose #1 (age 13), that the dose in considered valid. The series is complete."
2013-0497,"#1 @ 10 yrs - 1 day, #2 @ 10 yrs + 8 weeks - 5 days",03/20/2011,F,,,,Not complete,03/19/2021,MENACTRA,114,PMC,Not Valid,Age: Too Young,05/10/2021,MENACTRA,114,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,03/20/2027,03/20/2027,04/16/2028,MCV,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/02/2020,Recommended based on age,"v1.6: An EIPB clarification has resulted in a change to when dose 2 of MCV should be forecasted and validated.  The second dose must come on or after 16 years (- 4 days) of age to be considered valid.
v1.2: Same test case as previous version rolled younger to allow for the 10 year clarification by NIPInfo",1.6,This test case describes when dose #1 of a Mening vaccine is administered before 10 years of age and a repeat dose is administered at one month + 20 days later that the dose is considered valid.
2013-0498,"#1 @ 10 yrs - 1 day, #2 @ 10 yrs + 8 weeks",03/15/2011,F,,,,Not complete,03/14/2021,MENACTRA,114,PMC,Not Valid,Age: Too Young,05/10/2021,MENACTRA,114,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,03/15/2027,03/15/2027,04/11/2028,MCV,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/02/2020,Recommended based on minimum interval from invalid dose,"v1.6: An EIPB clarification has resulted in a change to when dose 2 of MCV should be forecasted and validated.  The second dose must come on or after 16 years (- 4 days) of age to be considered valid.
v1.2: Same test case as previous version rolled younger to allow for the 10 year clarification by NIPInfo",1.6,This test case describes when dose #1 of a Mening vaccine is administered at 10 years - 1 day and a repeat dose is administered at one month + 25 days later that the dose is considered valid.
2013-0499,"#1 @ 10 yrs, MCV4",05/10/2011,F,,,,Not complete,05/10/2021,MENACTRA,114,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,05/10/2027,05/10/2027,06/06/2028,MCV,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/01/2020,Recommended based on age,"v1.6: An EIPB clarification has resulted in a change to when dose 2 of MCV should be forecasted and validated.  The second dose must come on or after 16 years (- 4 days) of age to be considered valid.
v1.2: Same test case as previous version rolled younger to allow for the 10 year clarification by NIPInfo",1.6,This test case describes when dose #1 of a Mening vaccine is administered at age 10 years + 0 months that the dose is considered valid.
2013-0500,"#1 @ 10 yrs - 1 day, MCV4",05/11/2011,F,,,,Not complete,05/10/2021,MENACTRA,114,PMC,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/11/2022,05/11/2022,06/07/2024,MCV,05/10/2021,Age: Below Absolute Minimum,01/01/2013,11/15/2017,Recommended based on age,Same test case as previous version rolled younger to allow for the 10 year clarification by NIPInfo,1.2,This test case describes when dose #1 of a Mening vaccine is administered at 10 years-1 day that the dose is considered invalid.
2013-0501,"#1 @ 10 yrs - 1 day, #2 @ 10 yrs, 8 weeks - 4 days",03/19/2011,F,,,,Not complete,03/18/2021,MENACTRA,114,PMC,Not Valid,Age: Too Young,05/10/2021,MENACTRA,114,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,03/19/2027,03/19/2027,04/15/2028,MCV,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/02/2020,Recommended based on age,"v1.6: An EIPB clarification has resulted in a change to when dose 2 of MCV should be forecasted and validated.  The second dose must come on or after 16 years (- 4 days) of age to be considered valid.
v1.2: Same test case as previous version rolled younger to allow for the 10 year clarification by NIPInfo",1.6,This test case describes when dose #1 of a Mening vaccine is administered at 10 years - 1 day and a repeat dose is administered at one month + 21 days later that the dose is considered valid.
2013-0502,10 year old,05/10/2011,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/10/2022,05/10/2022,06/06/2024,MCV,05/10/2021,No Doses Administered,01/01/2013,05/29/2018,Recommended based on age,,1.0,This test case describes when a newborn is assessed for the first dose of a Mening that a CDS engine should forecast the dose at the recommended age.
2013-0503,Dose 1 to dose 2 interval 8 wks-5 days,01/20/2010,F,,,,Not complete,03/20/2021,"meningococcal MCV4, unspecified formulation",147,,Valid,,05/10/2021,"meningococcal MCV4, unspecified formulation",147,,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,01/20/2026,01/20/2026,02/16/2027,MCV,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,04/23/2018,Recommended based on age,v1.6: An EIPB clarification has resulted in a change to when dose 2 of MCV should be forecasted and validated.  The second dose must come on or after 16 years (- 4 days) of age to be considered valid.,1.6,"This test case describes when dose #2 of a Mening vaccine is administered too early (8 weeks - 5 days after dose #1), that the dose is not valid."
2013-0504,Dose 1 to dose 2 interval 8 wks-4 days,03/29/2005,F,,,,Complete,03/18/2021,"meningococcal MCV4, unspecified formulation",147,,Valid,,05/09/2021,"meningococcal MCV4, unspecified formulation",147,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,MCV,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/01/2020,Not recommended: series complete,v1.6: updated to reflect interval without also testing age attributes.  Simply made the patient older,1.6,This test case describes when dose #2 of a Mening vaccine is administered at an interval of 8 wks - 4 days from dose #1 (age 15 years + 11 months) that the dose is considered valid.  The series is complete.
2013-0505,Dose 1 to dose 2 interval 8 weeks,03/21/2005,F,,,,Complete,03/12/2021,"meningococcal MCV4, unspecified formulation",147,,Valid,,05/07/2021,"meningococcal MCV4, unspecified formulation",147,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,MCV,05/10/2021,Interval: At Minimum,01/01/2013,06/01/2020,Not recommended: series complete,v1.6: updated to reflect interval without also testing age attributes.  Simply made the patient older,1.6,This test case describes when dose #2 of a Mening vaccine is administered at an interval of 8 wks from dose #1 (age 15 years + 11 months) that the dose is considered valid.  The series is complete.
2013-0507,# 1 at age 11 years,05/10/2010,F,,,,Not complete,05/10/2021,"meningococcal MCV4, unspecified formulation",147,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,05/10/2026,05/10/2026,06/06/2027,MCV,05/10/2021,Age: At Minimum,01/01/2013,11/15/2017,Recommended based on age,v1.6: An EIPB clarification has resulted in a change to when dose 2 of MCV should be forecasted and validated.  The second dose must come on or after 16 years (- 4 days) of age to be considered valid.,1.6,This test case describes when dose #1 of a Mening vaccine is administered at age 11 years + 0 days that the dose is considered to be valid.  
2013-0508,age 22.  No doses; No forecast,05/10/1999,F,,,,Aged out,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,MCV,05/10/2021,No Doses Administered,01/01/2013,11/15/2017,Not recommended: too old,"v1.6: Updated Series Status from ""Not Complete"" to ""Aged Out"" to align with updated CDSi Logic Specification Series Statuses.",1.6,"This test case describes when an individual, age 22 years, is assessed for the first dose of a Mening vaccine that a CDS engine should not forecast a dose.  A dose is not recommended. The series status is Aged Out."
2013-0509,# 1 at age 15 years,05/02/2006,F,,,,Not complete,05/10/2021,"meningococcal MCV4, unspecified formulation",147,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,05/02/2022,05/02/2022,05/29/2023,MCV,05/10/2021,All Valid: Forecast Test,01/01/2013,06/01/2020,Recommended based on age,v1.6: An EIPB clarification has resulted in a change to when dose 2 of MCV should be forecasted and validated.  The second dose must come on or after 16 years (- 4 days) of age to be considered valid.,1.6,"This test case describes when the first dose of a Mening vaccine is administered at 15 years + 8 days, that the dose is considered to be valid."
2013-0510,# 1 at age 16 years -5 days,05/15/2005,F,,,,Not complete,05/10/2021,"meningococcal MCV4, unspecified formulation",147,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,07/05/2021,07/05/2021,06/11/2022,MCV,05/10/2021,All Valid: Forecast Test,01/01/2013,06/01/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a first dose of a Mening vaccine is administered at 16 years - 5 days that the dose is considered to be valid.
2013-0511,# 1 at age 16 years -4 days,05/14/2005,F,,,,Complete,05/10/2021,"meningococcal MCV4, unspecified formulation",147,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,MCV,05/10/2021,All Valid: Forecast Test,01/01/2013,06/01/2020,Not recommended: series complete,,1.0,"This test case describes when a dose of a Mening vaccine is administered at 16 years - 4 days, that the dose is considered to be valid. The series is complete."
2013-0512,# 1 at age 16 years,05/10/2005,F,,,,Complete,05/10/2021,"meningococcal MCV4, unspecified formulation",147,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,MCV,05/10/2021,All Valid: Forecast Test,01/01/2013,06/01/2020,Not recommended: series complete,,1.0,"This test case describes when a dose of a Mening vaccine is administered at 16 years + 0 days, that the dose is considered to be valid. The series is complete."
2013-0523,#1 at 15 months,02/10/2020,F,,,,Not complete,05/10/2021,M-M-R II,03,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,02/10/2024,03/09/2027,MMR,05/10/2021,All Valid: Forecast Test,01/01/2013,01/04/2018,Recommended based on age,Renamed to better reflect test case.,1.1,"This test case describes when a child receives the first dose of the MMR vaccine at 15 months of age, that the dose is considered to be valid."
2013-0524,#2 at 4 years,05/10/2017,F,,,,Complete,08/10/2018,M-M-R II,03,MSD,Valid,,05/10/2021,M-M-R II,03,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,MMR,05/10/2021,Age: At Recommended,01/01/2013,01/04/2018,Not recommended: series complete,Renamed to better reflect test case.,1.1,"This test case describes when the second dose of the MMR vaccine is administered at 4 years of age, that the dose is considered valid.  The series is complete."
2013-0525,#1 at 7 years,05/10/2014,F,,,,Not complete,05/10/2021,M-M-R II,03,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,MMR,05/10/2021,All Valid: Forecast Test,01/01/2013,05/29/2020,Recommended based on minimum interval from previous dose (catch-up),Renamed to better reflect test case.,1.1,"This test case describes when a child receives the first dose of the MMR vaccine at 7 years, that the dose is considered to be valid."
2013-0528,5 single antigen doses: 1 Measles; 2 Mumps; 2 Rubella,03/10/2016,F,,,,Not complete,03/10/2017,mumps,07,,Valid,,04/07/2017,MERUVAX II,06,MSD,Valid,,05/05/2017,ATTENUVAX,05,MSD,Valid,,04/07/2021,MERUVAX II,06,MSD,Valid,,05/07/2021,mumps,07,,Valid,,,,,,,,,,,,,,2,06/04/2021,06/04/2021,04/06/2023,MMR,05/10/2021,Single Antigen Administration,01/01/2013,03/19/2018,Recommended based on minimum interval from live virus vaccine,Renamed to better reflect test case.,1.1,"This test case describes when a child is administered  single antigen doses of Measles, Mumps, and Rubella, at the minimum age of 12 months and a second dose of the Mumps and Rubella antigens at 5 years of age, that the second dose of the Measles vaccine is recommended."
2013-0530,4 single antigen doses: 1 Measles; 2 Mumps; 1 Rubella,05/10/2016,F,,,,Not complete,05/10/2017,mumps,07,,Valid,,06/07/2017,MERUVAX II,06,MSD,Valid,,07/05/2017,ATTENUVAX,05,MSD,Valid,,05/10/2021,mumps,07,,Valid,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/06/2023,MMR,05/10/2021,Single Antigen Administration,01/01/2013,03/19/2018,Recommended based on minimum interval from live virus vaccine,Renamed to better reflect test case.,1.1,"This test case describes when a child is administered single antigen doses of Measles, Mumps, and Rubella, at the minimum age of 12 months and a second dose of the Mumps antigen at 5 years of age, that the second dose of the Measles and Rubella vaccine is recommended."
2013-0531,1 single antigen dose at 12M: 1 Measles,05/10/2020,F,,,,Not complete,05/10/2021,ATTENUVAX,05,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/10/2021,06/10/2021,10/07/2021,MMR,05/10/2021,Single Antigen Administration,01/01/2013,08/22/2019,Recommended based on minimum interval from previous dose (catch-up),"Renamed to better reflect test case. V1.4: Updated Earliest and Recommended date to adjust dates out 3 days.  Previous recommendation was 4 weeks from single dose administration, but this would result in the dose being forecasted too early for the second Measles at 13 months.",1.4,"This test case describes when a child is administered single antigen dose of Measles, at the minimum age of 12 months that the a second dose is recommended."
2013-0534,2 single antigen doses: 1 Measles; 1 Mumps,04/02/2020,F,,,,Not complete,04/02/2021,ATTENUVAX,05,MSD,Valid,,05/10/2021,mumps,07,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/07/2021,06/07/2021,08/29/2021,MMR,05/10/2021,Single Antigen Administration,01/01/2013,08/21/2019,Recommended based on minimum interval from live virus vaccine,V1.1: Renamed to better reflect test case.,1.1,"This test case describes when a child is administered single antigen dose of Measles and Mumps, at the minimum age of 12 months, that the second dose of the vaccines is recommended."
2013-0535,7 single antigen doses: 2 Measles; 3 Mumps; 2 Rubella,02/10/2016,F,,,,Complete,02/10/2017,mumps,07,,Valid,,03/10/2017,MERUVAX II,06,MSD,Valid,,04/07/2017,ATTENUVAX,05,MSD,Valid,,02/10/2021,mumps,07,,Valid,,03/10/2021,MERUVAX II,06,MSD,Valid,,04/07/2021,mumps,07,,Extraneous,Series Already Complete,05/10/2021,ATTENUVAX,05,MSD,Valid,,-,,,,MMR,05/10/2021,Single Antigen Administration,01/01/2013,03/19/2018,Not recommended: series complete,Renamed to better reflect test case.,1.1,"This test case describes when a child is administered single antigen doses of Measles, Mumps, and Rubella at the minimum age of 12 months, a second dose of the Measles, Mumps, and Rubella antigens at 5 years of age, and an inadvertentent dose of the Mumps vaccine that the series is complete."
2013-0536,3 single antigen doses: 1 Measles; 1 Mumps; 1 Rubella,01/15/2020,F,,,,Not complete,01/15/2021,mumps,07,,Valid,,02/15/2021,MERUVAX II,06,MSD,Valid,,05/10/2021,ATTENUVAX,05,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,01/15/2024,02/11/2027,MMR,05/10/2021,Single Antigen Administration,01/01/2013,03/19/2018,Recommended based on age,Renamed to better reflect test case.,1.1,"This test case describes when a child is administered single antigen doses of Measles, Mumps, and Rubella, at the minimum age of 12 months, that a second doses of the vaccines are recommended."
2013-0537,3 single antigen doses on same day: 1 Measles; 1 Mumps; 1 Rubella ,05/10/2020,F,,,,Not complete,05/10/2021,mumps,07,,Valid,,05/10/2021,MERUVAX II,06,MSD,Valid,,05/10/2021,ATTENUVAX,05,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/10/2021,05/10/2024,06/06/2027,MMR,05/10/2021,Single Antigen Administration,01/01/2013,03/19/2018,Recommended based on age,V1.1: Renamed to better reflect test case. V1.4: Updated Earliest date to reflect the earliest date of 13 months and not 12 months + 4 weeks to align with ACIP.,1.4,"This test case describes when a child is administered single antigen doses of Measles, Mumps, and Rubella, at the minimum age of 12 months, on the same day, that a second dose of the vaccines are recommended."
2013-0538,6 single antigen doses: 2 Measles; 2 Mumps; 2 Rubella,03/15/2016,F,,,,Complete,03/15/2017,mumps,07,,Valid,,04/12/2017,MERUVAX II,06,MSD,Valid,,05/10/2017,ATTENUVAX,05,MSD,Valid,,03/15/2021,mumps,07,,Valid,,04/12/2021,MERUVAX II,06,MSD,Valid,,05/10/2021,ATTENUVAX,05,MSD,Valid,,,,,,,,-,,,,MMR,05/10/2021,Single Antigen Administration,01/01/2013,03/19/2018,Not recommended: series complete,Renamed to better reflect test case.,1.1,"This test case describes when a child is administered single antigen doses of Measles, Mumps, and Rubella at the minimum age of 12 months, a second dose of the Measles, Mumps, and Rubella antigens at 5 years of age, that the series is complete."
2013-0539,3 single antigen doses: 2 Measles; 1 Rubella,05/28/2019,F,,,,Not complete,07/06/2020,ATTENUVAX,05,MSD,Valid,,12/23/2020,MERUVAX II,06,MSD,Valid,,05/10/2021,ATTENUVAX,05,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/07/2021,06/07/2021,06/07/2021,MMR,05/10/2021,Single Antigen Administration,01/01/2013,08/22/2019,Recommended based on minimum interval from live virus vaccine,Renamed to better reflect test case.,1.1,"This test case describes when a child is administered single antigen dose of Measles and Rubella, at the minimum age of 12 months, and a second dose of the Measles vaccine  at least 4 weeks later, that a second dose of the Rubella vaccine is recommended."
2013-0540,MMR # 1 at 12 months-5 days,05/15/2020,F,,,,Not complete,05/10/2021,M-M-R II,03,MSD,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/07/2021,06/07/2021,10/12/2021,MMR,05/10/2021,Age: Below Absolute Minimum,01/01/2013,01/04/2018,Recommended based on minimum interval from live virus vaccine,,1.0,"This test case describes when a child is administered the first dose of the MMR vaccine before 12 months of age, that the dose is not valid. "
2013-0541,MMR # 1 at 12 months-4 days,05/14/2020,F,,,,Not complete,05/10/2021,M-M-R II,03,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/14/2021,05/14/2024,06/10/2027,MMR,05/10/2021,Age: At Absolute Minimum,01/01/2013,05/29/2020,Recommended based on age,,1.0,"This test case describes when a child is administered the first dose of the MMR vaccine at 12 months - 4 days, that the dose is considered to be valid. "
2013-0542,MMR # 1 at 12 months,05/10/2020,F,,,,Not complete,05/10/2021,M-M-R II,03,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/10/2021,05/10/2024,06/06/2027,MMR,05/10/2021,Age: At Minimum,01/01/2013,01/04/2018,Recommended based on age,,1.0,"This test case describes when a child is administered the first dose of the MMR vaccine at 12 months, that the dose is considered to be valid. "
2013-0543,Newborn forecasting,05/10/2021,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/10/2022,05/10/2022,10/07/2022,MMR,05/10/2021,No Doses Administered,01/01/2013,01/04/2018,Recommended based on age,,1.0,This test case describes the forecasting of the first dose of the MMR vaccine for a newborn.
2013-0544,Dose 1 to dose 2 interval 28 days ,04/12/2019,F,,,,Complete,04/12/2021,M-M-R II,03,MSD,Valid,,05/10/2021,M-M-R II,03,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,MMR,05/10/2021,Interval: At Minimum,01/01/2013,01/04/2018,Not recommended: series complete,,1.0,"This test case describes when the second dose of the MMR vaccine is administered to a 2 year old child at 28 days after the first dose, that the dose is considered to be valid. The series is complete."
2013-0545,MMR and VZ given at age 12 months,05/10/2020,F,,,,Not complete,05/10/2021,M-M-R II,03,MSD,Valid,,05/10/2021,VARIVAX,21,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/10/2021,05/10/2024,06/06/2027,MMR,05/10/2021,Age: At Minimum,01/01/2013,01/04/2018,Recommended based on age,,1.0,"This test case describes when a dose of the Varicella vaccine is administered at the same time of a MMR vaccine, both are valid."
2013-0546,Doses 1 and 2 of MMR and VZ at ages 12 and 13 months,04/10/2020,F,,,,Complete,04/10/2021,M-M-R II,03,MSD,Valid,,04/10/2021,VARIVAX,21,MSD,Valid,,05/10/2021,M-M-R II,03,MSD,Valid,,05/10/2021,VARIVAX,21,MSD,Valid,,,,,,,,,,,,,,,,,,,,-,,,,MMR,05/10/2021,Age: At Minimum,01/01/2013,01/04/2018,Not recommended: series complete,,1.0,"This test case describes when the first doses of the MMR  and Varicella vaccines are administered at 12 months of age, and the second doses of those vaccines are administered at 13 months of age, that the doses are considered to be valid.  The series are complete."
2013-0547,VZ to MMR interval 28-1 day = invalid MMR,04/11/2020,F,,,,Not complete,04/13/2021,VARIVAX,21,MSD,Valid,,05/10/2021,M-M-R II,03,MSD,Not Valid,Live Virus Conflict,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/07/2021,06/07/2021,09/07/2021,MMR,05/10/2021,Live Virus: Below Minimum,01/01/2013,01/04/2018,Recommended based on minimum interval from live virus vaccine,,1.0,"This test case describes when the first doses of the Varicella vaccine is administered at 12 months of age, and the first dose of the MMR vaccine is administered at an interval of 28-1 day that the MMR vaccine dose is not valid."
2013-0548,VZ given at age 12 mo; MMR at age 12 mo+28 days,04/12/2020,F,,,,Not complete,04/12/2021,VARIVAX,21,MSD,Valid,,05/10/2021,M-M-R II,03,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,04/12/2024,05/09/2027,MMR,05/10/2021,Live Virus: At Minimum,01/01/2013,01/04/2018,Recommended based on age,,1.0,"This test case describes when the first dose of the Varicella vaccine is administered at 12 months of age and the first dose of the MMR vaccine is administered at 28 days later, that the doses are considered to be valid."
2013-0549,Dose 1 MMRV at 12 m-5 days,05/15/2020,F,,,,Not complete,05/10/2021,PROQUAD,94,MSD,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/07/2021,06/07/2021,10/12/2021,MMR,05/10/2021,Age: Below Absolute Minimum,01/01/2013,01/04/2018,Recommended based on minimum interval from live virus vaccine,,1.0,"This test case describes when a child is administered the first dose of the MMR vaccine (ProQuad) at 12 months -5 days, that the dose is not valid."
2013-0550,Dose 1 MMRV at 12 m-4 days,05/14/2020,F,,,,Not complete,05/10/2021,PROQUAD,94,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/14/2021,05/14/2024,06/10/2027,MMR,05/10/2021,Age: At Absolute Minimum,01/01/2013,05/29/2020,Recommended based on age,,1.0,"This test case describes when a child is administered the first dose of the MMR vaccine (ProQuad) at 12 months -4 days, that the dose is considered to be valid."
2013-0551,Dose 1 to dose 2 MMRV interval 28 days age < 15 months old= valid MMR,04/12/2020,F,,,,Complete,04/12/2021,PROQUAD,94,MSD,Valid,,05/10/2021,PROQUAD,94,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,MMR,05/10/2021,Interval: At Minimum,01/01/2013,05/29/2020,Not recommended: series complete,,1.0,"This test case describes when a child is administered the first dose of the MMR vaccine (ProQuad) at 12 months and the second dose at 28 days later,  that the doses are considered to be valid.  The series is complete."
2013-0552,Dose 1 to 2 MMRV interval 28 days in child ≥ 15 months old=valid MMR,04/12/2018,F,,,,Complete,04/12/2021,PROQUAD,94,MSD,Valid,,05/10/2021,PROQUAD,94,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,MMR,05/10/2021,Interval: At Minimum,01/01/2013,01/04/2018,Not recommended: series complete,,1.0,"This test case describes when a child is administered the first dose of the MMR vaccine (ProQuad) at 3 years of age and the second dose at 28 days later,  that the doses are considered to be valid.  The series is complete."
2013-0554,Dose 1 to 2 MMRV interval 28-4 days,03/16/2020,F,,,,Not complete,04/16/2021,PROQUAD,94,MSD,Valid,,05/10/2021,PROQUAD,94,MSD,Not Valid,Live Virus Conflict,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,03/16/2024,04/12/2027,MMR,05/10/2021,Live Virus: Below Minimum,01/01/2013,06/02/2020,Recommended based on age,Shifted dates of administration and forecast to strictly test the Live Virus conflict only.  Previously it was testing a couple conditions,1.1,"This test case describes when a child is administered the first dose of the MMR vaccine (ProQuad) at 13 months of age and the second dose at 24 days later, that the second dose is not valid."
2013-0555,MMR to MMRV interval 28 days=valid MMR # 2 ,04/12/2020,F,,,,Complete,04/12/2021,M-M-R II,03,MSD,Valid,,05/10/2021,PROQUAD,94,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,MMR,05/10/2021,Interval: At Minimum,01/01/2013,06/02/2020,Not recommended: series complete,,1.0,"This test case describes when a child is administered the first dose of the MMR vaccine at 12 months of age and the second dose (ProQuad) at 28 days later,  that the doses are considered to be valid.  The series is complete."
2013-0556,MMR to MMRV interval 24 days=not valid MMR # 2,03/16/2020,F,,,,Not complete,04/16/2021,M-M-R II,03,MSD,Valid,,05/10/2021,PROQUAD,94,MSD,Not Valid,Live Virus Conflict,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,03/16/2024,04/12/2027,MMR,05/10/2021,Live Virus: Below Minimum,01/01/2013,01/04/2018,Recommended based on age,V1.4: Final Guidance for MMRV live virus spacing is 28 days.  Grace period can't be applied.,1.4,"This test case describes when a child is administered the first dose of the MMR vaccine at 12 months of age and the second dose (ProQuad) at 24 days later,  that the second dose is not valid."
2013-0557,MMRV to MMR interval 28 days=valid MMR dose 2,03/12/2020,F,,,,Complete,04/12/2021,PROQUAD,94,MSD,Valid,,05/10/2021,M-M-R II,03,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,MMR,05/10/2021,Interval: At Minimum,01/01/2013,05/29/2020,Not recommended: series complete,,1.0,"This test case describes when a child is administered the first dose of the MMR vaccine (ProQuad) at 13 months of age and the second dose (MMR II) at 28 days later,  that the doses are considered to be valid.  The series is complete."
2013-0558,Dose 1 to dose 2 interval 4 wks between VZ and MMRV in any age child=valid MMR,04/02/2020,F,,,,Not complete,04/12/2021,VARIVAX,21,MSD,Valid,,05/10/2021,PROQUAD,94,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,04/02/2024,04/29/2027,MMR,05/10/2021,Interval: At Minimum,01/01/2013,01/04/2018,Recommended based on age,,1.0,"This test case describes when a child is administered the first dose of the Varicella vaccine at 12 months of age and a dose of the MMRV vaccine at 4 weeks later, that the doses are considered to be valid.  "
2013-0559,28 day interval between invalid VZ and subsequent MMRV=valid MMR and VZ,04/17/2020,F,,,,Not complete,04/12/2021,VARIVAX,21,MSD,Not Valid,Age: Too Young,05/10/2021,PROQUAD,94,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,04/17/2024,05/14/2027,MMR,05/10/2021,Live Virus: At Minimum,01/01/2013,01/04/2018,Recommended based on age,,1.0,"This test case describes when the first dose of the Varicella vaccine is administered before 12 months - 4 days and a MMRV vaccine is administered at 28 days later, that the MMRV (PRoQuad) vaccine dose is considered to be valid. "
2013-0562,Interval of < 24 days between an invalid MMR and a subsequent MMRV=no valid MMR's,04/22/2020,F,,,,Not complete,04/17/2021,M-M-R II,03,MSD,Not Valid,Age: Too Young,05/10/2021,PROQUAD,94,MSD,Not Valid,Live Virus Conflict,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/07/2021,06/07/2021,09/18/2021,MMR,05/10/2021,Live Virus: Below Minimum,01/01/2013,01/04/2018,Recommended based on minimum interval from live virus vaccine,,1.0,"This test case describes when the first dose of the MMR vaccine is administered before 12 months - 4 days and a MMRV vaccine (ProQuad)  is administered less than 28 days later, that neither are the doses are valid."
2013-0563,Interval of < 24 days between an invalid VZ and a subsequent MMRV=no valid MMR or VZ,04/22/2020,F,,,,Not complete,04/17/2021,VARIVAX,21,MSD,Not Valid,Age: Too Young,05/10/2021,PROQUAD,94,MSD,Not Valid,Live Virus Conflict,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/07/2021,06/07/2021,09/18/2021,MMR,05/10/2021,Live Virus: Below Minimum,01/01/2013,01/04/2018,Recommended based on minimum interval from live virus vaccine,,1.0,"This test case describes when the first dose of the Varicella vaccine is administered before 12 months - 4 days and a MMRV (ProQuad) vaccine is administered less than 28 days later, that the doses are not valid."
2013-0565,"Correctly administered single antigen M, M and R followed by MMR=series complete",05/04/2018,F,,,,Complete,07/10/2019,mumps,07,,Valid,,09/10/2019,MERUVAX II,06,MSD,Valid,,05/10/2020,ATTENUVAX,05,MSD,Valid,,05/04/2019,M-M-R II,03,MSD,Valid,,,,,,,,,,,,,,,,,,,,-,,,,MMR,05/10/2021,Single Antigen Administration,01/01/2013,03/19/2018,Not recommended: series complete,,1.0,"This test case describes when single antigens M, M, and R are administered to a child >  12 months of age followed by a MMR (4rth )dose a year later, that the doses are considered to be valid.  The series is complete.  "
2013-0570,Dose 2 at age 13 mo -5 days,04/15/2020,F,,,,Not complete,04/13/2021,M-M-R II,03,MSD,Valid,,05/10/2021,M-M-R II,03,MSD,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,04/15/2024,05/12/2027,MMR,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/02/2020,Recommended based on age,,1.0,"This test case describes when a child is administered the second dose of the MMR vaccine at 13 months - 5 days, that the dose is not valid."
2013-0571,Dose 2 at age 13 mo - 4 days ,04/14/2020,F,,,,Complete,04/14/2021,M-M-R II,03,MSD,Valid,,05/10/2021,M-M-R II,03,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,MMR,05/10/2021,Age: At Absolute Minimum,01/01/2013,05/29/2020,Not recommended: series complete,,1.0,"This test case describes when a child is administered the second dose of the MMR vaccine at 13 months - 4 days, that the dose is considered to be valid. The series is complete."
2013-0572,Dose 2 at age 13 mo ,04/10/2020,F,,,,Complete,04/10/2021,M-M-R II,03,MSD,Valid,,05/10/2021,M-M-R II,03,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,MMR,05/10/2021,Age: At Minimum,01/01/2013,01/04/2018,Not recommended: series complete,,1.0,"This test case describes when a child is administered the second dose of the MMR vaccine at 13 months, that the dose is considered to be valid. The series is complete."
2013-0573,Dose 1 to dose 2 interval 28 days-5 days,01/17/2019,F,,,,Not complete,04/17/2021,M-M-R II,03,MSD,Valid,,05/10/2021,M-M-R II,03,MSD,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,01/17/2023,02/13/2026,MMR,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,01/04/2018,Recommended based on age,,1.0,"This test case describes when a child is administered the second dose of the MMR vaccine at an interval of 28 -5 days, that the dose is not valid. "
2013-0574,Dose 1 to dose 2 interval 28-4 days ,03/16/2020,F,,,,Complete,04/16/2021,M-M-R II,03,MSD,Valid,,05/10/2021,M-M-R II,03,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,MMR,05/10/2021,Interval: At Absolute Minimum,01/01/2013,05/29/2020,Not recommended: series complete,,1.0,"This test case describes when a child is administered the second dose of the MMR vaccine at an interval of 28 -4 days, that the dose is considered to be valid. The series is complete. "
2015-0024,MMR: Patient is born before 01/01/1957,06/12/1956,F,,,,Immune,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,MMR,03/23/2015,No Doses Administered,06/23/2015,03/01/2018,Not recommended: immune,New test case for version 2.0 which expanded scope into Adult recommendations,1.0,"This test case describes when a patient was born before January 1, 1957, that the patient is considered to be Immune."
2019-0017,Adult with no previous doses of the MMR vaccine,05/10/1986,M,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/10/1987,05/10/1987,10/07/1987,MMR,05/10/2021,No Doses Administered,10/17/2018,05/29/2020,Recommended based on age,,4.2,This test cases describes when an adult patient has no known history of the MMR vaccine that a dose should be forecast.
2019-0018,Adult with a dose of the MMR vaccine,05/10/1986,M,,,,Complete,05/10/2021,MMR,03,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,MMR,05/10/2021,All Valid: Forecast Test,09/22/2019,11/14/2019,Not recommended: series complete,,4.2,"This test case describes when an adult patient received a dose of the MMR vaccine, that no additional doses are needed. Series is complete."
2019-0019,Adolescent with no dose of MMR vaccine,05/10/2005,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/10/2006,05/10/2006,10/07/2006,MMR,05/10/2021,No Doses Administered,11/11/2019,05/29/2020,Recommended based on age,,4.2,This test case describes when an adolescent patient has no known history of the MMR vaccine that a dose should be forecast.
2019-0020,Adolescent with 2nd dose of MMR vaccine at 4 weeks,04/12/2005,F,,,,Complete,04/12/2021,MMR,03,,Valid,,05/10/2021,MMR,03,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0,,,,MMR,05/10/2021,All Valid: Forecast Test,11/11/2019,05/29/2020,Not recommended: series complete,,4.2,"This test case describes when a patient receives the 2nd dose of the MMR vaccine at 4 weeks after the first dose, that the dose is considered to be valid.  The series is complete."
2019-0021,Adolescent with 2nd dose of MMR vaccine at 4 weeks - 5 days,04/17/2005,F,,,,Not complete,04/17/2021,MMR,03,,Valid,,05/10/2021,MMR,03,,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,MMR,05/10/2021,Interval: Below Absolute Minimum,11/11/2019,06/02/2020,Recommended based on interval,,4.2,"This test case describes when a patient is administered the second dose of the MMR vaccine at less than 4 weeks - 4 days, that another dose should be forecast."
2019-0022,Adolescent with 2nd dose of MMR vaccine at 4 weeks - 4 days,04/16/2005,F,,,,Complete,04/16/2021,MMR,03,,Valid,,05/10/2021,MMR,03,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0,,,,MMR,05/10/2021,All Valid: Forecast Test,11/11/2019,05/29/2020,Not recommended: series complete,,4.2,"This test case describes when a patient receives the 2nd dose of the MMR vaccine at 4 weeks - 4 days after the first dose, that the dose is considered to be valid.  The series is complete."
2013-0575,Newborn Testing,05/10/2021,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/21/2021,07/10/2021,09/06/2021,PCV,05/10/2021,No Doses Administered,01/01/2013,03/19/2018,Recommended based on age,,1.0,This test case describes the forecasting of a newborn for the first dose of the Pneumoccocal vaccine.
2013-0576,Dose # 1 PCV 13 at age 18 months,11/10/2019,F,,,,Not complete,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,07/05/2021,07/05/2021,07/05/2021,PCV,05/10/2021,All Valid: Forecast Test,01/01/2013,05/29/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when dose #1 of the Pneumococcal 13 vaccine is administered at age 18 months that the dose is considered to be valid and the patient is on a catch-up schedule.
2013-0577,Dose # 1 of PCV 7 at age 24 months.  Need one dose PCV 13. ,03/01/2008,F,,,,Not complete,03/01/2010,PREVNAR 7,100,WAL,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,04/26/2010,04/26/2010,04/26/2010,PCV,03/01/2010,All Valid: Forecast Test,01/01/2013,05/29/2020,Recommended based on minimum interval from previous dose (catch-up),"V1.3: The first dose was PCV7 and was marked as not valid.  This dose is valid, but the patient still needs a valid PCV13.",1.3,This test case describes when dose #1 of the Pneumococcal 7 vaccine is administered at age 24 months that the dose is considered to be valid. Forecast another dose.
2013-0578,Dose # 1 of PCV 13 at age 24 months.  Series complete.,05/10/2019,F,,,,Complete,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,PCV,05/10/2021,All Valid: Forecast Test,01/01/2013,05/29/2020,Not recommended: series complete,,1.0,This test case describes when dose #1 of the Pneumococcal 13 vaccine is administered at age 24 months that the dose is considered to be valid.  No additional dose should be forecasted.  The series is complete.
2013-0579,Dose # 2 PCV 13 at age 10 weeks-5 days,03/06/2021,F,,,,Not complete,04/13/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/06/2021,09/02/2021,PCV,05/10/2021,Age: Below Absolute Minimum,01/01/2013,01/04/2018,Recommended based on age,,1.0,"This test case describes when dose #2 of the Pneumococcal 13 vaccine is administered at  age 10 weeks - 5 days, that the dose is not valid.  "
2013-0580,Dose # 2 PCV 13 at age 10 weeks-4 days,03/05/2021,F,,,,Not complete,04/13/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/11/2021,09/05/2021,11/01/2021,PCV,05/10/2021,Age: At Absolute Minimum,01/01/2013,05/29/2020,Recommended based on age,,1.0,"This test case describes when dose #2 of the Pneumococcal 13 vaccine is administered at  age 10 weeks - 4 days, that the dose is considered to be valid.   "
2013-0581,Dose PCV 13 # 2 at age 10 weeks,03/01/2021,F,,,,Not complete,04/12/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,09/01/2021,10/28/2021,PCV,05/10/2021,Age: At Minimum,01/01/2013,01/04/2018,Recommended based on age,,1.0,"This test case describes when dose #2 of the Pneumococcal 13 vaccine is administered at  age 10 weeks, that the dose is considered to be valid.   "
2013-0582,Dose # 2 PCV 13 at age 4 months,01/10/2021,F,,,,Not complete,03/10/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,07/10/2021,09/06/2021,PCV,05/10/2021,Age: At Recommended,01/01/2013,01/04/2018,Recommended based on age,,1.0,"This test case describes when dose #2 of the Pneumococcal 13 vaccine is administered at  age 4 months, that the dose is considered to be valid.   "
2013-0583,"Dose # 1 PCV 13 at  age 7 months, dose # 2 at age 8 mos and current age ≥ 12 mos.",05/10/2020,F,,,,Not complete,12/10/2020,PREVNAR 13,133,PFR,Valid,,01/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,05/10/2021,05/10/2021,10/07/2021,PCV,05/10/2021,All Valid: Forecast Test,01/01/2013,05/29/2020,Recommended based on age,,1.0,This test case describes when a child is currently 12 months of age and was administered dose #1 at age 7 months and dose #2 at age 8 months of age that the doses are considered to be valid. A final dose is recommended at age 12 months.
2013-0584,Dose # 1 PCV 13 at 12 mo; dose # 2 at 1 yr 8 wks-5 days,03/20/2020,F,,,,Not complete,03/20/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,07/05/2021,07/05/2021,07/05/2021,PCV,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,05/29/2020,Recommended based on minimum interval from invalid dose,V1.2: Condensed the past due date to align with the earliest and recommended date since this child is in catch-up,1.2,"This test case describes when dose #1 of the Pneumococcal 13 vaccine is administered at 12 months, and the #2 of the Pneumococcal 13 vaccine is administered at 1 yr, 8 weeks - 5 days, that the second dose is not valid."
2013-0585,Dose # 1 PCV 13 at age 12 mos; # 2 at 1 yr 8 wks-4 days,03/19/2020,F,,,,Complete,03/19/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,PCV,05/10/2021,Interval: At Absolute Minimum,01/01/2013,05/29/2020,Not recommended: series complete,,1.0,"This test case describes when dose #1 of the Pneumococcal 13 vaccine is administered at 12 months, and the #2 dose of the Pneumococcal 13 vaccine is administered at 1 yr, 8 weeks - 4 days, that the second dose is valid. The patient is complete."
2013-0587,Dose # 1 PCV 13 at age 12 months; # 2 at age 14 mos.  Series complete. ,03/10/2020,F,,,,Complete,03/10/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,PCV,05/10/2021,All Valid: Forecast Test,01/01/2013,05/29/2020,Not recommended: series complete,,1.0,"This test case describes when dose #1 of the Pneumococcal 13 vaccine is administered at 12 months, and the #2 dose of the Pneumococcal 13 vaccine is administered at 14 months, that the second dose is considered to be valid."
2013-0588,Dose # 1 PCV 13 at 24 mo-5 days.  Valid but child needs another. ,05/15/2019,F,,,,Not complete,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,07/05/2021,07/05/2021,07/05/2021,PCV,05/10/2021,All Valid: Forecast Test,01/01/2013,05/29/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,"This test case describes when a child is administered the first dose of the Pneumococcal 13 vaccine at 24 months - 5 days, that the dose is considered to be valid, but a second dose is still needed."
2013-0589,Dose 1 PCV 13 at 24 m-4 days.  Series complete. ,05/14/2019,F,,,,Complete,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,PCV,05/10/2021,All Valid: Forecast Test,01/01/2013,05/29/2020,Not recommended: series complete,,1.0,"This test case describes when a child is administered the first  dose of the Pneumococcal 13 vaccine at 24 months - 4 days, that the dose is considered to be valid. No additional doses are recommended.  The series is complete."
2013-0590,Dose # 3 PCV 13 at age 14 weeks-5 days.,02/06/2021,F,,,,Not complete,03/17/2021,PREVNAR 13,133,PFR,Valid,,04/14/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/06/2021,10/03/2021,PCV,05/10/2021,Age: Below Absolute Minimum,01/01/2013,01/04/2018,Recommended based on age,,1.0,"This test case describes when dose #3 of the Pneumococcal 13 vaccine is administered to a child at 14 weeks- 5 days, that the dose is not valid."
2013-0591,Dose # 3 PCV 13 at age 14 weeks-4 days.,02/05/2021,F,,,,Not complete,03/16/2021,PREVNAR 13,133,PFR,Valid,,04/13/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,02/05/2022,02/05/2022,07/02/2022,PCV,05/10/2021,Age: At Absolute Minimum,01/01/2013,05/29/2020,Recommended based on age,,1.0,"This test case describes when dose #3 of the Pneumococcal 13 vaccine is administered to a child at 14 weeks- 4 days, that the dose is considered to be valid."
2013-0592,Dose # 3 PCV 13 at age 14 weeks,02/01/2021,F,,,,Not complete,03/15/2021,PREVNAR 13,133,PFR,Valid,,04/12/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,02/01/2022,02/01/2022,06/28/2022,PCV,05/10/2021,Age: At Minimum,01/01/2013,01/04/2018,Recommended based on age,,1.0,"This test case describes when dose #3 of the Pneumococcal 13 vaccine is administered to a child at 14 weeks, that the dose is considered to be valid."
2013-0593,Dose # 3 PCV 13 at 6 mo.,11/10/2020,F,,,,Not complete,01/10/2021,PREVNAR 13,133,PFR,Valid,,03/10/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,11/10/2021,11/10/2021,04/06/2022,PCV,05/10/2021,Age: At Recommended,01/01/2013,01/04/2018,Recommended based on age,,1.0,"This test case describes when dose #3 of the Pneumococcal 13 vaccine is administered to a child at 6 months, that the dose is considered to be valid."
2013-0594,Mixed vaccines: dose # 1 PCV 7 at 6 mo; # 2 PCV 13 at 8 mo; # 3 PCV 13 at 12 months.  Series complete. ,03/04/2010,F,,,,Complete,09/04/2010,PREVNAR 7,100,WAL,Valid,,11/04/2010,PREVNAR 13,133,PFR,Valid,,03/04/2011,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,PCV,03/04/2011,All Valid: Forecast Test,01/01/2013,03/02/2018,Not recommended: series complete,,1.0,"This test case describes when dose #1 of PCV 7 is administered at 6 months, dose #2 of PCV 13 is administered at 8 months, and dose #3 of PCV 13 is administered at 12 months, that the doses are considered to be valid.  The series is complete."
2013-0595,Mixed vaccines: dose # 1 PCV 7 at 7 mo; # 2 PCV 7 at 8 mo; #3 PCV 13 at 12 months.  Series complete. ,06/01/2009,F,,,,Complete,01/01/2010,PREVNAR 7,100,WAL,Valid,,02/01/2010,PREVNAR 7,100,WAL,Valid,,06/01/2010,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,PCV,06/01/2010,All Valid: Forecast Test,01/01/2013,05/29/2020,Not recommended: series complete,Minor typo in test case name corrected.,1.1,"This test case describes when dose #1 of PCV 7 is administered at 7 months, dose #2 of PCV 13 is administered at 8 months, and dose #3 of PCV 13 is administered at 12 months, that the doses are considered to be valid.  The series is complete."
2013-0596,Dose # 1 PCV 13 at age 6 weeks-5 days,04/03/2021,F,,,,Not complete,05/10/2021,PREVNAR 13,133,PFR,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/15/2021,06/03/2021,07/30/2021,PCV,05/10/2021,Age: Below Absolute Minimum,01/01/2013,10/17/2018,Recommended based on age,,1.0,This test case describes when dose #1 of the Pneumococcal vaccine is administered at age 6 weeks - 5 days that the dose is not valid.
2013-0597,"Dose # 1 PCV 13 at 6 mo; # 2 at 11 mo, # 3 at 12 mo",05/10/2020,F,,,,Not complete,11/10/2020,PREVNAR 13,133,PFR,Valid,,04/10/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,3,07/05/2021,07/05/2021,10/07/2021,PCV,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,08/11/2020,Recommended based on minimum interval from invalid dose,"V4.4 Updated the Evaluation test type from All valid doses: to Interval: Below Absolute Minimum
V1.2: At 12 Months of age and after the spacing must be 8 weeks or more.  Dose 3 was given on 12 Months, but wasn't spaced 8 weeks.  The forecast in this case remains unchanged.",4.4,"This test case describes when dose #1 of PCV 13 is administered at 6 months, dose #2 of PCV 13 is administered at 11 months, and dose #3 of PCV 13 is administered at 12 months, that dose #3 is not valid."
2013-0598,Dose # 4 PCV 13 at age 12 mo-5 days,05/15/2020,F,,,,Not complete,07/15/2020,PREVNAR 13,133,PFR,Valid,,09/15/2020,PREVNAR 13,133,PFR,Valid,,11/15/2020,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,4,07/05/2021,07/05/2021,10/12/2021,PCV,05/10/2021,Age: Below Absolute Minimum,01/01/2013,01/04/2018,Recommended based on minimum interval from inValid dose,,1.0,This test case describes when dose #4 of the PCV13 vaccine is administered at age 12 months - 5 days that the dose is not valid.
2013-0599,Dose # 4 PCV 13 at age 12 months-4 days.  Series complete. ,05/14/2020,F,,,,Complete,07/14/2020,PREVNAR 13,133,PFR,Valid,,09/14/2020,PREVNAR 13,133,PFR,Valid,,11/14/2020,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,-,,,,PCV,05/10/2021,Age: At Absolute Minimum,01/01/2013,05/29/2020,Not recommended: series complete,,1.0,This test case describes when dose #4 of the PCV13 vaccine is administered at age 12 months - 4 days that the dose is considered to be valid.  The series is complete.
2013-0600,Dose # 4 PCV 13 at 1 year.  Series complete. ,05/10/2020,F,,,,Complete,07/10/2020,PREVNAR 13,133,PFR,Valid,,09/10/2020,PREVNAR 13,133,PFR,Valid,,11/10/2020,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,-,,,,PCV,05/10/2021,Age: At Minimum,01/01/2013,01/04/2018,Not recommended: series complete,,1.0,This test case describes when dose #4 of the PCV13 vaccine is administered at age 12 months that the dose is considered to be valid.  The series is complete.
2013-0601,"4 doses of PCV 7, no PCV 13.  Needs one PCV 13. ",06/01/2009,F,,,,Not complete,08/01/2009,PREVNAR 7,100,WAL,Valid,,10/01/2009,PREVNAR 7,100,WAL,Valid,,12/01/2009,PREVNAR 7,100,WAL,Valid,,07/01/2010,PREVNAR 7,100,WAL,Valid,,,,,,,,,,,,,,,,,,,,5,08/26/2010,08/26/2010,08/26/2010,PCV,07/01/2010,All Valid: Forecast Test,01/01/2013,03/02/2018,Recommended based on minimum interval from previous dose (catch-up),The fourth dose of PCV7 was marked as Not Valid.  In fact this was a valid administration with a need for a subsequent PCV13 in 8 weeks time.  V1.3: Updated Eval and Forecast Test Type and adjusted the past due date to align with the earliest and recommended date per the subsequent dose recommendations of ACIP.,1.3,This test case describes when 4 doses of PCV 7 is administered that one dose of Pneumococcal 13 is needed.
2013-0602,Dose 1 invalid (age) as first of others,11/10/2020,F,,,,Not complete,12/11/2020,PREVNAR 13,133,PFR,Not Valid,Age: Too Young,02/25/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/07/2021,07/07/2021,PCV,05/10/2021,Age: Below Absolute Minimum,01/01/2013,05/29/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when the first dose of the Pneumococcal vaccine is  not valid.
2013-0603,Dose 2 invalid (age) in midst of others.   ,12/10/2020,F,,,,Not complete,01/19/2021,PREVNAR 13,133,PFR,Valid,,02/13/2021,PREVNAR 13,133,PFR,Not Valid,Age: Too Young,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/10/2021,08/06/2021,PCV,05/10/2021,Age: Below Absolute Minimum,01/01/2013,01/04/2018,Recommended based on age,,1.0,This test case describes when the second dose of the Pneumococcal vaccine is  not valid.
2013-0604,Dose # 3 invalid (age) in midst of others.   Four valid doses not required in this scenario.,04/28/2020,F,,,,Complete,06/08/2020,PREVNAR 13,133,PFR,Valid,,07/05/2020,PREVNAR 13,133,PFR,Valid,,07/16/2020,PREVNAR 13,133,PFR,Not Valid,Age: Too Young,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,-,,,,PCV,05/10/2021,Age: Below Absolute Minimum,01/01/2013,01/04/2018,Not recommended: series complete,,1.0,This test case describes when the third dose of the Pneumococcal vaccine is  not valid.
2013-0605,Dose 1 to dose 2 interval 28-5 days.,02/17/2021,F,,,,Not complete,04/17/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/17/2021,08/13/2021,PCV,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,01/04/2018,Recommended based on age,,1.0,This test case describes when the interval between dose #1 and dose #2 of the Pnuemococal vaccine is 28 - 5 days that the second dose is not valid.
2013-0606,Dose 1 to dose 2 interval 28-4 days,02/16/2021,F,,,,Not complete,04/16/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/16/2021,10/13/2021,PCV,05/10/2021,Interval: At Absolute Minimum,01/01/2013,05/29/2020,Recommended based on age,,1.0,This test case describes when dose #1 and dose #2 of the Pnuemococal 13 vaccine is administered at  28 - 4 days that the second dose is considered to be valid.
2013-0607,Dose # 1 PCV 13 at age 6 weeks-4 days,04/02/2021,F,,,,Not complete,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/11/2021,08/02/2021,09/29/2021,PCV,05/10/2021,Age: At Absolute Minimum,01/01/2013,05/29/2020,Recommended based on age,,1.0,This test case describes when dose #1 of the Pneumococcal 13 vaccine is administered at 6 weeks - 4 days that the dose is considered to be valid.
2013-0608,Dose 1 PCV 13 to dose 2 interval 28 days,02/12/2021,F,,,,Not complete,04/12/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/12/2021,10/09/2021,PCV,05/10/2021,Interval: At Minimum,01/01/2013,01/04/2018,Recommended based on age,,1.0,"This test case describes when dose #1 to dose #2 of the Pneumococcal 13 vaccine is administered at an interval of 28 days, that the second dose is considered to be valid."
2013-0609,Dose 2 to dose 3  interval  28-5 days,12/17/2020,F,,,,Not complete,02/17/2021,PREVNAR 13,133,PFR,Valid,,04/17/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/17/2021,08/13/2021,PCV,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,01/04/2018,Recommended based on age,,1.0,This test case describes when dose #2 to dose #3 of the Pnuemococcal 13 vaccine is administered at 28-5 days that dose #3 is not valid.
2013-0610,Dose 2 to dose 3 PCV 13 interval 28-4 days,11/16/2020,F,,,,Not complete,01/16/2021,PREVNAR 13,133,PFR,Valid,,04/16/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,11/16/2021,11/16/2021,04/12/2022,PCV,05/10/2021,Interval: At Absolute Minimum,01/01/2013,05/29/2020,Recommended based on age,,1.0,This test case describes when dose #2 to dose #3 of the Pnuemococcal 13 vaccine is administered at an interval of 28-4 days that dose #3 is considered to be valid.
2013-0611,Dose 2 to dose 3 PCV 13 interval 28 days,11/12/2020,F,,,,Not complete,01/12/2021,PREVNAR 13,133,PFR,Valid,,04/12/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,11/12/2021,11/12/2021,04/08/2022,PCV,05/10/2021,Interval: At Minimum,01/01/2013,01/04/2018,Recommended based on age,,1.0,This test case describes when dose #2 to dose #3 of the Pnuemococcal vaccine is administered at an interval of 28 days that dose #3 is considered to be valid.
2013-0612,Dose 3 PCV 13 to dose 4 interval 8 weeks-5 days,04/20/2020,F,,,,Not complete,10/20/2020,PREVNAR 13,133,PFR,Valid,,02/20/2021,PREVNAR 13,133,PFR,Valid,,03/20/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,4,07/05/2021,07/05/2021,09/16/2021,PCV,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,08/20/2018,Recommended based on minimum interval from inValid dose,,1.0,This test case describes when dose #3 to dose #4 of the Pnuemococcal 13 vaccine is administered at an interval of 8 weeks -5 days that dose #4 is not valid.
2013-0613,Dose 3 PCV 13 to dose 4 interval 8 wks-4 days.  Series complete.,04/19/2020,F,,,,Complete,10/19/2020,PREVNAR 13,133,PFR,Valid,,02/19/2021,PREVNAR 13,133,PFR,Valid,,03/19/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,-,,,,PCV,05/10/2021,Interval: At Absolute Minimum,01/01/2013,05/29/2020,Not recommended: series complete,,1.0,This test case describes when dose #3 to dose #4 of the Pnuemococcal 13 vaccine is administered at an interval of 8 weeks -4 days that dose #4 is considered to be valid. The series is complete.
2013-0614,Dose 3 PCV 13 to dose 4 interval 8 weeks.  Series complete.,04/15/2020,F,,,,Complete,10/15/2020,PREVNAR 13,133,PFR,Valid,,02/15/2021,PREVNAR 13,133,PFR,Valid,,03/15/2021,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,-,,,,PCV,05/10/2021,Interval: At Minimum,01/01/2013,04/23/2018,Not recommended: series complete,,1.0,This test case describes when dose #3 to dose #4 of the Pnuemococcal 13 vaccine is administered at an interval of 8 weeks that dose #4 is considered to be valid. The series is complete.
2013-0615,Invalid dose 2 (interval) in midst of others,05/10/2020,F,,,,Complete,06/27/2020,PREVNAR 13,133,PFR,Valid,,07/20/2020,PREVNAR 13,133,PFR,Not Valid,Interval: too short,11/10/2020,PREVNAR 13,133,PFR,Valid,,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,-,,,,PCV,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,01/04/2018,Not recommended: series complete,,1.0,"This test case describes when the second dose of the Pneumococcal vaccine is  not valid, but the patient is still complete since the last was after 12 months and 8 weeks from the previous dose."
2013-0616,Invalid dose 3 (interval) in midst of others,04/10/2020,F,,,,Complete,08/10/2020,PREVNAR 13,133,PFR,Valid,,11/18/2020,PREVNAR 13,133,PFR,Valid,,12/10/2020,PREVNAR 13,133,PFR,Not Valid,Interval: too short,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,-,,,,PCV,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,01/04/2018,Not recommended: series complete,,1.0,"This test case describes when the third dose of the Pneumococcal 13 vaccine is  not valid, but the patient is still complete since the last dose was after 12 months of age and 8 weeks since the previous dose."
2013-0617,InValid dose 4 (interval) in midst of others,02/22/2020,F,,,,Complete,04/22/2020,PREVNAR 13,133,PFR,Valid,,08/22/2020,PREVNAR 13,133,PFR,Valid,,02/11/2021,PREVNAR 13,133,PFR,Valid,,03/11/2021,PREVNAR 13,133,PFR,Not Valid,Interval: too short,05/06/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,-,,,,PCV,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,01/04/2018,Not recommended: series complete,,1.0,This test case describes when the fourth dose of the Pneumococcal 13 vaccine is  not valid.
2013-0618,Dose # 1 PCV 13 at age 6 weeks,03/29/2021,F,,,,Not complete,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/29/2021,09/25/2021,PCV,05/10/2021,Age: At Minimum,01/01/2013,01/04/2018,Recommended based on age,,1.0,"This test case describes when the dose #1 of the Pneumococcal 13 vaccine is administered at age 6 weeks, that the dose is considered to be valid."
2013-0619,4 doses of PCV 7 and 1 dose of PCV 13=series complete,06/06/2008,F,,,,Complete,08/06/2008,PREVNAR 7,100,WAL,Valid,,10/06/2008,PREVNAR 7,100,WAL,Valid,,12/06/2008,PREVNAR 7,100,WAL,Valid,,12/06/2009,PREVNAR 7,100,WAL,Valid,,03/05/2012,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,-,,,,PCV,03/05/2012,All Valid: Forecast Test,01/01/2013,03/02/2018,Not recommended: series complete,The fourth dose of PCV7 was marked as Not Valid.  In fact this was a valid administration.  The PCV13 which followed completed the series. V1.3 updated Evaluation Test Type,1.3,This test case describes when 4 doses of the PCV 7 vaccine and 1 dose of the PCV13 vaccine has been administered that the doses are considered to be valid.  The series is complete.
2013-0622,Dose # 1 PCV 13 at age 2 months,03/10/2021,F,,,,Not complete,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/10/2021,09/06/2021,PCV,05/10/2021,Age: At Recommended,01/01/2013,01/04/2018,Recommended based on age,,1.0,"This test case describes when dose #1 of the Pneumococcal 13 vaccine is administered at age 2 months, that the dose is considered to be valid."
2013-0624,Dose # 1 PCV 13 at age 11 months,06/10/2020,F,,,,Not complete,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,PCV,05/10/2021,All Valid: Forecast Test,01/01/2013,05/29/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,"This test case describes when dose #1 of the Pneumococcal 13 vaccine is administered at age 11 months, that the dose is considered to be valid, but the patient is now on the catch-up schedule."
2013-0625,Dose # 1 PCV 13 at age 12 months,05/10/2020,F,,,,Not complete,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,07/05/2021,07/05/2021,07/05/2021,PCV,05/10/2021,All Valid: Forecast Test,01/01/2013,05/29/2020,Recommended based on minimum interval from previous dose (catch-up),Past Due Date was incorrect.  Should be in alignment with the earliest and recommended.  Child is in catch-up schedule.,1.1,"This test case describes when dose #1 of the Pneumococcal 13 vaccine is administered at age 12 months, that the dose is considered to be valid."
2015-0021,Pneumococcal: Patient has received PCV13 and PPSV23,05/04/1955,F,,,,Complete,05/10/2020,PREVNAR 13,133,PFR,Valid,,05/10/2021,PNEUMOVAX 23,33,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,PCV,05/10/2021,All Valid: Forecast Test,06/23/2015,01/04/2018,Not recommended: series complete,New test case for version 2.0 which expanded scope into Adult recommendations. Update due to  MMWR (9/4/2015 / Vol.64 / No. 34) changing the minimal and recommended interval from PCV13 to PPSV23 in adults 65+ from 6-12 months to 1 year.,1.0,"This test case describes the assessment of a patient > age 65 years with a history of PCV13 and PPSV23 vaccine, that no additional doses are recommended.  The series is complete."
2015-0022,Adult Patient has received PCV13 but has no history of PPSV23,05/10/1956,F,,,,Not complete,05/10/2021,PREVNAR 13,133,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,05/10/2022,05/10/2022,,PCV,05/10/2021,All Valid: Forecast Test,06/23/2015,03/08/2018,Recommended based on interval,New test case for version 2.0 which expanded scope into Adult recommendations. Update due to  MMWR (9/4/2015 / Vol.64 / No. 34) changing the minimal and recommended interval from PCV13 to PPSV23 in adults 65+ from 6-12 months to 1 year.,1.0,"This test case describes the assessment of a patient > age 65 years with a history of PCV13 vaccine, but no history of the PPSV23 vaccine. "
2015-0023,Adult Patient has received PPSV23 at age 65 but has no history of PCV13.,04/24/1956,F,,,,Complete,05/10/2021,PNEUMOVAX 23,33,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PCV,05/10/2021,All Valid: Forecast Test,06/23/2015,11/04/2019,Recommended based on interval,"Test case updated per the new PCV recommendation (June 2019, ACIP Meeting) for healthy individuals >- 65 years.",4.2,"This test case describes when a patient age 65 years with a history of PCV23 vaccine, but has not received the PCV 13 series that no additional dose are recommended. The PCV series is complete."
2019-0008,Adult Patient 65 years with no history of PPSV23 vaccine,05/10/1956,M,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/10/2021,05/10/2021,,PCV,05/10/2021,No Doses Administered,07/01/2019,05/29/2020,Recommended based on age,,4.2,This test cases describes when an adult patient 65 years of age or older with no known history of the PPSV vaccine that a dose should be forecast.
2019-0009,Adult Patient 65 years with a dose of PPSV23 vaccine,05/10/1956,M,,,,Complete,05/10/2021,pneumococcal polysaccharide PPV23,33,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PCV,05/10/2021,All Valid: Forecast Test,07/01/2019,05/29/2020,Not recommended: series complete,4.2,4.2,"This test cases describes when an adult patient age 65 years with a history of the PPSV23 vaccine, that no additional doses should be forecast.  Series is complete."
2013-0626,Newborn Testing,05/10/2021,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/21/2021,07/10/2021,09/06/2021,POL,05/10/2021,No Doses Administered,01/01/2013,06/02/2020,Recommended based on age,,1.0,This test case describes when a child is a newborn and has not been administered a dose of the Polio vaccine that the first dose should be forecast.
2013-0627,Dose # 2 at age 10 weeks,03/01/2021,F,,,,Not complete,04/12/2021,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,09/01/2021,10/28/2022,POL,05/10/2021,Age: At Minimum,01/01/2013,06/12/2020,Recommended based on age,Typo on Past Due Date by one year.  ,1.1,This test case describes when a child is administered a second dose of the Polio vaccine at age 10 weeks that the dose is valid.  Another dose should be forecast.
2013-0628,Dose # 2 at age 4 months,01/10/2021,F,,,,Not complete,03/10/2021,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,07/10/2021,09/06/2022,POL,05/10/2021,Age: At Recommended,01/01/2013,06/12/2020,Recommended based on age,Typo on Past Due Date by one year.  ,1.1,This test case describes when a child is administered a second dose of the Polio vaccine at age 4 months that the dose is valid.  Another dose should be forecast.
2013-0629,Dose # 2 at age 3 years 9 months,08/10/2017,F,,,,Not complete,10/10/2017,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/07/2021,06/07/2021,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Recommended based on minimum interval from previous dose (catch-up),Rolled all birth dates forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a second dose of the Polio vaccine at age 3 years 9 months that the dose is valid.  Another dose should be forecast.
2013-0630,Dose # 2 at age 4 years 0 months,05/10/2017,F,,,,Not complete,05/10/2019,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,11/10/2021,11/10/2021,06/06/2024,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Recommended based on minimum interval from previous dose (catch-up),"Updated Forecast dose number to 3.

Polio should continue to be recommended in 4 weeks.  The dose should not be skipped until 4 years AND 6 months from previous dose. V2.1",3.3,This test case describes when a child is administered a second dose of the Polio vaccine at age 4 years that the dose is valid.  Another dose should be forecast.
2013-0631,Dose # 3 at age 14 weeks-5 days,02/06/2021,F,,,,Not complete,03/16/2021,IPOL,10,PMC,Valid,,04/13/2021,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/06/2021,10/03/2022,POL,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/12/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a third dose of the Polio vaccine at 14 weeks - 5 days that the dose is not valid.  A repeat dose should be forecast.
2013-0632,Dose # 3 at age 14 weeks - 4 days,02/05/2021,F,,,,Not complete,03/19/2021,IPOL,10,PMC,Valid,,04/16/2021,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,02/05/2025,02/05/2025,03/03/2028,POL,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/12/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a third dose of the Polio vaccine at 14 weeks - 4 days that the dose is valid.  Another dose should be forecast.
2013-0633,Dose # 3 at age 14 weeks,02/01/2021,F,,,,Not complete,03/15/2021,IPOL,10,PMC,Valid,,04/12/2021,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,02/01/2025,02/01/2025,02/28/2028,POL,05/10/2021,Age: At Minimum,01/01/2013,06/12/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a third dose of the Polio vaccine at 14 weeks that the dose is valid.  Another dose should be forecast.
2013-0634,Dose # 3 at age 6 months,11/10/2020,F,,,,Not complete,01/10/2021,IPOL,10,PMC,Valid,,03/10/2021,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,11/10/2024,11/10/2024,12/07/2027,POL,05/10/2021,Age: At Recommended,01/01/2013,06/12/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a third dose of the Polio vaccine at 6 months of age that the dose is valid.  Another dose should be forecast.
2013-0635,Dose # 3 at age 3 yrs 11.5 months old.,05/25/2017,F,,,,Not complete,07/25/2017,IPOL,10,PMC,Valid,,09/25/2017,IPOL,10,PMC,Valid,,04/30/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,10/30/2021,10/30/2021,06/21/2024,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Recommended based on minimum interval from previous dose (catch-up),Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a third dose of the Polio vaccine at 3 yrs 11.5 of age that the dose is valid.  Another dose should be forecast.
2013-0636,Dose # 3 at age 4 years-5 days.   Is valid as a dose but child will need another. ,05/15/2017,F,,,,Not complete,07/15/2017,IPOL,10,PMC,Valid,,09/15/2017,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,11/10/2021,11/10/2021,06/11/2024,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Recommended based on minimum interval from previous dose (catch-up),Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a third dose of the Polio vaccine at 4 years - 5 days of age that the dose is valid.  Another dose should be forecast.
2013-0637,# 1 and # 2 at ≥ 4 years.,04/12/2017,F,,,,Not complete,04/12/2021,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,11/10/2021,11/10/2021,05/09/2024,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Recommended based on minimum interval from previous dose (catch-up),"Updated Forecast dose number to 3.

",3.3,This test case describes when a child is administered a first and second dose of the Polio vaccine at greater than 4 years that the doses are valid.  Another dose should be forecast.
2013-0638,Dose # 3 at 4 years-4 days but not six months after dose 2.  Child will need another. ,05/14/2017,F,,,,Not complete,05/14/2018,IPOL,10,PMC,Valid,,12/14/2020,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,11/10/2021,11/10/2021,06/10/2024,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Recommended based on minimum interval from previous dose (catch-up),Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a third of the Polio vaccine at 4 years - 4 days but less than the six month interval from the second dose that the doses are valid.  Another dose should be forecast.
2013-0639,Dose # 3 at 4 years-4 days and ≥ 6 months since dose 2.  Series complete.,05/14/2017,F,,,,Complete,05/14/2018,IPOL,10,PMC,Valid,,10/14/2020,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Not recommended: series complete,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a third dose of the Polio vaccine at 4 years - 4 days and with an interval 6 months after the second dose that the doses are valid.  No further dose should be forecast.  The series is complete.
2013-0640,Dose # 3 at age 4 years but < 6 months after dose 2.  Valid but child will need a dose # 4. ,05/10/2017,F,,,,Not complete,05/10/2018,IPOL,10,PMC,Valid,,01/10/2021,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,11/10/2021,11/10/2021,06/06/2024,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Recommended based on minimum interval from previous dose (catch-up),"Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  
Previous dates were before the ACIP recommendations were published.",1.5,This test case describes when a child is administered a third dose of the Polio vaccine at 4 years but less than less 6 months after the second dose that the doses are valid.  Another dose should be forecast.
2013-0641,Dose # 3 at 4 years 0 months and ≥ 6 mo since dose 2.   Series complete. ,05/10/2017,F,,,,Complete,07/10/2017,IPOL,10,PMC,Valid,,09/10/2017,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Not recommended: series complete,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a third dose of the Polio vaccine at 4 years and greater than or equal to 6 months after the second dose that the doses are valid.  No further doses should be forecast.  The series is complete.
2013-0642,Dose # 4 at age 18 months.   ,11/10/2019,F,,,,Not complete,01/10/2020,IPOL,10,PMC,Valid,,03/10/2020,IPOL,10,PMC,Valid,,05/10/2020,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,5,11/10/2023,11/10/2023,12/07/2026,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Recommended based on age,Updated the 4rth dose as valid due to the new 5 dose IPV supporting data document,3.1,This test case describes when a child is administered a fourth dose of the Polio vaccine at 18 months after the third dose that the doses are valid.  Another dose should be forecast.
2013-0643,Dose # 4 at age 4 yrs-5 days,05/15/2017,F,,,,Not complete,08/15/2017,IPOL,10,PMC,Valid,,12/15/2017,IPOL,10,PMC,Valid,,05/16/2020,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,5,11/10/2021,11/10/2021,06/11/2024,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Recommended based on age,Updated the 4rth dose as valid due to the new 5 dose IPV supporting data document,3.1,This test case describes when a child is administered a fourth dose of the Polio vaccine at age 4 years - 5 days that the doses are valid.  Another dose should be forecast.
2013-0644,Dose # 4 at age 4 years-4 days.  Series complete.,05/14/2017,F,,,,Complete,08/14/2017,IPOL,10,PMC,Valid,,12/14/2017,IPOL,10,PMC,Valid,,05/15/2020,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,-,,,,POL,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/12/2020,Not recommended: series complete,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a fourth dose of the Polio vaccine at age 4 years - 4 days that the doses are valid.  No further doses should be forecast.  The series is complete.
2013-0645,Dose # 4 at age 4 years 0 days.  Series complete. ,05/10/2017,F,,,,Complete,07/10/2017,IPOL,10,PMC,Valid,,09/10/2017,IPOL,10,PMC,Valid,,01/11/2018,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,-,,,,POL,05/10/2021,Age: At Minimum,01/01/2013,06/12/2020,Not recommended: series complete,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a fourth dose of the Polio vaccine at age 4 years - 0 days that the doses are valid.  No further doses should be forecast.  The series is complete.
2013-0646,Invalid dose 1 (age) as first of others,11/03/2020,F,,,,Not complete,12/04/2020,IPOL,10,PMC,Not Valid,Age: Too Young,03/04/2021,IPOL,10,PMC,Valid,,05/04/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/01/2021,06/01/2021,06/30/2022,POL,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/04/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered an invalid first dose of the Polio vaccine at age one month and two valid doses at the appropriate ages and intervals that another dose should be forecast.
2013-0647,Invalid dose # 2 (age) in midst of others,11/10/2020,F,,,,Not complete,12/18/2020,IPOL,10,PMC,Valid,,01/14/2021,IPOL,10,PMC,Not Valid,Age: Too Young,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/07/2021,07/07/2022,POL,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/04/2020,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a child is administered an invalid second dose of the Polio vaccine at less than 10 weeks - 4 days of age but is administered a valid third dose at 4 weeks later that the dose is valid.  Another dose should be forecast.
2013-0648,Invalid dose 3 (age) in midst of others.  No additional dose required. The next dose  was at age 4 and ≥ 6 months since previous dose.  Series complete.,05/10/2017,F,,,,Complete,06/21/2017,IPOL,10,PMC,Valid,,07/16/2017,IPOL,10,PMC,Valid,,08/11/2017,IPOL,10,PMC,Not Valid,Age: Too Young,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,-,,,,POL,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/04/2020,Not recommended: series complete,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered an invalid third dose of the Polio vaccine at less than 14 weeks - 4 days of age but is administered a valid fourth dose at 6 months later that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0649,Dose 1 to dose 2 interval 28-5 days,02/17/2021,F,,,,Not complete,04/17/2021,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/17/2021,08/13/2021,POL,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/11/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a second dose of the Polio vaccine at an interval of 28-5 days after the first dose that the dose is not valid.  A repeat dose should be forecast.
2013-0650,Dose 1 to dose2  interval 28-4 days,02/16/2021,F,,,,Not complete,04/16/2021,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/16/2021,10/13/2022,POL,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/11/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a second dose of the Polio vaccine at an interval of 28-4 days after the first dose that the dose is valid.  A repeat dose should be forecast.
2013-0651,Dose 1 to dose 2 interval 28 days,02/12/2021,F,,,,Not complete,04/12/2021,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/12/2021,10/09/2022,POL,05/10/2021,Interval: At Minimum,01/01/2013,06/11/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a second dose of the Polio vaccine at an interval of 28 days after the first dose that the dose is valid.  Another dose should be forecast.
2013-0652,Dose 2 to dose 3 interval 28-5 days,12/17/2020,F,,,,Not complete,02/17/2021,IPOL,10,PMC,Valid,,04/17/2021,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/17/2021,08/13/2022,POL,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/11/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a third dose of the Polio vaccine at an interval of 28-5 days after the second dose that the dose is not valid.  A repeat dose should be forecast.
2013-0653,Dose 2 to dose 3 interval 28-4 days,02/01/2021,F,,,,Not complete,03/13/2021,IPOL,10,PMC,Valid,,04/16/2021,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,02/01/2025,02/01/2025,02/28/2028,POL,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/11/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a third dose of the Polio vaccine at an interval of 28-4 days after the second dose that the dose is valid.  Another dose should be forecast.
2013-0654,Dose 2 to dose 3 interval 28 days,12/12/2020,F,,,,Not complete,02/12/2021,IPOL,10,PMC,Valid,,04/12/2021,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,12/12/2024,12/12/2024,01/08/2028,POL,05/10/2021,Interval: At Minimum,01/01/2013,06/11/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a third dose of the Polio vaccine at an interval of 28 days after the second dose that the dose is valid.  Another dose should be forecast.
2013-0655,Dose 3 to dose 4 interval 6 m-5 days,04/10/2017,F,,,,Not complete,04/10/2018,IPOL,10,PMC,Valid,,04/10/2019,IPOL,10,PMC,Valid,,11/10/2020,IPOL,10,PMC,Valid,,05/05/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,5,11/05/2021,11/05/2021,05/07/2024,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/11/2020,Recommended based on minimum interval ,"V3.1: Updated the 4th dose as valid due to the new 5 dose IPV supporting data
11/17/2016 Updated the Forecast # to Dose number 5 due to vaccine being administered too early",3.1,This test case describes when a child is administered a fourth dose of the Polio vaccine at an interval of 6 months - 5 days after the third dose that the dose is not valid.  A repeat dose should be forecast.
2013-0656,Dose 3 to dose 4 interval 6 months-4 days.  Series complete.,05/10/2017,F,,,,Complete,05/10/2018,IPOL,10,PMC,Valid,,05/10/2019,IPOL,10,PMC,Valid,,11/14/2020,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,-,,,,POL,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/11/2020,Not recommended: series complete,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a fourth dose of the Polio vaccine at an interval of 6 months - 4 days after the third dose that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0657,Dose 3 to dose 4 interval 6 months.  Series complete. ,05/06/2017,F,,,,Complete,05/06/2018,IPOL,10,PMC,Valid,,05/06/2019,IPOL,10,PMC,Valid,,11/10/2020,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,-,,,,POL,05/10/2021,Interval: At Minimum,01/01/2013,06/11/2020,Not recommended: series complete,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a fourth dose of the Polio vaccine at an interval of 6 months after the third dose that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0658,Dose # 1 at age 6 weeks-5 days,04/03/2021,F,,,,Not complete,05/10/2021,IPOL,10,PMC,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/15/2021,06/03/2021,07/30/2021,POL,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/12/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a first dose of the Polio vaccine at an interval of 6 weeks- 5 days that the dose is not valid.  A repeat dose should be forecast.
2013-0659,Invalid dose 1 to dose 2 interval in midst of others. ,11/10/2020,F,,,,Not complete,01/10/2021,IPOL,10,PMC,Valid,,02/01/2021,IPOL,10,PMC,Not Valid,Interval: too short,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/07/2021,07/07/2022,POL,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/11/2020,Recommended based on minimum interval from previous dose (catch-up),Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a second dose of the Polio vaccine at an interval less than 4 weeks - 4 days from the first dose and a repeat dose of the vaccine at 4 weeks later that the dose is valid.  Another dose should be forecast.
2013-0660,Invalid dose 3 (interval) in midst of others makes no difference in forecasting if # 4 is ≥ 4 years old and ≥ 6 months after previous dose.  Series complete.,05/08/2017,F,,,,Complete,07/08/2017,IPOL,10,PMC,Valid,,09/08/2017,IPOL,10,PMC,Valid,,10/01/2017,IPOL,10,PMC,Not Valid,Interval: too short,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,-,,,,POL,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/11/2020,Not recommended: series complete,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a third dose of the Polio vaccine at an interval less than 4 weeks - 4 days from the second dose and a repeat dose of the vaccine at age 4 years that the dose is valid.  No further doses of the vaccine should be forecast.  The series is complete.
2013-0661,Mixed OPV/IPV where # 3 is after age 4 and ≥ 6 months after previous dose. Patient Complete,10/16/2011,F,,,,Complete,12/16/2011,OPV,02,,Valid,,02/16/2012,OPV,02,,Valid,,10/16/2016,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,POL,10/16/2016,All Valid: Forecast Test,01/01/2013,06/11/2020,Not recommended: series complete,"v3.3: Changed test case to mark patient complete per updated recommendations from ACIP in January 2017.
v1.5:Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.",3.3,This test case describes when a child is administered a third dose of the Polio vaccine at age 4 years and at an interval of 6 months from the previous that the dose is valid.  No further doses of the vaccine should be forecast.  The series is complete.
2013-0662,4 doses of mixed OPV/IPV with one after age 4=polio series complete,04/13/2011,F,,,,Complete,06/13/2011,OPV,02,,Valid,,08/13/2011,OPV,02,,Valid,,04/13/2014,IPOL,10,PMC,Valid,,04/17/2016,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,-,,,,POL,04/17/2016,All Valid: Forecast Test,01/01/2013,06/11/2020,Not recommended: series complete,"V3.5: Updated Assessment Date which wasn't rolled forward when other dates were rolled forward.
V1.5: Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.",3.5,This test case describes when a child is administered four doses of mixed OPV/IPV Polio vaccine with one dose given at age 4 years and at an interval of 6 months from the previous that the dose is valid.  No further doses of the vaccine should be forecast.  The series is complete.
2013-0664,Dose 1 given as Kinrix at age 2 mos.  Off-label but valid as IPV # 1. ,03/10/2021,F,,,,Not complete,05/10/2021,KINRIX,130,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/10/2021,09/06/2021,POL,05/10/2021,Vaccine: Off Label,01/01/2013,06/12/2020,Recommended based on age,,1.0,This test case describes when a child is administered a first dose of the Polio (Kinrix - allowable) vaccine that the dose is valid.  Another dose should be forecast.
2013-0665,Dose 2 given as Kinrix at age 4 mo.  Off label but valid as IPV 2. ,01/10/2021,F,,,,Not complete,03/16/2021,IPOL,10,PMC,Valid,,05/10/2021,KINRIX,130,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,07/10/2021,09/06/2022,POL,05/10/2021,Vaccine: Off Label,01/01/2013,06/11/2020,Recommended based on age,,1.0,This test case describes when a child is administered a second dose of the Polio (Kinrix - allowable) vaccine at age 4 months that the dose is valid.  Another dose should be forecast.
2013-0666,Dose 3 given as Kinrix at age 6 mos.  Off label but valid.,11/10/2020,F,,,,Not complete,01/12/2021,IPOL,10,PMC,Valid,,03/14/2021,IPOL,10,PMC,Valid,,05/10/2021,KINRIX,130,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,11/10/2024,11/10/2024,12/07/2027,POL,05/10/2021,Vaccine: Off Label,01/01/2013,06/11/2020,Recommended based on age,,1.0,This test case describes when a child is administered a third dose of the Polio (Kinrix - allowable) vaccine at age 6 months that the dose is valid.  Another dose should be forecast.
2013-0667,Kinrix at 12 months old.  ,04/15/2020,F,,,,Not complete,06/17/2020,IPOL,10,PMC,Valid,,08/19/2020,IPOL,10,PMC,Valid,,10/08/2020,IPOL,10,PMC,Valid,,05/10/2021,KINRIX,130,SKB,Valid,,,,,,,,,,,,,,,,,,,,5,04/15/2024,04/15/2024,05/12/2027,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Recommended based on age,"Updated the 4rth dose as valid due to the new 5 dose IPV supporting data document
Previous dates were before the ACIP recommendations were published.
11/17/2016 Updated the Forecast # to Dose number 5 due to vaccine being administered too early",3.1,This test case describes when a child is administered a fourth dose of the Polio (Kinrix - allowable) vaccine at 12 months of age that the dose is valid.  Another dose should be forecast.
2013-0668,Kinrix at age 4 years as dose 4=polio series complete,05/10/2017,F,,,,Complete,07/12/2017,PEDIARIX,110,SKB,Valid,,09/10/2017,PEDIARIX,110,SKB,Valid,,11/12/2017,PEDIARIX,110,SKB,Valid,,05/10/2021,KINRIX,130,SKB,Valid,,,,,,,,,,,,,,,,,,,,-,,,,POL,05/10/2021,Age: At Minimum,01/01/2013,06/12/2020,Not recommended: series complete,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a fourth dose of the Polio (Kinrix - allowable) vaccine at 4 years of age that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0669,Dose # 1 at age 6 weeks-4 days,04/02/2021,F,,,,Not complete,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/11/2021,08/02/2021,09/29/2021,POL,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/12/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a first dose of the Polio vaccine at 6 weeks - 4 days of age that the dose is valid.  Another dose should be forecast.
2013-0670,Kinrix as dose 4 at age 4 years-5 days,05/15/2017,F,,,,Not complete,07/08/2017,PEDIARIX,110,SKB,Valid,,09/01/2017,PEDIARIX,110,SKB,Valid,,01/11/2018,PEDIARIX,110,SKB,Valid,,05/10/2021,KINRIX,130,SKB,Valid,,,,,,,,,,,,,,,,,,,,5,11/10/2021,11/10/2021,06/11/2024,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Recommended based on age,"Updated the 4th dose as valid due to the new 5 dose IPV supporting data document
Previous dates were before the ACIP recommendations were published.
11/17/2016 Updated the Forecast # to Dose number 5 due to vaccine being administered too early",3.1,This test case describes when a child is administered a fourth dose of the Polio (Kinrix - allowable) vaccine at 4 years - 5 days of age that the dose is not valid.  Another dose should be forecast.
2013-0671,Kinrix as dose 4 at age 4 years-4 days= polio series complete,05/14/2017,F,,,,Complete,07/03/2017,PEDIARIX,110,SKB,Valid,,08/31/2017,PEDIARIX,110,SKB,Valid,,10/31/2017,PEDIARIX,110,SKB,Valid,,05/10/2021,KINRIX,130,SKB,Valid,,,,,,,,,,,,,,,,,,,,-,,,,POL,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/12/2020,Not recommended: series complete,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a fourth dose of the Polio (Kinrix - allowable) vaccine at 4 years - 4 days of age that the dose is valid.  Another dose should be forecast.
2013-0672,Dose # 1 at age 6 weeks,03/29/2021,F,,,,Not complete,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/29/2021,09/25/2021,POL,05/10/2021,Age: At Minimum,01/01/2013,06/12/2020,Recommended based on age,,1.0,This test case describes when a child is administered a first dose of the Polio vaccine at 6 weeks of age that the dose is valid.  Another dose should be forecast.
2013-0673,Dose # 1 at age 2 months,03/10/2021,F,,,,Not complete,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/10/2021,09/06/2021,POL,05/10/2021,Age: At Recommended,01/01/2013,06/12/2020,Recommended based on age,,1.0,This test case describes when a child is administered a first dose of the Polio vaccine at 2 months of age that the dose is valid.  Another dose should be forecast.
2013-0674,Dose # 2 at age 10 weeks-5 days,03/06/2021,F,,,,Not complete,04/13/2021,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/06/2021,09/02/2021,POL,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/11/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a second dose of the Polio vaccine at 10 weeks - 5 days of age that the dose is not valid.  A repeat dose should be forecast.
2013-0675,Dose # 2 at age 10 weeks-4 days,03/05/2021,F,,,,Not complete,04/16/2021,IPOL,10,PMC,Valid,,05/10/2021,IPOL,10,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/11/2021,09/05/2021,11/01/2022,POL,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/11/2020,Recommended based on age,Typo on Past Due Date by one year.  ,1.1,This test case describes when a child is administered a second dose of the Polio vaccine at 10 weeks - 4 days of age that the dose is valid.  Another dose should be forecast.
2013-0676,Newborn forecasting,05/10/2021,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/21/2021,07/10/2021,09/06/2021,POL,05/10/2021,No Doses Administered,01/01/2013,06/12/2020,Recommended based on age,,1.0,This test case describes when a child is a newborn and has not been administered a dose of the Polio vaccine that the first dose should be forecast.
2013-0677,# 2 Pediarix at 6 yrs 11.5 mo,05/26/2014,F,,,,Not complete,05/11/2017,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,11/10/2021,11/10/2021,11/10/2021,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Recommended based on minimum interval from previous dose (catch-up),Updated the Forecast number dose to 3. Updated DOB to curb future date issues.,3.3,This test case describes when a child is administered a second dose of the Polio vaccine at 6 years 11.5 months that the dose is valid.  Another dose should be forecast.
2013-0678,# 2 Pediarix at 7 yrs; # 1 at less than 12 mo. ,05/10/2014,F,,,,Not complete,08/10/2014,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,11/10/2021,11/10/2021,11/10/2021,POL,05/10/2021,Vaccine: Off Label,01/01/2013,06/12/2020,Recommended based on minimum interval from previous dose (catch-up),Updated the Forecast number dose to 3. Updated DOB to curb future date issues.,3.3,This test case describes when a child is administered a first dose of the Polio vaccine at 3 months of age and a second dose of the vaccine at 7 years of age that the doses are valid.  Another dose should be forecast.
2013-0679,# 2 Pediarix at 7 yrs; # 1 ≥ 12 mo.,05/10/2014,F,,,,Not complete,06/10/2015,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,11/10/2021,11/10/2021,11/10/2021,POL,05/10/2021,Vaccine: Off Label,01/01/2013,06/12/2020,Recommended based on minimum interval from previous dose (catch-up),Updated the Forecast number dose to 3. Updated DOB to curb future date issues.,3.3,This test case describes when a child is administered a first dose of the Polio vaccine at greater than 12 months of age and a second dose of the vaccine at 7 years of age that the doses are valid.  Another dose should be forecast.
2013-0680,# 1 and 2 Pediarix at ≥7 yrs  with 28 day interval.  Off label,04/12/2014,F,,,,Not complete,04/12/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,11/10/2021,11/10/2021,11/10/2021,POL,05/10/2021,Vaccine: Off Label,01/01/2013,06/12/2020,Recommended based on minimum interval from previous dose (catch-up),Updated the Forecast number dose to 3. Updated DOB to curb future date issues.,3.3,This test case describes when a child is administered a first dose of the Polio vaccine at 7 years of age and a second dose of the vaccine at 28 days later that the doses are valid.  Another dose should be forecast.
2013-0681,# 3 Pediarix at 14 wks-5 days,02/06/2021,F,,,,Not complete,03/16/2021,PEDIARIX,110,SKB,Valid,,04/13/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/06/2021,10/03/2022,POL,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/12/2020,Recommended based on age,"Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published. 
Typo on Past Due Date by one year.  V2.1",1.5,This test case describes when a child is administered a third dose of the Polio vaccine at an interval of 14 weeks - 5 days that the dose is not valid. A repeat dose should be forecast.
2013-0682,# 3 Pediarix at 14 wks-4 days.,02/05/2021,F,,,,Not complete,03/17/2021,PEDIARIX,110,SKB,Valid,,04/14/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,02/05/2025,02/05/2025,03/03/2028,POL,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/12/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a third dose of the Polio vaccine at an interval of 14 weeks - 4 days that the dose is valid. Another dose should be forecast.
2013-0683,# 3 Pediarix at 24 weeks-5 days.,11/28/2020,F,,,,Not complete,01/09/2021,PEDIARIX,110,SKB,Valid,,03/11/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,11/28/2024,11/28/2024,12/25/2027,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Recommended based on age,,1.0,This test case describes when a child is administered a third dose of the Polio vaccine at an interval of 24 weeks - 5 days that the dose is valid. Another dose should be forecast.
2013-0684,# 3 Pediarix at 24 weeks-4 days.,11/27/2020,F,,,,Not complete,01/08/2021,PEDIARIX,110,SKB,Valid,,03/10/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,11/27/2024,11/27/2024,12/24/2027,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Recommended based on age,,1.0,This test case describes when a child is administered a third dose of the Polio vaccine at an interval of 24 weeks - 4 days that the dose is valid. Another dose should be forecast.
2013-0685,# 3 Pediarix at 6 yrs 11.5 mo,05/22/2014,F,,,,Complete,03/22/2017,PEDIARIX,110,SKB,Valid,,06/25/2018,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Not recommended: series complete,Update to curb future administration dates,3.3,This test case describes when a child is administered a third dose of the Polio vaccine at age 6 years 11.5 months that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0686,# 4 Pediarix at 1 yr -5 days.,05/15/2020,F,,,,Not complete,07/15/2020,PEDIARIX,110,SKB,Valid,,09/15/2020,PEDIARIX,110,SKB,Valid,,11/21/2020,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,5,05/15/2024,05/15/2024,06/11/2027,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Recommended based on age,Updated the 4rth dose as valid due to the new 5 dose IPV supporting data document,3.1,This test case describes when a child is administered a fourth dose of the Polio vaccine at age 1 year - 5 days that the dose is valid.  Another dose should be forecast.
2013-0687,# 1 Pediarix at 6 wks-5 days,04/03/2021,F,,,,Not complete,05/10/2021,PEDIARIX,110,SKB,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/15/2021,06/03/2021,07/30/2021,POL,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/12/2020,Recommended based on age,,1.0,This test case describes when a child is administered a first dose of the Polio vaccine at age 6 weeks - 5 days that the dose is not valid.  A repeat dose should be forecast.
2013-0688,# 4 Pediarix at 1 yr -4 days,05/14/2020,F,,,,Not complete,07/14/2020,PEDIARIX,110,SKB,Valid,,10/14/2020,PEDIARIX,110,SKB,Valid,,12/28/2020,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,5,05/14/2024,05/14/2024,06/10/2027,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Recommended based on age,Updated the 4th dose as valid due to the new 5 dose IPV supporting data document,3.1,This test case describes when a child is administered a fourth dose of the Polio vaccine at age 1 year - 4 days that the dose is valid.  Another dose should be forecast.
2013-0689,# 4 Pediarix at 3 yrs 11.5 mo. ,05/26/2017,F,,,,Not complete,07/26/2017,PEDIARIX,110,SKB,Valid,,10/26/2017,PEDIARIX,110,SKB,Valid,,01/26/2018,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,5,11/10/2021,11/10/2021,06/22/2024,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Recommended based on age,Updated the 4rth dose as valid due to the new 5 dose IPV supporting data document,3.1,This test case describes when a child is administered a fourth dose of the Polio vaccine at age 3 years 11.5 months that the dose is valid.  Another dose should be forecast.
2013-0690,# 4 Pediarix at 4 yrs,05/10/2017,F,,,,Complete,09/13/2017,PEDIARIX,110,SKB,Valid,,03/08/2018,PEDIARIX,110,SKB,Valid,,07/15/2019,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,-,,,,POL,05/10/2021,Age: At Minimum,01/01/2013,06/12/2020,Not recommended: series complete,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a fourth dose of the Polio vaccine at age 4 years that the dose is valid.  No additional doses should be forecast.  The series is complete.
2013-0691,# 5 Pediarix at 4 yrs -5 days.,05/15/2017,F,,,,Not complete,07/15/2017,PEDIARIX,110,SKB,Valid,,08/15/2017,PEDIARIX,110,SKB,Valid,,12/16/2017,PEDIARIX,110,SKB,Valid,,08/24/2018,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Not Valid,Age: Too Young,,,,,,,,,,,,,5,11/10/2021,11/10/2021,06/11/2024,POL,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/12/2020,Recommended based on age,Updated the Forecast dose number to 5.,3.3,This test case describes when a child is administered a fifth dose of the Polio vaccine at age 4 years - 5 days that the dose is not valid.  A repeat dose should be forecast.
2013-0692,# 5 Pediarix at 4 yrs -4 days,05/14/2017,F,,,,Complete,07/14/2017,PEDIARIX,110,SKB,Valid,,08/14/2017,PEDIARIX,110,SKB,Valid,,12/15/2017,PEDIARIX,110,SKB,Valid,,08/23/2018,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,-,,,,POL,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/12/2020,Not recommended: series complete,Updated the 4th dose as valid due to the new 5 dose IPV supporting data document,3.1,This test case describes when a child is administered a fifth dose of the Polio vaccine at age 4 years - 4 days that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0693,# 5 Pediarix at 6 yrs 11.5 mo,05/26/2014,F,,,,Complete,07/26/2014,PEDIARIX,110,SKB,Valid,,09/26/2014,PEDIARIX,110,SKB,Valid,,11/26/2014,PEDIARIX,110,SKB,Valid,,06/26/2015,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,-,,,,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Not recommended: series complete,Update to curb future vaccine administration dates,3.3,This test case describes when a child is administered a fifth dose of the Polio vaccine at age 6 years 11.5 months that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0694,# 5 Pediarix at 7 yrs.  Off label,05/10/2014,F,,,,Complete,08/10/2014,PEDIARIX,110,SKB,Valid,,11/10/2014,PEDIARIX,110,SKB,Valid,,02/10/2015,PEDIARIX,110,SKB,Valid,,11/25/2015,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,-,,,,POL,05/10/2021,Vaccine: Off Label,01/01/2013,06/12/2020,Not recommended: series complete,Updated to curb future vaccine adminstration dates,3.3,This test case describes when a child is administered a fifth dose of the Polio vaccine at at age 7 years that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0695,Invalid age dose 1 as first of others. ,02/10/2021,F,,,,Not complete,03/18/2021,PEDIARIX,110,SKB,Not Valid,Age: Too Young,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/10/2021,08/06/2021,POL,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on age,,1.0,This test case describes when a child is administered an invalid first dose of the Polio vaccine but is administered a repeat dose at an interval greater than 6 weeks that the dose is valid.  Another dose should be forecast.
2013-0696,Invalid age dose 2 in midst of others,11/10/2020,F,,,,Not complete,12/18/2020,PEDIARIX,110,SKB,Valid,,01/13/2021,PEDIARIX,110,SKB,Not Valid,Age: Too Young,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/07/2021,07/07/2022,POL,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/12/2020,Recommended based on minimum interval from previous dose (catch-up),"Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published. 
Typo on Past Due Date by one year.  V2.1",1.5,This test case describes when a child is administered an invalid second dose of the Polio vaccine but is administered a repeat  dose at an interval  greater than or equal to 4 weeks that the repeat dose is valid.  Another dose should be forecast.
2013-0697,invalid age dose 3 in midst of others,05/10/2020,F,,,,Not complete,06/23/2020,PEDIARIX,110,SKB,Valid,,07/19/2020,PEDIARIX,110,SKB,Valid,,08/10/2020,PEDIARIX,110,SKB,Not Valid,Age: Too Young,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,4,05/10/2024,05/10/2024,06/06/2027,POL,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/12/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered an invalid third dose of the Polio vaccine but is administered a repeat  dose at an interval greater than or equal to 4 weeks that the repeat dose is valid.  Another dose should be forecast.
2013-0698,# 1 Pediarix at 6 wks-4 days,04/02/2021,F,,,,Not complete,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/11/2021,08/02/2021,09/29/2021,POL,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/12/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a first dose of the Polio vaccine at an interval of 6 months - 4 days that the dose is valid.  Another dose should be forecast.
2013-0699,"dose 1 to 2 Pediarix, interval 28-5 days",02/13/2021,F,,,,Not complete,04/17/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/13/2021,08/09/2021,POL,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/12/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a second dose of the Polio vaccine at an interval of 28 - 5 days that the dose is not valid.  A repeat dose should be forecast.
2013-0700,"dose 1 to 2 Pediarix, interval 28-4 days",02/16/2021,F,,,,Not complete,04/16/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/16/2021,10/13/2022,POL,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/12/2020,Recommended based on age,"Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published. 
Typo on Past Due Date by one year.  V2.1",2.1,This test case describes when a child is administered a second dose of the Polio vaccine at an interval of 28 - 4 days that the dose is valid.  Another dose should be forecast.
2013-0701,"dose 2 to 3 Pediarix, interval 28-5 days",12/17/2020,F,,,,Not complete,02/17/2021,PEDIARIX,110,SKB,Valid,,04/17/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/17/2021,08/13/2022,POL,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/12/2020,Recommended based on age,Typo on Past Due Date by one year.  ,1.1,This test case describes when a child is administered a third dose of the Polio vaccine at an interval of 28 - 5 days that the dose is not valid.  A repeat dose should be forecast.
2013-0702,"dose 2 to 3 Pediarix, interval 28-4 days",12/16/2020,F,,,,Not complete,02/16/2021,PEDIARIX,110,SKB,Valid,,04/16/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,12/16/2024,12/16/2024,01/12/2028,POL,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/12/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a second dose of the Polio vaccine at an interval of 28 - 4 days that the dose is valid.  Another dose should be forecast.
2013-0704,"dose 3 to 4 Pediarix, interval 6m-4 days",03/14/2020,F,,,,Not complete,05/14/2020,PEDIARIX,110,SKB,Valid,,07/14/2020,PEDIARIX,110,SKB,Valid,,11/14/2020,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,5,03/14/2024,03/14/2024,04/10/2027,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/12/2020,Recommended based on age,Updated the 4rth dose as valid due to the new 5 dose IPV supporting data document,3.1,This test case describes when a child is administered a fourth dose of the Polio vaccine at an interval of 6 month - 4 days that the dose is valid.  Another dose should be forecast.
2013-0707,invalid dose 1-2 interval in midst of others,01/10/2021,F,,,,Not complete,03/10/2021,PEDIARIX,110,SKB,Valid,,03/29/2021,PEDIARIX,110,SKB,Not Valid,Interval: too short,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,07/10/2021,09/06/2022,POL,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on age,"Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published. 
Typo on Past Due Date by one year.  V2.1",1.5,This test case describes when a child is administered an invalid second dose of the Polio vaccine but is administered a repeat  dose at an interval  greater than or equal to 4 weeks that the repeat dose is valid.  Another dose should be forecast.
2013-0708,invalid dose 2-3 interval in midst of others,05/10/2020,F,,,,Not complete,07/10/2020,PEDIARIX,110,SKB,Valid,,09/10/2020,PEDIARIX,110,SKB,Valid,,10/03/2020,PEDIARIX,110,SKB,Not Valid,Interval: too short,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,4,05/10/2024,05/10/2024,06/06/2027,POL,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered an invalid third dose of the Polio vaccine but is administered a repeat  dose at an interval greater than or equal to 4 weeks that the repeat dose is valid.  Another dose should be forecast.
2013-0709,# 1 Pediarix at 6 wks,03/29/2021,F,,,,Not complete,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/29/2021,09/25/2021,POL,05/10/2021,Age: At Minimum,01/01/2013,06/15/2020,Recommended based on age,,1.0,This test case describes when a child is administered the first dose of the Polio vaccine (Pediarix) at 6 weeks of age that the dose is valid.  Another dose should be forecast.
2013-0712,# 1 Pediarix at 6 yrs 11.5 mo,05/25/2014,F,,,,Not complete,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/15/2020,Recommended based on minimum interval from previous dose (catch-up),Updated DOB to curb future date issues.,3.3,This test case describes when a child is administered a first dose of the Polio vaccine (Pediarix) at 6 years 11.5 months that the dose is valid.  Another dose should be forecast.
2013-0713,# 1 Pediarix at 7 yrs,05/10/2014,F,,,,Not complete,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,POL,05/10/2021,Vaccine: Off Label,01/01/2013,06/15/2020,Recommended based on minimum interval from previous dose (catch-up),Updated DOB to curb future date issues.,3.3,This test case describes when a child is administered a first dose of the Polio vaccine (Pediarix) at 7 years of age that the dose is valid.  Another dose should be forecast.
2013-0714,# 2 Pediarix at 10 wks-5 days,03/06/2021,F,,,,Not complete,04/13/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/06/2021,09/02/2021,POL,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on age,,1.0,This test case describes when a child is administered a second dose of the Polio (Pediarix) vaccine at 10 weeks - 5 days of age that the dose is not valid.  A repeat dose should be forecast.
2013-0715,# 2 Pediarix at 10 wks-4 days,03/05/2021,F,,,,Not complete,04/14/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/11/2021,09/05/2021,11/01/2022,POL,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/15/2020,Recommended based on age,Typo on Past Due Date by one year.  ,1.1,This test case describes when a child is administered a second dose of the Polio vaccine (Pediarix) at 10 weeks - 4 days of age that the dose is valid.  Another dose should be forecast.
2013-0716,# 2 Pediarix at 10 wks,03/01/2021,F,,,,Not complete,04/10/2021,PEDIARIX,110,SKB,Valid,,05/10/2021,PEDIARIX,110,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,09/01/2021,10/28/2022,POL,05/10/2021,Age: At Minimum,01/01/2013,06/15/2020,Recommended based on age,Typo on Past Due Date by one year.  ,1.1,This test case describes when a child is administered a second dose of the Polio vaccine (Pediarix) at 10 weeks of age that the dose is valid.  Another dose should be forecast.
2013-0717,Newborn,05/10/2021,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/21/2021,07/10/2021,09/06/2021,POL,05/10/2021,No Doses Administered,01/01/2013,06/15/2020,Recommended based on age,,1.0,This test case describes when a child is a newborn and has not been administered a dose of the Polio vaccine that the first dose should be forecast.
2013-0718,# 2 Pentacel at 6 yrs 11.5 mo. Off label but counts.,05/26/2014,F,,,,Not complete,02/16/2017,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,11/10/2021,11/10/2021,11/10/2021,POL,05/10/2021,Vaccine: Off Label,01/01/2013,06/15/2020,Recommended based on minimum interval from previous dose (catch-up),Updated the Forecast Dose number to 3. Updated DOB to curb future date issues.,3.3,This test case describes when a child is administered a second dose of the Polio vaccine (Pentacel) at age 6 years 11.5 months that the dose is valid.  Another dose should be forecast.
2013-0719,Pentacel at 7 yrs; # 1 at age < 12 mo.   Off label use. ,05/10/2014,F,,,,Not complete,10/19/2014,IPOL,10,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,11/10/2021,11/10/2021,11/10/2021,POL,05/10/2021,Vaccine: Off Label,01/01/2013,06/15/2020,Recommended based on minimum interval from previous dose (catch-up),Updated the Forecast Dose number to 3. Updated DOB to curb future date issues.,3.3,This test case describes when a child is administered a first dose of the Polio vaccine (Pentacel) at less than 12 months of age and a second dose of the vaccine at 7 years of age that the doses are valid.  Another dose should be forecast.
2013-0720,# 2 Pentacel at 7 yrs; # 1 at age ≥ 12 mo.,05/10/2014,F,,,,Not complete,07/13/2015,IPOL,10,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,11/10/2021,11/10/2021,11/10/2021,POL,05/10/2021,Vaccine: Off Label,01/01/2013,06/15/2020,Recommended based on minimum interval from previous dose (catch-up),Updated the Forecast Dose number to 3. Updated DOB to curb future date issues.,3.3,This test case describes when a child is administered a first dose of the Polio vaccine (Pentacel) at greater than 12 months of age and a second dose of the vaccine at 7 years of age that the doses are valid.  Another dose should be forecast.
2013-0721,# 3 Pentacel at 14 wks-5 days,02/06/2021,F,,,,Not complete,03/16/2021,PENTACEL,120,PMC,Valid,,04/13/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/06/2021,10/03/2022,POL,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on age,"Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published. 
Typo on Past Due Date by one year.  V2.1",1.5,This test case describes when a child is administered a third dose of the Polio vaccine (Pentacel) at 14 weeks - 5 days that the dose is not valid.  A repeat dose should be forecast.
2013-0722,# 3 Pentacel at 14 wks-4 days,02/05/2021,F,,,,Not complete,03/15/2021,PENTACEL,120,PMC,Valid,,04/12/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,02/05/2025,02/05/2025,03/03/2028,POL,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/15/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a third dose of the Polio vaccine (Pentacel) at 14 weeks - 4 days that the dose is valid.  Another dose should be forecast.
2013-0723,# 3 Pentacel at 6 yrs 11.5 mo,05/25/2014,F,,,,Complete,07/25/2014,IPOL,10,PMC,Valid,,09/25/2014,IPOL,10,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,POL,05/10/2021,Vaccine: Off Label,01/01/2013,06/15/2020,Not recommended: series complete,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a third dose of the Polio vaccine at 6 years 11.5 months that the dose is valid.  No further doses should be administered.  The series is complete.
2013-0724,# 4 Pentacel at 1 yr -5 days.  ,05/15/2020,F,,,,Not complete,07/15/2020,PENTACEL,120,PMC,Valid,,09/15/2020,PENTACEL,120,PMC,Valid,,11/15/2020,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,5,05/15/2024,05/15/2024,06/11/2027,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/15/2020,Recommended based on age,Updated the 4rth dose as valid due to the new 5 dose IPV supporting data document,3.1,This test case describes when a child is administered a fourth dose of the Polio vaccine (Pentacel) at age 1 year - 5 days that the dose is valid.  Another dose should be forecast.
2013-0725,# 4 Pentacel at 1 yr -4 days,05/14/2020,F,,,,Not complete,07/14/2020,PENTACEL,120,PMC,Valid,,09/14/2020,PENTACEL,120,PMC,Valid,,11/14/2020,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,5,05/14/2024,05/14/2024,06/10/2027,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/15/2020,Recommended based on age,Updated the 4rth dose as valid due to the new 5 dose IPV supporting data document,3.1,This test case describes when a child is administered a fourth dose of the Polio vaccine (Pentacel) at age 1 year - 4 days that the dose is valid.  Another dose should be forecast.
2013-0726,# 4 Pentacel ≥ age 12 mo,05/10/2020,F,,,,Not complete,07/10/2020,PENTACEL,120,PMC,Valid,,09/10/2020,PENTACEL,120,PMC,Valid,,11/10/2020,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,5,05/10/2024,05/10/2024,06/06/2027,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/15/2020,Recommended based on age,Updated the 4rth dose as valid due to the new 5 dose IPV supporting data document,3.1,This test case describes when a child is administered a fourth dose of the Polio vaccine (Pentacel) at age 12 months that the dose is valid.  Another dose should be forecast.
2013-0727,# 4 Pentacel at 4 yrs,05/10/2017,F,,,,Complete,09/19/2017,PENTACEL,120,PMC,Valid,,05/02/2018,PENTACEL,120,PMC,Valid,,11/11/2020,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,-,,,,POL,05/10/2021,Age: At Minimum,01/01/2013,06/15/2020,Not recommended: series complete,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a fourth dose of the Polio vaccine (Pentacel) at age 4 years that the dose is valid.  Another dose should be forecast.
2013-0728,# 1 Pentacel at 6 wks-5 days,04/03/2021,F,,,,Not complete,05/10/2021,PENTACEL,120,PMC,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/15/2021,06/03/2021,07/30/2021,POL,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a first dose of the Polio vaccine (Pentacel) at age 6 weeks - 5 days that the dose is not valid.  A repeat dose should be forecast.
2013-0729,# 5 Pentacel at ≥ 4 yrs,04/19/2017,F,,,,Complete,03/19/2018,PENTACEL,120,PMC,Valid,,06/19/2018,PENTACEL,120,PMC,Valid,,09/19/2018,PENTACEL,120,PMC,Valid,,02/20/2019,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,-,,,,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/15/2020,Not recommended: series complete,Updated the 4rth dose as valid due to the new 5 dose IPV supporting data document,3.1,This test case describes when a child is administered a fifth dose of the Polio vaccine (Pentacel) at equal to or greater than age 4 years that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0730,# 4 Pentacel at 5 yrs=off label ,05/08/2016,F,,,,Complete,09/08/2016,PENTACEL,120,PMC,Valid,,03/07/2017,PENTACEL,120,PMC,Valid,,05/09/2017,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,-,,,,POL,05/10/2021,Vaccine: Off Label,01/01/2013,06/15/2020,Not recommended: series complete,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a fourth dose of the Polio vaccine (Pentacel) at 5 years that the dose is valid.  No further doses should be forecast.  The series is complete.
2013-0731,invalid age dose 1 as first of others,11/10/2020,F,,,,Not complete,12/15/2020,PENTACEL,120,PMC,Not Valid,Age: Too Young,03/10/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/07/2021,07/07/2022,POL,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on minimum interval from previous dose (catch-up),Typo on Past Due Date by one year.  ,1.1,This test case describes when a child is administered an invalid first dose of the Polio vaccine but is administered a repeat and second dose at the appropriate interval that the doses are valid.  Another dose should be forecast.
2013-0732,invalid age dose 2 in midst of others,05/08/2020,F,,,,Not complete,06/15/2020,PENTACEL,120,PMC,Valid,,07/12/2020,PENTACEL,120,PMC,Not Valid,Age: Too Young,09/29/2020,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,4,05/08/2024,05/08/2024,06/04/2027,POL,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered an invalid second dose of the Polio vaccine (due to age) but is administered a repeat and third dose at the appropriate interval that the doses are valid.  Another dose should be forecast.
2013-0733,invalid age dose 3 in midst of others,04/04/2020,F,,,,Not complete,05/12/2020,PENTACEL,120,PMC,Valid,,06/09/2020,PENTACEL,120,PMC,Valid,,07/06/2020,PENTACEL,120,PMC,Not Valid,Age: Too Young,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,4,04/04/2024,04/04/2024,05/01/2027,POL,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered an invalid third dose of the Polio vaccine but is administered a repeat dose at the appropriate interval that the repeat dose is valid.  Another dose should be forecast.
2013-0734,"dose 1 to 2 Pentacel, interval 28-5 days",02/21/2021,F,,,,Not complete,04/17/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/21/2021,08/17/2021,POL,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a second dose of the Polio vaccine (Pentacel) at an interval of 28 - 5 days that the dose is not valid.  A repeat dose should be forecast.
2013-0735,"dose 1 to 2 Pentacel, interval 28-4 days",02/12/2021,F,,,,Not complete,04/16/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/12/2021,10/09/2022,POL,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/15/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a second dose of the Polio vaccine (Pentacel) at an interval of 28 - 4 days that the dose is valid.  Another dose should be forecast.
2013-0736,"dose 2 to 3 Pentacel, interval 28-5 days",12/17/2020,F,,,,Not complete,02/17/2021,PENTACEL,120,PMC,Valid,,04/17/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/17/2021,08/13/2022,POL,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a third dose of the Polio vaccine (Pentacel) at an interval of 28 - 5 days that the dose is not valid.  A repeat dose should be forecast.
2013-0737,"dose 2 to 3 Pentacel, interval 28-4 days",12/16/2020,F,,,,Not complete,02/16/2021,PENTACEL,120,PMC,Valid,,04/16/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,4,12/16/2024,12/16/2024,01/12/2028,POL,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/15/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a second dose of the Polio vaccine (Pentacel) at an interval of 28 - 4 days that the dose is valid.  Another dose should be forecast.
2013-0739,# 1 Pentacel at 6 wks-4 days,04/02/2021,F,,,,Not complete,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/11/2021,08/02/2021,09/29/2021,POL,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/15/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered the first dose of the Polio vaccine (Pentacel) at 6 weeks - 4 days of age that the dose is valid.  Another dose should be forecast.
2013-0740,"dose 3 to 4 Pentacel, interval 6m-4 days",03/14/2020,F,,,,Not complete,05/14/2020,PENTACEL,120,PMC,Valid,,09/14/2020,PENTACEL,120,PMC,Valid,,11/14/2020,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,5,03/14/2024,03/14/2024,04/10/2027,POL,05/10/2021,All Valid: Forecast Test,01/01/2013,06/15/2020,Recommended based on age,Updated the 4th dose as valid due to the new 5 dose IPV supporting data document,3.1,This test case describes when a child is administered a fourth dose of the Polio vaccine (Pentacel) at an interval of 6 month - 4 days that the dose is valid.  Another dose should be forecast.
2013-0743,invalid dose 1-2 interval in midst of others,11/19/2020,F,,,,Not complete,01/19/2021,PENTACEL,120,PMC,Valid,,02/11/2021,PENTACEL,120,PMC,Not Valid,Interval: too short,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,06/07/2021,07/16/2022,POL,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on minimum interval from previous dose (catch-up),Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered an invalid second dose of the Polio vaccine (Pentacel) but is administered a repeat dose at an interval greater than or equal to 4 weeks that the repeat dose is valid.  Another dose should be forecast.
2013-0744,invalid dose 2-3 interval in midst of others,05/07/2020,F,,,,Not complete,07/07/2020,PENTACEL,120,PMC,Valid,,09/07/2020,PENTACEL,120,PMC,Valid,,09/28/2020,PENTACEL,120,PMC,Not Valid,Interval: too short,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,4,05/07/2024,05/07/2024,06/03/2027,POL,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered an invalid third dose of the Polio vaccine (Pentacel) but is administered a repeat dose at an interval greater than or equal to 4 weeks that the repeat dose is valid.  Another dose should be forecast.
2013-0747,# 1 Pentacel at 6 wks,03/29/2021,F,,,,Not complete,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/29/2021,09/25/2021,POL,05/10/2021,Age: At Minimum,01/01/2013,06/15/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered the first dose of the Polio vaccine (Pentacel) at 6 weeks of age that the dose is valid.  Another dose should be forecast.
2013-0748,# 1 Pentacel at 6 yrs 11.5 mo,05/22/2014,F,,,,Not complete,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,POL,05/10/2021,Vaccine: Off Label,01/01/2013,06/15/2020,Recommended based on minimum interval from previous dose (catch-up),Updated DOB to curb future date issues.,3.3,This test case describes when a child is administered a first dose of the Polio vaccine (Pentacel) at 6 years 11.5 months that the dose is valid.  Another dose should be forecast.
2013-0749,# 1 Pentacel at 7 yrs.  Off label,05/10/2014,F,,,,Not complete,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/07/2021,POL,05/10/2021,Vaccine: Off Label,01/01/2013,06/15/2020,Recommended based on minimum interval from previous dose (catch-up),Updated DOB to curb future date issues.,3.3,This test case describes when a child is administered a first dose of the Polio vaccine (Pentacel) at 7 years of age that the dose is valid.  Another dose should be forecast.
2013-0750,# 2 Pentacel at 10 wks-5 days,03/06/2021,F,,,,Not complete,04/13/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/06/2021,09/02/2021,POL,05/10/2021,Age: Below Absolute Minimum,01/01/2013,06/15/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a second dose of the Polio (Pentacel) vaccine at 10 weeks - 5 days of age that the dose is not valid.  A repeat dose should be forecast.
2013-0751,# 2 Pentacel at 10 wks-4 days,03/05/2021,F,,,,Not complete,04/12/2021,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/11/2021,09/05/2021,11/01/2022,POL,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/15/2020,Recommended based on age,Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made.  Previous dates were before the ACIP recommendations were published.,1.5,This test case describes when a child is administered a second dose of the Polio vaccine (Pentacel) at 10 weeks - 4 days of age that the dose is valid.  Another dose should be forecast.
2013-0752,# 2 Pentacel at 6 yrs .  Off label,05/10/2015,F,,,,Not complete,05/10/2016,PENTACEL,120,PMC,Valid,,05/10/2021,PENTACEL,120,PMC,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,11/10/2021,11/10/2021,06/06/2022,POL,05/10/2021,Vaccine: Off Label,01/01/2013,06/15/2020,Recommended based on minimum interval from previous dose (catch-up),Updated the Forecast Dose number to 3. Updated DOB to curb future date issues.,3.3,This test case describes when a child is administered a second dose of the Polio vaccine (Pentacel) at 6 years of age that the dose is valid.  Another dose should be forecast.
2013-0753,Newborn forecast,05/10/2021,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/21/2021,07/10/2021,,ROTA,05/10/2021,No Doses Administered,01/01/2013,11/15/2017,Recommended based on age,,1.0,This test case describes when a newborn is assessed for the first dose of a Rotavirus vaccine. 
2013-0754,Dose # 3 Rotateq at age 14 weeks,02/01/2021,F,,,,Complete,03/15/2021,ROTATEQ,116,MSD,Valid,,04/12/2021,ROTATEQ,116,MSD,Valid,,05/10/2021,ROTATEQ,116,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,ROTA,05/10/2021,Age: At Minimum,01/01/2013,12/07/2017,Not recommended: series complete,,1.0,This test case describes when dose #3 of RotaTeq vaccine is administered at 14 weeks of age that the dose is considered to be valid.  The series is complete.
2013-0755,Dose # 3 Rotateq at age 6 months,11/10/2020,F,,,,Complete,01/10/2021,ROTATEQ,116,MSD,Valid,,03/10/2021,ROTATEQ,116,MSD,Valid,,05/10/2021,ROTATEQ,116,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,ROTA,05/10/2021,Age: At Recommended,01/01/2013,12/07/2017,Not recommended: series complete,,1.0,This test case describes when dose #3 of a RotaTeq vaccine is administered at 6 months of age that the dose is considered to be valid.  The series is complete.
2013-0756,Dose 1 to dose 2 Rotateq interval 28-5 days,02/27/2021,F,,,,Not complete,04/17/2021,ROTATEQ,116,MSD,Valid,,05/10/2021,ROTATEQ,116,MSD,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/27/2021,08/23/2021,ROTA,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,12/07/2017,Recommended based on age,,1.0,This test case describes when dose #2 of a RotaTeq vaccine is administered less than 4 weeks - 4 days from the previous dose that the dose is not valid.
2013-0757,Dose 1 to dose 2 Rotateq interval 28-4 days,02/26/2021,F,,,,Not complete,04/16/2021,ROTATEQ,116,MSD,Valid,,05/10/2021,ROTATEQ,116,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/26/2021,10/23/2021,ROTA,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/02/2020,Recommended based on age,,1.0,This test case describes when dose #2 of a RotaTeq vaccine is administered at least 4 weeks - 4 days from dose #1 that the dose is considered to be valid.  
2013-0758,Dose 1 to dose 2 Rotateq interval 28 days,02/22/2021,F,,,,Not complete,04/12/2021,ROTATEQ,116,MSD,Valid,,05/10/2021,ROTATEQ,116,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/22/2021,10/19/2021,ROTA,05/10/2021,Interval: At Minimum,01/01/2013,12/07/2017,Recommended based on age,,1.0,This test case describes when dose #2 of a RotaTeq vaccine is administered at least 4 weeks from dose #1 that the dose is considered to be valid.  
2013-0759,Dose 2 to dose 3 Rotateq  interval 28-5 days,01/14/2021,F,,,,Not complete,03/12/2021,ROTATEQ,116,MSD,Valid,,04/17/2021,ROTATEQ,116,MSD,Valid,,05/10/2021,ROTATEQ,116,MSD,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,07/14/2021,09/10/2021,ROTA,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,12/07/2017,Recommended based on age,,1.0,This test case describes when dose #3 of a RotaTeq vaccine is administered at 4 weeks  - 5 days from dose #2 that the dose is not valid.
2013-0760,Dose 2 to dose 3 Rotateq interval  28-4 days,01/13/2021,F,,,,Complete,03/11/2021,ROTATEQ,116,MSD,Valid,,04/16/2021,ROTATEQ,116,MSD,Valid,,05/10/2021,ROTATEQ,116,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,ROTA,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/02/2020,Not recommended: series complete,,1.0,This test case describes when dose #3 of a RotaTeq vaccine is administered at 4 weeks  - 4 days from dose #2 that the dose is considered to be valid. The series is complete.
2013-0761,Dose 2 to dose 3 Rotateq interval 28 days,01/09/2021,F,,,,Complete,03/07/2021,ROTATEQ,116,MSD,Valid,,04/12/2021,ROTATEQ,116,MSD,Valid,,05/10/2021,ROTATEQ,116,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,ROTA,05/10/2021,Interval: At Minimum,01/01/2013,12/07/2017,Not recommended: series complete,,1.0,"This test case describes when dose #3 of a RotaTeq vaccine is administered at, at least 14 weeks of age and at least 4 weeks (28 days) from dose #2, that the dose is considered to be valid. The series is complete."
2013-0762,Dose # 1 Rotarix at age 6 weeks-5 days,04/03/2021,F,,,,Not complete,05/10/2021,ROTARIX,119,SKB,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/15/2021,06/03/2021,,ROTA,05/10/2021,Age: Below Absolute Minimum,01/01/2013,12/07/2017,Recommended based on age,,1.0,"This test case describes when a Rotarix vaccine dose is administered at an age of 6 weeks - 5 days, that the dose is not valid."
2013-0763,Dose # 1 Rotarix at age 6 weeks-4 days ,04/02/2021,F,,,,Not complete,05/10/2021,ROTARIX,119,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/11/2021,08/02/2021,09/29/2021,ROTA,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/02/2020,Recommended based on age,,1.0,"This test case describes when a Rotarix vaccine dose is administered at an age of 6 weeks - 4 days, that the dose is considered to be valid."
2013-0764,Dose # 1 Rotateq at age 6 weeks-5 days,04/03/2021,F,,,,Not complete,05/10/2021,ROTATEQ,116,MSD,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/15/2021,06/03/2021,,ROTA,05/10/2021,Age: Below Absolute Minimum,01/01/2013,12/07/2017,Recommended based on age,,1.0,This test case describes when dose #1 of the RotaTeq vaccine is administered at 6 weeks - 5 days that the dose is not valid.
2013-0765,Dose # 1 Rotarix at age 6 weeks,03/29/2021,F,,,,Not complete,05/10/2021,ROTARIX,119,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/29/2021,09/25/2021,ROTA,05/10/2021,Age: At Minimum,01/01/2013,12/07/2017,Recommended based on age,,1.0,"This test case describes when dose #1 of the Rotarix vaccine is administered at 6 weeks of age, that the dose is considered to be valid."
2013-0766,Dose # 2 Rotarix at age 10 weeks-5 days,03/06/2021,F,,,,Not complete,04/15/2021,ROTARIX,119,SKB,Valid,,05/10/2021,ROTARIX,119,SKB,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/06/2021,09/02/2021,ROTA,05/10/2021,Age: Below Absolute Minimum,01/01/2013,12/07/2017,Recommended based on age,,1.0,This test case describes when dose #2 of Rotarix is administered at 10 weeks - 5 days of age that the dose is not valid.
2013-0767,Dose # 2 Rotarix at age 10 weeks-4 days,03/05/2021,F,,,,Complete,04/16/2021,ROTARIX,119,SKB,Valid,,05/10/2021,ROTARIX,119,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,ROTA,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/02/2020,Not recommended: series complete,,1.0,This test case describes when dose #2 of Rotarix is administered at 10 weeks - 4 days of age that the dose is considered to be valid.
2013-0768,Dose # 2 Rotarix at age 10 weeks,03/01/2021,F,,,,Complete,04/12/2021,ROTARIX,119,SKB,Valid,,05/10/2021,ROTARIX,119,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,ROTA,05/10/2021,Age: At Minimum,01/01/2013,12/07/2017,Not recommended: series complete,,1.0,This test case describes when dose #2 of Rotarix is administered at 10 weeks of age that the dose is considered to be valid.
2013-0769,Dose 1 to dose 2 Rotarix interval 28-5 days,02/17/2021,F,,,,Not complete,04/17/2021,ROTARIX,119,SKB,Valid,,05/10/2021,ROTARIX,119,SKB,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/17/2021,08/13/2021,ROTA,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,12/07/2017,Recommended based on age,,1.0,This test case describes when dose #2 of Rotarix is administered at an interval of 28 - 5 days that the dose is not valid.
2013-0770,Dose 1 to dose 2 Rotarix interval 28-4 days,02/16/2021,F,,,,Complete,04/16/2021,ROTARIX,119,SKB,Valid,,05/10/2021,ROTARIX,119,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,ROTA,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/02/2020,Not recommended: series complete,,1.0,This test case describes when dose #2 of Rotarix is administered at an interval of 28 - 4 days that the dose is considered to be valid.
2013-0771,Dose 1 to dose 2 Rotarix interval 28 days,02/12/2021,F,,,,Complete,04/12/2021,ROTARIX,119,SKB,Valid,,05/10/2021,ROTARIX,119,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,ROTA,05/10/2021,Interval: At Minimum,01/01/2013,12/07/2017,Not recommended: series complete,,1.0,This test case describes when dose #2 of Rotarix is administered at an interval of 28 days that the dose is considered to be valid.
2013-0772,≥15 weeks old with no rota vax:  no forecast for rotavirus,01/25/2021,F,,,,Aged out,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,ROTA,05/10/2021,No Doses Administered,01/01/2013,12/07/2017,Not recommended: too old,"v1.6: Updated Series Status from ""Not Complete"" to ""Aged Out"" to align with updated CDSi Logic Specification Series Statuses.",1.6,"This test case describes when a infant reaches 15 weeks of age at assessment, with no previous doses administered, that a Rotavirus vaccine should not be recommended. Patient is Aged Out."
2013-0773,Dose # 1 ≥ 15 weeks old ,01/21/2021,F,,,,Not complete,05/10/2021,ROTARIX,119,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,07/18/2021,ROTA,05/10/2021,All Valid: Forecast Test,01/01/2013,12/07/2017,Recommended based on minimum interval from previous dose (catch-up),,1.0,This test case describes when a infant has received dose #1 of a Rotavirus vaccine at age 15 weeks that dose #2 should be forecasted. 
2013-0774,8 months old with only one rota vax,09/10/2020,F,,,,Not complete,12/10/2020,ROTARIX,119,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,01/07/2021,01/10/2021,03/09/2021,ROTA,05/10/2021,All Valid: Forecast Test,01/01/2013,01/09/2018,Recommended based on age,Child is exactly 8 months old based on the Assessment Date and should still be recommended for administration.,1.1,"This test case describes when an 8 month old infant was administered a previous dose of a Rotavirus vaccine at 3 months of age, that a second dose should be forecasted."
2013-0775,Dose # 1 Rotateq at age 6 weeks-4 days ,04/02/2021,F,,,,Not complete,05/10/2021,ROTATEQ,116,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/11/2021,08/02/2021,09/29/2021,ROTA,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/02/2020,Recommended based on age,,1.0,This test case describes when an infant is administered a dose of RotaTeq at age 6 weeks - 4 days that the dose is considered to be valid.
2013-0776,Rotateq at 2 months; rotarix at 4 mo,01/10/2021,F,,,,Not complete,03/10/2021,ROTATEQ,116,MSD,Valid,,05/10/2021,ROTARIX,119,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,07/10/2021,09/06/2021,ROTA,05/10/2021,Age: At Recommended,01/01/2013,12/07/2017,Recommended based on age,,1.0,This test case describes when an infant is administered doses of RotaTeq at 2 and 4 months of age that the doses are considered to be valid.
2013-0777,Rotatrix at 2 mo; rotateq at 4 mo,01/10/2021,F,,,,Not complete,03/10/2021,ROTARIX,119,SKB,Valid,,05/10/2021,ROTATEQ,116,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,07/10/2021,09/06/2021,ROTA,05/10/2021,Age: At Recommended,01/01/2013,12/07/2017,Recommended based on age,,1.0,This test case describes when an infant is administered a dose of Rotarix at 2 months of age and a dose of RotaTeq at 4 months of age that the doses are considered to be valid.
2013-0778,Unspecified rotavirus at 2 and 4 mo,01/10/2021,F,,,,Not complete,03/10/2021,"rotavirus, unspecified formulation",122,,Valid,,05/10/2021,"rotavirus, unspecified formulation",122,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,07/10/2021,09/06/2021,ROTA,05/10/2021,Age: At Recommended,01/01/2013,12/07/2017,Recommended based on age,,1.0,This test case describes when an infant is administered doses of Unspecified Rotavirus vaccines at 2 and 4 months of age that the doses are considered to be valid. Forecast a third dose.
2013-0781,Dose # 1 Rotateq at age 6 weeks,03/29/2021,F,,,,Not complete,05/10/2021,ROTATEQ,116,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/29/2021,09/25/2021,ROTA,05/10/2021,Age: At Minimum,01/01/2013,12/08/2017,Recommended based on age,,1.0,"This test case describes when an infant is administered a dose of RotaTeq at age 6 weeks, that the dose is considered to be valid."
2013-0782,Dose # 2 Rotateq at age 10 weeks-5 days,03/06/2021,F,,,,Not complete,04/15/2021,ROTATEQ,116,MSD,Valid,,05/10/2021,ROTATEQ,116,MSD,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,07/06/2021,09/02/2021,ROTA,05/10/2021,Age: Below Absolute Minimum,01/01/2013,12/08/2017,Recommended based on age,,1.0,This test case describes when dose #2 of RotaTeq is administered at 10 weeks - 5 days of age that the dose is not valid.
2013-0783,Dose # 2 Rotateq at age 10 weeks-4 days,03/05/2021,F,,,,Not complete,04/16/2021,ROTATEQ,116,MSD,Valid,,05/10/2021,ROTATEQ,116,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/11/2021,09/05/2021,11/01/2021,ROTA,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/02/2020,Recommended based on age,,1.0,This test case describes when dose #2 of RotaTeq is administered at 10 weeks - 4 days of age that the dose is considered to be valid.
2013-0784,Dose # 2 Rotateq at age 10 weeks,03/01/2021,F,,,,Not complete,04/12/2021,ROTATEQ,116,MSD,Valid,,05/10/2021,ROTATEQ,116,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,09/01/2021,10/28/2021,ROTA,05/10/2021,Age: At Minimum,01/01/2013,12/08/2017,Recommended based on age,,1.0,This test case describes when dose #2 of RotaTeq is administered at 10 weeks of age that the dose is considered to be valid.
2013-0785,Dose # 3 Rotateq at age 14 weeks-5 days,02/06/2021,F,,,,Not complete,03/17/2021,ROTATEQ,116,MSD,Valid,,04/14/2021,ROTATEQ,116,MSD,Valid,,05/10/2021,ROTATEQ,116,MSD,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,3,06/07/2021,08/06/2021,10/03/2021,ROTA,05/10/2021,Age: Below Absolute Minimum,01/01/2013,12/08/2017,Recommended based on age,,1.0,This test case describes when dose #3 of RotaTeq vaccine is administered at 14 weeks - 5 days of age that the dose is not valid.  
2013-0786,Dose # 3 Rotateq at age 14 weeks-4 days,02/05/2021,F,,,,Complete,03/19/2021,ROTATEQ,116,MSD,Valid,,04/16/2021,ROTATEQ,116,MSD,Valid,,05/10/2021,ROTATEQ,116,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,ROTA,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/02/2020,Not recommended: series complete,,1.0,This test case describes when dose #3 of RotaTeq vaccine is administered at 14 weeks - 4 days of age that the dose is considered to be valid.  The series is complete.
2013-0789,#1 at 15 months,02/10/2020,F,,,,Not complete,05/10/2021,VARIVAX,21,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,08/02/2021,02/10/2024,03/09/2027,VAR,05/10/2021,All Valid: Forecast Test,01/01/2013,01/02/2018,Recommended based on age,Improved test case name and forecast test type to acurately reflect what was being tested,1.1,This test case describes the administering of dose #1 of varicella at 15 months. 
2013-0795,No doses of Varicella: current age 13Y -1D,05/11/2008,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/11/2009,05/11/2009,10/08/2009,VAR,05/10/2021,No Doses Administered,01/01/2013,01/03/2018,Recommended based on age,,1.0,This test case describes the forecasting of dose #1 of varicella at the age of 13 years - 1 day.
2013-0798,#1 at 1 year,05/10/2020,F,,,,Not complete,05/10/2021,VARIVAX,21,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,08/10/2021,05/10/2024,06/06/2027,VAR,05/10/2021,Age: At Minimum,01/01/2013,01/02/2018,Recommended based on age,,1.0,This test case describes the administering of dose #1 of varicella at 12 months or 1 year of age.
2013-0803,# 1 at 12 months-5 days,05/15/2020,F,,,,Not complete,05/10/2021,VARIVAX,21,MSD,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/07/2021,06/07/2021,10/12/2021,VAR,05/10/2021,Age: Below Absolute Minimum,01/01/2013,01/02/2018,Recommended based on minimum interval from live virus vaccine,,1.0,This test case describes that the administering of dose #1 of varicella at 12 months - 5 days is considered not valid.
2013-0804,VAR # 1 at 12 months-4 days,05/14/2020,F,,,,Not complete,05/10/2021,VARIVAX,21,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,08/14/2021,05/14/2024,06/10/2027,VAR,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/02/2020,Recommended based on age,,1.0,This test case describes the administering of dose #1 of varicella at 12 months - 4 days to be considered as a valid dose.
2013-0806,Newborn forecasting,05/10/2021,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/10/2022,05/10/2022,10/07/2022,VAR,05/10/2021,No Doses Administered,01/01/2013,01/02/2018,Recommended based on age,,1.0,This test case describes the forecasting of dose #1 of varicella at 12 months of age for a newborn. 
2013-0807,# 2 at age 13 years + 28 days,04/12/2008,F,,,,Complete,04/12/2021,VARIVAX,21,MSD,Valid,,05/10/2021,VARIVAX,21,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,VAR,05/10/2021,Age: At Minimum,01/01/2013,06/05/2020,Not recommended: series complete,,1.0,This test case describes when the second dose of the Varicella vaccine is administered at 13 years + 28 days that the dose is considered to be valid.
2013-0808,Dose 1 to dose 2 interval 28-1 days  in child < 13 years,04/12/2020,F,,,,Not complete,04/13/2021,VARIVAX,21,MSD,Valid,,05/10/2021,VARIVAX,21,MSD,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,08/02/2021,04/12/2024,05/09/2027,VAR,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,01/02/2018,Recommended based on age,v1.6: Incorrect Forecast Test Type was used and has been updated to reflect how the recommended date was forecasted.,1.6,This test case describes when the 2nd dose of varicella vaccine is administered at 28-1 day in a child < 13 years of age that the dose is considered not valid.
2013-0809,Dose 1 to dose 2 interval 28 days  in child < 13 yrs old,02/12/2012,F,,,,Complete,04/12/2021,VARIVAX,21,MSD,Valid,,05/10/2021,VARIVAX,21,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,VAR,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/05/2020,Not recommended: series complete,,1.0,This test case describes the administering of the 2nd dose of varicella 28 days after the first dose.
2013-0810,Dose 1 to dose 2 interval 28-5 days  in child ≥ 13 yrs old,01/17/2008,F,,,,Not complete,04/17/2021,VARIVAX,21,MSD,Valid,,05/10/2021,VARIVAX,21,MSD,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,07/04/2021,VAR,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,01/04/2018,Recommended based on minimum interval from invalid dose,Past Due Date was updated to reflect an 8 week interval per ACIP guidelines after last administered dose.,3.1,This test case describes when the 2nd dose of varicella vaccine is administered at 28-5 days after the 1st dose in a child that is 13 years of age that the dose is considered to be not valid.
2013-0811,Dose 1 to dose 2 interval 28-4 days  in child ≥ 13 years old,01/16/2008,F,,,,Complete,04/16/2021,VARIVAX,21,MSD,Valid,,05/10/2021,VARIVAX,21,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,VAR,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/05/2020,Not recommended: series complete,,1.0,This test case describes when the 2nd dose of varicella is administered at 28-4 days after the 1st dose in a child that is 13 years of age that the dose is considered to be valid.
2013-0812,Dose 1 to dose 2 interval 28 days in child ≥ 13 years old,11/12/2007,F,,,,Complete,04/12/2021,VARIVAX,21,MSD,Valid,,05/10/2021,VARIVAX,21,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,VAR,05/10/2021,Interval: At Absolute Minimum,01/01/2013,06/05/2020,Not recommended: series complete,,1.0,"This test case describes when the 2nd dose of varicella vaccine is administered at least 28 days after the first dose, in a child that is 13 years of age, that the dose is considered valid."
2013-0813,VZ and MMR given on same day at age 12 months,05/10/2020,F,,,,Not complete,05/10/2021,M-M-R II,03,MSD,Valid,,05/10/2021,VARIVAX,21,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,08/10/2021,05/10/2024,06/06/2027,VAR,05/10/2021,Age: At Minimum,01/01/2013,01/04/2018,Recommended based on age,,1.0,"This test case describes that when two live virus vaccines (MMR and Varicella) are administered on the same date, that a second dose of the vaccines are recommended."
2013-0814,Doses 1 and 2 of VZ and MMR given at ages 12 months and 4 weeks later,04/14/2020,F,,,,Not complete,04/10/2021,M-M-R II,03,MSD,Valid,,04/10/2021,VARIVAX,21,MSD,Valid,,05/08/2021,M-M-R II,03,MSD,Valid,,05/08/2021,VARIVAX,21,MSD,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,2,07/31/2021,04/14/2024,05/11/2027,VAR,05/10/2021,Age: At Absolute Minimum,01/01/2013,04/21/2021,Recommended based on interval,"V4.8: Made a slight change in the age of the patient to adjust for February-to-March 28 day month issues causing false negatives when cases are generated in March. 
v4.3: Added Evaluation Reason on last dose (too young)
v3.3: Updated per the 2017 General Best Practice Guidelines (Table 3-1, footnote (x) which indicates a 13 month absolute minimum age for Varicella-2.",4.8,"This test case describes when dose #2 of the varicella vaccine is administered at less than 13 months of age, that the dose is considered to be invalid and a repeat dose should be administered at 12 weeks later. "
2013-0815,MMR to VZ interval 28-1 day = invalid VZ.,04/13/2020,F,,,,Not complete,04/13/2021,M-M-R II,03,MSD,Valid,,05/10/2021,VARIVAX,21,MSD,Not Valid,Live Virus Conflict,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/07/2021,06/07/2021,09/09/2021,VAR,05/10/2021,Live Virus: Below Minimum,01/01/2013,01/04/2018,Recommended based on minimum interval from live virus vaccine,,1.0,This test case describes when a MMR vaccine is administered first and a Varicella vaccine is administered at 28-1 days after the MMR vaccine dose that the varicella vaccine dose is not valid.
2013-0816,MMR given at age 12 mo; VZ at age 12 mo+28 days,04/12/2020,F,,,,Not complete,04/12/2021,M-M-R II,03,MSD,Valid,,05/10/2021,VARIVAX,21,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,08/02/2021,04/12/2024,05/09/2027,VAR,05/10/2021,Live Virus: At Minimum,01/01/2013,01/04/2018,Recommended based on age,,1.0,This test case describes when a MMR vaccine is administered at age 12 months and a Varicella vaccine is administered at 28 days later that the doses are valid and that a second dose of the varicella vaccine should be forecasted.
2013-0817,# 1 at age 12 mo-5 days,05/15/2020,F,,,,Not complete,05/10/2021,VARIVAX,21,MSD,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/07/2021,06/07/2021,10/12/2021,VAR,05/10/2021,Age: Below Absolute Minimum,01/01/2013,01/04/2018,Recommended based on minimum interval from live virus vaccine,,1.0,"This test case describes when the first dose of the varicella vaccine is administered at 12 months - 5 days of age, that the vaccine dose is not valid."
2013-0818,# 1 MMRV at 12 m-5 days,05/15/2020,F,,,,Not complete,05/10/2021,PROQUAD,94,MSD,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/07/2021,06/07/2021,10/12/2021,VAR,05/10/2021,Age: Below Absolute Minimum,01/01/2013,01/04/2018,Recommended based on minimum interval from live virus vaccine,,1.0,"This test case describes when a varicella vaccine (ProQuad) is administered at 12 months - 5 days of age, that the vaccine dose is not considered to be valid, and that the dose should be repeated."
2013-0819,# 1 MMRV at 12 m-4 days,05/14/2020,F,,,,Not complete,05/10/2021,PROQUAD,94,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,08/14/2021,05/14/2024,06/10/2027,VAR,05/10/2021,Age: At Absolute Minimum,01/01/2013,06/02/2020,Recommended based on age,,1.0,"This test case describes when the first dose of varicella vaccine (ProQuad) is administered at 12 months - 4 days of age, that it is considered to be valid, and a second dose should be forecasted."
2013-0820,# 1 MMRV at 12 months ,05/10/2020,F,,,,Not complete,05/10/2021,PROQUAD,94,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,08/10/2021,05/10/2024,06/06/2027,VAR,05/10/2021,Age: At Minimum,01/01/2013,01/04/2018,Recommended based on age,,1.0,This test case describes when the first dose of the varicella vaccine (PROQUAD) is administered at 12 months that the dose is considered to be valid.
2013-0821,Dose 1 to dose 2 MMRV interval 28 days in child < 15 months,03/12/2020,F,,,,Complete,04/12/2021,PROQUAD,94,MSD,Valid,,05/10/2021,PROQUAD,94,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,VAR,05/10/2021,Interval: At Absolute Minimum,01/01/2013,01/04/2018,Not recommended: series complete,,1.0,This test case describes when the second dose of the varicella vaccine (PROQUAD)  is administered at 13 months + 28 days that the dose is considered valid.
2013-0822,Dose 1 to dose 2 MMRV interval 28 days in child ≥ 15 months old=valid VZ,01/27/2020,F,,,,Complete,04/10/2021,PROQUAD,94,MSD,Valid,,05/08/2021,PROQUAD,94,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,VAR,05/10/2021,Interval: At Minimum,01/01/2013,12/23/2020,Not recommended: series complete,,1.0,This test case describes when the second dose of the varicella vaccine (PROQUAD)  is administered at 15 months +11 days that the dose is considered valid.
2013-0823,Dose 1 to dose 2 MMRV interval 28-1 days,03/18/2017,F,,,,Not complete,04/12/2021,PROQUAD,94,MSD,Valid,,05/09/2021,PROQUAD,94,MSD,Not Valid,Live Virus Conflict,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,08/01/2021,08/01/2021,04/14/2024,VAR,05/10/2021,Interval: Below Absolute Minimum,01/01/2013,01/04/2018,Recommended based on minimum interval from invalid dose,,1.0,This test case describes when the second dose of the varicella vaccine (PROQUAD)is administered at 28 - 1 days that the dose is not valid.
2013-0824,MMR to MMRV interval 28 days=valid VZ # 1,04/12/2020,F,,,,Not complete,04/12/2021,M-M-R II,03,MSD,Valid,,05/10/2021,PROQUAD,94,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,08/02/2021,04/12/2024,05/09/2027,VAR,05/10/2021,Live Virus: At Minimum,01/01/2013,01/04/2018,Recommended based on age,,1.0,This test case describes when a MMR vaccine is given at 12 months and a MMRV (PROQUAD) vaccine is administered at one month later that the doses are considered to be valid.
2013-0825,MMR to MMRV interval 27 days=invalid as VZ # 1,04/12/2020,F,,,,Not complete,04/13/2021,M-M-R II,03,MSD,Valid,,05/10/2021,PROQUAD,94,MSD,Not Valid,Live Virus Conflict,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/07/2021,06/07/2021,09/08/2021,VAR,05/10/2021,Live Virus: Below Minimum,01/01/2013,01/04/2018,Recommended based on minimum interval from live virus vaccine,,1.0,"This test case describes when a MMR vaccine is given at 12 months + 1 day and a MMRV (PROQUAD) vaccine is administered at one year and 28 days, that  that the MMR vaccine is not valid.."
2013-0826,Dose 1 to dose 2  MMRV interval 12 weeks in child < 13 years old  ,08/10/2017,F,,,,Complete,02/10/2021,PROQUAD,94,MSD,Valid,,05/05/2021,PROQUAD,94,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,VAR,05/10/2021,Interval: At Minimum,01/01/2013,01/04/2018,Not recommended: series complete,,1.0,This test case describes when the second dose of a MMR vaccine (PROQUAD) is administered > 28 days that the series is considered complete.
2013-0827,Dose 1 to dose 2 interval of 4 wks between VZ and MMRV in any age child=both valid,04/01/2020,F,,,,Complete,04/11/2021,VARIVAX,21,MSD,Valid,,05/09/2021,PROQUAD,94,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,VAR,05/10/2021,Interval: At Minimum,01/01/2013,12/23/2020,Not recommended: series complete,,1.0,This test case describes when a MMRV (PROQUAD) vaccine is administered at least 4 week after a varicella vaccine dose that the Varicella two dose series is considered complete.
2013-0829,28 day interval between invalid VZ and subsequent MMRV=valid VZ,04/17/2020,F,,,,Not complete,04/12/2021,VARIVAX,21,MSD,Not Valid,Age: Too Young,05/10/2021,PROQUAD,94,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,08/02/2021,04/17/2024,05/14/2027,VAR,05/10/2021,Live Virus: At Minimum,01/01/2013,01/04/2018,Recommended based on age,,1.0,This test case describes when a MMRV (PROQUAD) vaccine is administered at least 4 week after an invalid varicella vaccine dose that the PROQUAD vaccine dose is considered valid. Forecast dose 2.
2013-0831,Interval of < 24 days between an invalid VZ and a subsequent MMRV=not valid VZ,04/21/2020,F,,,,Not complete,04/16/2021,VARIVAX,21,MSD,Not Valid,Age: Too Young,05/10/2021,PROQUAD,94,MSD,Not Valid,Live Virus Conflict,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/07/2021,06/07/2021,09/17/2021,VAR,05/10/2021,Live Virus: Below Minimum,01/01/2013,01/04/2018,Recommended based on minimum interval from live virus vaccine,"Forecast Dates were forecasting Dose 2, but the patient is still trying to satisfy target dose #1.  Dates were updated to reflect a forecast for dose 1 based on live virus spacing.",1.1,"This test case describes when a MMRV (PROQUAD) vaccine is administered less than 24 days from an invalid dose of varicella vaccine dose, that the dose is not valid.  Forecast dose #1 of varicella vaccine."
2013-0832,LAIV given at age 3 years; VZ at age 3 years + 27 days,04/13/2018,F,,,,Not complete,04/13/2021,Flumist quadrivalent,149,MED,Valid,,05/10/2021,VARIVAX,21,MSD,Not Valid,Live Virus Conflict,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/07/2021,06/07/2021,06/07/2021,VAR,05/10/2021,Live Virus: Below Minimum,01/01/2013,03/12/2018,Recommended based on minimum interval from live virus vaccine,,1.0,"This test case describes when a varicella vaccine dose is administered at less than 28 days after an Influenza (LAIV) vaccine dose , that the Varicella dose is not valid."
2013-0833,LAIV given at age 3 years; VZ at age 3 years + 28 days,04/12/2018,F,,,,Not complete,04/12/2021,Flumist quadrivalent,149,MED,Valid,,05/10/2021,VARIVAX,21,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,08/02/2021,04/12/2022,05/09/2025,VAR,05/10/2021,Live Virus: At Minimum,01/01/2013,03/12/2018,Recommended based on age,,1.0,This test case describes when a Varicella vaccine is administered at least 28 days after an Influenza (LAIV) vaccine that the Varicella vaccine dose is considered to be valid. Forecast 2nd dose.
2013-0840,# 1 MMR at 12.5 mo; VZ not given=need 28 day interval for VZ,04/24/2020,F,,,,Not complete,05/09/2021,M-M-R II,03,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,06/06/2021,06/06/2021,09/20/2021,VAR,05/10/2021,All Valid: Forecast Test,01/01/2013,01/27/2020,Recommended based on minimum interval from live virus vaccine,v4.3: moved the assessment date out one day to ensure live virus forecasting is engaged,4.3,"This test case describes when an MMR vaccine is administered at 12.5 months of age and Varicella wasn't, that a Varicella vaccine should be forecast 28 days later to provide proper live virus vaccine spacing."
2013-0842,# 2 at age 12 mo+ 4 Weeks,04/14/2020,F,,,,Not complete,04/10/2021,VARIVAX,21,MSD,Valid,,05/08/2021,VARIVAX,21,MSD,Not Valid,Age: Too Young,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,07/31/2021,04/14/2024,05/11/2027,VAR,05/10/2021,Age: At Absolute Minimum,01/01/2013,04/21/2021,Recommended based on interval,"v4.8: Made a slight change in the age of the patient to adjust for February-to-March 28 day month issues causing false negatives when cases are generated in March. 
V2.x: Updated per the 2017 General Best Practice Guidelines (Table 3-1, footnote (x) which indicates a 13 month absolute minimum age for Varicella-2.",4.8,"This test case describes when dose 2 of the Varicella vaccine is administered at less than 13 months of age, that the dose is not valid. "
2013-0843,# 2 at age 15 mo.,02/10/2020,F,,,,Complete,02/10/2021,VARIVAX,21,MSD,Valid,,05/10/2021,VARIVAX,21,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,VAR,05/10/2021,Age: At Minimum,01/01/2013,01/04/2018,Not recommended: series complete,,1.0,This test case describes when the second dose of Varicella Vaccine is administered at age 15 months that the dose is considered valid and the series is complete.
2013-0844,# 1 at age ≥ 13 years old,05/07/2008,F,,,,Not complete,05/10/2021,VARIVAX,21,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,07/04/2021,VAR,05/10/2021,All Valid: Forecast Test,01/01/2013,06/02/2020,Recommended based on minimum interval from previous dose (catch-up),Past Due Date was updated to reflect an 8 week interval per ACIP guidelines after last administered dose.,3.1,This test case describes when a Varicella vaccine is administered at age 13 years that the  second dose is considered to be valid and a second dose should be forecasted at 4 weeks later.
2015-0001,Varicella: Zoster dose in lieu of  first dose of Varicella for adult patient,05/10/1985,F,,,,Not complete,05/10/2021,ZOSTAVAX,121,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,07/04/2021,VAR,05/10/2021,Vaccine: Off Label,06/23/2015,02/12/2019,Recommended based on interval,Past Due Date was updated to reflect an 8 week interval per ACIP guidelines after last administered dose.,1.0,"This test case describes when a ZVL vaccine dose is given in lieu of a Varicella vaccine to an adult less than 50 years, that the dose should be considered as a valid first dose of the Varicella vaccine."
2015-0002,Varicella: Adult patient has received 2 doses of the Varicella Vaccine at least 4 weeks apart,04/05/1998,F,,,,Complete,04/05/2021,VARIVAX,21,MSD,Valid,,05/10/2021,VARIVAX,21,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,VAR,05/10/2021,All Valid: Forecast Test,06/23/2015,01/04/2018,Not recommended: series complete,New test case for version 2.0 which expanded scope into Adult recommendations,1.0,This test case describes when 2 dose of the Varicella vaccine has been administered to an Adult at least 4 weeks apart that the doses are considered valid and the series is complete.
2019-0023,Adult patient with no doses of the Varicella vaccine.,05/10/1999,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/10/2000,05/10/2000,10/07/2000,VAR,05/10/2021,No doses administered,11/13/2019,06/02/2020,Recommended based on age,,4.2,This test cases describes when an adult patient has not been administered any doses of the Varicella vaccine that the first dose should be forecast.
2019-0024,Adult patient with dose #2 at 4 weeks,04/12/1990,F,,,,Complete,04/12/2021,varicella,21,,Valid,,05/10/2021,varicella,21,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,VAR,05/10/2021,All Valid: Forecast Test,11/13/2019,06/02/2020,Not recommended: series complete,,4.2,This test cases describes when an adult patient has been administered the second dose of the Varicella vaccine at 4 weeks that no additional doses should be forecast.  Series is complete.
2019-0025,Adult patient with dose #2 at 4 weeks - 4 days,04/16/1990,F,,,,Complete,04/16/2021,varicella,21,,Valid,,05/10/2021,varicella,21,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,VAR,05/10/2021,Interval: At Absolute Minimum,11/13/2019,06/02/2020,Not recommended: series complete,,4.2,"This test cases describes when an adult patient has been administered the second dose of the Varicella vaccine at 4 weeks - 4 days, that no additional doses should be forecast.  Series is complete."
2019-0026,Adult patient with dose #2 at 4 weeks - 5 days,04/17/1990,F,,,,Not complete,04/17/2021,varicella,21,,Valid,,05/10/2021,varicella,21,,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,06/07/2021,06/07/2021,07/04/2021,VAR,05/10/2021,Interval: Below Absolute Minimum,11/13/2019,06/02/2020,Recommended based on interval,,4.2,"This test cases describes when an adult patient has been administered the second dose of the Varicella vaccine at 4 weeks - 5 days, that another dose should be forecast."
2015-0013,Zoster: Zoster Dose administered at 50 years of age,05/10/1971,F,,,,Not complete,05/10/2021,ZOSTAVAX,121,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,07/05/2021,07/05/2021,,ZOSTER,05/10/2021,All Valid: Forecast Test,06/23/2015,04/19/2018,Recommended based on age,"V3.4: Test case updated to accommodate new ACIP Zoster recommendations.
V2.0: New test case for version 2.0 which expanded scope into Adult recommendations",3.4,"This test case describes when a patient is administered ZVL at age 50 years, that the first dose of the RZV vaccine should be forecasted at 8 weeks later."
2015-0014,Zoster: Zoster Dose administered at 60 years of age,04/26/1961,F,,,,Not complete,05/10/2021,ZOSTAVAX,121,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,07/05/2021,07/05/2021,,ZOSTER,05/10/2021,All Valid: Forecast Test,06/23/2015,04/19/2018,Recommended based on age,"V3.4: Test case updated to accommodate new ACIP Zoster recommendations.
V2.0: New test case for version 2.0 which expanded scope into Adult recommendations",3.4,"This test case describes when a patient is administered a dose of ZVL (Zostavax) at age 60 years, that the first dose of the RZV (Shingrix) vaccine should be forecasted."
2015-0016,Zoster: Patient is overdue at 62 years of age for Zoster dose ,04/24/1959,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,04/24/2009,04/24/2009,,ZOSTER,05/10/2021,No Doses Administered,06/23/2015,04/19/2018,Recommended based on age,"V3.4: Test case updated to accommodate new ACIP Zoster recommendations.
V2.0: New test case for version 2.0 which expanded scope into Adult recommendations",3.4,"This test case describes when a patient is 62 years of age and has not been administered a Zoster vaccine, that dose 1 (Shingrix) of the 2 dose series should be forecasted."
2015-0018,Zoster: MMR to Zoster interval 28 days,04/12/1968,F,,,,Not complete,04/12/2021,M-M-R II,03,MSD,Valid,,05/10/2021,ZOSTAVAX,121,MSD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,07/05/2021,07/05/2021,,ZOSTER,05/10/2021,Live Virus: At Minimum,06/23/2015,04/19/2018,Recommended based on age,"V3.4: Test case updated to accommodate new ACIP Zoster recommendations.
V2.0: New test case for version 2.0 which expanded scope into Adult recommendations",3.4,"This test case describes when a patient is administered a Zoster (ZVL) vaccine dose 28 days after a MMR vaccine dose, that the Zoster vaccine dose in considered valid. The engine should forecast dose #1 of the Zoster (Shingrix) vaccine."
2015-0019,Zoster: MMR to Zoster interval 28 - 1 days,04/13/1970,F,,,,Not complete,04/13/2021,M-M-R II,03,MSD,Valid,,05/10/2021,ZOSTAVAX,121,MSD,Not Valid,Live Virus Conflict,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,07/05/2021,07/05/2021,,ZOSTER,05/10/2021,Live Virus: Below Minimum,06/23/2015,04/19/2018,Recommended based on minimum interval from live virus vaccine,"V3.4: Updated test case to reflect updated Zoster recommendations for Shingrix.
V2.0: New test case for version 2.0 which expanded scope into Adult recommendations",3.4,This test case describes when a patient is in early 50's and is administered a Zoster vaccine dose 28 -1 days after a MMR vaccine dose that the ZVL (Zostavax) vaccine dose is considered invalid. Zoster should be forecast in the future.
2018-0001,Zoster: Patient has received dose 1 of the RZV (Shingrix) series,05/10/1971,F,,,,Not complete,05/10/2021,zoster recombinant,187,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,07/05/2021,07/05/2021,01/06/2022,ZOSTER,05/10/2021,All Valid: Forecast Test,03/27/2018,04/19/2018,Recommended based on interval,,3.4,"This test case describes when a patient is administered dose #1 of the RZV vaccine, that a second dose should be forecast."
2018-0002,Zoster: Dose #2 of the RZV (Shringrix) vaccine administered at two months after dose #1,03/15/1971,M,,,,Complete,03/15/2021,zoster recombinant,187,,Valid,,05/10/2021,zoster recombinant,187,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,ZOSTER,05/10/2021,All Valid: Forecast Test,03/27/2018,04/19/2018,Not recommended: series complete,,3.4,"This test case describes when a patient is administered dose #2 of the RZV vaccine at two months after dose #1, that the dose is considered to be valid."
2018-0003,Zoster: Dose #2 (Shingrix) administered at 4 weeks after dose #1,04/12/1971,F,,,,Complete,04/12/2021,zoster recombinant,187,,Valid,,05/10/2021,zoster recombinant,187,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,ZOSTER,05/10/2021,All Valid: Forecast Test,03/27/2018,04/19/2018,Not recommended: series complete,,3.4,This test case describes when a patient is administered dose #2 of the RZV vaccine 4 weeks after the first dose that the series is considered complete.
2018-0004,Zoster: Dose #2 of Shingrix administered at one year after dose #1,05/10/1969,F,,,,Complete,05/10/2020,zoster recombinant,187,,Valid,,05/10/2021,zoster recombinant,187,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,ZOSTER,05/10/2021,All Valid: Forecast Test,03/27/2018,05/29/2020,Not recommended: series complete,,3.4,"This test case describes when an adult patient is administered the second dose, of the Shingrix vaccine, at one year later that the dose is considered to be valid. Series is complete."
2018-0005,Zoster: Dose #2 (Shingrix) administered at 4 weeks - 1 days after dose #1,04/12/1971,M,,,,Complete,04/12/2021,zoster recombinant,187,,Valid,,05/09/2021,zoster recombinant,187,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ZOSTER,05/10/2021,Interval: At Absolute Minimum ,03/27/2018,05/29/2020,Not recommended: series complete,"V4.0 Per SME Guidance, the four day grace period can be used. Second dose has been changed to ""valid"".
V3.5: Previous version was calculating the forecast from the first dose. This has been corrected to be from the previous dose (invalid dose #2).",4.0,"This test case describes when an adult patient is administered the second dose of Shingrix vaccine at 4 weeks - 1 day, that the dose is considered to be valid."
2018-0006,Zoster: Patient is 50 with no previous history of Shringrix vaccine,05/10/1971,F,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/10/2021,05/10/2021,,ZOSTER,05/10/2021,No Doses Administered,03/27/2018,04/19/2018,Recommended based on age,,3.4,This test case describes when a patient is age 50 that dose 1 of the Shringrix vaccine should be forecasted.
2018-0008,Zoster: Dose #1 of RZV administered 4 weeks after previous dose of ZVL,04/12/1971,F,,,,Not complete,04/12/2021,ZOSTAVAX,121,MSD,Valid,,05/10/2021,zoster recombinant,187,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,07/05/2021,07/05/2021,01/06/2022,ZOSTER,05/10/2021,Interval: At Absolute Minimum,03/28/2018,04/09/2019,Recommended based on minimum interval ,,3.4,"This test case describes when a patient is administered the first dose of RZV (Shingrix) at 4 weeks after a previous dose of ZVL (Zostavax), that the dose is considered valid. Per current guidance, RZV is recommended to be spaced 8 weeks after ZVL, but it does not need to be repeated if administered at any point prior to that 8 weeks up to and including the same day."
2018-0009,Zoster: ZVL and RZV (Shingrix) vaccine doses administered on the same day/time,05/10/1971,F,,,,Not complete,05/10/2021,zoster live,121,,Valid,,05/10/2021,zoster recombinant,187,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,07/05/2021,07/05/2021,01/06/2022,ZOSTER,05/10/2021,Age: At Recommended,03/28/2018,04/19/2018,Recommended based on interval,,3.4,"This test case describes when a patient receives a dose of ZVL (Shingrix)  and RZV (Zostavax) on the same day, that the doses are considered to be valid."
2018-0011,Zoster: Dose #1 of Shingrix 8 weeks after Dose #2 of Varicella vaccine,04/15/1971,F,,,,Not complete,03/15/2018,VARIVAX,21,MSD,Valid,,03/15/2021,varicella,21,,Valid,,05/10/2021,SHINGRIX,187,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,2,07/05/2021,07/05/2021,01/06/2022,ZOSTER,05/10/2021,All Valid: Forecast Test,04/11/2018,04/19/2018,Recommended based on minimum interval,,3.4,"This test case describes when a patient is administered a dose of Zoster (Shingrix) vaccine 8 weeks after the second dose of Varicella vaccine, that the doses are considered to be valid."
2018-0012,"Zoster: Dose #1 of Shingrix, 4 weeks after Dose #2 of Varicella vaccine",04/12/1971,F,,,,Not complete,04/12/2018,VARIVAX,21,MSD,Valid,,04/12/2021,varicella,21,,Valid,,05/10/2021,SHINGRIX,187,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,2,07/05/2021,07/05/2021,01/06/2022,ZOSTER,05/10/2021,All Valid: Forecast Test,04/11/2018,04/19/2018,Recommended based on minimum interval,,3.4,This test case describes when dose #1 of the Shingrix vaccine is administered less than 8 weeks after the 2nd dose of the Varicella vaccine that the doses are considered to be valid.
2018-0013,Zoster: Dose #1 of RZV administered 8 weeks after previous dose of ZVL,03/15/1970,F,,,,Not complete,03/15/2021,ZOSTAVAX,121,MSD,Valid,,05/10/2021,SHINGRIX,187,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,07/05/2021,07/05/2021,01/06/2022,ZOSTER,05/10/2021,Interval: At Minimum,04/11/2018,05/29/2020,Recommended based on interval,,3.4,"This test case describes when an adult patient is administered the first dose of RZV 8 weeks after a previous dose of ZVL, that the dose is valid."
2018-0014,Zoster: Patient has received all three doses of the zoster vaccine,03/15/1970,F,,,,Complete,03/15/2020,ZOSTAVAX,121,MSD,Valid,,03/15/2021,SHINGRIX,187,SKB,Valid,,05/10/2021,SHINGRIX,187,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,ZOSTER,05/10/2021,All Valid: Forecast Test,04/18/2018,05/29/2020,Not recommended: series complete,,4.0,This test case describes when an adult patient receives three (valid) doses of the Zoster vaccine that the series is considered Complete.
2019-0001,Zoster: Dose #2 (Shingrix) administered at 4 weeks - 5 days after dose #1,04/12/1971,M,,,,Not complete,04/12/2021,zoster recombinant,187,,Valid,,05/05/2021,zoster recombinant,187,,Not Valid,Interval: too short,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/30/2021,06/30/2021,01/01/2022,ZOSTER,05/10/2021,Interval: Below Absolute Minimum,03/27/2018,02/07/2019,Recommended based on minimum interval from invalid dose,,4.0,"This test case describes that when a patient is administered the second dose of Shingrix vaccine at less than 4 weeks - 4 days, that the dose is considered not valid."
2019-0002,Zoster: Dose #2 (Shingrix) administered at 4 weeks - 4 days after dose #1,04/12/1971,M,,,,Complete,04/12/2021,zoster recombinant,187,,Valid,,05/06/2021,zoster recombinant,187,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,ZOSTER,05/10/2021,All Valid: Forecast Test,03/27/2018,06/02/2020,Recommended based on minimum interval from invalid dose,,4.0,"This test case describes that when a patient is administered the second dose of Shingrix vaccine at 4 weeks - 4 day, that the dose is considered to be valid."
2019-0003,Zoster: Dose #1 of RZV administered 0 Days after previous dose of ZVL,03/15/1970,F,,,,Not complete,03/15/2021,ZOSTAVAX,121,MSD,Valid,,03/15/2021,SHINGRIX,187,SKB,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3,05/10/2021,05/10/2021,11/11/2021,ZOSTER,05/10/2021,All Valid: Forecast Test,04/11/2018,05/29/2020,Recommended based on interval,,4.1,"This test case describes when an adult patient is administered the first dose of RZV 0 days after a previous dose of ZVL, that the doses are valid."
2020-0011,Dose #1 of Pfizer Covid-19 Vaccine ,04/19/1989,M,,,,Not complete,04/19/2021,Pfizer-BioNTech COVID-19 Vaccine,208,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,05/10/2021,05/10/2021,05/30/2021,COVID-19,05/10/2021,All Valid: Forecast Test,10/06/2020,03/02/2021,Recommended based on interval,Added latest recommended interval.,4.6,"This test case describes when a patient is administered the first dose of the PFizer Covid-19 vaccine, that the dose is valid."
2020-0012,2nd dose of Pfizer Covid-19 Vaccine at 21 days ,04/19/1989,F,,,,Complete,04/19/2021,Pfizer-BioNTech COVID-19 Vaccine,208,PFR,Valid,,05/10/2021,Pfizer-BioNTech COVID-19 Vaccine,208,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,COVID-19,05/10/2021,All Valid: Forecast Test,10/06/2020,03/02/2021,Not Recommended: series complete,,4.5,"This test case describes when a patient is administered the second dose of the PFizer Covid-19 vaccine at 21 days after the first dose, that the dose is valid."
2020-0013,2nd dose of Pfizer Covid-19 Vaccine at 21 - 5 days ,04/19/1989,F,,,,Complete,04/19/2021,Pfizer-BioNTech COVID-19 Vaccine,208,PFR,Valid,,05/05/2021,Pfizer-BioNTech COVID-19 Vaccine,208,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,COVID-19,05/10/2021,All Valid Forecast Test,10/06/2020,03/02/2021,Not Recommended: series complete,,4.5,"This test case describes when a patient is administered the second dose of the PFizer Covid-19 vaccine at 21-5 days after the first dose, that the dose is valid."
2020-0014,2nd dose of Pfizer Covid-19 Vaccine at 21 - 4 days,04/19/1989,M,,,,Complete,04/19/2021,Pfizer-BioNTech COVID-19 Vaccine,208,PFR,Valid,,05/06/2021,Pfizer-BioNTech COVID-19 Vaccine,208,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,COVID-19,05/10/2021,All Valid: Forecast Test,10/06/2020,03/02/2021,Not Recommended: series complete,,4.5,"This test case describes when a patient is administered the second dose of the PFizer Covid-19 vaccine at 21 - 4 days after the first dose, that the dose is valid."
2020-0015,2nd dose of Covid-19 Vaccine different product (Moderna) at an interval of 28 days,04/12/2001,F,,,,Complete,04/12/2021,Pfizer-BioNTech COVID-19 Vaccine,208,PFR,Valid,,05/10/2021,Moderna COVID-19 Vaccine,207,MOD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,COVID-19,05/10/2021,All Valid: Forecast Test,10/06/2020,05/10/2021,Not Recommended: series complete,"v4.8: Changed age of patient from 16 to 20. This test case was intended to test mixed product use, but was testing both mixed product and minimum ages. The outcome is the same (2 valid doses with a complete series).",4.8,"This test case describes when a patient is administered a different Covid-19 vaccine (Moderna) at 28 days after the first dose,  that the dose is valid."
2020-0016,Dose #1 of the Moderna Covid-19 Vaccine ,05/10/1956,F,,,,Not complete,05/10/2021,Moderna COVID-19 Vaccine,207,MOD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,06/07/2021,06/07/2021,06/20/2021,COVID-19,05/10/2021,All Valid: Forecast Test,10/06/2020,03/02/2021,Recommended based on interval,Added latest recommended interval.,4.6,This test case describes when a patient is administered a first dose of the Covid-19 (Moderna) vaccine that the dose is valid and that a second dose should be forecast.
2020-0017,2nd dose of Moderna Covid-19 Vaccine at 28 days ,04/12/1956,F,,,,Complete,04/12/2021,Moderna COVID-19 Vaccine,207,MOD,Valid,,05/10/2021,Moderna COVID-19 Vaccine,207,MOD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,COVID-19,05/10/2021,All Valid: Forecast Test,10/06/2020,03/02/2021,Not Recommended: series complete,,4.5,"This test case describes when a patient is administered a second dose of the Moderna Covid-19 vaccine at 28 days after the first dose, that the dose is valid."
2020-0018,2nd dose of Moderna Covid-19 Vaccine at 28 - 5 days ,04/12/1956,F,,,,Complete,04/12/2021,Moderna COVID-19 Vaccine,207,MOD,Valid,,05/05/2021,Moderna COVID-19 Vaccine,207,MOD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,COVID-19,05/10/2021,All Valid: Forecast Test,10/06/2020,03/02/2021,Not Recommended: series complete,,4.5,"This test case describes when a patient is administered the second dose of the Moderna Covid-19 vaccine at 28 - 5 days after the first dose, that the dose is valid."
2020-0019,2nd dose of Moderna Covid-19 Vaccine at 28 - 4 days ,04/16/1956,F,,,,Complete,04/16/2021,Moderna COVID-19 Vaccine,207,MOD,Valid,,05/10/2021,Moderna COVID-19 Vaccine,207,MOD,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,COVID-19,05/10/2021,All Valid: Forecast Test,10/06/2020,03/02/2021,Not Recommended: series complete,,4.5,"This test case describes when a patient is administered a second dose of the Covid-19 vaccine (Moderna) at 28-4 days after the first dose, that the dose is valid."
2020-0020,2nd dose of Covid-19 Vaccine different product (Pfizer) at 28 days ,04/12/1956,F,,,,Complete,04/12/2021,Moderna COVID-19 Vaccine,207,MOD,Valid,,05/10/2021,Pfizer-BioNTech COVID-19 Vaccine,208,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,COVID-19,05/10/2021,All Valid: Forecast Test,10/06/2020,03/02/2021,Not Recommended: series complete,,4.5,"This test case describes when a patient is administered a different second dose of the Covid-19 vaccine at an interval of 28 days after the first dose, that the dose is valid."
2020-0021,Unspecified Covid 19 vaccine given as dose #1,04/12/1956,F,,,,Not complete,04/12/2021,"SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED",213,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,05/10/2021,05/10/2021,05/23/2021,COVID-19,05/10/2021,All Valid: Forecast Test,10/06/2020,03/02/2021,Recommended based on interval,Added latest recommended interval.,4.6,This test case describes when a patient has been administered an Unspecified Covid-19 Vaccine as a first dose that a second dose should be forecast.
2020-0022,Dose #1 of Pfizer Covid-19 Vaccine (age 12 years),05/10/2009,M,,,,Not complete,05/10/2021,Pfizer-BioNTech COVID-19 Vaccine,208,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,05/31/2021,05/31/2021,06/20/2021,COVID-19,05/10/2021,All Valid: Forecast Test,10/06/2020,05/10/2021,Recommended based on interval,"v4.8 Changed age of patient from 16 to 12 years based on new ACIP guidelines for Pfizer vaccine eligibility.
v4.6 Added latest recommended interval.",4.8,"This test case describes when a patient is administered the first dose of the Pfizer Covid-19 vaccine (at age 12 years), that the dose is valid."
2020-0023,Patient with no previous dose of vaccine (age 12 years),05/10/2009,M,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,05/10/2021,05/10/2021,,COVID-19,05/10/2021,No Doses Administered,10/06/2020,05/10/2021,Recommended based on age,v4.8 Changed age of patient from 16 to 12 years based on new ACIP guidelines for Pfizer vaccine eligibility.,4.8,This test case describes when a patient (12 years of age) has no previous history of the Covid-19 vaccine.
2020-0024, Patient is less than 12 years of age with no previous dose of the Covid-19 vaccine,07/15/2009,M,,,,Not complete,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,07/15/2021,07/15/2021,,COVID-19,05/10/2021,All Valid: Forecast Test,10/06/2020,05/10/2021,Recommended based on age,v4.8 Changed age of patient from 16 to 12 years based on new ACIP guidelines for Pfizer vaccine eligibility.,4.8,This test case describes when a patient is less than 12 years of age and has no previous history of the Covid-19 vaccine.
2020-0025,Dose #2 of Pfizer Covid-19 Vaccine at 21 days (age 12 years),04/19/2009,M,,,,Complete,04/19/2021,Pfizer-BioNTech COVID-19 Vaccine,208,PFR,Valid,,05/10/2021,Pfizer-BioNTech COVID-19 Vaccine,208,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,COVID-19,05/10/2021,All Valid: Forecast Test,10/06/2020,05/10/2021,Not Recommended: series complete,v4.8 Changed age of patient from 16 to 12 years based on new ACIP guidelines for Pfizer vaccine eligibility.,4.8,This test case describes when a patient is administered the second dose of the PFizer Covid-19 vaccine at 21 days after the first dose.
2020-0026,Dose #2 of Pfizer Covid-19 Vaccine at 21 - 4 days (age 12 years),04/19/2009,M,,,,Complete,04/19/2021,Pfizer-BioNTech COVID-19 Vaccine,208,PFR,Valid,,05/06/2021,Pfizer-BioNTech COVID-19 Vaccine,208,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,COVID-19,05/10/2021,All Valid: Forecast Test,10/06/2020,05/10/2021,Not Recommended: series complete,v4.8 Changed age of patient from 16 to 12 years based on new ACIP guidelines for Pfizer vaccine eligibility.,4.8,This test case describes when a patient is administered the second dose of the Pfizer Covid-19 vaccine at 21 - 4 days after the first dose.
2020-0027,Dose #2 of Pfizer Covid-19 Vaccine at 21 - 5 days (age 12 years),04/19/2009,M,,,,Complete,04/19/2021,Pfizer-BioNTech COVID-19 Vaccine,208,PFR,Valid,,05/05/2021,Pfizer-BioNTech COVID-19 Vaccine,208,PFR,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,,,COVID-19,05/10/2021,All Valid: Forecast Test,10/06/2020,05/10/2021,Not Recommended: series complete,v4.8 Changed age of patient from 16 to 12 years based on new ACIP guidelines for Pfizer vaccine eligibility.,4.8,This test case describes when a patient is administered the second dose of the Pfizer Covid-19 vaccine at 21 - 5 days after the first dose that the dose is valid.
2021-0001,Patient is >18 years and has received the Janssen Covid-19 vaccine,05/10/1994,M,,,,Complete,05/10/2021,"COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL",212,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COVID-19,05/10/2021,All Valid: Forecast Test,10/06/2020,04/12/2021,Recommended based on interval,,4.7,"This test case describes when a patient is administered the Janssen Covid-19 vaccine, that the dose is valid. No additional dose are needed. Series is complete."
2021-0002,"Dose #1 of Covid 19 vaccine given as Pfizer, Dose #2 as Janssen",04/12/1956,F,,,,Complete,04/12/2021,"COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose",208,,Not Valid,Inadvertent Vaccine,05/10/2021,"COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL",212,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COVID-19,05/10/2021,All Valid: Forecast Test,10/06/2020,04/12/2021,Recommended based on interval,,4.7,"This test case describes when a patient has been administered the first dose of the Covid-19 vaccine as Pfizer and a second dose administered at 4 weeks later, as Janssen, that the Pfizer dose is considered to be invalid, and the Janssen dose is to be considered valid.  The series is complete."
2021-0003,Dose #1 of Covid 19 vaccine given as Moderna Dose #2 as Janssen,04/12/1979,F,,,,Complete,04/12/2021,"COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5 mL dose",207,,Not Valid,Inadvertent Vaccine,05/10/2021,"COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL",212,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COVID-19,05/10/2021,All Valid: Forecast Test,10/06/2020,05/10/2021,Recommended based on interval,,4.7,"This test case describes when a patient has been administered the first dose of the Covid-19 vaccine as Moderna and a second dose administered at 4 weeks later, as Janssen, that the Moderna dose is considered to be invalid, and the Janssen dose is to be considered valid.  The series is complete."
2021-0004," Dose #1 Unspecified Covid 19 vaccine, Dose #2 given as Janssen",04/12/1968,F,,,,Complete,04/12/2021,"SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED",213,,Not Valid,Inadvertent Vaccine,05/10/2021,"COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL",212,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COVID-19,05/10/2021,All Valid: Forecast Test,10/06/2020,05/10/2021,Recommended based on interval,,4.7,"This test case describes when a patient has been administered the first dose of the Covid-19 vaccine as Unspecified, and a second dose, given at 4 weeks later,  as Janssen, that the Janssen dose is valid. Series is complete"
2021-0005,Patient is <18 years and has received the Janssen Covid-19 vaccine,05/10/2005,M,,,,Complete,05/10/2021,"COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL",212,,Valid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COVID-19,05/10/2021,All Valid: Forecast Test,10/06/2020,05/10/2021,Recommended based on interval,,4.7,"This test case describes when a patient is administered the Janssen Covid-19 vaccine, that the dose is valid. No additional dose are needed. Series is complete."
